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Obesity	  	  
Obesity	  prevalence	  has	  nearly	  doubled	  since	  1980,	  and	   in	  2008	  more	  than	  1.4	  billion	  
adults	  were	  overweight	  of	  whom	  200	  million	  men	  and	  300	  million	  women	  were	  obese.	  
Strikingly,	   more	   than	   40	   million	   children	   under	   the	   age	   of	   five	   are	   obese	   (1).	  
Furthermore,	  obesity	   is	  associated	  with	  metabolically	   related	  diseases	  such	  as	   type	  2	  
diabetes,	   cardiovascular	   diseases,	   and	   certain	   forms	   of	   cancer.	   Therefore,	   strategies	  
are	  warranted	  to	  counteract	  this	  global	  epidemic.	  Obesity	  develops	  as	  a	  consequence	  
of	   a	   positive	   energy	   balance	   in	   which	   energy	   intake	   exceeds	   energy	   expenditure.	  
Increasing	   energy	   expenditure	   would	   thus	   be	   beneficial	   in	   restoring	   this	   energy	  
balance,	   by	   inducing	   weight	   loss	   and	   weight	   maintenance.	   One	   potential	   way	   to	  
increase	  energy	  expenditure	  is	  by	  activating	  and	  recruiting	  brown	  adipose	  tissue	  (BAT).	  
This	  type	  of	  adipose	  tissue	  has	  the	  capacity	  to	  generate	  heat,	  thereby	  wasting	  energy	  
instead	  of	  storing	  it	  like	  in	  white	  adipose	  tissue	  (WAT).	  	  
History	  and	  function	  of	  brown	  adipose	  tissue	  	  
The	   first	   report	   on	   BAT	   already	   dates	   from	   1551	   when	   the	   Swiss	   naturalist	   Conrad	  
Gessner	  discovered	  BAT	  in	  marmots	  and	  called	  it	  “neither	  fat	  nor	  flesh”	  (2).	  At	  the	  end	  
of	   the	   nineteenth	   and	   beginning	   of	   the	   twentieth	   century,	   BAT	   was	   found	   in	   many	  
mammals	   (around	   55	   species)	   including	   humans.	   During	   that	   time,	   BAT	   was	   given	  
several	   names,	   such	   as	   the	   ‘primitive	   fat	   organ’,	   ‘fat	   gland’,	   ‘hibernating	   gland’,	  
‘interscapular	   gland’,	   ‘gland-­‐like	   fat	   tissue’,	   and	   for	   the	   first	   time	   as	   ‘brown	   fat’	   by	  
Hammar	  in	  1895	  (3).	  These	  names	  already	  indicated	  its	  distinct	  morphological	  features	  
compared	  to	  WAT.	  	  
	   During	   the	   early	   1900’s,	   the	   function	   of	   BAT	   was	   not	   known,	   although	   it	   was	  
believed	   that	   it	   was	   different	   from	   WAT	   given	   its	   distinct	   morphological	   features.	  
Cramer	  (1920)	  hypothesized	  that	  BAT	  was	  likely	  an	  important	  secreting	  gland	  due	  to	  its	  
gland	   like	   anatomical	   structure	   with	   high	   vascularization,	   and	   connection	   with	   the	  
thyroid	   and	   adrenal	   gland	   (3).	   Interestingly,	   Cramer	   thought	   that	   BAT	  might	   also	   be	  
important	   in	   maintaining	   adequate	   levels	   of	   certain	   vitamins	   since	   the	   fat	   and	   lipid	  
content	   of	   BAT	   were	   exhausted	   in	   animals	   that	   died	   due	   to	   vitamin	   free	   diets.	  
However,	  it	  took	  until	  the	  1960’s	  before	  the	  true	  physiological	  function	  of	  this	  type	  of	  
fat	  tissue	  became	  clear:	  heat	  production	  (4).	  	  
	   Since	   all	   true	   hibernators	   possess	   BAT	   it	   was	   thought	   that	   this	   organ	   could	   be	  
involved	  in	  maintaining	  a	  stable	  body	  temperature	  and	  arousal	  during	  hibernation.	   In	  
1964,	   Smith	   &	   Roberts	   showed	   in	   rats	   that	   BAT	   activity	   increased	   upon	   cold	  
acclimation	   (4).	   Cold	   acclimation	   led	   to	   increased	   total	   BAT	   mass	   and	   concurrent	  
increments	  in	  oxygen	  consumption	  measured	  in	  vitro.	  From	  then	  onwards	  research	  in	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the	   1960s	   and	   1970s	   contributed	   greatly	   to	   the	   understanding	   of	   BAT	   anatomy	   and	  
physiology	   and	   its	   role	   in	   nonshivering	   thermogenesis	   (NST),	   which	   is	   the	   regulated	  
heat	  production	  during	   cold	  exposure	  without	   shivering.	  However,	   it	   took	  until	   1978	  
when	   the	   full	   thermogenic	   potential	   of	   BAT	   was	   realized	   (5),	   and	   the	   protein	  
responsible	   for	   the	   energy	   dissipation	   in	   the	   mitochondrion	   was	   discovered,	   called	  
uncoupling	  protein1	  (UCP1)	  (6).	  Interestingly,	  one	  year	  later	  it	  was	  demonstrated	  that	  
BAT	  might	  play	  an	  important	  role	  in	  diet-­‐induced	  thermogenesis	  (DIT),	  releasing	  excess	  
energy	   intake	   as	   heat	   due	   to	   an	   unbalanced	   diet	   (7).	   These	   findings	   regained	   the	  
interest	  in	  the	  role	  of	  BAT	  in	  humans	  (Figure	  1).	  
	  	  
	  
Figure	  1.	  Total	  publications	   in	  PubMed	  each	  year	  
on	   search	   term:	   ‘brown	   adipose	   tissue’.	   BAT	   =	  
brown	  adipose	  tissue.	  
Brown	  adipose	  tissue	  in	  humans	  
The	  observation	   that	  humans	  possess	  BAT	  was	  already	  done	   in	   the	   late	  19th	   century	  
(8).	  Anatomical	  studies	  in	  human	  infants	  showed	  that	  this	  highly	  vascularized	  BAT	  was	  
located	   in	   subpleural	   tissue,	   in	   the	   axilla,	   around	   the	   kidneys,	   and	   between	   the	  
scapulae,	  the	  latter	  being	  regarded	  as	  a	  separate	  anatomical	  organ	  (‘the	  interscapular	  
gland’).	   In	  adults	  BAT	  was	  mainly	   found	   in	  the	  neck	  region,	  around	  the	  clavicle	  bone,	  
surrounding	  the	  trachea	  and	  large	  blood	  vessels	  (3).	  Bonnot	  (1908)	  described	  BAT	  from	  
a	   human	   subject	   as:	   “it	   is	   pink	   in	   colour	   and	   lobulated,	   presenting	   much	   the	  
appearance	  of	  a	  fresh	  pancreas”	  (8).	  Furthermore,	  It	  was	  also	  evident	  that	  the	  amount	  
of	   BAT	  diminished	   soon	   after	   birth	   in	   humans,	  whereas	   this	  was	  not	   true	   for	  BAT	   in	  
rodents	  and	  hibernating	  animals	  (3).	  
	   A	  more	  detailed	  anatomical	  distribution	  of	  BAT	  was	  shown	  in	  the	  1960s	  and	  1970s	  
in	  infants	  (9)	  and	  adults	  (10).	  It	  was	  found	  that	  the	  largest	  sites	  of	  BAT	  were	  located	  in	  
the	   axillary-­‐deep	   cervical	   and	   perirenal	   depots.	  Moreover,	   it	   was	   observed	   that	   the	  
prominent	  kite-­‐shaped	   interscapular	  site	   in	   infants	  was	  quantitatively	  unimportant	   in	  
human	   adults.	   It	   was	   also	   suggested	   that	   human	   BAT	   had	   thermogenic	   capacities	  
based	   on	   the	   histological	   features	   of	   BAT	   from	   infants	   (9)	   and	   adult	   humans	   (11).	  
Histological	   analysis	   showed	   that	   BAT	   cytoplasm	   was	   densely	   packed	   with	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mitochondria	  and	  was	  highly	  vascularized,	  just	  as	  in	  rodents.	  Interestingly,	  the	  Finnish	  
post-­‐mortem	  survey	  by	  Huttunen	  et	  al.	  demonstrated	  that	  outdoor	  workers,	  exposed	  
to	  cold,	  contained	  BAT	  whereas	  indoor	  workers	  did	  not	  (11).	  Finally	  it	  was	  shown	  that	  
mitochondria	   from	   human	   BAT	   contained	   UCP1	   with	   comparable	   biochemical	  
characteristics	   as	   from	   animals	   (12).	   However	   studies	   that	   tried	   to	   determine	   the	  
functional	  capacity	  of	  human	  BAT	  were	  somewhat	  disappointing.	  Astrup	  et	  al.	   (1985)	  
measured	  the	  contribution	  of	  perirenal	  BAT	  activity	  during	  ephedrine	  administration.	  
BAT	  thermogenesis	  was	  estimated	  by	  measuring	  both	  temperature,	  via	  thermocouples	  
placed	  deeply	   in	  perirenal	  adipose	   tissues,	  and	  blood	   flow	   in	  perirenal	  BAT	   (13).	  The	  
estimated	   contribution	   of	   BAT	   to	   ephedrine-­‐induced	   thermogenesis	   was	   low,	   and	   a	  
more	   important	   role	   was	   given	   to	   skeletal	   muscle.	   Furthermore,	   Cunningham	   et	   al.	  
(1985)	   confirmed	   this	   minor	   role	   by	   in	   vitro	   measurements	   with	   human	   perirenal	  
adipose	  tissue	  determining	  the	  oxygen	  uptake	  capacity.	  These	  findings	  dampened	  the	  
scientific	  interest	  in	  human	  BAT.	  	  
	   Twenty	  years	  later	  the	  role	  of	  BAT	  in	  human	  energy	  metabolism	  has	  become	  a	  hot	  
topic	  again.	  This	  revived	  interested	  was	  initiated	  by	  Nedergaard	  et	  al.	  (14)	  in	  2007,	  who	  
reviewed	   several	   radiology	   papers	   that	   suggested	   the	   presence	   of	   BAT	   in	   cancer	  
patients.	  These	  reports	  showed	  the	  uptake	  of	  [18F]fluorodeoxyglucose	  (FDG)	  in	  adipose	  
tissue	   from	   cancer	   patients	  who	   underwent	   a	   clinical	   positron	   emission	   tomography	  
(PET)/computed	  tomography	  (CT)-­‐scan.	  Subsequently,	  in	  2009,	  three	  dedicated	  human	  
studies	   using	   [18]FDG-­‐PET/CT	   imaging	   demonstrated	   that	   cold	   exposure	   increased	  
glucose	  uptake	  in	  fat	  tissue	  located	  in	  supraclavicular	  and	  neck	  region	  (15-­‐17).	  Adipose	  
biopsies	  from	  the	  neck	  region	  where	  [18]FDG-­‐uptake	  was	  found	  showed	  the	  presence	  
of	  UCP-­‐1,	  confirming	  that	  the	  tissue	  was	  BAT	  indeed	  (16,	  18).	  	  
	   In	   rodents,	   brown	   adipocytes	   are	   present	   in	   typical	   BAT	   depots,	   such	   as	   the	  
interscapular	   depot,	   and	   these	   cells	   are	   known	   as	   ‘classical’	   brown	   adipocytes.	  
However,	   brown-­‐like	   fat	   cells	   can	   also	   appear	   in	   typical	   WAT	   depots	   (e.g.	   inguinal	  
region)	   upon	   cold	   or	   pharmacological	   treatment,	   a	   process	   called	   ‘browning’.	   These	  
cells	  are	  named	  brite	  (BRown-­‐in-­‐whITE)	  (19)	  or	  beige	  (20)	  adipocytes.	  Gene	  expression	  
profiling	   demonstrated	   that	   these	   adipocytes	   likely	   originate	   from	   a	   different	   cell	  
lineage	  as	   the	  classical	  brown	  adipocytes	   (20),	  although	  browning	  of	  WAT	  might	  also	  
occur	  via	  transdifferentiation	  of	  white	  adipocytes	  (21).	  Both	  classical	  brown	  adipocytes	  
as	   beige	   adipocytes	   have	   recently	   been	   identified	   in	   humans	   by	   means	   of	   gene	  
expression	  profiling	  (22,	  23).	  Results	  thus	  far	  point	  towards	  human	  BAT	  having	  a	  more	  
‘beige’	  phenotype	  (20,	  24).	  	  
	   This	   rediscovery	   of	   functional	   human	   BAT	   in	   2009	   has	   put	   the	   tissue	   on	   the	  
scientific	   agenda	   again	   as	   illustrated	   in	   Figure	   1.	   Interestingly,	   several	   studies	   have	  
found	  that	  BAT	  activity	  is	  inversely	  correlated	  with	  body	  fat	  percentage	  and	  body	  mass	  
index	  suggesting	  that	  BAT	  might	  be	   involved	   in	  obesity	  development	  (15,	  17,	  25,	  26).	  
Given	  its	  high	  metabolic	  capacity,	  BAT	  is	  seen	  as	  a	  potential	  target	  to	  increase	  energy	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expenditure	   and	   thus	   as	   a	   therapeutic	   for	   obesity	   and	   its	   secondary	   metabolic	  
complications	  such	  as	  type	  2	  diabetes.	  
BAT	  physiology	  
The	  BAT	  mediated	  heat	  production,	  or	  thermogenesis,	  takes	  place	  in	  the	  mitochondria	  
of	  the	  brown	  adipocyte.	  The	  function	  of	  the	  mitochondrion	  is	  to	  convert	  energy	  from	  
carbohydrates,	  fat	  and	  proteins	  into	  adenosine	  triphosphate	  (ATP),	  which	  is	  the	  energy	  
carrier	  molecule	   that	   can	  be	  utilized	  by	  all	   energy	   requiring	  processes	   in	   the	   cell.	   To	  
form	  ATP,	  ATP	  synthase	   (complex	  V	  of	   the	  electron	   transport	   chain)	  uses	   the	  proton	  
gradient	   created	   over	   the	   inner	   mitochondrial	   membrane	   by	   the	   electron	   transport	  
chain	   to	   generate	  energy	  necessary	   to	   couple	   a	  phosphate	   to	  ADP	   to	   form	  ATP.	   The	  
UCP1	   molecule,	   located	   in	   the	   inner	   mitochondrial	   membrane,	   is	   capable	   of	  
uncoupling	  this	  process	  by	  facilitating	  the	  flow	  of	  protons	  back	  into	  the	  mitochondrial	  
matrix	  thereby	  preventing	  ATP	  production	  leading	  to	  heat	  production	  (Figure	  2)	  (27).	  	  
	   The	  UCP-­‐1	  induced	  thermogenesis	  (e.g.	  during	  cold	  exposure)	   is	  under	  control	  of	  
the	  hypothalamus	   (28,	  29).	   The	  peripheral	   signals	   coming	   from	  cold	   receptors	   in	   the	  
skin	  and	  core	  are	  integrated	  by	  the	  hypothalamus.	  When	  thermogenesis	  is	  needed,	  the	  
brain	  exerts	   its	  actions	  via	  the	  sympathetic	  nervous	  system	  (SNS).	  The	  SNS	  stimulates	  
thermogenesis	   by	   releasing	   the	   neurotransmitter	   norepinephrine	   (NE)	   at	   the	  
postsynaptic	  nerve	  endings	  triggering	  the	  adrenergic	  receptors	  (α1-­‐,	  α2-­‐	  β1-­‐,	  β2-­‐,	  β3-­‐ARs)	  
(Figure	  2).	  Furthermore,	  it	  stimulates	  the	  adrenal	  medulla	  to	  release	  both	  epinephrine	  
and	  NE	  as	  hormones.	  (27).	  A	  role	  for	  the	  SNS	  in	  regulating	  BAT	  activity	  in	  humans	  has	  
been	  shown	  in	  two	  patients	  with	  the	  Horner’s	  syndrome.	  In	  this	  case	  study,	  unilateral	  
sympathetic	  denervation	  led	  to	  unilateral	  123I-­‐metaiodobenzylguanidine	  (MIBG)	  uptake	  
(30),	   which	   reflects	   the	   sympathetic	   activity	   of	   the	   tissue,	   and	   unilateral	   [18F]FDG	  
uptake	   (31)	   in	   the	   neck	   demonstrating	   that	   the	   SNS	   is	   involved	   in	   mediating	   BAT	  
glucose	   uptake.	   Moreover,	   human	   fat	   biopsies	   from	   the	   neck	   showed	   dense	   SNS	  
innervation	   (18)	   and	   β3-­‐AR	   mRNA	   (16)	   in	   UCP-­‐1	   positive	   cells.	   In	   addition,	  
pheochromocytoma	  patients,	  who	  have	  elevated	  levels	  of	  NE	  due	  to	  a	  catecholamine-­‐
secreting	  tumour	  in	  the	  adrenal	  gland,	  have	  high	  rates	  of	  [18F]FDG	  uptake	  in	  BAT	  in	  the	  
basal	   state	   (32-­‐35),	  which	  disappears	   after	   tumour	   resection	   (32,	   35).	   These	   findings	  
underline	   the	   important	   role	   for	   the	   SNS	   and	   the	   adrenergic	   receptors	   in	  mediating	  
BAT	  thermogenesis.	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Figure	  2.	  Schematic	  overview	  of	  sympathetic	  activation	  of	  brown/beige	  adipocytes.	  Cold	  exposure	  is	  sensed	  
by	   the	  cold	   receptors	   in	   the	  skin	  and	  body	  core,	  which	  send	   the	   information	   to	   the	  hypothalamus	  via	   the	  
sensory	  nerves.	  If	  the	  stimulus	  is	  sufficient,	  the	  sympathetic	  nervous	  system	  (SNS)	  is	  activated	  and	  releases	  
norepinephrine	  (NE)	  at	  the	  synaptic	  clefts.	  Subsequently,	  NE	  binds	  to	  the	  adrenergic	  receptors	  and	  activate	  
cyclic	   adenosine	  monophosphate	   (cAMP),	  which	  next	   stimulates	  protein	  kinase	  A	   (PKA)	   thereby	  activating	  
hormone	  sensitive	  lipase	  (HSL).	  HSL	  hydrolyzes	  triglycerides	  (TG)	  thereby	  releasing	  free	  fatty	  acids	  (FFA)	  that	  
activate	  uncoupling	  protein	  1	  (UCP1)	  and	  also	  enter	  the	  mitochondrion	  for	  beta-­‐oxidation	  (β-­‐ox).	  The	  NADH	  
and	  FADH	  is	  used	  for	  protons	  (H+),	  which	  are	  pumped	  through	  the	  protein	  complexes	  (white	  boxes)	  of	  the	  
electron	  transport	  chain	  (ETC)	  thereby	  forming	  a	  proton-­‐motive	  force	  that	  drives	  the	  protons	  back	  in	  to	  the	  
mitochondrion	   via	   UCP1.	   The	   energy	   stored	   in	   the	   proton	   motive	   force	   is	   then	   released	   as	   heat	   (27).	  
Furthermore,	  when	   the	  cell	   is	  activated	  by	   the	  SNS,	  glucose	   transporters	   (glut)	   take	  up	   the	  glucose	   tracer	  
[18F]FDG.	  The	  tracer	  is	  then	  phosphorylated	  by	  hexokinase	  (HK)	  to	  glucose-­‐6-­‐phosphate,	  which	  is	  not	  further	  
metabolized	  and	  trapped	  in	  the	  cell.	  This	  is	  can	  be	  detected	  by	  the	  PET-­‐scanner.	  ARs	  =	  adrenergic	  receptors,	  
NE	  =	  norepinephrine,	  SNS	  =	  sympathetic	  nervous	  system.	  	  
The	  role	  of	  BAT	  in	  facultative	  thermogenesis	  
It	  is	  well	  established	  in	  rodents	  that	  BAT	  plays	  an	  important	  role	  in	  NST,	  as	  ablation	  of	  
BAT	   leads	   to	   cold	   intolerance	   in	   these	   animals	   (27).	   In	   humans,	   several	   studies	  have	  
indicated	   a	   relationship	   between	   BAT	   activity	   and	   NST	   (26,	   36-­‐38).	   However,	   the	  
quantitative	  contribution	  of	  BAT	  to	  NST	  is	  not	  known.	  Tracer	  studies	  show	  conflicting	  
results	  (36,	  39).	  Little	   is	  known	  about	  the	  role	  of	  BAT	  in	  DIT.	  DIT	  can	  be	  divided	  in	  an	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obligatory	  and	  a	   facultative	  part.	  The	  obligatory	  part	  of	  energy	  expenditure	   is	  due	  to	  
the	   intake	   and	   processing	   of	   the	   food	   (40),	   whereas	   the	   remaining	   part	   of	   DIT	   is	  
facultative,	   which	   likely	   involves	   mitochondrial	   uncoupling,	   futile	   cycles	   and/or	   ion	  
shuttling	   across	   membranes	   (41).	   Rothwell	   &	   Stock	   in	   1978	   demonstrated	   that	  
overfeeding	  rodents	  with	  nutrient-­‐poor	  diets	  for	  periods	  of	  weeks	  did	  lead	  to	  less	  than	  
expected	  weight	   gain	   based	  on	   their	   caloric	   intake	   (7).	   This	   low	  metabolic	   efficiency	  
was	  accompanied	  with	  increased	  BAT	  activity.	  In	  addition	  to	  this	  adaptive	  form	  of	  DIT,	  
several	  studies	  in	  rats	  have	  shown	  that	  BAT	  is	  activated	  upon	  a	  single	  meal	  as	  well	  (42-­‐
45),	  indicating	  that	  it	  might	  burn	  off	  excessive	  caloric	  intake	  in	  the	  postprandial	  phase.	  
This	  active	  role	  for	  BAT	  in	  DIT	  and	  weight	  regulation	  is	  not	  generally	  accepted,	  since	  in	  
several	  genetic	  models	  of	  thermogenesis	  no	  clear	  evidence	  was	  found	  for	  diet-­‐driven	  
thermogenesis	   (as	  reviewed	   in	   (46)).	  However,	  Feldmann	  et	  al.	  did	  show	  that	  UCP1-­‐/-­‐	  
mice	   held	   during	   thermoneutral	   conditions	   developed	   obesity	   due	   to	   abolished	   DIT	  
(47).	  	  
	   Overfeeding	  studies	  in	  humans	  demonstrated	  a	  large	  variation	  in	  weight	  gain	  (48).	  
For	   example,	   the	   classical	   paper	   by	   Bouchard	   et	   al	   (49)	   showed	   that	   excess	   energy	  
intake	  of	  353	  MJ	  in	  100	  days	  induced	  a	  weight	  gain	  of	  4.3	  to	  13.3	  kg.	  The	  energy	  intake	  
was	  standardized	  which	  suggests	   that	   the	  variation	  was,	   in	  addition	   to	  differences	   in	  
physical	   activity,	   was	   caused	   by	   variation	   in	   DIT.	   In	   1999,	   Stock	   did	   a	   reanalysis	   of	  
twelve	   human	   overfeeding	   studies	   and	   showed	   that	   overfeeding	   low	   protein	   diets	  
resulted	   in	   a	   lower	   metabolic	   efficiency	   and	   hypothesized	   that	   this	   was	   a	   result	   of	  
increased	   DIT	   (50).	   Finally,	   Wijers	   et	   al	   (2007)	   demonstrated	   that	   cold-­‐induced	  
thermogenesis	  was	  related	  to	  DIT,	  suggesting	  comparable	  underlying	  mechanisms	  (51).	  
Whether	  BAT	  is	  involved	  deserves	  further	  investigation.	  
	   Altogether	  these	  findings	  suggest	  that	  BAT	  might	  be	  relevant	  in	  both	  NST	  and	  DIT,	  
with	  a	  crucial	  role	  for	  the	  SNS	  in	  mediating	  these	  processes.	  The	  SNS	  can	  be	  studied	  by	  
mimicking	   its	   activity	   through	   stimulation	   of	   the	   adrenergic	   receptors.	   Studies	   in	  
rodents	  indeed	  revealed	  β-­‐adrenergic	  stimulated	  BAT	  thermogenesis	  (52).	  In	  humans,	  
it	   has	   been	   shown	   that	   β-­‐adrenergic	   stimulation	   increases	   thermogenesis	   (53),	  
however	  whether	  BAT	  is	  involved	  is	  unknown.	  In	  addition	  to	  targeting	  BAT	  via	  the	  SNS,	  
alternative	   routes	   have	   also	   been	   demonstrated	   in	   rodents.	   Several	   endogenous	  
hormones	  have	  been	  demonstrated	  to	  stimulate	  both	  classical	  as	  beige	  adipocytes	  (54,	  
55).	  One	  such	  hormone	  is	  irisin.	  This	  myokine	  is	  released	  upon	  endurance	  exercise	  and	  
was	   shown	   to	   increase	   browning	   in	   rodents	   (56).	   Thus,	   both	   targeting	   the	   SNS	   and	  
these	   alternative	   routes	   might	   increase	   the	   metabolic	   capacity	   of	   BAT	   and	   thereby	  
increasing	  energy	  expenditure	  in	  humans.	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Outline	  of	  the	  thesis	  
This	  thesis	  starts	  by	  reviewing	  the	  anatomy	  and	  physiology	  of	  BAT	  from	  rodents	  with	  
humans	   in	   chapter	   2.	   In	   addition,	   the	   current	   known	   effective	   and	   potential	   BAT	  
simulators	  in	  humans	  are	  addressed.	  In	  chapter	  3	  we	  studied	  the	  role	  of	  BAT	  in	  DIT	  by	  
measuring	  energy	  expenditure	  and	  BAT	  activity	   in	  young	  adult	  males	  upon	  the	  intake	  
of	   a	   high-­‐calorie,	   carbohydrate-­‐rich	   meal.	   The	   results	   were	   compared	   with	   cold,	  
fasting,	  and	  thermoneutral	  conditions.	   In	  chapter	  4	  we	  examined	  the	  role	  of	  the	  SNS	  
and	   the	   adrenergic	   receptors	   in	   regulating	   BAT	   thermogenesis	   in	   humans.	   This	   was	  
studied	  in	  young	  adult	  men	  by	  measuring	  energy	  expenditure	  and	  BAT	  activity	  during	  
systemic	  infusion	  of	  the	  non-­‐selective	  β-­‐AR-­‐agonist	  isoprenaline.	  We	  compared	  this	  to	  
cold-­‐induced	   BAT	   activity	   in	   the	   same	   subjects.	   Studies	   in	   mice	   have	   demonstrated	  
that	   endurance	   exercise	   could	   stimulate	   BAT	   and	   recruit	   brown/beige	   adipocytes	   in	  
WAT	  via	  the	  myokine	   irisin.	  We	  tested	  this	   in	  humans	  by	  comparing	  BAT	  activity	  and	  
browning	   of	   subcutaneous	   abdominal	   WAT	   of	   endurance	   trained	   athletes	   and	  
sedentary	  males	  (chapter	  5).	  In	  chapter	  6,	  the	  effects	  of	  chronic	  exposure	  to	  extreme	  
cold	  on	  NST	  and	  BAT	  activity	  was	  measured	  in	  the	  Dutch	  ‘Iceman’,	  who	  holds	  multiple	  
records	   involving	   exposure	   to	   extreme	   cold.	   As	   a	   control,	   we	   measured	   his	   non-­‐
acclimatized	  monozygotic	   twin	  brother.	   In	  chapter	   7,	   the	  main	   findings	  of	   this	   thesis	  
are	   discussed	   and	   are	   put	   in	   a	   broader	   perspective.	   Finally,	   recommendations	   for	  
future	   research	  on	  human	  BAT	   are	   addressed	   as	  well	   as	   the	  potential	   of	   stimulating	  
BAT	  in	  humans.	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Abstract	  
In	   rodents,	   brown	   adipose	   tissue	   (BAT)	   is	   a	   metabolic	   organ	   that	   produces	   heat	   in	  
response	  to	  cold	  and	  dietary	  intake	  through	  mitochondrial	  uncoupling.	  For	   long	  time,	  
BAT	  was	   considered	   to	   be	   solely	   important	   in	   small	  mammals	   and	   infants,	   however	  
recent	   studies	  have	  shown	  that	  BAT	   is	  also	   functional	   in	  adult	  humans.	   Interestingly,	  
the	   presence	   and/or	   functionality	   of	   this	   thermogenic	   tissue	   is	   diminished	   in	   obese	  
people,	  suggesting	  a	  link	  between	  human	  BAT	  and	  body	  weight	  regulation.	  In	  the	  last	  
years,	   evidence	   has	   also	   emerged	   for	   the	   existence	   of	   adipocytes	   that	  may	   have	   an	  
intermediate	  thermogenic	  phenotype	  between	  white	  and	  brown	  adipocytes,	  so	  called	  
brite	   or	   beige	   adipocytes.	   Together,	   these	   findings	   have	   resulted	   in	   a	   renewed	  
interested	  in	  (human)	  brown	  adipose	  tissue	  and	  pathways	  to	  increase	  the	  activity	  and	  
recruitment	  of	  these	  thermogenic	  cells.	  Stimulating	  BAT	  hypertrophy	  and	  hyperplasia	  
in	   humans	   could	   be	   a	   potential	   strategy	   to	   target	   obesity.	   Here	   we	   will	   review	  
suggested	  pathways	   leading	   to	  BAT	  activation	   in	  humans,	   and	  discuss	  novel	  putative	  
BAT	  activators	  in	  rodents	  into	  human	  perspective.	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Introduction	  
Brown	   adipose	   tissue	   (BAT)	   is	   a	   crucial	   organ	   in	   facultative	   thermogenesis	   (acute	  
response)	   and	   has	   a	   great	   plasticity	   to	   respond	   to	   long-­‐term	   changes	   (e.g.	   cold	  
acclimation),	   known	   as	   adaptive	   thermogenesis.	   In	   addition	   to	   its	   important	   role	   in	  
maintaining	  thermal	  homeostasis,	  BAT	  is	  likely	  to	  be	  involved	  in	  energy	  homeostasis	  as	  
well,	   since	   ablation	   of	   the	   essential	   protein	   for	   heat	   production	   in	   BAT,	   uncoupling	  
protein-­‐1	   (UCP-­‐1),	   leads	   to	   an	   obese	   phenotype	   in	  mice	   housed	   at	   a	   thermoneutral	  
temperature	   (1).	   Furthermore,	   it	   has	   been	   shown	   in	   mice	   that	   BAT	   is	   involved	   in	  
plasma	   triglyceride	   clearance	   (2)	   and	   glucose	   homeostasis	   (3,	   4).	   This	   implies	   the	  
important	  role	  of	  BAT	  in	  rodents	  to	  combat	  obesity	  and	  its	  related	  metabolic	  diseases,	  
such	   as	   diabetes	   and	   cardiovascular	   disease.	   Interestingly,	   prospective	   studies	   have	  
now	  demonstrated	  BAT	  to	  be	  present	  and	  functional	  in	  most	  (prevalence	  varying	  from	  
40	  to	  100%)	  young	  lean	  human	  adults	  by	  exposing	  them	  to	  cold	  (5-­‐11).	  Importantly,	  an	  
inverse	  relationship	  has	  been	  shown	  between	  adiposity	  and	  BAT	  activity,	   indicating	  a	  
relationship	   between	   BAT	   and	   obesity	   (8,	   12-­‐14).	   In	   addition,	   there	   is	   evidence	   that	  
BAT	  contributes	  to	  nonshivering	  thermogenesis	  (6-­‐8,	  10,	  11),	  although	  this	  relationship	  
has	  not	   always	  been	   found	   (9,	   14).	   It	   has	  been	  estimated	   that	   fully	   activated	  BAT	   in	  
humans	   can	   contribute	   to	   5%	   of	   the	   basal	   metabolic	   rate	   (15).	   This	   means	   that	  
stimulation	   of	   BAT	   can	   have	   an	   impact	   on	   long-­‐term	   energy	   balance	   and	   thus	   body	  
weight,	  however	  only	  when	  other	  factors	  (e.g.	  food	  intake)	  remain	  stable	  (16).	  Maybe	  
more	  important,	  stimulation	  of	  BAT	  could	  be	  supportive	  in	  body	  weight	  maintenance.	  
Therefore,	  finding	  strategies	  to	  increase	  BAT	  activity	  and	  recruitment	  in	  humans	  could	  
be	  important	  to	  combat	  obesity	  and	  its	  related	  chronic	  metabolic	  diseases.	  Currently,	  
much	   effort	   is	   being	   put	   in	   finding	   ways	   to	   increase	   BAT	   thermogenesis	   and	   the	  
recruitment	   of	   brown	   adipocytes	   in	   rodents.	   The	   recent	   discovery	   of	   the	   so-­‐called	  
brown-­‐in-­‐white	   (brite)	  or	  beige	  adipocytes	  has	   further	   increased	   the	   interest	   in	  BAT.	  
Increased	   “browning”	  of	  WAT	   could	  be	   an	   attractive	  way	   to	   induce	  weight	   loss.	   It	   is	  
therefore	   important	   to	   find	  strategies	   to	   increase	  the	  thermogenic	  machinery	  of	  BAT	  
and	   brown-­‐like	   tissues	   in	   humans.	   This	   review	  will	   provide	   an	   overview	   of	   the	  most	  
promising	  pathways	  to	  increase	  BAT	  activity	  and	  recruitment	  in	  humans.	  	  
Brown,	  beige	  and	  white	  adipose	  tissue	  
Brown	  versus	  white	  adipose	  tissue	  
In	   rodents,	  brown	  adipose	   tissue	   is	   clearly	  distinguishable	   from	  white	  adipose	   tissue,	  
since	   it	   is	   richly	   innervated	   by	   the	   sympathetic	   nervous	   system	   (SNS),	   is	   highly	  
vascularized,	   and	   contains	   brown	   adipocytes	   with	   several	   small	   lipid	   vacuoles	   and	  
many	   large	  mitochondria	   (17).	  Unique	   for	   the	   brown	   adipocyte	   is	   the	   protein	  UCP-­‐1	  
located	   in	   the	   inner	   mitochondrial	   membrane,	   which	   allows	   protons	   in	   the	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intermembrane	   space	   to	   re-­‐enter	   the	  mitochondrial	  matrix	   without	   generating	   ATP,	  
ultimately	  resulting	  in	  heat	  production.	  
	   White	  and	  brown	  adipose	  tissue	  in	  mice	  can	  be	  found	  in	  distinctive	  or	  classical	  (i.e.	  
pure	   white	   or	   pure	   brown)	   depots	   (Figure	   1A).	   All	   these	   depots	   have	   been	  
characterized	   by	   genetic	   markers,	   and	   have	   a	   distinct	   genetic	   profile	   that	   probably	  
determines	  its	  function	  (18).	  Note	  that	  these	  adipose	  tissue	  depots	  sometimes	  are	  also	  
viewed	  as	  one	  organ,	  known	  as	  the	  adipose	  organ	  (19).	  
	   The	   largest	   BAT	   depot	   found	   in	   mice,	   iBAT,	   is	   predominantly	   found	   in	   human	  
neonates	  and	  infants,	  and	  then	  gradually	  disappears	  after	  childhood	  (20)	  and	  is	  rarely	  
seen	   in	   human	   adults	   (Figure	   1B).	   In	   adult	   humans,	   BAT	   ([18F]FDG-­‐uptake)	   is	   often	  
found	   in	  the	  neck,	   the	  mediastinum	  (para-­‐aortic),	  and	  above	  the	  kidney	  (suprarenal),	  
which	  is	  comparable	  to	  some	  BAT	  depots	  (cBAT,	  mBAT,	  prBAT)	  in	  mice.	  Furthermore,	  
BAT	   in	  humans	   is	   located	  along	   the	   spinal	   cord,	   in	   the	  axillary	  and	  abdominal	   region	  
(suprarenal	  and	  perihepatic),	  and	  sometimes	  in	  areas	  such	  as	  the	  abdominal	  wall	  and	  
acromial–clavicular	   area.	   The	   most	   prominent	   and	   most	   reported	   BAT	   depot	   in	  
humans	  is	  supraclavicular	  BAT,	  which	  has	  not	  been	  found	  as	  a	  distinct	  depot	  in	  mice.	  
	  
	  
Figure	  1.	  Overview	  of	  brown	  adipose	  tissue	  and	  beige	  adipose	  depots	  in	  rodents	  and	  humans.	  (A)	  Image	  of	  a	  
mouse	  demonstrating	  classical	  BAT	  depots	  and	  WAT	  depots	  that	  are	  susceptible	  to	  browning	  (beige	  depots).	  
(B)	  The	  upper	  part	  shows	  a	  PET	  image	  of	  a	  lean	  human	  adult	  demonstrating	  18F-­‐FDG-­‐uptake	  in	  BAT	  locations	  
during	   cold	   exposure	   and	   the	   lower	   image	   a	   transversal	   PET/CT	   fusion	   slice,	   which	   demonstrates	   a	   rare	  
example	  of	  interscapular	  BAT	  in	  a	  lean	  human	  adult.	  (C)	  Overview	  of	  depot	  specific	  markers	  for	  both	  BAT	  and	  
beige	  depots	   in	  mice.	   (D)	  Overview	  of	  depot	  specific	  markers	  determined	   in	  human	  BAT	  based	  on	  marker	  
found	  in	  beige	  depots	  from	  mice.	  BAT	  =	  Brown	  adipose	  tissue,	  WAT	  =	  White	  adipose	  tissue.	  *Measured	  in	  
children	  (21),	  **Measured	  in	  human	  adults	  (22).	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Brown	  like	  cells	  in	  white	  adipose	  tissue	  	  
In	  addition	  to	  classical	  BAT,	  a	  distinct	  type	  of	  adipocytes	  has	  been	  found	  within	  WAT	  
depots,	   the	   so-­‐called	  brite	   (23)	   or	  beige	   adipocytes	   (22).	   However,	   this	   is	   still	   under	  
dispute	   as	  white	   fat	   cells	  may	   differentiate	   into	   brown	   fat	   cells	   (24).	   At	   present,	   no	  
consensus	  on	  the	  terminology	  of	  these	  brown-­‐like	  white	  adipocytes	  has	  been	  reached,	  
and	   is	   urgently	   awaited.	   However,	   for	   sake	   of	   clarity	   we	   will	   refer	   to	   these	   cells	   as	  
beige	  adipocytes	   in	   the	  remainder	  of	   this	   review.	  These	  beige	  adipocytes	  can	  appear	  
within	   WAT	   depots	   after	   long-­‐term	   adrenergic	   stimulation	   and	   cold	   exposure,	   and	  
especially	  appear	   in	  the	   inguinal	  depot.	   In	  the	  basal	  state,	   these	  beige	  cells	  resemble	  
the	  unilocular	  white	  adipocytes,	  whereas	  upon	  stimulation	   these	  cells	  obtain	  a	  more	  
brown	  like	  phenotype.	  Furthermore,	  these	  cells	  do	  not	  express	  the	  myogenic	  markers	  
nor	   the	   brown	   adipocyte	   specific	  markers	   Zic1,	   Lhx8,	  Meox2,	   and	   PRDM16	   (23),	   but	  
express	   specific	  markers	   as	  well	   (e.g.	   Hoxc9)	   (18).	   Interestingly,	  Wu	   et	   al.	   (22)	  were	  
able	   to	   isolate	   brown-­‐like	   cells	   from	   the	   subcutaneous	   (inguinal)	   adipose	   depot	   and	  
found	   a	   distinct	   pool	   of	   progenitors	   giving	   rise	   to	   these	   so-­‐called	   beige	   cell	   lines.	  
Linkage	   of	   the	   expressed	   genes	   after	  microarray	   analysis	   in	   these	   cell	   lines	   revealed	  
that	   beige	   adipocytes	   are	   identical,	   but	   not	   similar,	   to	   classical	   brown	   adipocytes.	  
These	  beige	  adipocytes	  were	  characterized	  by	  unique	  genetic	  markers,	  such	  as	  CD137,	  
Tmem26,	  and	  Tbx1,	  and	  did	  not	  contain	  unique	  BAT	  markers	   such	  as	  Ebf3,	  Eva1	  and	  
Fbxo31	   (Figure	   1C).	   Furthermore,	   they	   found	   that	  unstimulated	  beige	   cells	   resemble	  
white	   adipocytes	   since	   they	   have	   similar	   low	   expression	   of	   the	   brown	   adipocyte	  
markers	  UCP-­‐1,	  Cidea,	  and	  Cox7a1.	  However,	  upon	  cAMP	  stimulation	  absolute	   levels	  
of	   UCP-­‐1	   mRNA	   and	   respiratory	   capacity	   were	   comparable	   to	   classical	   brown	  
adipocytes.	  In	  coherence	  with	  this,	  Petrovic	  et	  al.	  (23)	  showed	  beige	  cell	  recruitment	  in	  
the	   inguinal	   depot,	   and	   that	   even	   the	   purest	   WAT	   depot	   (epididymal)	   contains	  
preadicpocytes	  that	  can	  be	  induced	  to	  functional	  beige	  adipocytes.	  Again,	  a	  low	  basal	  
UCP-­‐1	   expression	  was	   found	  during	  baseline	   conditions,	   however,	   after	   rosiglitazone	  
(PPARγ	  activator)	  treatment	  beige	  cells	  increased	  UCP-­‐1	  expression	  and	  demonstrated	  
many	   features	   of	   the	   classical	   brown	   adipocytes.	   Moreover,	   oxygen	   consumption	  
increased	  after	  treating	  these	  cells	  with	  norepinephrine.	   In	  conclusion,	   it	   is	  clear	  that	  
beige	   adipocytes	   are	   molecular	   and	   developmentally	   different	   from	   classical	   brown	  
adipocytes,	   however,	   after	   stimulation	   these	   cells	   show	   comparable	   thermogenic	  
potential.	  	  
Type	  of	  brown	  adipocytes	  in	  humans	  
Do	  humans	  have	  brown,	  beige	  or	  both	  types	  of	  adipocytes?	  Studies	  measuring	  BAT	  via	  
FDG-­‐PET/CT	  cannot	  determine	  the	  type	  of	  BAT,	  as	  it	  merely	  measures	  glucose	  uptake.	  
However,	  biopsies	  from	  the	  supraclavicular	  region	  (25)	  and	  the	  perithyroid	  region	  (26)	  
have	   already	   demonstrated	   a	   mixture	   of	   both	   white	   and	   brown	   adipocytes,	   and	  
showed	  that	  brown	  adipocytes	  occur	  as	  islands	  within	  WAT.	  The	  clearly	  brown	  colored	  
depots	  as	  found	  in	  mice,	  have	  not	  (yet)	  been	  found	  in	  humans.	  Interestingly,	  a	  recent	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study	  has	  examined	  several	  adipose	  depots	  in	  13	  post-­‐mortem	  children	  (aged	  between	  
3	  days	  and	  18	  years)	  and	  also	   found	   the	  brown	   like	   cells	  dispersed	  within	  WAT	   (21).	  
These	   brown	   adipocyte	   islands	   were	   located	   in	   the	   subcutaneous	   supraclavicular	  
areas,	   posterior	   mediastinum,	   retroperitoneal,	   intra-­‐abdominal,	   and	   mesenteric	  
depots.	  	  
	   In	  the	  study	  by	  Wu	  et	  al.	  (22),	  human	  adipose	  tissue	  biopsies	  (both	  WAT	  and	  BAT)	  
from	   the	   supraclavicular	   area	   were	   analyzed	   for	   gene	   expression.	   Interestingly,	   we	  
found	  increased	  mRNA	  expression	  of	  the	  genes	  that	  were	  characteristic	  for	  beige	  cells	  
(CD137,	  Tmem26,	  Tbx1)	  and	  not	  classical	  murine	  BAT	  (Ebf3,	  Eva1,	  Fbxo31)	  (Figure	  1D).	  
In	   addition,	   we	   also	   performed	   immunohistochemistry	   to	   identify	   the	   beige	   marker	  
proteins	   (CD137	   and	   Tmem26),	   and	   found	   positive	   staining	   for	   both	   proteins	   in	   the	  
UCP-­‐1	  positive	  cells.	  Thus,	  human	  BAT	  from	  the	  supraclavicular	  area	  in	  adults	  has	  beige	  
characteristics.	   In	  the	  study	  by	  Sharp	  et	  al.	  (21),	  total	  RNA	  was	  isolated	  from	  the	  BAT	  
depots	  from	  post-­‐mortem	  children,	  and	  interestingly,	  all	  BAT	  depots	  expressed	  beige-­‐
cell	  selective	  genes	  and	  no	  classical	  brown	  fat-­‐selective	  genes	  (Figure	  1D).	  They	  found	  
that	  these	  BAT	  depots	  correlated	  well	  with	  the	  expression	  of	  brown	  fat	  genes	  such	  as	  
PGC1α	  and	  PRDM16,	  and	  with	  beige-­‐cell	  genes	  (e.g.	  Cited1),	  however	  not	  with	  classical	  
BAT	   genes	   (e.g.	   Zic1)	   (21).	   These	   findings	   thus	   indicate	   that	   human	   BAT	   may	   be	  
composed	  of	  mainly	  beige	  adipocytes.	  	  
BAT	  physiology	  
Crucial	   in	   activating	   BAT	   thermogenesis	   is	   the	   sympathetic	   nervous	   system	   (SNS).	  
Furthermore,	   the	  thermogenic	  capacity	  of	  BAT	   is	  dependent	  on	  the	  thyroid	  hormone	  
axis	   as	   well.	   After	   sympathetic	   stimulation,	   norepinephrine	   (NE)	   is	   released	   at	   the	  
nerve	  endings	  activating	  the	  adrenergic	  receptors	  on	  the	  brown	  adipocytes.	  This	  leads	  
to	  increased	  cAMP	  levels	  activating	  protein	  kinase	  A	  (PKA),	  which	  has	  both	  acute	  and	  
chronic	   effects	   on	  BAT.	   The	   acute	   response	   of	   PKA	   is	   to	   increase	   lipolysis	   leading	   to	  
increased	   cytosolic	   FFA	   levels.	   These	   FFA’s	   are	   essential	   for	   mitochondrial	   energy	  
dissipation,	   as	   they	   are	   both	   used	   as	   substrates	   and	   to	   activate	   UCP-­‐1	   in	   the	   inner	  
mitochondrial	   membrane.	   This	   acute	   effect	   increases	   UCP-­‐1	   activity	   within	   seconds.	  
On	   the	   other	   hand,	   prolonged	   stimulation	   of	   BAT	   for	   hours	   and	   days	   will	   result	   in	  
increased	  amounts	  of	  UCP-­‐1	  protein,	  mitochondrial	  biogenesis,	   and	  both	  hyperplasia	  
and	  hypertrophy	  of	   BAT	   (27).	   The	   thyroid	  hormone	  works	   synergistic	  with	  NE	   and	   is	  
required	  to	  generate	  the	  full	  thermogenic	  response	  (28).	  Crucial	  is	  the	  enzyme	  type	  II	  
iodothyronine	  deiodinase	  (D2,	  which	  can	  transform	  the	  inactive	  prohormone	  thyroxine	  
(T4)	  into	  the	  bioactive	  hormone	  triiodothyronine	  (T3).	  	  
	   In	  contrast	  to	  the	  extensive	  knowledge	  in	  rodents,	  the	  regulation	  and	  activation	  of	  
human	   BAT	   is	   still	   fairly	   unknown.	   However,	   both	   the	   SNS	   and	   the	   thyroid	   axis	   are	  
thought	   to	  be	  crucial	   in	  activation	  of	  BAT	   in	  humans	   too.	   For	   instance,	  patients	  with	  
CHAPTER	  2 	  
25	  	  
pheochromocytoma,	   who	   have	   elevated	   plasma	   catecholamine	   levels	   due	   to	   a	  
catecholamine-­‐secreting	  tumor	  in	  de	  adrenal	  gland,	  had	  high	  rates	  of	  [18F]FDG-­‐uptake	  
in	  BAT	  in	  the	  basal	  state	  (29-­‐32),	  which	  disappeared	  after	  resection	  of	  the	  tumor	  (29,	  
32).	  Thus,	  high	  systemic	  levels	  of	  NE	  can	  activate	  human	  BAT,	  indicating	  a	  role	  for	  the	  
adrenergic	   part	   of	   the	   SNS.	   In	   support,	   inhibition	   of	   β-­‐adrenergic	   receptors	   with	  
propranolol	   diminished	   [18F]FDG-­‐uptake	   in	   the	   supraclavicular	   BAT	   during	   room	  
temperature	   (33,	   34).	   In	   2009,	   anatomical	   evidence	   for	   the	   SNS	   involvement	   in	   BAT	  
was	   found,	   as	  BAT	  biopsies	   from	   the	  perithyroid	   (26)	   and	   supraclavicular	   region	   (25)	  
demonstrated	   sympathetic	   innervation	   and	   mRNA	   expression	   of	   the	   β3-­‐adrenergic	  
receptor	   respectively.	   Finally,	   disruption	   of	   the	   sympathetic	   fibers	   completely	  
abolished	  [18F]FDG-­‐uptake	  in	  BAT	  in	  a	  patient	  with	  the	  Horner	  Syndrome	  (deficiency	  of	  
sympathetic	  activity)	  (35).	  With	  respect	  to	  the	  thyroid	  hormone	  axis,	  it	  is	  known	  from	  
patients	   that	   thyroid	   hormone	   replacement	   has	   significant	   effects	   on	   resting	   energy	  
expenditure	  (36).	  It	  has	  also	  been	  shown	  that	  elevated	  levels	  of	  thyroid	  hormones	  are	  
able	  to	   increase	  mitochondrial	  uncoupling	   in	  skeletal	  muscle	   (37,	  38).	  Although	  these	  
results	   may	   suggest	   that	   thyroid	   hormone	   also	   plays	   a	   role	   in	   activation	   of	   BAT,	  
evidence	  for	  such	  a	  role	  in	  humans	  has	  so	  far	  not	  been	  demonstrated.	  	  
Known	  BAT	  activators	  in	  humans	  
Since	   the	  discovery	  of	   functional	   BAT	   in	   adult	   humans,	   some	   studies	  have	  examined	  
possible	  routes	  to	  activate	  BAT	  in	  humans,	  which	  will	  be	  discussed	  here.	  	  
Cold	  exposure	  and	  acclimatization	  
Currently,	  the	  strategy	  for	  which	  most	  evidence	  has	  been	  gathered	  to	  activate	  BAT	  in	  
humans	  is	  cold	  exposure.	  In	  our	  cold	  exposure	  experiments	  we	  applied	  a	  personalized	  
cooling	  protocol	  in	  which	  we	  decreased	  ambient	  temperature	  until	  shivering	  occurred	  
(16–17	   °C)	   and	   then	   increased	   temperature	   slightly	   again.	   At	   these	   mild	   cold	  
temperatures,	   cold-­‐induced	   thermogenesis	   levels	   in	   young	   lean	   male	   adults	   were	  
observed	   between	   5%	   and	   30%	   (9,	   14).	   Brown	   adipose	   tissue	   was	   present	   in	   all	  
individuals,	   however	   the	   activity	   level	   of	   BAT	   did	   not	   correlate	   to	   cold-­‐induced	  
thermogenesis.	   Other	   studies	   did	   find	   a	   relationship	   between	   BAT	   presence	   and/or	  
activity	   and	   cold-­‐induced	   thermogenesis	   (6-­‐8,	   11,	  39).	  Cold	  exposure	   likely	   increased	  
BAT	  activity	  via	  the	  SNS	  as	  shown	  by	  increased	  plasma	  NE	  levels	  during	  cold	  exposure	  
(6,	  9).	  	  
	   It	   is	  well	   known	   from	  animal	   studies	   that	   long-­‐term	   cold	   exposure	   leads	   to	   BAT	  
recruitment	  in	  both	  BAT	  and	  WAT	  depots	  (40).	  A	  cold	  acclimation	  study	  in	  humans	  in	  
1961	   demonstrated	   that	   long-­‐term	   cold	   exposure	   was	   effective	   to	   increase	   cold-­‐
induced	  thermogenesis	  in	  man,	  with	  a	  decrease	  in	  shivering,	  indicating	  a	  potential	  role	  
for	  BAT	   (41).	  Preliminary	   results	   from	  our	   lab	   confirm	   this	  adaptive	   response	   to	   cold	  
ENERGY	  DISS IPATION	   IN 	  BROWN	  ADIPOSE 	  T ISSUE	  
26	  
acclimation	   as	   both	   cold-­‐induced	   (non-­‐shivering)	   thermogenesis	   and	   BAT	   activity	  
increase	  (unpublished	  results).	  	  
Isoprenaline	  and	  ephedrine	  
Rodent	   studies	   have	   clearly	   demonstrated	   that	   BAT	   can	   be	   activated	   (acute)	   and	  
recruited	   (chronic)	   upon	   adrenergic	   receptor	   agonist	   treatment.	   Recently,	   three	  
studies	  measured	  the	  effect	  of	  adrenergic	  stimulation	  on	  BAT	  activity	  in	  human	  adults.	  
We	  measured	  BAT	  activity	  in	  lean	  human	  adults	  during	  infusion	  of	  the	  non-­‐selective	  β-­‐
adrenergic	  agonist	   isoprenaline,	  and	  compared	  this	  to	  cold	  exposure	  (9).	   Isoprenaline	  
infusion	   increased	   energy	   expenditure	   with	   20%	   comparable	   to	   levels	   during	   cold	  
exposure	   (17%).	   Surprisingly,	  nine	  out	  of	   ten	   subjects	   showed	  no	  BAT	  activity	  during	  
isoprenaline	   infusion,	   whereas	   cold	   exposure	   increased	   BAT	   activity	   in	   all	   subjects.	  
Cypess	   et	   al.	   (5)	   studied	   the	   effects	   of	   ephedrine	   (1	   mg/kg),	   which	   is	   a	  
sympathomimetic	   drug	   activating	   β-­‐adrenergic	   receptors	   directly	   and	   indirectly	   by	  
enhancing	  NE	  release	   from	  the	  sympathetic	   terminals,	  on	  BAT	  activity	  and	  compared	  
this	  with	  cold	  exposure	  and	  placebo.	  In	  coherence	  with	  our	  results	  (9),	  ephedrine	  did	  
not	   result	   in	   BAT	   activity	   measured	   by	   FDG-­‐PET/CT	   measurements,	   whereas	   cold	  
exposure	   activated	   BAT	   in	   all	   subjects	   (5).	   However,	   a	   recent	   study	   using	   higher	  
dosages	  of	  ephedrine	  (2.5	  mg/kg)	  did	  find	  increased	  BAT	  activity	  in	  six	  out	  of	  nine	  lean	  
human	  adults,	  however	  not	  in	  obese	  subjects	  (42).	  This	  is	  the	  first	  study	  that	  showed	  
that	  pharmacological	  treatment	  of	  BAT	  in	  humans	  is	  possible.	  The	  activity	  level	  of	  BAT	  
was	  still	  4-­‐fold	  lower	  than	  observed	  during	  cold	  exposure.	  The	  explanation	  for	  the	  lack	  
of	   effect	   of	   systemic	   adrenergic	   stimulation	   on	   BAT	   activation	   is	   likely	   that	   the	  
concentrations	   of	   NE	   reached	   at	   the	   brown	   adipocyte	   cell	   surface	   during	   central	  
stimulation	   (e.g.	   cold	   exposure)	   are	   higher	   than	   systemically	   reached	   by	   the	  
sympathomimetics	  used	  in	  these	  studies.	  Thus,	  pharmacological	  stimulation	  of	  BAT	  is	  
possible,	   however	   high	   dosages	   are	   required.	   A	  major	   burden	   of	   very	   high	   levels	   of	  
sympathomimetic	  drugs	  is	  the	  cardiovascular	   load	  induced	  by	  adrenergic	  agonists.	  All	  
three	  studies	  observed	  increased	  blood	  pressure	  and	  heart	  rate	  levels,	  with	  the	  highest	  
increase	   in	   systolic	  blood	  pressure	   (45	  mmHg)	  measured	   in	   the	   study	  by	  Carey	  et	  al.	  
(42).	  	  
Capsinoids	  
Another	  route	  to	  activate	  BAT	  via	  the	  SNS	  is	  via	  ingestion	  of	  certain	  food	  components.	  
One	   such	   component	   are	   the	   capsinoids	   (non-­‐pungent	   capsaicin	   analogs),	   the	   active	  
compound	   found	   in	   chili	   pepper,	  which	   is	   known	   to	   increase	   BAT	   activity	   in	   rodents	  
(43),	  and	  RMR	  in	  humans	  (44),	  although	  this	  has	  not	  been	  consistenly	  shown	  (among	  
others:	   (45)).	   A	   recent	   study	   showed	   that	   capsinoids	   could	   be	   effective	   in	   activating	  
BAT	   in	   humans	   (10),	  without	   inducing	   unwanted	   side-­‐effects.	   Although	   they	   did	   not	  
directly	   measure	   the	   effect	   of	   capsinoid	   intake	   on	   BAT	   activity,	   they	   found	   that	  
subjects	   with	   BAT	   (based	   on	   cold	   PET-­‐CT)	   showed	   a	   higher	   increase	   in	   energy	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expenditure	  upon	  capsinoid	   intake	  compared	   to	  subjects	  without	  BAT.	  The	  proposed	  
mechanism	   is	   that	   capsinoids	   activate	   the	   transient	   receptor	   potential	   channel	   1	  
(TRPV1)	   located	   in	   the	   upper	   digestive	   tract	   leading	   to	   increased	   sympathetic	   nerve	  
activity	  to	  BAT,	  as	  demonstrated	  in	   interscapular	  BAT	  in	  rats	  (46).	  Direct	  evidence	  for	  
the	   effect	   of	   capsinoids	   on	   BAT	   in	   humans	   is	   needed	   to	   draw	   definite	   conclusions.	  
Furthermore,	   whether	   long-­‐term	   administration	   of	   these	   bioactive	   compounds	   can	  
induce	  weight	  loss	  via	  BAT	  remains	  to	  be	  studied.	  
Insulin	  	  
Another	  way	   to	   induce	   glucose	   uptake	   in	   BAT	   is	   via	   insulin	   (6).	   In	   this	   study,	   insulin	  
infusion	   (hyperinsulinemic	   euglycemia)	   was	   compared	   with	   cold	   exposure	   on	   BAT	  
glucose	  uptake	  and	  perfusion.	  They	  showed	  that	   insulin	   increased	  [18F]FDG-­‐uptake	   in	  
BAT	   to	   similar	   levels	   as	   in	   skeletal	  muscle,	   and	  much	   higher	   than	   in	  WAT.	   This	   was	  
most	   likely	  due	  to	  the	  high	  expression	  of	  GLUT4	   in	  BAT	  compared	  to	  WAT.	  However,	  
the	   increased	   [18F]FDG-­‐uptake	   in	   BAT	   was	   not	   accompanied	   by	   increased	   perfusion,	  
suggesting	   that	   glucose	   is	   solely	   transported	   in	   BAT	   without	   concomitant	  
thermogenesis	  taking	  place.	  Since	  insulin	  leads	  to	  high	  glucose	  uptake	  in	  BAT,	  it	  would	  
be	   interesting	   to	   measure	   whether	   BAT	   is	   involved	   in	   glucose	   uptake,	   and	   possibly	  
thermogenesis,	  in	  the	  postprandial	  state	  as	  well.	  It	   is	  known	  from	  rodent	  studies	  that	  
single	  meals	  can	  activate	  BAT,	  which	  could	  be	  due	  to	  insulin	  release	  (47).	  	  
Novel	  putative	  BAT	  activators	  	  
Next	   to	   the	   known	   activators	   of	   BAT	   as	   described	   above,	   novel	   findings	   in	   mainly	  
rodent	  studies	  hint	  towards	  other	  potentially	  important	  activators	  of	  BAT.	  The	  focus	  of	  
this	  paragraph	  will	  be	  on	  the	  hormones	  irisin	  (released	  by	  muscle)	  and	  the	  natriuretic	  
peptides	  (released	  by	  heart).	  We	  have	  chosen	  for	  these	  hormones	  as	  they	  are	  released	  
under	   physiological	   conditions	   (exercise	   and	   cardiac	   stress),	   and	   because	   there	   is	  
already	  indirect	  evidence	  of	  these	  activators	  in	  humans.	  For	  information	  on	  the	  other	  
potential	  BAT	  activators	  we	  would	  like	  to	  refer	  to	  other	  reviews	  (48,	  49).	  
Exercise	  and	  brown	  adipose	  tissue:	  irisin	  
Exercise	   is	  well	   known	   for	   its	   beneficial	   effects	   on	   systemic	  metabolism.	   In	   the	   past	  
decades,	   several	   animal	   studies	   have	   investigated	   whether	   exercise	   has	   beneficial	  
effects	  on	  BAT	  activity	  and	  recruitment.	  It	  was	  hypothesized	  that	  exercise	  could	  affect	  
BAT	   function	   via	   the	   SNS,	   as	   exercise	   is	   known	   to	   increase	   general	   SNS	   activity	   (50).	  
However,	  most	  studies	  did	  not	   find	  any	  stimulatory	  effect	  of	  exercise	  on	  BAT	  activity	  
(50-­‐53),	  except	  for	  studies	  using	  swimming	  exercise	  protocols	  (54-­‐56),	  which	  probably	  
induced	  BAT	  activity	  to	  compensate	  for	  the	  heat	  loss	  to	  the	  water.	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   However,	  recent	  studies	  in	  rodents	  did	  observe	  stimulating	  effects	  of	  exercise	  on	  
brown	  and	  beige	  adipocytes	  (57-­‐60).	  A	  study	  in	  rats	  demonstrated	  that	  a	  low	  level	  of	  
exercise	   training	   is	   beneficial	   for	   the	   metabolic	   response	   upon	   cold	   exposure	   in	  
classical	  BAT	  (58).	  It	  was	  shown	  that	  exercise	  in	  combination	  with	  cold	  exposure	  led	  to	  
an	  increase	  in	  UCP-­‐1	  expression	  in	  BAT,	  whereas	  cold	  exposure	  (12	  °C)	  alone	  did	  not,	  
suggesting	   that	   physical	   activity	   is	   required	   for	   an	   optimal	   heat	   producing	   BAT	  
machinery.	  Xu	  et	  al.	   (60)	   found	   that	  exercise	   in	  mice	   led	   to	   increased	   recruitment	  of	  
adipogenic	   progenitor	   cells	   in	   interscapular	   BAT	   and	   increased	   UCP-­‐1	   expression	  
(~twofold).	  Interestingly,	  in	  addition	  to	  these	  stimulating	  effects	  of	  exercise	  on	  classical	  
BAT,	   they	   found	   an	   increased	   expression	   of	   the	   thermogenic	   gene	   program	   in	  
epidydimal	   (visceral)	   adipose	   tissue,	   including	   increased	   UCP-­‐1	   levels	   (~twofold).	  
Another	  study	  showed	  the	  occurrence	  of	  beige	  cells	  within	  the	  retroperitoneal	  depot	  
(visceral)	   of	   rats	   already	   after	   one	   week	   of	   exercise	   (61).	   Quantification	   of	   UCP-­‐1	  
positive	   adipocytes	   within	   the	   retriperitoneal	   WAT	   showed	   a	   8-­‐fold	   increase	   in	   the	  
number	  of	  brown	  cells	  in	  the	  exercise	  group	  versus	  controls.	  	  
	   Interestingly,	   a	   recent	   study	   demonstrated	   that	   endurance	   exercise	  
predominantly	  results	  in	  browning	  of	  subcutaneous	  WAT	  (57).	  In	  this	  study,	  Boström	  et	  
al.	   found	   that	   mice	   overexpressing	   the	   transcriptional	   coactivator	   PGC1-­‐α	   showed	  
increased	   browning	   in	   inguinal	   WAT.	   Since	   exercise	   also	   increases	   PGC1-­‐α,	   they	  
examined	   the	   effect	   of	   endurance	   exercise	   on	   markers	   of	   browning	   and	   observed	  
similar	  effects.	  In	  further	  studies,	  they	  identified	  a	  new	  hormone	  called	  irisin,	  which	  is	  
released	   by	   skeletal	   muscle	   after	   proteolysis	   of	   the	   membrane	   protein	   FNDC5.	  
Boström	   et	   al.	   found	   that	   the	   irisin	   precursor	   FNDC5	   induced	   browning	   in	   primary	  
subcutaneous	  white	  adipocytes	  demonstrated	  by	   increased	  UCP1	  mRNA	  (7–500-­‐fold)	  
and	   the	   upregulation	   of	   thermogenic	   genes	   (Ucp1,	   Elovl3,	   Cox7a1	   and	   Otop1).	  
Adenoviral-­‐mediated	  overexpression	  of	  FNDC5	  in	  mouse	  liver	  resulted	  in	  plasma	  irisin	  
levels	  to	  be	  increased	  3–4-­‐fold,	  which	  increased	  UCP1	  mRNA	  13-­‐fold	  in	  subcutaneous	  
WAT.	  Furthermore,	  the	  same	  technique	  was	  used	  in	  C557BL/6	  mice,	  which	  are	  prone	  
to	  diet-­‐induced	  obesity	   and	  diabetes,	   and	   increased	   irisin	   levels	   leading	   to	   improved	  
glucose	   tolerance,	   decreased	   fasting	   insulin,	   increased	   oxygen	   consumption	   and	  
reduced	   body	   weight.	   Together	   these	   results	   demonstrate	   the	   possible	   beneficial	  
effects	   of	   endurance	   exercise	   on	   the	   recruitment	   of	   beige	   cells	  within	   subcutaneous	  
white	   adipose	   tissue,	   and	  moreover,	   the	  potential	   of	   irisin	   to	   induce	  a	  more	  healthy	  
metabolic	  phenotype.	  	  
	   Are	   these	   stimulating	   effects	   of	   exercise	   on	   the	   recruitment	   of	   beige	   cells	  
translatable	   to	   humans?	   Importantly,	   the	   authors	   showed	   that	   irisin	   in	   mice	   and	  
humans	  are	  100%	  identical	  and	  that	  plasma	  irisin	   levels	  were	   increased	  twofold	  after	  
10	   weeks	   of	   endurance	   training	   in	   human	   subjects	   (57).	   Interestingly,	   a	   study	   in	  
patients	   with	   heart	   failure	   demonstrated	   increased	   FNDC5	   expression	   in	   skeletal	  
muscle	   in	   the	   patient	   group	   with	   a	   better	   aerobic	   performance	   (62).	   Conversely,	   a	  
recent	   study	   by	   Timmons	   et	   al.	   (63)	   demonstrated	   that	   the	   stimulating	   effect	   of	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exercise	   on	   FNDC5	   is	   limited.	   They	   analyzed	   FNDC5	   induction	   by	   means	   of	   gene	  
expression	   arrays	   in	   muscle	   biopsies	   from	   ~200	   subjects	   from	   different	   exercise	  
programs	   (both	   endurance	   and	   resistance	   straining)	   from	   earlier	   published	   studies.	  
They	  found	  that	  endurance	  exercise	  (6	  weeks	  of	  endurance	  cycling)	  in	  young	  adults	  as	  
well	   as	   resistance	   training	   in	   20–80	   year	   old	   men	   did	   not	   increase	   FNDC5	   mRNA.	  
However,	   only	   highly	   active	   elderly	   subjects	   did	   show	   increased	   (30%)	   FNDC5	  
compared	  to	  sedentary	  controls.	  The	  authors	  therefore	  conclude	  that	  the	  stimulatory	  
effect	   of	   exercise	   on	   irisin	   production	   is	   limited	   and	   that	   irisin	   probably	   has	   little	  
contribution	  to	  the	  overall	  broad	  benefits	  of	  exercise	  on	  metabolic	  status.	  	  
	   Another	   recent	   paper	   on	   irisin	   presented	   data	   from	   cross-­‐sectional	   and	  
interventional	   studies	   on	   the	   physiological	   role	   of	   irisin	   in	   humans	   looking	   at	  
correlations	   with	   anthropometric,	   metabolic,	   and	   hormonal	   parameters	   (64).	   The	  
presence	  of	   FNDC5	   in	  human	   tissues,	   in	   skeletal	  muscle	  but	   also	   in	   the	  pericardium,	  
intracranial	   artery,	   and	   rectum	   (cardiac	   and	   smooth	   muscles)	   was	   confirmed	   and	  
muscle	   mass	   was	   found	   to	   be	   the	   primary	   predictor	   of	   circulating	   irisin	   in	   humans.	  
However	   no	   support	   for	   a	   beneficial	   role	   for	   irisin	   in	  metabolic	   regulation	   in	   a	   cross	  
sectional	   study	   of	   117	   middle-­‐aged	   women	   (BMI	   range	   20–47.7	   kg/m2)	   was	   found.	  
Interestingly,	   acute	   anaerobic	   exercise	   (sprint	   exercise)	   in	   young	   healthy	   subjects	  
increased	  irisin	  levels,	  whereas	  chronic	  exercise	  of	  8	  weeks	  (three	  times	  sprint	  exercise	  
per	  week)	   did	   not.	   It	   is	   important	   to	   note	   that	   this	   study	   solely	   looked	   at	   anaerobic	  
exercise;	   it	   is	   known	   that	   aerobic	   exercise	   increases	   PGC1α	   to	   a	   greater	   extent	   than	  
anaerobic	   exercise	   (65),	   and	   this	   (aerobic)	   type	   of	   exercise	   would	   thus	   be	   more	  
effective	  in	  irisin	  production.	  	  
	   These	   first	   human	   studies	   question	   the	   potential	   beneficial	   effects	   of	   irisin	   on	  
metabolic	   status.	   However,	   prospective	   studies	   that	   measure	   the	   direct	   effects	   of	  
exercise	   on	   browning	   are	   required,	   and	   prospective	   studies	   should	   focus	   on	   aerobic	  
exercise	   protocols.	   In	   addition	   to	   the	   physiological	   release	   of	   irisin	   by	   exercise,	   the	  
therapeutic	  use	  of	  irisin	  in	  human	  clinical	  trials	  should	  be	  investigated.	  	  
Natriuretic	  peptides	  and	  brown	  adipose	  tissue	  
A	   recent	   study	   showed	   that	   the	   cardiac	   natriuretic	   peptides	   (NPs)	   are	   capable	   of	  
browning	  white	  adipocytes	  from	  mice	  and	  humans	  (66).	  The	  cardiac	  peptides,	  atrial	  NP	  
(ANP)	  and	   the	  ventricular	   form	   (BNP),	   are	  predominantly	   known	   for	   their	   role	   in	   the	  
homeostatic	   control	   of	   blood	   pressure,	   by	   promoting	   vasodilatation,	   natriuresis	   and	  
diuresis,	  and	  inhibiting	  renin	  and	  aldosterone	  release	  (67).	  Later,	  these	  hormones	  were	  
also	  found	  to	  regulate	  lipolysis	  as	  demonstrated	  both	  in	  vitro	  as	  in	  vivo	  (68).	  Natriuretic	  
peptides	  mediate	  these	   lipolytic	  effects	  predominantly	  via	  the	  NP	  receptor	  A	  (NPRA),	  
whereas	   the	   clearance	   receptor	   (NPRC)	   removes	   the	   peptides	   from	   the	   circulation.	  
Binding	  of	   the	  NPs	   to	   the	   guanylyl	   cyclase	   receptor	  NPRA	   leads	   to	   increased	   cellular	  
cGMP,	  which	   stimulates	   lipolysis	   by	   acting	  on	  HSL	   (69).	   These	   lipolytic	   effects	   of	   the	  
NPs	  were	  only	  observed	  in	  human	  WAT,	  and	  were	  thought	  to	  be	  primate	  specific	  due	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to	   the	   high	   expression	   of	   clearance	   receptors	   and	   a	   low	   expression	   of	   “biologically	  
active”	  receptors	  in	  other	  species	  (68).	  	  
	   This	   was	   confirmed	   in	   the	   study	   by	   Bordicchia	   et	   al.	   (66),	   in	   which	   primary	  
adipocyte	   cultures	   from	   wildtype	   mice	   showed	   no	   lipolytic	   response	   upon	   ANP	  
infusion.	   However,	   in	   NPRC	   knockout	  mice	   they	   did	   find	   increased	   lipolysis	   in	   these	  
adipocytes,	   indicating	   the	   inhibitory	   effects	   of	   this	   clearance	   receptor.	   Interestingly,	  
these	  knockout	  mice	  had	  reduced	  adipose	  tissue	  mass	  and	  a	  more	  brownish	  adipose	  
tissue	  phenotype.	   In	  support,	  brown	  adipocyte	  marker	  genes,	  such	  as	  PRDM16,	  were	  
elevated	   in	  both	  BAT	  and	  WAT	  (inguinal	  and	  epididymal).	  These	  results	   indicated	  the	  
browning	  effects	  on	  WAT	  via	  the	  NPs.	  It	  was	  then	  shown	  that	  exposing	  mice	  to	  cold	  (4°	  
for	  6	  h)	  significantly	  increased	  plasma	  BNP	  levels,	  and	  ANP	  and	  BNP	  mRNA	  expression	  
in	   the	  heart.	   Furthermore,	   BNP	   infusion	   in	  mice	   increased	  UCP-­‐1	   and	  PGC-­‐1α	  mRNA	  
expression	   in	   both	  WAT	   and	   BAT	   (66).	   Altogether,	   these	   data	   demonstrate	   that	   the	  
NPs	  have	  the	  capacity	  to	  enhance	  BAT	  activity	  and	  recruitment	  in	  mice	  in	  vitro	  and	   in	  
vivo.	  
	   Do	  these	  NPs	  exert	  similar	  effects	  in	  humans?	  Administering	  ANP	  systemically	  and	  
via	   a	  microdialysis	   probe	   increased	   lipolysis	   in	  healthy	  men	   (70).	  One	   functional	   role	  
for	  the	  lipolytic	  effects	  of	  NPs	  could	  be	  substrate	  supply	  of	  fatty	  acids	  to	  the	  heart	  and	  
muscle	   during	   aerobic	   exercise	   (71).	   In	   addition,	   it	   is	   thought	   that	   the	   NPs	   are	  
important	  regulators	  in	  postprandial	  fatty	  acid	  oxidation	  in	  humans	  (72).	  Interestingly,	  
it	   is	   known	   in	   humans	   that	   low	  NP	   levels	   are	   associated	  with	   hypertension,	   obesity,	  
insulin	  resistance	  and	  diabetes	  (73,	  74).	  Furthermore,	  weight	  loss	  in	  obese	  subjects	  by	  
lifestyle	   intervention	   (75-­‐78)	   showed	   that	  BNP	   levels	  are	   increased	  after	  weight	   loss.	  
Interestingly	  patients	  with	  heart	  failure	  who	  suffer	  from	  severe	  weight	  loss	  (cachexia)	  
have	  increased	  levels	  of	  both	  forms	  of	  NPs	  (79,	  80),	  and	  elevated	  energy	  expenditure	  
levels,	   and	   it	   could	   be	   suggested	   that	   elevated	   NP	   levels	   increase	   brown	   adipocyte	  
recruitment	  and	  activity	  leading	  to	  elevated	  EE.	  Birkenfeld	  et	  al.	  (70,	  72)	  showed	  that	  
ANP	  infusion	  increased	  postprandial	  energy	  expenditure,	  however	  energy	  expenditure	  
in	   the	   fasted	   state	   was	   not	   affected.	   The	   dosage	   (25	   ng/kg/min)	   of	   ANP	   used	   by	  
Birkenfeld	   et	   al.	   (72)	   increased	   plasma	   ANP	   concentrations	   fourfold	   (approximately	  
300	   pg/mL),	   which	   is	   lower	   than	   found	   in	   heart	   failure	   patients	   (>500	   pg/mL).	   This	  
relative	   low	  dose	   already	   affected	   lipid	  mobilization	   and	  postprandial	   thermogenesis	  
(and	  possibly	  BAT)	  without	  causing	  any	  adverse	  effects.	  Currently,	   therapeutic	  use	  of	  
NPs	   (carperitide	   and	   nesiritide)	   in	   patients	   with	   acute	   heart	   failure	   and	   acutely	  
decompensated	  heart	  failure	  is	  only	  possible	  by	  means	  of	  infusion	  and	  not	  orally	  (81).	  
	   The	  potential	  effect	  of	  NPs	  on	  browning	  in	  humans	  has	  been	  demonstrated	  in	  the	  
study	  of	  Bordicchia	  et	  al.,	  where	  they	  tested	  whether	  NPs	  could	  induce	  a	  thermogenic	  
gene	   program	   in	   differentiated	   human	   multipotent	   adipose-­‐derived	   stem	   (hMADS)	  
cells	  and	  subcutaneous	  adipocytes.	  Interestingly,	  both	  ANP	  and	  BNP	  activated	  PGC-­‐1α	  
and	   UCP-­‐1	   expression,	   induced	   mitochondrial	   biogenesis,	   and	   increased	   uncoupled	  
and	  total	   respiration.	  These	   findings	   imply	   the	  potential	   role	  of	   the	  NPs	   in	   increasing	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acute	  thermogenesis	  and	  brown	  adipocyte	  recruitment	  in	  humans.	  They	  demonstrated	  
that	  the	  mechanism	  of	  action	  of	  the	  NP’s	  share	  a	  common	  downstream	  target	  with	  the	  
adrenergic	   pathway,	   namely	   p38	   MAPK.	   Activation	   of	   the	   p38	   MAPK	   pathway	  
ultimately	  leads	  to	  increased	  transcription	  of	  UCP-­‐1	  and	  PGC-­‐1α	  (66).	  	  Moreover,	  it	  was	  
shown	  that	  ANP	  treatment	  of	  hMADS	  led	  to	  a	  similar	   increase	  in	  UCP-­‐1,	  PGC-­‐1α,	  and	  
cytochrome	  c	  protein	  levels	  as	  shown	  during	  β-­‐adrenergic	  treatment.	  The	  authors	  also	  
found	  that	  both	  the	  adrenergic	  and	  NP’s	  signaling	  pathways	  work	  additive	  at	  very	  low	  
(physiological)	  concentrations.	  The	  activation	  pathway	  of	  the	  NPs	  could	  therefore	  play	  
a	  prominent	   role	   in	  addition	   to	   the	  well-­‐known	  adrenergic	  pathway	   in	   inducing	  both	  
short-­‐term	  as	   long-­‐term	  effects	  on	  BAT.	  Currently,	   this	   is	   the	  only	  direct	  evidence	  of	  
browning	  effects	  via	  NPs	  in	  humans	  and	  future	  studies	  are	  warranted.	  	  
Conclusions	  and	  perspectives	  
The	  current	  global	  obesity	  problem	  is	  affecting	  more	  than	  1.4	  billion	  adults	  of	  20	  years	  
and	   older,	   and	   strikingly,	   more	   than	   40	  million	   children	   under	   the	   age	   of	   five	   were	  
overweight	   in	   2010	   (WHO).	   Obesity	   goes	   along	   with	   increased	   risk	   on	   developing	  
diseases	   such	   as	   type	   2	   diabetes	   and	   cardiovascular	   diseases.	   Finding	   strategies	   to	  
induce	   weight	   loss	   are	   therefore	   necessary.	   Currently,	   brown	   adipose	   tissue	   is	  
regarded	   as	   a	   potential	   tissue	   to	   tackle	   obesity	   due	   to	   its	   great	   capacity	   to	   increase	  
energy	  expenditure	  and	  thereby	  stimulating	  weight	  loss.	  The	  rediscovery	  of	  functional	  
BAT	   in	   humans	  has	   resulted	   in	   an	   explosion	  of	   BAT	   studies,	   especially	   in	   rodents,	   to	  
find	  potential	  molecules	  that	  could	  lead	  to	  BAT	  hypertrophy	  and	  hyperplasia.	  It	  is	  now	  
clear	  that	  a	  third	  type	  of	  adipocyte	  exists,	  the	  beige	  adipocyte,	  which	  can	  be	  recruited	  
within	  WAT	  after	  cold	  acclimation	  and	  long-­‐term	  adrenergic	  receptor	  stimulation.	  This	  
distinct	  type	  of	  adipocyte	  has	  shown	  to	  arise	  from	  a	  different	  lineage	  as	  the	  other	  two	  
types,	   although	   functionally	   and	   metabolically	   seen	   it	   is	   similar	   to	   the	   brown	  
adipocyte.	  Current	  evidence	  shows	  that	  human	  BAT	  is	  likely	  composed	  of	  mainly	  beige	  
adipocytes.	  	  
	   Prospective	   studies	   in	   humans	   are	   scarce,	   mostly	   because	   of	   the	   difficulties	  
associated	  with	  the	  technique	  to	  measure	  BAT	  activity	  (PET-­‐CT).	  Nevertheless,	  current	  
studies	   have	   shown	   that	   cold	   exposure	   is	   the	   most	   effective	   in	   stimulating	   BAT	   in	  
humans.	  Adjusting	  ambient	  temperature	  in	  public	  buildings	  to	  the	  lower	  range	  of	  our	  
thermoneutral	   zone	   could	   therefore	   be	   a	   sensible	   and	   physiological	  way	   to	   increase	  
thermogenesis	   by	   increasing	   the	   thermogenic	   potential	   of	   BAT.	   Adrenergic	   agonists	  
(isoprenaline	  and	  ephedrine)	  have	  not	  shown	  to	  be	  effective	  in	  BAT	  activation	  as	  high	  
dosages	   are	   required.	   This	   indicates	   that	   pharmacological	   activation	   of	   BAT	   via	   the	  
adrenergic	   part	   of	   the	   SNS	   is	   difficult.	   Furthermore,	   a	  major	   drawback	   of	   adrenergic	  
agonists	   and	   sympathomimetics	   is	   the	   associated	   cardiovascular	   stress.	   Sympathetic	  
activation	  via	  capsinoids	  could	  be	  a	  way	  to	   increase	  energy	  expenditure	  and	  possibly	  
ENERGY	  DISS IPATION	   IN 	  BROWN	  ADIPOSE 	  T ISSUE	  
32	  
weight	  loss	  (with	  low	  risks	  of	  adverse	  events),	  and	  the	  indirect	  evidence	  of	  BAT	  being	  a	  
mediator	   is	   promising.	   Insulin	   has	   been	   shown	   to	   induce	   glucose	   uptake	   in	   BAT	   to	  
higher	  levels	  than	  WAT,	  and	  comparable	  to	  skeletal	  muscle.	  However,	  since	  perfusion	  
of	  BAT	  was	  absent,	  it	  remains	  unclear	  whether	  actual	  thermogenesis	  takes	  place	  after	  
insulin	  stimulation.	  	  
	   Interestingly,	  studies	   in	  rodents	  have	  shown	  additional	  pathways	  to	  activate	  BAT	  
and	  recruit	  beige	  adipocytes.	  Two	  of	   them	  –	   irisin	  and	  NPs	  –	  have	   recently	  attracted	  
much	   attention,	   but	   definitive	   answers	   in	   humans	   are	   so	   far	   lacking.	   Therefore,	   the	  
coming	  years	  are	  crucial	  in	  finding	  and	  testing	  novel	  activators	  of	  BAT	  in	  human	  clinical	  
trials,	  but	  most	  of	  all	   to	   test	   the	  hypothesis	   that	  activation	  of	  BAT	  may	   indeed	  be	  of	  
importance	   in	   the	   treatment	   of	   human	   obesity.	   Furthermore,	   future	   studies	   should	  
also	   reveal	   if	   continuous	  activation	  of	  mitochondrial	  uncoupling	   in	  BAT	  could	   lead	   to	  
hyperthermia,	  as	  has	  previously	  been	  shown	  to	  occur	  when	  dinitrophenol	  was	  used	  in	  
humans	  to	  obtain	  weight	  loss.	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Abstract	  
Background:	   Studies	   in	   rodents	   have	   shown	   that	   brown	   adipose	   tissue	   (BAT)	   is	  
activated	  upon	  food	  intake,	  thereby	  reducing	  metabolic	  efficiency.	  	  
Objective:	  The	  present	  study	  investigated	  whether	  a	  single	  high-­‐calorie,	  carbohydrate-­‐
rich	  meal	  activates	  BAT	  in	  lean	  human	  adults.	  	  
Design:	  BAT	  activity	  was	  studied	  in	  eleven	  lean	  adult	  men	  (age:	  23.6	  ±	  2.1	  years;	  BMI:	  
22.4	  ±	  2.1	  kg/m2)	  after	  consumption	  of	  a	  high-­‐calorie,	  carbohydrate-­‐rich	  meal	  (1622	  ±	  
222	  kcal;	  78%	  CHO,	  12%	  P,	  10%	  F).	  BAT	  activity	  during	  2	  hours	  of	  mild	  cold	  exposure	  
served	   as	   a	   positive	   control	   experiment.	   BAT	   activity	   was	   assessed	   by	  
[18F]fluorodeoxyglucose-­‐positron	   emission-­‐tomography-­‐computed	   tomography	  
([18F]FDG-­‐PET-­‐CT).	  Energy	  expenditure	  was	  measured	  by	  indirect	  calorimetry.	  
Results:	   Postprandial	   [18F]FDG-­‐uptake	   in	   BAT	   (1.65	   ±	   0.99	   SUVmean)	   was	   significantly	  
higher	  than	   in	  subcutaneous	   (0.35	  ±	  0.15	  SUVmean,	  P	  <	  0.05)	  and	  visceral	   (0.49	  ±	  0.24	  
SUVmean,	  P	   <	   0.05)	  WAT,	   and	   liver	   (0.95	   ±	   0.28	   SUVmean,	  P	   <	   0.05).	   Postprandial	   BAT	  
activity	   was	   lower	   compared	   to	   cold-­‐induced	   BAT	   activity	   (7.19	   ±	   2.09	   SUVmean).	  
However,	   postprandial	   BAT	   activity	   may	   have	   been	   underestimated	   due	   to	   high	  
postprandial	  [18F]FDG-­‐uptake	  in	  skeletal	  muscle	  compared	  to	  cold	  (1.36	  ±	  0.31	  vs.	  0.59	  
±	  0.07	  SUVmean,	  P	  <	  0.05),	   reducing	   [
18F]FDG	  bioavailability	   for	  BAT	  and	  other	   tissues.	  
There	  was	  no	  direct	  relationship	  between	  BAT	  and	  diet-­‐induced	  thermogenesis	  (DIT).	  	  	  
Conclusions:	  Glucose	  uptake	   in	  BAT	   is	   increased	  after	  a	  meal	   in	  humans	   indicating	  a	  
role	   for	  BAT	   in	   reducing	  metabolic	  efficiency.	  However,	   the	  quantitative	  contribution	  
of	   BAT	   to	   DIT,	   relative	   to	   other	   tissues	   such	   as	   skeletal	   muscle	   remains	   to	   be	  
investigated.	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Introduction	  
Brown	   adipose	   tissue	   (BAT)	   is	   currently	   considered	   as	   a	   potential	   preventive	   and	  
therapeutic	   target	   for	   the	   combat	   against	   obesity	   and	   its	   related	  metabolic	   diseases	  
due	  to	   its	  high	  metabolic	  capacity.	   It	   is	  now	  well	  established	  that	  BAT	  is	  functional	   in	  
human	  adults	   (1,	  2)	  and	   that	   it	   could	  contribute	   to	  cold-­‐induced	   thermogenesis	   (CIT)	  
(3-­‐6).	   Indeed,	   BAT	   is	   well	   known	   for	   its	   role	   in	   maintaining	   thermal	   homeostasis	   in	  
small	   rodents	   and	   infants	   during	   cold	   challenges	   (7).	   However,	   in	   addition	   to	   its	  
thermoregulatory	   function,	  BAT	  may	  also	  be	   involved	   in	  maintaining	  energy	  balance.	  
Interestingly,	  it	  has	  been	  shown	  that	  cold-­‐induced	  BAT	  activity	  is	  lower	  in	  obese	  people	  
(1,	  6,	  8).	  
	   It	  was	  originally	  believed	   that	  deletion	  of	  uncoupling	  protein-­‐1	   (UCP-­‐1),	  which	   is	  
crucial	  for	  heat	  production,	  did	  not	  induce	  obesity	  in	  mice	  spontaneously.	  However,	  a	  
recent	   study	   showed	   that	   these	   mice	   do	   develop	   obesity	   during	   thermoneutral	  
conditions	  (9).	  UCP-­‐1-­‐ablated	  mice	  are	  more	  susceptible	  to	  obesity	  during	  overfeeding	  
due	   to	   a	   high	  metabolic	   efficiency,	   indicating	   that	   a	   greater	   fraction	   of	   the	   ingested	  
energy	  is	  saved	  in	  body	  energy	  stores	  (9).	  In	  contrast,	  wild	  type	  rodents	  have	  a	  lower	  
metabolic	  efficiency	  because	  BAT	  wastes	  excessive	  caloric	  intake,	  as	  demonstrated	  by	  
increased	   BAT	   recruitment	   and	   enhanced	   norepinephrine-­‐induced	   thermogenesis	  
during	   high	   fat	   feeding	   and	   voluntary	   overeating	   (9,	   10).	   It	   was	   believed	   that	   this	  
decrease	   in	  metabolic	   efficiency	   during	   overfeeding	  was	   due	   to	   nutrient-­‐deficient	   or	  
unbalanced	  diets.	  In	  1999,	  Stock	  explored	  this	  theory	  in	  humans,	  and	  in	  his	  reanalysis	  
of	  twelve	  overfeeding	  studies	  he	  showed	  that	  overfeeding	  low-­‐protein	  diets	  resulted	  in	  
a	  lower	  weight	  gain	  than	  expected	  based	  on	  the	  caloric	  intake,	  and	  hypothesized	  that	  
this	  was	  due	  to	  increased	  thermogenesis,	  and	  thus	  possibly	  via	  BAT	  activation	  (11).	  The	  
role	  of	  BAT	  in	  maintaining	  energy	  balance	  is	  however	  not	  generally	  supported	  (12).	  
	   In	  addition	  to	  this	  adaptive	  response	  of	  BAT	  upon	  long-­‐term	  overfeeding	  nutrient	  
deficient	   diets,	   single	  meals	   are	   also	   known	   to	   induce	   an	   increase	   in	   thermogenesis,	  
known	  as	  diet-­‐induced	   thermogenesis	   (DIT),	   and	   is	   comprised	  of	  an	  obligatory	  and	  a	  
facultative	   part	   (13).	   The	   obligatory	   component	   of	   DIT	   includes	   the	   required	   energy	  
needed	   for	   digestion,	   absorption,	   distribution	   and	   storage	   of	   the	   nutrients,	  whereas	  
the	   facultative	   part	   wastes	   a	   fraction	   of	   the	   ingested	   energy	   as	   heat	   (14).	   Several	  
rodent	  studies	  have	  demonstrated	  that	  a	  single	  meal	   leads	  to	  BAT	  activation	  (15-­‐20),	  
and	  moreover	  that	  cold-­‐acclimated	  animals	  have	  increased	  DIT	  (21).	  Therefore,	  these	  
rodent	  data	  suggest	  that	  even	  after	  a	  single	  meal,	  BAT	  can	  be	  activated	  to	  waste	  a	  part	  
of	   the	  energy	   intake	  as	  heat.	  Again,	   such	  evidence	   is	   lacking	   in	  humans.	  Here	  we	  set	  
out	  to	  investigate	  if	  a	  single	  meal	  is	  able	  to	  activate	  BAT	  in	  humans.	  Since	  it	  is	  thought	  
that	  the	  sympathetic	  nervous	  system	  (SNS)	  plays	  an	  important	  role	   in	  facultative	  DIT,	  
and	  because	  it	  is	  known	  from	  human	  studies	  that	  of	  all	  macronutrients	  carbohydrates	  
are	  the	  most	  potent	  SNS	  stimulators	  (14),	  we	  tested	  the	  effects	  of	  a	  high-­‐calorie,	  high-­‐
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carbohydrate	  meal	  on	  BAT	  activity	  in	  humans,	  and	  compared	  this	  to	  cold-­‐activated	  BAT	  
activity	  as	  a	  positive	  control.	  	  
Subjects	  and	  methods	  	  
Subjects	  
Eleven	  healthy	  lean	  men	  (age:	  23.6	  ±	  2.1	  years;	  BMI:	  22.4	  ±	  2.1	  kg/m2)	  were	  recruited	  
by	   advertising	   in	   the	   Maastricht	   University	   Medical	   Centre+.	   All	   subjects	   signed	   a	  
written	   informed	   consent	   and	  underwent	   a	   standard	  medical	   examination.	   The	   local	  
medical	  ethical	  committee	  approved	  the	  study	  protocol	  and	  all	  subjects	  were	  treated	  
according	  to	  declaration	  of	  Helsinki	  of	  1975,	  as	  revised	  in	  1983.	  	  
Study	  design	  and	  measurements	  
Brown	   adipose	   tissue	   activity	   was	   determined	   during	   two	   experimental	   conditions,	  
after	   the	   intake	  of	   a	   high-­‐calorie	  meal	   and	  during	  mild	   cold	   exposure.	   The	  mild	   cold	  
experiment	  was	  conducted	  in	  6	  out	  of	  11	  subjects	  and	  served	  as	  a	  positive	  control.	  The	  
experiments	   were	   conducted	   in	   Maastricht	   (The	   Netherlands)	   during	   the	   months	  
September	   till	   December,	   with	   outside	   temperatures	   varying	   between	   0	   and	   20	   °C.	  
Subjects	  arrived	  in	  the	  morning	  after	  an	  overnight	  fast	  and	  were	  asked	  to	  refrain	  from	  
heavy	   exercise	   on	   the	   previous	   day.	   After	   arrival,	   subjects	   ingested	   a	   telemetric	   pill	  
(CoreTemp,	   HT150002,	   USA)	   for	   core	   temperature	  measurement	   and	   a	   cannula	  was	  
inserted	   in	   the	   antecubital	   vein	   for	   blood	   sampling.	   Subsequently,	   subjects	   were	  
equipped	  with	  wireless	  temperature	  sensors	  (iButtons,	  Maxim	  integrated,	  USA)	  at	  the	  
14	   sites	   prescribed	   by	   ISO-­‐standard	   9886:2004	   (Ergonomics	   –	   Evaluation	   of	   thermal	  
strain	   by	  physiological	  measurements,	   International	   Standards	  Organization,	  Geneva,	  
Switzerland),	   a	   heart	   rate	   monitor	   across	   the	   chest	   (Polar	   T31,	   USA)	   and	   a	   blood	  
pressure	   cuff	   on	   the	   left	   upper	   arm	   (Cresta,	   Taiwan)	   in	   order	   to	   measure	   skin	  
temperatures,	  heart	  rate,	  and	  blood	  pressure	  respectively.	  Laser	  Doppler	  probes	  were	  
attached	  for	  skin	  perfusion	  measurements	  at	  the	  ventral	  side	  of	  the	  hand	  at	  the	  base	  
of	   the	   thumb,	   at	   the	   ventral	   side	   of	   the	   hallux	   (Perimed	   PF4000,	   Sweden),	   at	   the	  
ventral	   side	   of	   the	   forearm	   halfway	   between	   the	   elbow	   and	   the	   wrist,	   and	   at	   the	  
abdomen	  halfway	  between	  the	  umbilicus	  and	  the	  left	  lateral	  side	  of	  the	  body	  (Perimed	  
PF5000,	  Sweden).	  Subjects	  were	  measured	  in	  a	  specially	  equipped	  air-­‐permeable	  tent	  
(Colorado	   altitude	   training,	   USA),	   in	   which	   ambient	   temperature	   could	   be	   tightly	  
controlled.	  During	  the	  measurements,	  subjects	  wore	  standardized	  clothing	  (0.49	  clo).	  
	   The	  meal	   intake	  experiment	  started	  with	  a	  baseline	  measurement	  of	  45	  minutes	  
(Figure	  1)	  after	  which	  each	  subject	  ingested	  a	  high-­‐calorie	  (average:	  1622	  ±	  222	  kcal),	  
carbohydrate-­‐rich	   (78%	   CHO,	   10%	   F,	   12%	   P)	   meal	   consisting	   of	   50%	   of	   their	   daily	  
required	  energy	   intake.	  Subject’s	  total	  daily	  required	  energy	   intake	  was	  based	  on	  the	  
basal	  metabolic	   rate	  determined	  by	   the	  Harris	  &	  Benedict	   formula	   (22)	  multiplied	  by	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the	   physical	   activity	   level	   (PAL),	  which	  was	   based	  on	   the	  Baecke	  Questionnaire	   (23).	  
The	  meal	   was	   served	   by	   the	   researcher	   in	   a	   liquid	   form	   (Nutriprotein	   and	   Nutrical,	  
Nutricia,	   the	   Netherlands),	   in	   order	   to	   obtain	   maximal	   uptake	   rate	   in	   the	   gastro-­‐
intestinal	   tract.	   After	   the	   subjects	   finished	   the	   meal	   (within	   15	   minutes),	   energy	  
expenditure	  was	  measured	  for	  two	  hours.	  The	  [18F]FDG-­‐tracer	  (50	  MBq,	  1.35	  mCi)	  was	  
injected	   75	   minutes	   after	   the	   completion	   of	   the	   meal,	   as	   pilot	   studies	   (n=6)	   in	   our	  
laboratory	   showed	   the	  highest	  peak	   in	  postprandial	  energy	  expenditure	  at	   this	   time-­‐
point,	   assuming	   maximal	   BAT	   activity.	   For	   the	   analysis	   of	   postprandial	   energy	  
expenditure	   a	   stable	   period	   of	   20	   minutes	   after	   the	   tracer	   injection	   was	   averaged.	  
Diet-­‐induced	   thermogenesis	  was	  measured	  as	   the	   increase	   (in	  percentage)	  of	  energy	  
expenditure	  during	  these	  20	  minutes	  compared	  to	  baseline.	  This	  period	  was	  chosen	  to	  
relate	  DIT	  to	  BAT	  activity,	  as	  the	  latter	  is	  determined	  in	  the	  post-­‐tracer	  period	  as	  well.	  
Blood	  samples	  were	  drawn	  during	  baseline,	  30	  minutes,	  60	  minutes	  and	  120	  minutes	  
after	   the	   meal.	   Subjects	   were	   transferred	   to	   the	   positron	   emission	   PET-­‐CT	   scanner	  
(Gemini	  TF	  PET-­‐CT,	  Philips,	  The	  Netherlands)	  one	  hour	  after	  the	  tracer	  injection	  in	  both	  
experiments	   in	  order	   to	  measure	  BAT	  activity.	  Although	  we	  are	  aware	   that	   [18F]FDG-­‐
uptake	   measures	   glucose	   uptake,	   and	   not	   directly	   BAT	   oxidative	   metabolism	   and	  
thermogenesis,	  we	  use	  BAT	  activity	  and	  [18F]FDG-­‐uptake	  as	  reciprocal	  terms.	  
	   The	  mild	   cold	   experiment	   consisted	   of	   a	   baseline	  measurement	   of	   45	  minutes,	  
followed	  by	  two	  hours	  of	  mild	  cold	  exposure	  in	  which	  we	  used	  a	  personalized	  cooling	  
protocol	   (24)	   in	   order	   to	   obtain	  maximal	   non-­‐shivering	   thermogenesis.	  We	  used	   the	  
same	   post-­‐tracer	   period	   as	   in	   the	   meal	   experiment	   for	   cold-­‐induced	   energy	  
expenditure	   analysis.	   Cold-­‐induced	   thermogenesis	   was	   defined	   as	   the	   percentual	  
increase	  in	  energy	  expenditure	  during	  this	  period	  compared	  to	  baseline.	  The	  [18F]FDG	  
tracer	  was	   injected	   one	   hour	   after	   the	   onset	   of	   cold	   exposure.	   Blood	   samples	  were	  
drawn	  during	  baseline	  and	  after	  one	  hour	  of	  cold	  exposure.	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Figure	   1.	   Study	   protocol.	   Both	   experiments	   started	   with	   a	   baseline	   period	   of	   45	   minutes	   during	   25	   °C	  
degrees.	  A	  blood	  sample	  was	  taken	  at	  the	  end	  of	  this	  period.	  In	  the	  meal	  experiment,	  subjects	  were	  asked	  to	  
ingest	  the	  meal	  within	  15	  minutes.	  The	  postprandial	  period	  lasted	  for	  120	  minutes.	  One	  hour	  and	  15	  minutes	  
after	  the	  meal,	  the	  [18]F-­‐FDG	  tracer	  (t	  =	  75	  min)	  was	  injected	  followed	  by	  the	  PET-­‐CT	  scan	  one	  hour	  later.	  The	  
rest	  period	  of	  15	  minutes	  was	  held	  to	  standardize	  the	  time	  between	  injection	  and	  PET-­‐CT	  scan	  (one	  hour).	  
Blood	   samples	  were	   taken	  30,	   60	  and	  120	  minutes	  after	   the	  meal.	   The	  mild	   cold	  exposure	   lasted	   for	  120	  
minutes,	   and	   one	   hour	   after	   the	   onset	   of	   the	   cold	   exposure	   a	   blood	   sample	  was	   taken	   and	   the	   [18]F-­‐FDG	  
tracer	  was	  injected.	  The	  PET-­‐CT	  scan	  was	  conducted	  one	  hour	  after	  the	  [18]F-­‐FDG	  injection	  (t=120).	  
PET	  protocol	  and	  analysis	  
The	  PET-­‐CT	  scanning	  protocol	  and	  analysis	  were	  similar	   to	  our	  previous	  studies	  using	  
static	   imaging	   (24),	   in	  which	  a	   low-­‐dose	  CT	   scan	   (120	  kV,	  30	  mAs)	  preceded	   the	  PET	  
scan.	  The	  PET	  scan	  was	  used	  to	  determine	  the	  FDG-­‐uptake	  and	  the	  CT	  image	  was	  used	  
for	   attenuation	   and	   scatter	   correction	   of	   the	   PET	   scan.	   We	   used	   PMOD	   software,	  
version	  3.0	  (PMOD	  Technologies)	  for	  the	  analysis	  of	  BAT	  activity.	  The	  PET-­‐images	  were	  
checked	   for	   remaining	   radioactivity	   at	   the	   injection	   site,	   and	   these	   concentrations	  
were	  all	  below	  1%	  of	  the	  total	  activity	  of	   [18F]FDG	  present	   in	  the	  body	  at	  the	  time	  of	  
scanning.	  
	   Together,	  the	  researcher	  and	  a	  nuclear-­‐medicine	  physician	  (BB)	  analyzed	  the	  PET-­‐
CT	  images.	  We	  analyzed	  the	  average	  SUV	  (SUVmean)	  in	  the	  cold	  and	  meal	  experiment	  in	  
supraclavicular	  BAT,	   subcutaneous	  WAT	  and	  visceral	  WAT,	   skeletal	  muscle,	   liver,	  and	  
brain.	   The	   SUVmean	   of	   each	   tissue	   was	   calculated	   by	   selecting	   cubes	   as	   volume	   of	  
interests	   on	   the	   relevant	   tissues.	   The	   same	   anatomical	   locations	   were	   used	   in	   the	  
analysis	  of	  both	  experiments.	  The	  SUVmean	  of	  BAT	  was	  measured	  in	  the	  supraclavicular	  
fat	   area	   (total	   volume	   2.67	   cm3).	   To	   determine	   the	   average	   [18F]FDG-­‐uptake	   in	   the	  
deltoid	   muscle	   and	   the	   triceps	   and	   biceps	   brachii	   muscle,	   we	   analyzed	   the	   middle	  
(thickest)	  part	  of	  these	  muscles	  in	  both	  arms.	  The	  uptake	  in	  the	  erector	  spinae	  muscle	  
was	  measured	  in	  the	  cervical	  (C-­‐7),	  thoracic	  (T-­‐8),	  and	  lumbal	  (L-­‐3)	  part	  of	  the	  muscle	  
(total	   volume	   in	   muscle	   32	   cm3).	   The	   subcutaneous	   WAT	   was	   measured	   in	   the	  
dorsolumbar	  region	  near	  vertebrae	  L-­‐3	  and	  L-­‐4	  (8	  cm3),	  whereas	  the	  visceral	  WAT	  was	  
measured	   behind	   the	   xiphoid	   (0.14	   cm3).	   The	   middle	   part	   of	   liver	   was	   chosen	   for	  
analysis	   and	   we	   avoided	   uptake	   in	   large	   blood	   vessels	   by	   carefully	   distinguishing	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between	  the	  liver	  segments	  (4	  cm3).	  Brain	  activity	  was	  measured	  in	  the	  right	  and	  left	  
cerebellum	  (8	  cm3).	  Adipose	  tissue	  was	  distinguished	  from	  muscle	  tissue	  by	  means	  of	  
Hounsfield	  Units	  (CT	  scan),	  in	  which	  adipose	  tissue	  was	  considered	  to	  lie	  within	  -­‐10	  to	  -­‐
180	  HU	  and	  skeletal	  muscle	  between	  +15	  and	  +100	  HU.	  	  
Blood	  analysis	  	  
Blood	  was	  collected	  from	  the	  antecubital	  vein	  to	  determine	  several	  blood	  parameters.	  
Plasma	   concentrations	   of	   free	   fatty	   acids	   (NEFA-­‐HR	   set,	   Wako	   Chemicals,	   Neuss,	  
Germany),	  free	  glycerol	  (Glycerol	  kit,	  R-­‐Biopharm,	  Darmstadt,	  Germany)	  total	  glycerol	  
(ABX	  Triglyceriden	  CP,	  Radiometer,	  Horiba	  ABX,	  Montpellier,	  France)	  and	  glucose	  (ABX	  
Glucose	  HK	  CP,	  Radiometer,	  Horiba	  ABX,	  Montpellier,	   France)	  were	  determined	  on	  a	  
COBAS	   FARA	   centrifugal	   spectrophotometer	   (Roche	   Diagnostica,	   Basel,	   Switzerland).	  
Plasma	   triglyceride	   concentrations	  were	   calculated	   by	   subtracting	   free	   glycerol	   from	  
the	  total	  glycerol	  concentrations,	  and	  serum	  insulin	  was	  analyzed	  on	  a	  Gamma	  Counter	  
(2470	  Automatic	  Gamma	  Counter	  Wizard2™	  Wallac,	   Perkin	  Elmer,	  USA)	  with	  a	  Human	  
Insulin	   specific	  RIA	  kit	   (Milipore,	  USA).	  Plasma	  norepinephrine	  and	  epinephrine	  were	  
analyzed	   using	   reagents	   from	   Recipe	   (Recipe	   Chemicals	   and	   Instruments,	   Munich,	  
Germany)	  on	  a	  HPLC	  through	  electrochemical	  detection.	  
Statistical	  analysis	  
Statistical	  analysis	  was	  performed	  with	  IBM	  SPSS	  Statistics18.0	  for	  Mac.	  Reported	  data	  
are	   expressed	   as	  means	   ±	   SD.	   The	   differences	   between	   baseline	   and	   cold	   exposure	  
have	   been	   compared	   by	  Wilcoxon’s	   test	   (n=6).	   	   Paired	   sample	   t-­‐tests	   were	   used	   to	  
compare	   the	   difference	   between	   baseline	   and	   dietary	   intake	   (n=11).	   The	   SUVmean	  
values	   for	   the	   various	   tissues	   in	   the	   cold	   and	   meal	   experiment	   were	   compared	   by	  
Wilcoxon’s	  test	  (n=6).	  Blood	  parameters	  within	  the	  meal	  experiment	  were	  analyzed	  by	  
one-­‐way	   ANOVA	   with	   Bonferroni	   correction	   for	   post	   hoc	   analysis.	   Spearman	   rank	  
correlation	   (n=6)	  and	  Pearson	  correlation	   (n=11)	  were	  performed	   in	  order	  to	   identify	  
relationships	   between	   variables.	   P	   values	   of	   less	   than	   0.05	   were	   considered	   as	  
statistically	  significant.	  
Results	  
Cold	  –and	  diet-­‐induced	  thermogenesis	  
Energy	   expenditure	   significantly	   increased	   in	   the	   postprandial	   phase	   compared	   to	  
baseline	   (P	   <	   0.001;	   Figure	   2A),	   with	   an	   average	   DIT	   of	   19.9%	   (range	   6.9	   –	   31.3%).	  
During	  cold	  exposure,	  energy	  expenditure	  significantly	  increased	  compared	  to	  baseline	  
as	  well	  (P	  =	  0.028;	  Figure	  2A),	  with	  an	  average	  CIT	  of	  13.1%	  (range	  7	  –	  17.1%).	  There	  
was	  no	  relationship	  between	  CIT	  and	  DIT	  (n=6).	  As	  expected,	  the	  respiratory	  quotient	  
significantly	   increased	   after	   the	   meal	   (P	   <	   0.001;	   Figure	   2B).	   Furthermore,	  
BROWN	  ADIPOSE 	  T ISSUE 	  ACTIV ITY 	  AFTER	  D IETARY	   INTAKE 	  
44	  
carbohydrate	   oxidation	   increased	   after	   the	  meal	   (P	   <	   0.001;	  Figure	   2C),	  whereas	   fat	  
oxidation	   decreased	   (P	   =	   0.027;	   Figure	   2D).	   During	   cold	   exposure,	   there	   was	   a	  
preference	   for	   the	  use	  of	   fat	   as	   a	   substrate	  as	   shown	  by	   the	  decrease	   in	   respiratory	  
quotient	   (P	   =	   0.041)	   and	   increase	   in	   fat	   oxidation	   (P	   =	   0.028).	   The	   oxidation	   of	  
carbohydrates	   decreased	   during	   cold	   exposure	   (P	   =	   0.046).	   The	   effects	   of	   both	  
interventions	  on	  heart	  rate,	  blood	  pressure,	  and	  body	  temperatures	  are	  summarized	  in	  
Table	  1.	  
	  
Table	   1.	   The	   effect	   of	   the	   meal	   and	   cold	   exposure	   on	   metabolic,	   cardiovascular,	   and	   thermoregulatory	  
parameters	  
	   Meal	  (n=11)	   Cold	  (n=6)	  
Parameter	   Baseline	   Meal	   	   Baseline	   Cold	  
Heart	  rate	  (beats/min)	   61±7.9	   74±10.2	  **	   55±3.5	  	   52±3.2	  *	  
Systolic	  blood	  pressure	  (mmHg)	   119±6	   126±6.8	  **	   120±9.2	  	   133±8.9	  *	  	  
Diastolic	  blood	  pressure	  (mmHg)	   70±6.1	   71±6.8	  	   73±3.2	   82±6.2	  *	  	  
Mean	  Skin	  Temperature	  (°C)	   33.2±0.4	   33.5±0.4	  **	   32.7±0.3	   28.8±0.5	  *	  
Core	  Temperature	  (°C)	   36.9±0.1	   36.8±0.3	  *	   36.9±0.2	   36.9±0.2	  
Proximal	  Temperature	  (°C)	   34.2±0.3	   35.0±0.4	  **	  	   33.3±0.6	   30.8±1.2	  *	  
Distal	  Temperature	  (°C)	   31.2±1.8	   31.1±2.1	  	   30.8±1.2	   22.6±1.1	  *	  
Gradient	  proximal,	  distal	  (°C)	   3.0±1.8	   3.9±2.5	  *	   2.5±1.9	   8.2±2.0	  *	  
All	  values	  are	  means	  ±	  SDs.	  Paired	  sample	  t-­‐test	  was	  used	  to	  analyze	  differences	  between	  meal	  and	  baseline	  
and	  Wilcoxon	  test	  to	  analyze	  differences	  between	  cold	  and	  baseline.	  *	  P	  <	  0.05,	  **	  P	  <	  0.001	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Figure	  2.	  Mean	  (±SD)	  energy	  expenditure	  and	  substrate	  oxidation	  after	  meal	   intake	  and	  cold	  exposure.	  (A)	  
Energy	  expenditure,	   (B)	   respiratory	  quotient,	   (C)	   carbohydrate	  oxidation,	   (D)	   fat	  oxidation	  during	  baseline	  
(white	  bars)	  and	  intervention	  (black	  bars)	  in	  the	  postprandial	  state	  (n	  =	  11)	  and	  during	  cold	  exposure	  (n	  =	  6)	  
measured	  during	   the	  post-­‐tracer	  period.	  Wilcoxon	   signed-­‐rank	   tests	  were	  used	   to	  measure	   the	  difference	  
between	  both	  experiments.	  *	  Significantly	  different	  from	  baseline,	  P	  <	  0.05.	  **	  Significantly	  different	  from	  
baseline,	  P	  <	  0.001.	  CHO,	  carbohydrate;	  EE,	  energy	  expenditure;	  RQ,	  respiratory	  quotient.	  
Glucose	  uptake	  in	  brown	  adipose	  tissue	  and	  additional	  tissues	  
The	   [18F]FDG-­‐uptake	   in	   the	   upper	   body	   is	   depicted	   in	   Figure	   3A,	   3B.	   Interestingly,	  
average	   postprandial	   [18F]FDG-­‐uptake	   in	   BAT	   (1.65	   ±	   0.99	   SUVmean)	   was	   markedly	  
higher	  than	  in	  subcutaneous	  (0.35	  ±	  0.15	  SUVmean,	  P	  <	  0.001)	  and	  visceral	  (0.49	  ±	  0.24	  
SUVmean,	  P	  <	  0.001)	  WAT,	  and	  in	  the	  liver	  (0.95	  ±	  0.28	  SUVmean,	  P	  =	  0.042)	  (Figure	  3C).	  
The	  average	  [18F]FDG-­‐uptake	  trended	  to	  be	  higher	  compared	  to	  skeletal	  muscle	  (1.36	  ±	  
0.31	  SUVmean),	  although	   this	  difference	  was	  not	   statistically	   significant.	  The	  activity	   in	  
BAT	  was	  comparable	  to	  the	  brain	  (1.81	  ±	  0.42	  SUVmean,	  NS).	  	  
	   Cold	   exposure	   activated	   BAT	   as	   demonstrated	   by	   [18F]FDG-­‐uptake	   in	   the	   neck,	  
supraclavicular,	   paraspinal,	   para-­‐aortic,	   axillary,	  mediastinal,	   and	   perirenal	   regions	   in	  
all	  subjects	  (Figure	  3A,	  3B).	  Also	  during	  cold	  exposure,	  the	  [18F]FDG-­‐uptake	  was	  similar	  
in	  BAT	   (7.19	  ±	  2.09	  SUVmean)	   and	  brain	   (7.19	  ±	  0.74	  SUVmean)	   (Figure	   3D).	   	  Uptake	  of	  
[18F]FDG	  in	  BAT	  was	  significantly	  higher	  than	  in	  skeletal	  muscle	  (0.59	  ±	  0.07	  SUVmean,	  P	  =	  
0.028)	  ,	  subcutaneous	  WAT	  (0.18	  ±	  0.05	  SUVmean,	  P	  =	  0.028),	  visceral	  WAT	  (0.51	  ±	  0.23	  
SUVmean,	  P	  =	  0.028),	  and	  the	  liver	  (1.83	  ±	  0.28	  SUVmean,	  P	  =	  0.028).	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   Comparing	   meal	   with	   cold	   exposure	   demonstrated	   that	   the	   [18F]FDG-­‐uptake	   in	  
BAT	  (P	  =	  0.028),	  liver	  (P	  =	  0.028)	  and	  brain	  (P	  =	  0.043)	  were	  significantly	  lower	  during	  
the	  meal	  experiment	  compared	  to	  cold	  exposure	  (Figure	  3E),	  whereas	  skeletal	  muscle	  
uptake	  was	   significantly	  higher	  during	   the	  meal	   experiment	   (P	   =	   0.028).	   This	   reflects	  
the	   well-­‐known	   role	   of	   skeletal	   muscle	   in	   postprandial	   glucose	   homeostasis.	   The	  
[18F]FDG-­‐uptake	   in	   WAT	   was	   not	   significantly	   different	   between	   cold	   and	   meal,	  




Figure	  3.	  Mean	  (±SD)	  uptake	  of	  [18F]FDG	  in	  BAT	  and	  other	  tissues	  during	  cold	  exposure	  and	  the	  postprandial	  
state.	  (A)	  [18F]FDG	  PET	  images	  of	  one	  subject	  demonstrating	  BAT	  activity	  (black	  arrows)	  after	  the	  meal	  (left)	  
and	   during	   cold	   exposure	   (right).	   (B)	   Transversal	   CT	   (top)	   and	   PET/CT	   fusion	   slices	   of	   the	   supraclavicular	  
region	  demonstrating	  BAT	  activity	  (white	  arrows)	  after	  the	  meal	  (middle)	  and	  during	  cold	  exposure	  (bottom).	  
(C)	  Comparison	  (paired	  sample	  t-­‐tests)	  of	  [18F]FDG-­‐uptake	  in	  BAT	  with	  several	  tissues	  after	  the	  meal	  (n=11,	  #	  
n=8).	  (D)	  Comparison	  (Wilcoxon	  signed-­‐rank	  tests)	  of	  [18F]FDG-­‐uptake	  in	  BAT	  with	  several	  tissues	  during	  cold	  
exposure	   (n=6,	  #	  n=5).	   (E)	  Comparison	   (Wilcoxon	   signed-­‐rank	   tests)	  of	   the	   [18F]FDG-­‐uptake	  after	   the	  meal	  
CHAPTER	  3 	  
47	  	  
with	   cold	   exposure	   (n=6,	   #	   n=5).	   (F)	   Illustration	   of	   the	   [18F]FDG-­‐uptake	   in	   all	   tissues	   relative	   to	   the	   brain	  
(cerebellum)	  to	  indicate	  tracer	  competition.	  The	  [18F]FDG-­‐uptake	  in	  the	  cerebellum	  was	  set	  at	  100%,	  as	  brain	  
glucose	   uptake	  was	   expected	   to	   be	   constant	   during	   both	   interventions.	  Wilcoxon	   signed-­‐rank	   tests	   were	  
used	  to	  determine	  the	  differences	  in	  [18F]FDG-­‐uptake	  between	  the	  cold	  and	  meal	  experiment	  (n=6,	  #	  n=5).	  
(G)	  Comparison	  (Mann-­‐Whitney	  U	  test)	  of	  the	  postprandial	  [18F]FDG-­‐uptake	  (current	  study)	  with	  the	  uptake	  
in	  the	  fasted	  state	  during	  thermoneutral	  conditions	  measured	  in	  a	  previous	  study	  (n=3)(1).	  *	  P	  <0.05,	  **	  P	  
<0.001	  significantly	  different	  from	  BAT.	  §	  P	  <	  0.05	  cold	  exposure	  significantly	  different	  from	  the	  postprandial	  
state.	  $	  P	  <	  0.05	  postprandial	  state	  significantly	  different	  from	  fasted	  thermoneutral	  conditions.	  BAT,	  brown	  
adipose	   tissue;	  CT,	   computed	   tomography;	  PET,	  positron	  emission	   tomography;	   SM,	   skeletal	  muscle;	   SUV,	  
standard	  uptake	  value;	  WATs,	  subcutaneous	  white	  adipose	  tissue;	  WATv,	  visceral	  white	  adipose	  tissue.	  
	  
The	  high	  postprandial	  [18F]FDG-­‐uptake	  in	  skeletal	  muscle,	  combined	  with	  	  the	  fact	  that	  
total	  mass	  of	  skeletal	  muscle	  is	  much	  larger	  than	  any	  other	  organ	  in	  the	  human	  body,	  
resulted	  in	  a	  marked	  change	  in	  [18F]FDG	  distribution	  volume	  and	  a	  large	  fraction	  of	  the	  
[18F]FDG	  tracer	  to	  be	  directed	  to	  muscle.	  This	  high	  [18F]FDG-­‐uptake	  in	  skeletal	  muscle	  
might	  have	  reduced	  the	  availability	  of	  [18F]FDG	  for	  other	  tissues,	  which	  is	  clearly	  visible	  
in	   the	   cerebellum	   (Figure	   3A).	   Normally,	   glucose	   uptake/metabolism	   is	   held	   fairly	  
constant	   in	   the	   brain,	   since	   glucose	   is	   the	   brain’s	   major	   fuel.	   We	   therefore	  
hypothesized	   that	   this	   tracer	   competition	   might	   have	   underestimated	   true	   glucose	  
uptake	  in	  BAT.	  In	  order	  to	  correct	  for	  this,	  we	  also	  expressed	  the	  SUVmean	  in	  the	  tissues	  
as	  percentages	  of	   total	   [18F]FDG-­‐uptake	   in	  the	  cerebellum	  (Figure	  3F)	   (25).	  We	  chose	  
the	  cerebellum	  as	  a	  representative	  brain	  region	  because	  it	  has	  been	  shown	  previously	  
that	   cold	   exposure	   does	   not	   affect	   metabolism	   in	   the	   cerebellum	   (26),	   and	  
furthermore	  that	  the	  cerebellum	  is	  the	  most	  reliable	  reference	  area	  in	  the	  brain	  during	  
mild	  hyperglycemic	  conditions	  (25).	  	  Figure	  3F	  illustrates	  the	  possible	  underestimation	  
of	   [18F]FDG-­‐uptake	   in	  BAT	  (and	  the	  other	  tissues)	  during	  postprandial	  conditions,	  and	  
indicates	   that	  glucose	  uptake	   in	  BAT	   in	   the	  postprandial	  state	  may	  be	  comparable	   to	  
the	  cold-­‐stimulated	  condition.	  	  
	   In	  addition,	  we	  compared	  the	  postprandial	  [18F]FDG-­‐uptake	  with	  the	  uptake	  in	  the	  
fasted	  state	  measured	  during	  thermoneutral	  conditions	   in	  a	  previous	  study	   (n=3)	   (1).	  
The	   [18F]FDG-­‐uptake	   in	   BAT	   was	   significantly	   higher	   during	   the	   postprandial	   state	  
compared	   to	   fasted	   thermoneutral	   (FTN)	   conditions	   (meal:	   1.65	   ±	   0.99	   versus	   FTN:	  
0.51±	   0.05	   SUVmean,	   P	   =	   0.024,	   Figure	   3G),	   confirming	   increased	   postprandial	   BAT	  
glucose	   uptake.	   Furthermore,	   postprandial	   [18F]FDG-­‐uptake	   in	   skeletal	   muscle	   was	  
higher	  (meal:	  1.36	  ±	  0.31	  SUVmean	  versus	  FTN:	  0.54	  ±	  0.07	  SUVmean,	  P	  =	  0.01),	  whereas	  
the	  uptake	   in	   the	   liver	  was	   lower	   (meal:	  0.95	  ±	  0.28	  SUVmean	  versus	  FTN:	  1.62	  ±	  0.36	  
SUVmean,	  P	  =	  0.024)	  compared	   to	  FTN	  conditions.	  Unfortunately,	  we	  could	  not	  obtain	  
the	  [18F]FDG-­‐uptake	  values	  in	  the	  brain	  during	  the	  FTN	  conditions.	  	  
	   We	  also	  analyzed	  the	  relationships	  between	  BAT	  and	  energy	  expenditure	  in	  both	  
experiments.	   Interestingly,	   there	   was	   a	   significant	   relation	   between	   CIT	   and	   cold-­‐
induced	   BAT	   activity	   (r	   =	   0.83,	   P	   =	   0.042;	   n=6).	   However,	   there	   was	   no	   association	  
between	  postprandial	  BAT	  activity	  and	  DIT	  (r	  =	  0.11,	  NS;	  n=11).	  Finally,	  we	  did	  not	  find	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a	   relationship	  between	  cold-­‐induced	  BAT	  activity	   and	  postprandial	  BAT	  activity	   (r	  =	   -­‐
0.49,	  NS;	  n=6).	  	  
Hormones,	  metabolites,	  and	  cold	  acclimatization	  
As	  expected,	  the	  intake	  of	  the	  carbohydrate-­‐rich	  meal	  significantly	  suppressed	  lipolysis	  
already	  after	  30	  minutes	  as	  demonstrated	  by	  decreased	  plasma	  free	  fatty	  acids	  (FFA’s)	  
(P	   	   <	   0.001)	   and	   free	   glycerol	   (P	   =	   0.031)	   concentrations,	   and	   remained	   significantly	  
suppressed	   during	   the	   entire	   experiment.	   The	   meal	   significantly	   increased	   plasma	  
glucose	   concentrations	   at	   all	   time	   points	   (P	   <	   0.001),	   as	   well	   as	   plasma	   insulin	  
concentrations	   (t=30,	   P	   =	   0.004;	   t=60	   and	   t=120,	   p	   <	   0.001).	   Norepinephrine	   (NE)	  
concentrations	  tended	  to	  increase	  after	  the	  meal	  (P	  =	  0.10).	  In	  contrast,	  cold	  exposure	  
increased	   lipolysis	   as	   shown	   by	   increased	   FFA	   (P	   =	   0.028)	   and	   free	   glycerol	  
concentrations	   (Table	   2).	   Furthermore,	   plasma	   norepinephrine	   concentration	   was	  
significantly	   increased	   during	   cold	   exposure	   (P	   =	   0.028)	   suggesting	   increased	  
sympathetic	  norepinephrine	  spill	  over.	  We	  found	  no	  correlation	  between	  postprandial	  
NE	  concentrations	  and	  both	  BAT	  activity	  and	  DIT.	  In	  addition	  no	  correlation	  was	  found	  
between	   NE	   and	   cold-­‐induced	   BAT	   activity	   and	   thermogenesis.	   We	   found	   a	  
relationship	  between	  plasma	  insulin	  concentrations	  (AUC)	  and	  BAT	  activity	  (r	  =	  0.61,	  P	  
=	  0.045),	  whereas	  no	  relationship	  was	  present	  between	  plasma	  glucose	  concentrations	  
(AUC)	  and	  BAT	  activity	  (r	  =	  -­‐0.08,	  P	  =	  0.812).	  
	   Interestingly	  we	   observed	   a	   negative	   relationship	   between	   the	   average	   outdoor	  
temperatures	  during	  the	  two	  weeks	  previous	  to	  the	  experiment	   (obtained	  from	   local	  
weather	  station)	  and	  postprandial	  [18F]FDG-­‐uptake	  in	  BAT	  (r	  =	  -­‐0.72,	  P	  =	  0.012,	  Figure	  
4A),	  subcutaneous	  WAT	  (r	  =	  -­‐0.60,	  P	  =	  0.046,	  Figure	  4B),	  and	  visceral	  WAT	  (r	  =	  -­‐0.83,	  P	  
=	  0.002,	  Figure	  4C).	  	  
	  
Table	  2.	  Hormone	  and	  metabolite	  concentrations	  in	  the	  postprandial	  state	  and	  during	  cold	  exposure	  
	   Meal	  (n=11)	   Cold	  (n=6)	  
Parameter	   Baseline	   Diet	  30	  min	   Diet	  60	  min	   Diet	  120	  min	   	  Baseline	   Cold	  60	  min	  
FFA	  (µmol/L)	   378±64	   201±63	  **	   98.2±26.8	  **	   68.2±10.4	  **	   401±93	   756±154	  *	  
Glyc	  free	  (µmol/L)	   51.8±12.5	   39.8±9.8	  *	   32.7±15.4	  *	   28.6±15.3	  **	   55.9±10.8	   123±36	  *	  
TG	  (µmol/L)	   750±253	   926±417	   934±422	   815±307	   776±234	   811±273	  
Glucose	  (mmol/L)	   5.1±0.2	   7.9±1.3	  **	   7.2±1.3	  **	   6.6±0.8	  **	   5.1±0.2	   5.0±0.2	  
Insulin	  (mU/mL)	   12.5±3.3	   155±99	  *	   120±33	  **	   124±59	  **	   12.3±2.1	   12.7±1.7	  
NE	  (ng/L)	   318±148	   429±253	   385±175	   369±152	   239±101	   641±140	  *	  
Epi	  (ng/L)	   32.0±10.6	   26.3±9.3	   28.6±12.6	   32.0±12.6	   29.6±9.1	   26.2±11.8	  
All	  values	  are	  means	  ±	  SDs.	  ANOVA	  with	  Bonferroni	  correction	  was	  used	  to	  analyze	  differences	  between	  the	  
meal	  and	  baseline	  and	  Wilcoxon	  test	   to	  analyze	  differences	  between	  cold	  and	  baseline.	  *	  P	  <	  0.05,	  **	  P	  <	  
0.001.	  Epi,	  epinephrine;	  Glyc,	  glycerol;	  FFA,	  free	  fatty	  acids;	  NE,	  norepinephrine	  TG,	  triglycerides.	  
	  
CHAPTER	  3 	  
49	  	  
	  
Figure	   4.	  Relationship	  between	  postprandial	   [18F]FDG-­‐uptake	   in	  BAT	   (A),	  WATs	   (B),	  and	  WATv	   (C)	  with	   the	  
mean	  outdoor	  temperature	  over	  2	  weeks	  previous	  to	  the	  meal	  experiment.	  BAT,	  brown	  adipose	  tissue;	  FDG,	  
fluorodeoxyglucose;	   r,	   Pearson	   correlation	   coefficient;	   WATs,	   subcutaneous	   white	   adipose	   tissue,	   WATv,	  
visceral	  white	  adipose	  tissue.	  	  
Discussion	  
We	  here	  show	  postprandial	  glucose	  uptake	  in	  BAT	  in	  lean	  young	  adult	  men.	  We	  found	  
that	   the	   average	   [18F]FDG-­‐uptake	   in	  BAT	   after	   a	   high-­‐calorie,	   carbohydrate-­‐rich	  meal	  
was	  higher	  compared	  to	  WAT	  and	  the	  liver.	  In	  fact,	  [18F]FDG-­‐uptake	  in	  BAT	  tended	  to	  
be	  higher	  compared	  to	  skeletal	  muscle,	  which	  is	  well-­‐known	  for	  its	  role	  in	  postprandial	  
glucose	   homeostasis,	   and	   comparable	   to	   the	   brain.	   Furthermore,	   [18F]FDG-­‐uptake	   in	  
BAT	  during	  the	  postprandial	  state	  was	  significantly	  higher	  compared	  to	  the	  fasted	  state	  
(during	   thermoneutral	   conditions)	   measured	   in	   a	   previous	   study	   (1).	   These	   results	  
indicate	  that	  a	  single	  meal	  may	  be	  able	  to	  activate	  human	  brown	  adipose	  tissue.	  
The	   absolute	   magnitude	   of	   postprandial	   BAT	   activity	   was	   lower	   compared	   to	   cold-­‐
induced	   BAT	   activity,	   which	   is	   in	   agreement	   with	   findings	   in	   rodent	   studies	   (7).	  
However,	   postprandial	   BAT	   activity	  may	   have	   been	   underestimated	   due	   to	   the	   high	  
tracer	   uptake	   in	   skeletal	   muscle,	   thereby	   diminishing	   tracer	   bioavailability	   for	   other	  
tissues.	  This	  was	  clearly	  illustrated	  by	  a	  decrease	  in	  [18F]FDG-­‐uptake	  in	  the	  cerebellum,	  
which	   glucose	   uptake/metabolism	   was	   expected	   to	   be	   constant	   during	   both	  
experimental	   conditions.	   This	   unexpected	   decrease	   of	   [18F]FDG-­‐uptake	   has	   been	  
observed	   previously	   during	   postprandial	   mild	   hyperglycemic	   conditions	   (110-­‐160	  
mg/dL	   ≈	   6.2	   –	   8.9	   mmol/L)	   (25).	   Adjusting	   for	   this	   “stealing	   effect”,	   by	   expressing	  
[18F]FDG-­‐uptake	  relative	  to	  the	  cerebellum,	  suggests	  that	  postprandial	  glucose	  uptake	  
in	   BAT	   is	   comparable	   to	   cold-­‐induced	   BAT	   activation.	   It	   should	   be	   noted	   that	   this	  
adjustment	   assumes	   that	   glucose	   uptake	   in	   the	   cerebellum	   is	   unaffected	   by	   meal	  
consumption.	   In	   addition	   to	   the	   stealing	   phenomenon,	   the	   [18F]FDG-­‐uptake	   in	   the	  
brain	  could	  also	  be	  reduced	  due	  to	  increased	  saturation	  of	  the	  glucose	  transporters	  by	  
glucose	   originating	   from	   the	   meal	   (27).	   Nevertheless,	   postprandial	   [18F]FDG-­‐uptake	  
was	  highest	  in	  BAT	  of	  all	  peripheral	  tissues	  studied.	  	  
	   So	   far,	   an	   effect	   of	  meal	   consumption	   on	   BAT	   activity	   in	   humans	   has	   not	   been	  
studied	  directly.	  A	  recent	  study	  in	  humans	  examined	  the	  effects	  of	  a	  high	  fat	  meal	  on	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BAT	   activity,	   however	   these	  measurements	  were	   combined	  with	   cold	   exposure	   (28).	  
[18F]FDG-­‐uptake	   in	   BAT	   upon	   cold	   exposure	   was	   higher	   when	   subjects	   were	   in	   the	  
fasted	  state	  compared	  to	  the	  (high-­‐fat)	  fed	  state.	  Although	  these	  results	  seem	  contrary	  
to	  our	  findings,	  they	  are	  also	  confounded	  by	  the	  high	  glucose	  uptake	  in	  skeletal	  muscle	  
after	   the	   high-­‐fat	   meal,	   which	   precludes	   separation	   of	   the	   effects	   of	   cold	   from	   the	  
effect	   of	   meal	   on	   BAT	   activity.	   	   In	   fact,	   the	   authors	   also	   concluded	   that	   the	   lower	  
uptake	   in	   BAT	   was	   likely	   due	   to	   tracer	   dilution	   by	   skeletal	   muscle.	   They	   did	   not	  
measure	  uptake	  in	  the	  brain,	  although	  the	  PET-­‐image	  depicted	  in	  their	  paper	  indicates	  
reduced	   postprandial	   brain	   [18F]FDG-­‐uptake	   compared	   to	   cold	   exposure.	   The	  
advantage	  of	  our	  study	   is	   that	  we	  did	  not	  combine	  the	  postprandial	   study	  with	  cold-­‐
exposure	  in	  one	  single	  experimental	  test,	  which	  allows	  us	  to	  directly	  test	  the	  effect	  of	  a	  
single	  meal	  on	  BAT	  activity.	  
	   Another	  human	  study	  investigated	  the	  effects	  of	  insulin	  infusion	  (hyperinsulinemic	  
euglycemic	  clamp)	  on	  glucose	  uptake	  in	  BAT	  (in	  a	  warm	  environment)	  and	  found	  that	  
the	   uptake	   rate	   was	   higher	   compared	   to	   WAT	   and	   comparable	   to	   skeletal	   muscle,	  
indicating	  BAT	  to	  be	  an	   insulin	  sensitive	   tissue	   (5).	   In	  contrast	   to	  cold	  exposure,	   they	  
did	  not	  find	  increased	  BAT	  perfusion,	  which	  shows	  that	  insulin	  by	  itself	  does	  not	  induce	  
BAT	  thermogenesis,	  for	  which	  BAT	  perfusion	  is	  an	  indirect	  measure.	  Furthermore,	  they	  
did	   not	   find	   increased	   plasma	   NE	   concentrations,	   suggesting	   no	   sympathetic	  
stimulation	  by	   insulin.	  Whether	   in	  the	  present	  study	  BAT	  glucose	  uptake	  reflects	  BAT	  
thermogenesis	   or	   solely	   insulin	   mediated	   glucose	   uptake	   without	   concomitant	   heat	  
production	   cannot	   be	   determined.	   Interestingly,	   we	   did	   find	   a	   relationship	   between	  
plasma	   insulin	   concentrations	   and	   BAT	   activity,	   indicating	   a	   likely	   role	   for	   insulin	   in	  
mediating	  BAT	  glucose	  uptake	  and	  possibly	  thermogenesis.	  
	   In	  rodents,	  experiments	  have	  repeatedly	  shown	  BAT	  activation	  after	  single	  meals.	  
It	  has	  been	  demonstrated	  that	  a	  single	  meal	   increases	  mitochondrial	  uncoupling	   (15)	  
and	  blood	  flow	  (18)	  in	  BAT,	  as	  well	  as	  oxygen	  consumption	  measured	  in	  vitro	  (19,	  20).	  
This	   is	   likely	   regulated	   via	   the	   SNS,	   since	   NE	   concentrations	   and	   turnover	   also	  
increased	  after	  a	   single	  meal	   (17).	   In	   the	  present	   study	  NE	  concentrations	   tended	   to	  
increase	  after	  the	  meal	  suggesting	  postprandial	  sympathetic	  stimulation.	  We	  however	  
did	  not	   find	   a	   relationship	  between	  postprandial	   [18F]FDG-­‐uptake	   in	  BAT	  and	  plasma	  
NE.	   The	   increased	   sympathetic	   drive	   after	   a	   single	  meal	   found	   in	   rodents	   is	   possibly	  
regulated	   via	   elevated	   concentrations	   of	   glucose	   and	   insulin	   activity	   sensed	   by	   the	  
hypothalamus	  (7).	  This	  might	  be	  true	  for	  insulin	  in	  humans	  as	  well	  as	  demonstrated	  by	  
its	  relationship	  with	  [18F]FDG-­‐uptake	  in	  BAT	  in	  the	  present	  study.	  
	   Although	  [18F]FDG-­‐PET/CT	  scanning	  merely	  measures	  glucose	  uptake,	  it	  would	  be	  
tempting	  to	  suggest	   that	  the	  meal	   induced	  BAT	  thermogenesis.	  However,	  we	  did	  not	  
find	   a	   relation	   between	   BAT	   activity	   and	   DIT.	   It	   should	   be	   noted	   that	   the	   potential	  
contribution	  of	  BAT	  to	  the	  facultative	  part	  of	  DIT	   is	  difficult	  to	  detect	  via	  whole	  body	  
energy	  expenditure	  (29).	  Unfortunately,	  we	  were	  not	  able	  to	  distinguish	  between	  the	  
facultative	  and	  obligatory	  part	  of	  DIT	   in	  the	  current	  experiment.	  With	  respect	  to	  cold	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exposure,	   we	   did	   find	   a	   correlation	   between	   BAT	   activity	   and	   CIT,	   which	   has	   been	  
shown	  previously	  (3,	  5,	  6),	  although	  not	  consistently	  (1,	  24).	  	  
	   Interestingly,	  we	  found	  a	  relationship	  between	  postprandial	  BAT	  activity	  and	  the	  
outdoor	   temperature	   averaged	   over	   two	   weeks	   previous	   to	   the	   experiment.	   This	   is	  
likely	   due	   to	   an	   adaptation	   of	   BAT	   to	   long-­‐term	   cold	   exposure	   (i.e.	   cold	  
acclimatization).	   This	   could	   suggest	   that	   the	   contribution	   of	   BAT	   to	   postprandial	  
thermogenesis	   may	   be	   enhanced	   by	   cold-­‐acclimatization,	   which	   has	   been	   shown	   in	  
rats	  (21).	   It	  could	  thus	  be	  speculated	  that	  BAT	  most	  likely	  contributes	  to	  postprandial	  
glucose	  uptake	  and	  possibly	  thermogenesis	  during	  cold	  seasons.	  	  
	   In	   conclusion,	   glucose	   uptake	   in	   BAT	   increases	   after	   a	   single	   meal	   in	   humans	  
indicating	  a	  role	  for	  BAT	  in	  reducing	  metabolic	  efficiency.	  However,	  we	  did	  not	  find	  a	  
direct	  relation	  between	  BAT	  activity	  and	  DIT.	  The	  quantitative	  contribution	  of	  BAT	  to	  
DIT,	   as	   well	   as	   its	   role	   in	   energy	   balance	   regulation,	   remains	   to	   be	   investigated	   in	  
future	   research.	   It	  would	   also	   be	   important	   to	   determine	  whether	   postprandial	   BAT	  
activity	  is	  reduced	  in	  overweight	  and	  obese	  subjects.	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Abstract	  
Brown	  adipose	  tissue	  (BAT)	   is	  currently	  considered	  as	  a	  target	  to	  combat	  obesity	  and	  
diabetes	   in	   humans.	   BAT	   is	   densely	   innervated	   by	   the	   sympathetic	   nervous	   system	  
(SNS)	  and	  can	  be	  stimulated	  by	  beta-­‐adrenergic	  agonists,	  at	  least	  in	  animals.	  However,	  
the	  exact	  role	  of	  the	  beta-­‐adrenergic	  part	  of	  the	  SNS	  in	  BAT	  activation	  in	  humans	  is	  not	  
known	   yet.	   Here	   we	   measured	   BAT	   activity	   by	   [18F]fluorodeoxyglucose	   ([18F]FDG)	  
PET/CT	   imaging	   in	   10	   lean	   men	   during	   systemic	   infusion	   of	   the	   non-­‐selective	   beta-­‐
agonist	   isoprenaline	   (ISO)	   and	   compared	   this	   with	   cold	   activated	   BAT	   activity.	   ISO	  
successfully	  mimicked	   sympathetic	   stimulation	   as	   shown	  by	   increased	   cardiovascular	  
and	  metabolic	   activity.	   Energy	   expenditure	   increased	   to	   similar	   levels	   as	   during	   cold	  
exposure.	  Surprisingly,	  BAT	  was	  not	  activated	  during	  beta-­‐adrenergic	  stimulation.	  We	  
next	   examined	  whether	   the	   high	   plasma	   free	   fatty	   acids	   (FFA)	   levels	   induced	   by	   ISO	  
competed	   with	   glucose	   ([18F]FDG)-­‐uptake	   in	   BAT	   locations	   by	   blocking	   lipolysis	   with	  
acipimox	   (ACI).	   ACI	   successfully	   lowered	   plasma	   FFA,	   but	   did	   not	   increase	   [18F]FDG-­‐
uptake	   in	   BAT.	   We	   therefore	   conclude	   that	   systemic	   non-­‐selective	   beta-­‐adrenergic	  
stimulation	   by	   ISO	   at	   concentrations	   that	   increase	   energy	   expenditure	   to	   the	   same	  
extent	  as	  cold	  exposure	  does	  not	  activate	  BAT	  in	  humans,	  indicating	  that	  other	  tissues	  
are	  responsible	  for	  the	  increased	  beta-­‐adrenergic	  thermogenesis.	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Introduction	  
Brown	  adipose	  tissue	   (BAT)	   is	  present	  and	  functional	   in	  human	  adults,	  as	  was	  shown	  
recently	  (1-­‐3).	  Due	  to	  its	  high	  metabolic	  capacity,	  this	  organ	  is	  of	  great	  interest	  in	  the	  
current	  worldwide	  obesity	  problem	  and	   its	   related	  metabolic	  diseases	  such	  as	  type	  2	  
diabetes.	  In	  support,	  several	  studies	  in	  humans	  have	  shown	  that	  adiposity	  is	  negatively	  
correlated	  with	  BAT	  presence	  and	  activity	  (1,	  2,	  4,	  5).	  Moreover,	  a	  study	  by	  Bartelt	  et	  
al.	   (6)	   showed	   in	  mice	   that	   BAT	   is	   involved	   in	   triglyceride	   clearance	   and	   thus	   could	  
improve	   blood	   lipid	   profile.	   Furthermore,	   transplantation	   of	   BAT	   in	   streptozotocin	  
(STZ)-­‐diabetic	  mice	  improved	  glucose	  homeostasis	  and	  reversed	  type	  1	  diabetes	  (7).	  In	  
humans,	  it	  has	  been	  shown	  that	  glucose	  uptake	  in	  BAT	  can	  increase	  12-­‐fold	  during	  cold	  
exposure	  (8).	  A	  recent	  study	  demonstrated	  cold-­‐induced	  fatty	  acid	  oxidation	  in	  BAT	  (9).	  
This	   study	  also	   showed	   that	  oxidative	  metabolism	   in	  BAT	  contributed	   to	  whole	  body	  
energy	  expenditure	  during	  acute	  cold	  exposure.	  Therefore,	  BAT	   is	  currently	   regarded	  
as	   an	   organ	   with	   preventive	   and	   therapeutic	   potential	   for	   diseases	   related	   to	   the	  
metabolic	  syndrome.	  
	   From	   animal	   studies	   it	   is	   clear	   that	   BAT	   is	   under	   hypothalamic	   control	   and	   is	  
densely	   innervated	   by	   the	   sympathetic	   nervous	   system	   (SNS)	   (10).	   When	  
thermogenesis	  is	  needed	  (e.g.	  in	  the	  cold),	  postganglionic	  sympathetic	  neurons	  release	  
norepinephrine	   (NE)	  acting	  on	   (mainly)	   the	  beta-­‐adrenergic	   receptors	  present	  on	   the	  
cell	   surface,	   leading	   to	   the	  activation	  of	  uncoupling	  protein-­‐1	   (UCP-­‐1).	  This	  protein	   is	  
located	  in	  the	  inner	  mitochondrial	  membrane,	  and	  is	  responsible	  for	  the	  generation	  of	  
heat	  by	  uncoupling	  respiration	  from	  ATP-­‐synthesis	  (11).	  	  
	   In	  humans	  several	  studies	  indicate	  the	  role	  of	  the	  sympathetic	  nervous	  system	  in	  
cold-­‐	   induced	   thermogenesis	   and	   BAT	   activation.	   Cold-­‐induced	   thermogenesis	   in	  
humans	   correlates	   significantly	   with	   fasting	   norepinephrine	   plasma	   concentrations	  
(12).	   In	   support,	   Zingaretti	   et	   al.	   (13)	   showed	   that	   human	   brown	   adipocytes	   are	  
innervated	  by	   the	  SNS,	   and	  Virtanen	  et	  al.	   (3)	  demonstrated	   the	  presence	  of	   the	  ß3-­‐
adrenergic	   receptor	   (ß3-­‐AR)	  mRNA	   in	   these	   cells.	   Finally,	   blocking	   the	   ß1-­‐	   and	   ß2-­‐AR	  
receptor	  through	  oral	  administration	  of	  propranolol	  decreased	  [18F]FDG	  uptake	  in	  BAT	  
in	  cancer	  patients	  at	  room	  temperature	  (14,	  15),	  indicating	  a	  role	  for	  these	  receptors	  in	  
activating	  BAT	  under	   these	  conditions.	  Although	   the	   role	  of	  ß-­‐AR	  stimulation	  on	  BAT	  
has	   not	   been	   directly	   examined	   in	   humans,	   its	   role	   in	   stimulating	   thermogenesis	   in	  
humans	   is	  well	  established	  (16),	  making	   it	   likely	   that	  ß-­‐AR	  receptor	  stimulation	  could	  
be	  an	  alternative	  way	  to	  activate	  BAT.	  	  
	   Here	  we	  use	  the	  non-­‐selective	  ß-­‐AR	  agonist	  ISO	  to	  mimic	  ß-­‐adrenergic	  SNS	  activity	  
and	   investigate	   its	   effect	  on	  BAT	  activity,	   and	  performed	  cold	  exposure	  as	  a	  positive	  
control.	  We	  show	  that	  ISO	  stimulated	  thermogenesis	  to	  similar	  levels	  as	  cold	  exposure;	  
however,	  BAT	  was	  not	  involved	  in	  the	  thermogenic	  effect	  of	  ISO.	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Research	  design	  and	  methods	  
The	  ethics	  committee	  of	  Maastricht	  University	  Medical	  Centre	  (MUMC+)	  approved	  the	  
study	   protocol.	   All	   study	   participants	   provided	   written	   informed	   consent	   and	   all	  
procedures	  conformed	  the	  standards	  of	  the	  Declaration	  of	  Helsinki.	  
Subjects	  
A	   total	   of	   10	   healthy	  male	   subjects	   (age	   22.5	   ±	   2.5	   years,	   BMI	   21.6	   ±	   1.6	   kg/m2,	   fat	  
percentage	   15.6	   ±	   2.9%)	   were	   enrolled	   in	   the	   study.	   All	   subjects	   were	   screened	   for	  
medical	   history	   and	   status.	   Cardiovascular	   status	   was	   screened	   by	   means	   of	   an	  
electrocardiogram	   (ECG)	   and	   blood	   pressure	   measurement.	   All	   subjects	   had	   normal	  
blood	   glucose	   levels.	   Body	   composition	   was	   determined	   by	   means	   of	   dual	   x-­‐ray	  
absorptiometry	  (DXA,	  Hologic,	  type	  Discovery	  A,	  USA).	  	  
Study	  design	  
First,	  the	  subjects	  underwent	  a	  mild	  cold	  experiment	  in	  order	  to	  define	  BAT	  presence	  
and	   activity,	   followed	   by	   the	   ISO	   experiment.	   Subsequently	   five	   out	   of	   ten	   subjects	  
underwent	   a	   second	   ISO	   experiment	   in	   combination	   with	   ACI.	   A	   minimal	   washout	  
period	  of	  5	  days	  was	  taken	  between	  the	  experiments.	  	  
	   Subjects	  were	  measured	  in	  the	  morning	  after	  overnight	  fasting	  and	  were	  asked	  to	  
refrain	  from	  heavy	  exercise	  24	  hours	  before	  the	  measurements.	  After	  arrival,	  subjects	  
swallowed	   a	   telemetric	   pill	   (CoreTemp	   HT150002,	   USA)	   for	   core	   temperature	  
measurement	   and	   iButtons	   (Maxim	   integrated,	   USA)	  were	   placed	   on	   14	   ISO-­‐defined	  
sites	  to	  measure	  skin	  temperature	  (17).	  A	  chest	  strap	  (Polar	  T31,	  USA)	  and	  a	  pressure	  
cuff	   (Cresta,	   Taiwan)	   were	   attached	   to	   measure	   heart	   rate	   and	   blood	   pressure,	  
respectively.	  Laser	  Doppler	  probes	  were	  attached	  for	  skin	  perfusion	  measurements	  at	  
the	  ventral	  side	  of	  the	  hand	  at	  the	  base	  of	  the	  thumb,	  at	  the	  ventral	  side	  of	  the	  hallux	  
(Perimed	   PF4000,	   Sweden)	   at	   the	   ventral	   side	   of	   the	   forearm	   halfway	   between	   the	  
elbow	  and	  the	  wrist,	  and	  at	  the	  abdomen	  halfway	  between	  the	  umbilicus	  and	  the	  left	  
lateral	  side	  of	  the	  body	  (Perimed	  PF5000,	  Sweden).	  Finally,	  a	  canula	  was	  inserted	  in	  the	  
left	   antecubital	   vein	   for	   blood	   sampling	   during	   cold	   exposure.	   During	   the	   ISO	  
experiments	   a	   second	   canula	   in	   the	   antecubital	   vein	   of	   the	   contralateral	   arm	   was	  
placed	  for	  ISO	  infusion.	  The	  measurements	  were	  performed	  in	  a	  specially	  equipped	  air-­‐
permeable	  tent	  (Colorado	  altitude	  training,	  USA),	  in	  which	  ambient	  temperature	  could	  
be	   tightly	   controlled.	   Subjects	   were	   measured	   in	   semi-­‐supine	   position	   in	   a	  
nephrodialysis	   chair	   in	   order	   to	   lie	   comfortably.	   During	   the	  measurements,	   subjects	  
wore	  standardized	  clothing	  (0.49	  clo).	  	  
Mild	  cold	  experiment	  
The	  protocol	  started	  with	  a	  baseline	  period	  of	  45	  minutes	  in	  thermoneutral	  conditions	  
(24-­‐25	   ºC),	   followed	   by	   two	   hours	   of	   mild	   cold	   exposure	   in	   which	   an	   individualized	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protocol	  was	  used.	  Each	  subject	  was	  cooled	  down	  until	  shivering	  occurred.	  After	  this,	  
air	   temperature	  was	  slightly	   increased	  until	   shivering	  stopped.	  Mild	  cold	  was	  applied	  
by	  means	  of	  air-­‐conditioning.	  After	  one	  hour	  of	  cold	  exposure	  the	  [18F]FDG	  tracer	  was	  
injected	  intravenously.	  Subjects	  were	  asked	  to	   lie	  still	  during	  the	  experiment	   in	  order	  
to	   prevent	   artifact	   by	   muscle	   activity.	   Shivering	   was	   detected	   visually	   and	   subjects	  
were	  asked	   to	   report	   shivering	  on	  a	   self-­‐created	  Visual	  Analog	  Scale	   (VAS)	  every	   ten	  
minutes.	   The	   cooling	   protocol	   has	   been	   validated	   previously	   (5).	   	   After	   the	   cooling	  
protocol,	   subjects	   were	   transferred	   to	   the	   positron	   emission	   tomography	   (PET)	   and	  
computed	  tomography	  (CT)	  scanner	  (Gemini	  TF	  PET-­‐CT,	  Philips,	  The	  Netherlands).	  	  
ISO	  experiment	  	  	  	  
After	  the	  baseline	  period	  of	  45	  minutes,	  ISO	  (ISO	  sulfate)	  was	  infused	  intravenously	  in	  
the	  antecubital	  vein	  in	  incremental	  dosages	  (6,	  12	  and	  24	  ng	  (kg	  fat-­‐free	  mass–1	  min–1)	  
for	  30	  minutes	   (dose	  1	  and	  2)	  and	  55	  minutes	   (dose	  3).	  A	  previous	   study	  has	   shown	  
that	  it	  takes	  about	  8	  minutes	  for	  each	  ISO	  dose	  to	  reach	  a	  steady	  state	  concentration	  in	  
the	  body	   (18).	  The	  extended	  duration	  of	  each	  dose	  was	  necessary	   to	  obtain	  a	   stable	  
period	   for	   energy	   expenditure.	   The	   [18F]FDG	   tracer	   was	   injected	   intravenously	   ten	  
minutes	  after	  the	  start	  of	  dose	  3.	   	  Venous	  blood	  samples	  were	  taken	  during	  baseline	  
and	  at	  the	  end	  of	  each	  dose.	  Cardiovascular	   function	  was	  continuously	  monitored	  by	  
means	  of	  electrocardiography	  (Cardiolife	  TEC	  7100K,	  Nihon	  Kohden,	  Japan)	  and	  blood	  
pressure.	  	  
ISO	  experiment	  in	  combination	  with	  ACI	  
Subsequently,	   five	   subjects	  underwent	  a	   second	   ISO	  experiment,	   in	  which	   two	   times	  
250-­‐mg	  of	  ACI	  was	  given	  orally	  (2	  hours	  before-­‐	  and	  at	  the	  start	  of	  baseline)	  to	  lower	  
circulating	  fatty	  acids.	  ACI	   is	  a	  nicotinic	  acid	  derivative	  and	  blocks	   lipolyis	   in	  fat	  tissue	  
by	   decreasing	   cyclic	   AMP,	   and	   therefore	   decreasing	   the	   lipolytic	   effects	   of	   hormone	  
sensitive	   lipase	   (19).	  The	  experimental	  protocol	  was	  similar	   to	   the	   ISO	  experiment	  as	  
explained	   before.	   One	   subject	   did	   not	   ingest	   the	   second	   capsule	   due	   to	   adverse	  
effects.	   However,	   plasma	   FFA	   levels	   during	   the	   tracer	   injection	   were	   still	   lower	  
compared	  to	  ISO	  (ISO+ACIdose3:	  171	  versus	  ISOdose3:	  631	  µmol/l).	  
PET	  scanning	  protocol	  
One	  hour	  before	   the	  PET-­‐CT	  scan,	   subjects	  were	   intravenously	   injected	  with	  50	  MBq	  
(1.35	   mCi)	   of	   [18F]FDG.	   Imaging	   started	   with	   a	   low-­‐dose	   CT	   scan	   (120	   kV,	   30	   mAs),	  
immediately	  followed	  by	  a	  PET	  scan.	  A	  total	  of	  6	  to	  7	  bed	  positions	  (6	  minutes	  per	  bed	  
position)	  were	  necessary	  to	  cover	  the	  area	  where	  BAT	  is	  usually	  found	  (i.e.	  abdominal-­‐,	  
thoracic-­‐	  and	  neck	  region).	  The	  PET	  image	  was	  used	  to	  determine	  the	  [18F]FDG-­‐uptake	  
and	   the	   CT	   image	   was	   used	   for	   PET	   attenuation	   correction	   and	   localization	   of	   the	  
[18F]FDG-­‐uptake	   sites.	   The	  voxel	   size	  of	  both	   reconstructed	   image	   sets	  was	  4	   x	  4	   x	  4	  
mm3.	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PET	  analysis	  
We	   used	   PMOD	   software,	   version	   3.0	   (PMOD	   Technologies)	   for	   the	   analysis	   of	   BAT	  
activity.	  Both	  the	  researcher	  and	  a	  nuclear-­‐medicine	  physician	  interpreted	  the	  PET-­‐CT	  
image.	  The	  regions	  of	  interest	  were	  manually	  outlined	  in	  each	  slice	  (4mm)	  in	  the	  fusion	  
(PET	  and	  CT)	  image.	  We	  handled	  two	  criteria	  to	  qualify	  [18F]FDG-­‐uptake	  as	  BAT	  activity	  
in	  these	  regions.	  First,	  the	  region	  drawn	  should	  be	  localized	  in	  fat	  tissue	  as	  determined	  
by	   the	  CT	  scan	   (Hounsfield	  Units:	   -­‐10	   to	   -­‐180).	  Second,	   the	  SUV	  value	   in	  each	   region	  
should	  be	  at	  least	  1.5	  (approximately	  6	  times	  higher	  than	  in	  WAT).	  BAT	  activity	  of	  each	  
region	  is	  determined	  by	  the	  average	  SUV	  uptake	  (SUV	  mean)	  times	  the	  volume	  of	  the	  
region	   (cm3),	   expressed	   as	   SUV	   total.	   To	   compare	   SUV	  mean	   in	   BAT,	  WAT,	   skeletal	  
muscle,	  we	  drew	   regions	  of	   interest	   in	   the	   supraclavicular	  BAT	   region,	   subcutaneous	  
abdominal	  adipose	  tissue,	  and	   in	  both	  arms	  on	  the	  deltoid	  muscle.	   In	  order	  to	   locate	  
the	   supraclavicular	   BAT	   region	  during	   the	   two	   ISO	  experiments,	  we	  used	   the	  PET-­‐CT	  
fusion	  image	  during	  cold	  exposure	  as	  a	  reference.	  	  
Statistical	  analysis	  
Statistical	   analysis	  was	   performed	  with	   PASW	   Statistics	   18.0	   for	  Mac.	   Reported	   data	  
are	   expressed	   as	  means	   ±	   SD.	   Paired	   sample	   t-­‐tests	   were	   used	   to	   compare	   findings	  
between	   baseline	   and	   cold,	   and	   one-­‐way	   ANOVA	   for	   repeated	   measurements	   with	  
post	  hoc	  analysis,	  including	  Bonferroni	  correction,	  to	  compare	  baseline	  with	  the	  three	  
ISO	   doses.	   Wilcoxon’s	   test	   was	   used	   measure	   differences	   within	   the	   ISO	   and	   ACI	  
experiment	   and	   between	   ISO	   and	   the	   ISO	   and	  ACI	   experiment.	   Two-­‐way	  ANOVA	   for	  
repeated	  measurements	  was	  used	  to	  compare	  cold	  exposure	  with	  ISOdose3.	  Both	  study	  
phase	  (baseline	  versus	  intervention)	  and	  study	  type	  (cold	  versus	  ISOdose3)	  were	  taken	  as	  
independent	   variables	   in	   the	   model	   and	   the	   interaction	   effect	   between	   these	   two	  
variables	  were	  analyzed.	  Spearman	  rank	  correlation	  was	  used	  to	   identify	  correlations	  
between	   variables.	   P	   values	   of	   less	   than	   0.05	   were	   considered	   as	   statistically	  
significant.	  
Blood	  analysis	  	  
Venous	  blood	  was	  collected	  for	  analysis	  of	  several	  blood	  parameters.	  The	  supernatant	  
(plasma)	   was	   used	   for	   analysis	   of	   free	   fatty	   acids	   (NEFA-­‐HR	   set,	   Wako	   Chemicals,	  
Neuss,	  Germany)	   free	   glycerol	   (Glycerol	   kit,	   R-­‐Biopharm,	  Darmstadt,	  Germany),	   total	  
glycerol	   (ABX	   Triglyceriden	   CP,	   Radiometer,	   Horiba	   ABX,	   Montpellier,	   France)	   and	  
glucose	  (ABX	  Glucose	  HK	  CP,	  Radiometer,	  Horiba	  ABX,	  Montpellier,	  France)	  on	  a	  COBAS	  
FARA	   centrifugal	   spectrophotometer	   (Roche	   Diagnostica,	   Basel,	   Switzerland).	  
Triglycerides	   levels	  were	  calculated	  by	  using	   the	  difference	   in	   total	  and	   free	  glycerol.	  	  
Serum	  insulin	  was	  analyzed	  with	  a	  Human	  Insulin	  specific	  RIA	  kit	  (Milipore,	  USA)	  on	  a	  
Gamma	   Counter	   (2470	   Automatic	   Gamma	   Counter	   Wizard2™	   Wallac,	   Perkin	   Elmer,	  
USA).	  Thyroid	  related	  hormones	  were	  determined	  from	  the	  supernatant	  of	  the	  serum.	  
Plasma	   thyroid	   stimulating	   hormone	   (TSH)	   was	   measured	   by	   an	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electrochemiluminescence	   immunoassay	   (ECLIA)	   kit	  on	  a	  COBAS	  6000	   system	   (Roche	  
Diagnostica,	  Basel,	  Switzerland).	  Total	  thyroxine	  (T4)	  was	  determined	  by	  a	  solid-­‐phase,	  
competitive	   chemiluminescent	   enzyme	   immunoassay	   on	   an	   Immulite	   2000	   system	  
(Siemens,	  New	  York,	  USA).	   Free	   thyroxine	   (FT4)	  was	   analyzed	  by	   a	   solid	  phase	   time-­‐
resolved	   fluoroimmunoassay	   FT4	   kit	   on	   an	   AutoDELFIA	   system	   (PerkinElmer,	   Inc.,	  
Massachusetts,	  USA).	  
Results	  
ISO	  and	  cold-­‐induced	  thermogenesis	  
We	   first	   examined	   the	   effect	   of	   increasing	   doses	   of	   ISO	   in	   lean	   healthy	   subjects	   on	  
thermogenesis.	   ISO	   significantly	   increased	   energy	   expenditure	   (p	   <	   0.001,	   one-­‐way	  
ANOVA),	  with	  the	  highest	  increase	  of	  19.7	  ±	  7.2	  %	  during	  24	  ng/kg	  fat-­‐free	  mass–1	  min–
1	  (Figure	  1A).	  We	  then	  compared	  this	  increase	  in	  energy	  expenditure	  with	  the	  increase	  
observed	  during	  cold	  exposure.	  Cold	  exposure	  increased	  energy	  expenditure	  to	  similar	  
levels	  (baseline:	  1.17	  ±	  0.10;	  mild	  cold:	  1.37	  ±	  0.13	  kcal/min;	  p	  <0.001),	  with	  an	  average	  
cold	   induced	   thermogenesis	   of	   16.9	   ±	   7.8	   %	   (Figure	   1B).	   There	   was	   no	   interaction	  
effect	   between	   cold	   exposure	   and	   ISO	   on	   energy	   expenditure	   (p	   >	   0.05,	   two-­‐way	  
ANOVA),	  confirming	  a	  similar	  increase	  in	  energy	  expenditure.	  Both	  cold	  exposure	  and	  
ISO	   significantly	   decreased	   the	   respiratory	   exchange	   ratio	   (Table	   1).	   There	   was	   no	  
difference	  between	  cold	  exposure	  and	  ISO	  (p	  >	  0.05,	  two-­‐way	  ANOVA).	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Figure	   1.	   Isoprenaline-­‐	   and	   cold-­‐induced	   thermogenesis	   (A)	   energy	   expenditure	   during	   baseline	   and	   the	  
three	   ISO	  doses.	   (B)	   Energy	   expenditure	  during	  baseline	   and	   cold	   exposure.	   (C)	   Relationship	  between	   the	  
plasma	   norepinephrine	   level	   and	   cold-­‐induced	   thermogenesis.	   Values	   are	   expressed	   as	  means	   ±	   SD.	   *P	   <	  
0.05,	  **P	  <	  0.001,	  ISO	  (n=10)	  and	  cold	  exposure	  (n=10).	  	  
	  
Stimulation	  of	   the	  ß-­‐AR	  receptors	   leads	   to	  an	   increase	   in	  heart	   rate	   (mainly	  ß-­‐1)	  and	  
vasodilatation	  of	  blood	  vessels	  (16).	  We	  found	  that	  ISO	  increased	  heart	  rate	  (baseline	  
60	   ±	   5	   bpm	   versus	   ISOdose3:	   84	   ±	   10	   bpm,	   p	   <0.001)	   and	   systolic	   blood	   pressure	  
(baseline	  121	  ±	  9	  mmHg	  versus	  ISOdose3:	  148	  ±	  14	  mmHg,	  p	  <0.001)	  (Table1),	  due	  to	  its	  
inotropic	   and	   chronotropic	   effects	   on	   the	   heart.	   Diastolic	   blood	   pressure	   was	  
unchanged	  during	  ISO.	  	  
	   With	   respect	   to	   body	   temperatures	   (Table	   1),	   ISO	   significantly	   increased	   skin	  
temperature	   in	   the	   proximal	   area,	   whereas	   it	   dropped	   in	   the	   distal	   areas.	   Skin	  
perfusion	   corresponded	   to	   these	   temperature	   changes,	   demonstrating	   decreased	  
perfusion	  in	  the	  hand	  and	  increased	  perfusion	  in	  the	  abdominal	  region.	  Cold	  exposure	  
increased	  both	  systolic	  and	  diastolic	  blood	  pressure,	  whereas	  it	  decreased	  heart	  rate.	  
As	   expected,	   cold	   exposure	   decreased	   skin	   temperatures	   and	   skin	   perfusion	   in	   the	  
hand,	  but	  slightly	  increased	  core	  temperature.	  The	  effects	  during	  ISO	  dose	  1	  and	  dose	  
2	  are	  presented	  in	  Table	  S1	  (supplemental	  data).	  	  
	   We	  measured	  several	  blood	  metabolites	  and	  hormones	  as	  demonstrated	  in	  Table	  
S2	   and	  S3	   (supplemental	   data).	   Plasma	   norepinephrine	   levels	  were	   increased	   during	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cold	  exposure	  (244	  ±	  72	  ng/L	  versus	  463	  ±	  143	  ng/L,	  p	  <	  0.001),	  as	  shown	  previously	  (8,	  
12),	  however	  not	  during	  ISO.	  A	  significant	  relation	  was	  found	  between	  norepinephrine	  
levels	   and	   cold-­‐induced	   thermogenesis	   (R	   =	   .64,	   p	   <	   0.05)	   (Figure	   1C),	   however	   not	  
with	  BAT	  activity	  during	  cold	  (R	  =	  -­‐.09,	  p	  =	  0.80).	  Cold	  exposure	  significantly	  increased	  
plasma	  FFA	  (baseline:	  324	  ±	  84	  μmol/L	  versus	  cold:	  637	  ±	  398	  μmol/L,	  p	  <	  0.05),	  free	  
glycerol	  (baseline:	  56.6	  ±	  14.4	  μmol/L	  versus	  cold:	  106.7	  ±	  59.6	  μmol/L,	  p	  <	  0.05),	  and	  
triglycerides	   (baseline:	   638	   ±	   171	   μmol/L	   versus	   cold:	   685	   ±	   200	   μmol/L,	   p	   <	   0.05),	  
whereas	  plasma	  glucose	  decreased	  (baseline:	  4.9	  ±	  0.4	  mmol/L	  versus	  cold:	  4.7	  ±	  0.4	  
mmol/L,	   p	   <	   0.05).	   As	   expected,	   serum	   insulin	   levels	  were	   significantly	   increased	   by	  
ISO.	  	  
	  
Table	  1.	  Cardiovascular	  effects,	  skin	  perfusion,	  and	  body	  temperatures	  during	  cold	  exposure	  and	  ISO.	  
	   Cold	   ISO	  
Parameter	   Baseline	   Cold	   	   Baseline	   Dose	  3	  
EE	  (kcal/min)	   1.17±0.10	   1.37±0.13	  **	   1.21±0.12	   1.45±0.15	  **	  
RER	  (VCO2/VO2)	   0.87±0.05	   0.81±0.05	  **	   0.85±0.03	   0.80±0.02	  **	  
Heart	  rate	  (bpm)	   57±7.2	  	   54±4.7	  *	   59.8±4.8	   84±10.2	  **	  
Systolic	  BP	  (mmHg)	   119±9.2	  †	   123±6.9	  *	  †	   121±9.1	   148±13.8	  **	  
Diastolic	  BP	  (mmHg)	   64±3.1	  †	   73±3.9	  **	  †	   66±4.3	   63±8.7	  	  
SP	  hand	  (%)	   100	   11±8	  **	   100	   30±13	  **	  
SP	  abdomen	  (%)	   100	   129±71	   100	   196±57	  **	  
Tcore	  (°C)	   36.8±0.25	   37.0±0.2	  *	   36.8±0.2	   36.7±0.2	  	  
Tmean	  skin	  (°C)	   32.7±0.6	   29.0±0.5	  **	   33.1±0.4	   33.6±0.3	  **	  
Tproximal	  (°C)	   33.3±0.9	   31.2±1.3	  **	   34.0±0.5	   35.1±0.4	  **	  
Tdistal	  (°C)	   31.1±1.4	   22.9±1.4	  **	   31.8±1.5	   30.0±1.7	  **	  
Tgradient	  prox/dis	  (°C)	   2.3±1.4	   8.3±2.2	  **	   2.3±1.7	   5.2±2.0	  **	  
The	  ISO	  dose	  3	  is	  24	  ng	  (kg	  fat-­‐free	  mass	  (FFM)-­‐1	  min-­‐1).	  Results	  are	  expressed	  as	  means	  ±	  SD.	  The	  difference	  
between	  intervention	  and	  baseline	  was	  used	  for	  statistical	  analysis.	   *P	  <	  0.05,	   **P	  <	  0.001,	   ISO	  (n=10),	  cold	  
exposure	  (n=10),	  †	  n=9.	  See	  also	  Table	  S1.	  EE,	  energy	  expenditure;	  RER,	  respiratory	  exchange	  ratio;	  BP,	  blood	  
pressure;	  SP,	  skin	  perfusion;	  T,	  temperature.	  
BAT	  activity	  during	  ISO	  and	  cold	  exposure	  
We	   next	   studied	   if	   ISO	   activates	   BAT	   at	   a	   dose	   that	   increases	   thermogenesis	   to	   a	  
similar	  extent	  as	  cold	  exposure.	  As	  expected,	  cold	  exposure	  led	  to	  substantial	  [18F]FDG-­‐
uptake	   in	   the	   neck,	   supraclavicular,	   paraspinal,	   para-­‐aortic,	   axillary,	  mediastinal,	   and	  
perirenal	  regions	  (891	  ±	  1027	  SUV	  total,	  Figure	  2B,	  2E).	  The	  anatomical	  location	  of	  BAT	  
was	   comparable	   to	   previous	   findings,	   with	   the	   largest	   depot	   in	   the	   supraclavicular	  
region	   (Figure	   2E).	   Surprisingly,	   after	   ISO	   in	   9	   out	   of	   10	   subjects,	   no	   detectable	  
[18F]FDG-­‐uptake	   in	   BAT	   locations	   could	   be	   observed	   (Figure	   2C,	   2F),	   despite	   the	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thermogenic	  effect	  of	  ISO.	  In	  only	  one	  subject	  BAT	  activity	  was	  observed	  (SUV	  total	  =	  
838).	  	  
	   In	   addition	   to	   BAT,	   other	   tissues	   may	   contribute	   to	   cold-­‐	   or	   ISO	   induced	  
thermogenesis.	  Therefore,	  we	  examined	   the	  average	  uptake	  of	   [18F]FDG	   into	  skeletal	  
muscle	   and	  WAT	   (Figure	   2H).	   Interestingly,	   the	   average	   SUV	   uptake	   (SUV	  mean)	   in	  
skeletal	  muscle	  was	  similar	  during	  ISO	  and	  cold	  exposure	  (ISO:	  0.53	  ±	  0.07	  versus	  cold:	  
0.50	   ±	   0.08	   SUV	   mean,	   p	   =	   0.26).	   Similarly,	   [18F]FDG-­‐uptake	   in	   WAT	   was	   also	  
comparable	  during	  ISO	  and	  during	  cold	  exposure	  (ISO:	  0.28	  ±	  0.10	  versus	  cold:	  0.27	  ±	  
0.07	  SUV	  mean,	  p	  =	  0.90).	  	  
	  
	  
Figure	   2.	  BAT	  activity	  during	   ISO	   infusion	  and	  cold	  exposure.	   (A)	  CT	   image	  of	   the	   supraclavicular	  area.	   (B)	  
Cold	  exposure	   [18F]FDG-­‐PET/CT	   image	  showing	  cold-­‐activated	  BAT.	   (C)	   ISO	   [18F]FDG-­‐PET/CT	   image	  showing	  
no	   BAT	   activity	   during	   ISO.	   (D)	   ISO	   +	   ACI	   [18F]FDG-­‐PET/CT	   image	   showing	   no	   effect	   on	   [18F]FDG-­‐uptake	   in	  
supraclavicular	  BAT.	  (E)	  Cold	  exposure	  [18F]FDG-­‐PET/CT	  image	  of	  the	  upper	  body	  showing	  BAT	  activity	  in	  the	  
neck,	   supraclavicular,	   paraspinal,	   para-­‐aortic,	   axillary,	  mediastinal,	   and	   perirenal	   regions.	   (F)	   ISO	   [18F]FDG-­‐
PET/CT	  image	  of	  showing	  no	  BAT	  activity	  during	  ISO.	  (G)	  ISO	  +	  ACI	  [18F]FDG-­‐PET/CT	  image	  showing	  no	  effect	  
on	  [18F]FDG-­‐uptake	  in	  BAT	  locations.	  (H)	  SUV	  mean	  values	  for	  BAT,	  SM,	  and	  WAT	  during	  cold	  exposure,	  ISO,	  
and	  ISO	  +	  ACI;	  ISO	  (n	  =	  10),	  ISO	  +	  ACI	  (n	  =	  5).	  
ISO	  and	  ACI	  	  
The	  current	  method	  to	  detect	  BAT	  activity	  is	  by	  measuring	  radiolabeled	  glucose	  uptake	  
([18F]FDG).	  It	  is	  known	  that	  ISO	  stimulates	  lipolysis	  in	  white	  adipose	  tissue	  and	  that	  high	  
fatty	   acid	   levels	   may	   compete	   with	   glucose	   for	   uptake	   in	   multiple	   tissues	   (20).	   We	  
therefore	   next	   examined	   if	   the	   ISO-­‐induced	   increase	   in	   plasma	   FFA	   might	   compete	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with	   glucose	   for	   uptake	   into	   BAT.	   Indeed,	   ISO	   led	   to	   an	   increase	   in	   plasma	  
concentration	   of	   FFA	   to	   very	   high	   levels	   (Figure	   3A,	   Table	   S2).	   The	   nicotinic	   acid	  
derivative	  ACI	  was	  used	  to	  block	  lipolysis	  in	  WAT	  (19).	  Indeed,	  ACI	  significantly	  reduced	  
the	  concentration	  of	  FFA	  by	  ~78%	  in	  the	  plasma	  (ISO:	  934	  ±	  276	  versus	  ISO+ACI:	  207	  ±	  
140	   µmol/l,	   p	   <	   0.05)	   (Table	   S2)	   and	   resulted	   in	   an	   increased	   whole-­‐body	   glucose	  
oxidation	  as	  demonstrated	  by	  the	  increase	  in	  the	  respiratory	  exchange	  ratio	  (ISO:	  0.81	  
±	  0.02	  versus	   ISO+ACI:	  0.92	  ±	  0.04,	  p<0.001)	   (Figure	  3B).	  Lowering	  circulating	  plasma	  
FFA	  levels	  by	  ACI	  very	  clearly	   increased	  the	  uptake	  of	  [18F]FDG	  into	  the	  heart;	   indeed	  
demonstrating	   that	   substrate	   competition	   can	   affect	   [18F]FDG-­‐uptake	   (Figure	   3D).	  
Next,	  we	  examined	  if	  ISO	  would	  lead	  to	  [18F]FDG-­‐uptake	  in	  BAT	  when	  plasma	  FFA	  were	  
reduced	  by	  ACI.	  The	  reduction	  of	  plasma	  FFA	  levels	  did	  not	  lead	  to	  enhanced	  [18F]FDG-­‐
uptake	   in	   BAT	   in	   4	   out	   of	   5	   subjects.	   One	   person	   showed	   a	   slight	   increase	   in	   BAT	  
activity,	   however	   this	  BAT	  activity	  was	  minimal	   compared	   to	   the	  activity	  during	  mild	  
cold	  exposure	  (ISO+ACI:	  27	  versus	  cold:	  3132	  SUV	  total).	  Furthermore,	  ACI	  did	  not	  lead	  
to	   enhanced	   [18F]FDG-­‐uptake	   in	   skeletal	   muscle.	   The	   combination	   of	   ISO	   with	   ACI	  
significantly	   increased	   energy	   expenditure	   by	   12.8%	   (p	   <	   0.05).	   This	   was,	   however,	  
significantly	  lower	  compared	  to	  ISO	  infusion	  alone	  (p	  <	  0.05)	  (Figure	  3C).	  The	  effects	  of	  
ACI	   in	   combination	   with	   ISO	   on	   cardiovascular	   effects,	   skin	   perfusion,	   and	   body	  
temperatures	  are	  presented	  in	  Table	  S1	  (supplemental	  data).	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Figure	   3.	   The	   effects	   of	   ACI	   on	   FFA	   levels,	   substrate	   use,	   energy	   expenditure,	   and	   [18F]FDG-­‐uptake.	   (A)	  
Plasma	   FFA	   levels	   during	   ISO	   and	   ISO	   +	   ACI.	   (B)	   Respiratory	   exchange	   ratio	   during	   ISO	   and	   ISO	  +	   ACI.	   (C)	  
Energy	  expenditure	  during	  ISO	  and	  ISO	  +	  ACI.	  (D)	  The	  left	  panel	  shows	  the	  3D-­‐reconstructed	  PET-­‐images	  in	  
five	  subjects	  during	  ISO	  infusion	  indicating	  no	  brown	  fat	  activity	  and	  a	  low	  [18F]FDG-­‐uptake	  in	  the	  heart.	  The	  
right	  panel	  shows	  the	  same	  individuals	  during	  ISO	  in	  combination	  with	  ACI.	  ACI	  increases	  [18F]FDG-­‐uptake	  in	  
the	  heart	  as	  indicated	  by	  the	  black	  arrows,	  however	  not	  in	  BAT	  locations.	  Values	  are	  expressed	  as	  means	  ±	  
SD.	   *significant	   difference	  between	   ISO	   and	   ISO	  +	  ACI	   (P	   <	   0.05),	   **P	   <	   0.001,	   #significant	   difference	   (p	   <	  
0.05)	  between	  ISO	  +	  ACI	  dose	  and	  baseline,	  ISO	  (n=10)	  ISO	  +	  ACI	  (n=5).	  
Discussion	  
There	  is	  compelling	  evidence	  that	  BAT	  in	  animals	  is	  under	  sympathetic	  control	  and	  can	  
be	   activated	   through	   ß-­‐AR	   stimulation	   (11).	   However,	   the	   exact	   role	   of	   the	   SNS	   in	  
activating	  BAT	  in	  humans	  is	  less	  clear.	  The	  main	  objective	  of	  this	  study	  was	  to	  examine	  
whether	  non-­‐selective	  ß-­‐AR	  stimulation	  through	  ISO	  activates	  BAT	  in	  humans.	  Contrary	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to	   our	   expectations,	   the	   results	   show	   that	   ISO	   does	   not	   activate	   BAT	   in	   humans,	  
despite	  the	  observed	  increase	  in	  thermogenesis.	  
	   Cold	   exposure	   increased	   energy	   expenditure	   by	   ~17%,	   comparable	   to	   cold-­‐
induced	  thermogenesis	  levels	  reported	  earlier	  (1).	  This	  increased	  thermogenesis	  upon	  
cold	   exposure	   was	   accompanied	   by	   increased	   BAT	   activity	   in	   anatomical	   locations	  
comparable	  to	  previous	  findings,	  with	  the	   largest	  depot	   in	  the	  supraclavicular	  region.	  
Interestingly,	  cold	  exposure	  increased	  plasma	  triglycerides	  in	  the	  present	  study,	  which	  
seems	  to	  be	   in	  contrast	  to	  the	  triglyceride	  clearance	  by	  BAT	  occurring	   in	  mice	  during	  
cold	  exposure	   (6).	  However,	   it	  has	  already	  been	  previously	  shown	  by	  Vallerand	  et	  al.	  
(21)	   that	   the	  FFA’s	  needed	   for	  enhanced	   lipid	  oxidation	  during	  cold	  exposure	  do	  not	  
originate	   from	   plasma	   triglycerides,	   but	   rather	   from	   intracellular	   lipolysis.	   More	  
research	  is	  needed	  to	  investigate	  if	  BAT	  can	  affect	  triglyceride	  clearance	  in	  humans.	  
	   Furthermore,	   we	   confirm	   that	   short-­‐term	   cold	   exposure	   increased	   plasma	  
norepinephrine	   levels	   as	   previously	   found	   by	   Orava	   et	   al.	   (8),	   and	   that	   these	   levels	  
were	   related	   to	   cold-­‐induced	   thermogenesis.	   Based	   on	   these	   results	   and	   evidence	  
obtained	  from	  rodent	  BAT	  studies,	  we	  hypothesized	  that	  mimicking	  ß-­‐adrenergic	  SNS	  
activation	  by	  infusion	  of	  the	  ß-­‐AR	  agonist	  ISO	  would	  activate	  BAT	  in	  humans.	  	  
	   ISO	  indeed	  mimicked	  ß-­‐adrenergic	  sympathetic	  activity	  as	  shown	  by	  the	  increased	  
heart	   rate	   and	   whole	   body	   energy	   expenditure.	   The	   increase	   of	   ~20%	   in	   energy	  
expenditure	   during	   ISO	  was	   comparable	   to	   that	   during	   previous	   studies	  with	   similar	  
dosages	  (22-­‐24).	  Contrary	  to	  our	  expectations,	  however,	  ISO	  did	  not	  activate	  BAT	  in	  9	  
out	  of	  10	  subjects.	  In	  rodents,	  brown	  adipose	  tissue	  has	  been	  shown	  to	  have	  a	  dense	  
ß-­‐AR	   receptor	   population.	   Both	   in	   vitro	   (25,	   26)	   and	   in	   vivo	   (27,	   28)	   experiments	   in	  
animals	  have	  shown	   that	   stimulating	   these	   receptors	   leads	   to	  BAT	  activation.	  Also	   in	  
humans	   the	   ß-­‐AR	   receptor	   family	   is	   likely	   to	   be	   involved	   in	   BAT	   thermogenesis,	   as	  
demonstrated	  by	  the	  presence	  of	  ß3-­‐AR	  mRNA	  in	  human	  supraclavicular	  BAT	  (3),	  and	  
the	  inhibition	  of	  BAT	  activity	  by	  ß-­‐AR	  receptor	  antagonism	  (14,	  15).	  Moreover,	  a	  recent	  
study	   by	  Mattson	   et	   al.	   (27)	   showed	   the	   presence	   of	  mRNA	   of	   all	   ß-­‐AR	   subtypes	   in	  
human	   multipotent	   adipocyte	   derived	   stem	   (MADS)	   cells	   differentiated	   into	   brown	  
adipocytes.	   Stimulating	   these	   cells	   by	   ISO	   and	   CL-­‐316243	   (ß3-­‐AR	   agonist)	   led	   to	  
increased	  UCP-­‐1	  mRNA	  and	  protein	  levels,	  indicating	  ß-­‐AR	  receptor	  involvement	  in	  cell	  
activation.	  We	  were	  therefore	  surprised	  not	  to	  find	  BAT	  activity	  upon	  ß-­‐AR	  stimulation.	  	  
	   In	  the	  present	  study	  we	  measured	  BAT	  activity	  in	  humans	  by	  means	  of	  radioactive	  
[18F]FDG-­‐uptake.	   Theoretically,	   however,	   high	   plasma	   FA	   levels	   may	   compete	   with	  
glucose	  for	  cellular	  uptake,	  thereby	  underestimating	  true	  BAT	  activity.	  Therefore,	  due	  
to	  the	   lipolytic	  effects	  of	   ISO,	  we	  hypothesized	  that	  the	  high	  plasma	  FFA	  levels	  might	  
have	   competed	   with	   glucose	   ([18F]FDG)	   uptake.	   We	   showed	   that	   the	   simultaneous	  
administration	  of	  ISO	  and	  ACI,	  which	  inhibits	  lipolysis,	  was	  able	  to	  lower	  fatty	  acids	  and	  
that	   this	   resulted	   in	   elevated	   glucose	   uptake	   in	   the	   heart,	   illustrating	   that	   indeed	  
substrate	   competition	   may	   be	   a	   factor	   determining	   [18F]FDG-­‐uptake.	   However,	  
lowering	   circulating	   fatty	   acid	   levels	   did	   not	   lead	   to	   increased	   tracer	   uptake	   in	   BAT	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locations.	  One	   could	   argue	   that	   BAT	   thermogenesis	  was	   blunted	   by	  ACI	   through	   the	  
inhibition	   of	   lipolysis	   by	   lowering	   cAMP	   levels	   as	   seen	   in	   white	   adipose	   tissue.	  
However,	  two	  animal	  studies	  showed	  no	  effect	  of	  nicotinic	  acid	  (ACI	  is	  a	  derivative	  of	  
nicotinic	   acid)	   on	   FFA	   and	   cAMP	   levels	   in	   BAT	   (29,	   30),	   which	   demonstrates	   no	  
inhibiting	   effects	   of	   ACI	   on	   BAT	   activation.	   	   The	   fact	   that	   the	   increase	   in	   energy	  
expenditure	  upon	  ISO	  with	  ACI	  was	  8%	  lower	  compared	  to	  ISO	  alone	  can	  most	  likely	  be	  
explained	  by	  the	  reduction	  in	  plasma	  FFA	  levels,	  as	  previously	  shown	  (31).	  	  
	   Based	   on	   these	   findings	   we	   can	   conclude	   that	   systemic	   non-­‐selective	   ß-­‐AR	  
stimulation,	  at	  concentrations	  that	  increase	  energy	  expenditure	  to	  the	  same	  extent	  as	  
cold	   exposure,	   does	  not	   activate	  BAT	   in	  humans.	   It	   is	   surprising	   that	   blocking	   the	  ß1	  
and	  ß2-­‐receptors	  by	  propranolol	  decreases	  BAT	  activity	   (14,	  15),	  whereas	   stimulating	  
these	  receptors	  by	   ISO	  does	  not	  activate	  human	  BAT.	   	  A	  plausible	  explanation	   is	  that	  
the	   systemic	   concentration	   of	   ISO	   was	   not	   sufficient	   to	   trigger	   the	   ß-­‐receptors	   on	  
brown	   adipocytes.	   The	   concentrations	   of	   norepinephrine	   that	   occur	   at	   the	  
postsynaptic	   areas	   are	   high	   (~100	   nM)	   during	   central	   sympathetic	   stimulation	   (e.g.	  
cold),	   which	   cannot	   be	   reached	   in	   plasma	   during	   physiological	   conditions	   (25).	   We	  
cannot	   exclude	   the	   possibility	   that	   higher	   doses	   of	   ISO	   are	   able	   to	   stimulate	   BAT	   in	  
humans.	   However,	   these	   high	   doses	   would	   lead	   to	   unwanted	   side	   effects	   such	   as	  
tachycardia,	   arrhythmias	   and	   pronounced	   systolic	   blood	   pressure	   elevations.	   Central	  
stimulation	   therefore	   remains	   an	   interesting	   option	   for	   future	   studies,	   although	  
achieving	  such	  in	  human	  studies	  will	  be	  difficult.	  	  
	   Interestingly,	   these	   findings	   thus	   show	   that	  metabolic	  processes	   in	   tissues	  other	  
than	   BAT	   cause	   the	   ISO	   induced	   thermogenesis.	   ß-­‐AR	   receptors	   are	   expressed	   in	  
various	  tissues,	  such	  as	  the	  heart,	  skeletal	  muscle,	  adipose	  tissue,	  liver,	  bronchi,	  blood	  
vessels,	   and	   the	   pancreas	   (16).	   A	   small	   part	   of	   the	   increased	   thermogenesis	   can	   be	  
explained	   by	   the	   energy	   cost	   of	   cardiac	   and	   respiratory	   work	   upon	   sympathetic	  
stimulation	   (32).	   However,	   skeletal	   muscle	   likely	   explains	   a	   major	   part.	   The	  
contribution	   of	   skeletal	   muscle	   to	   epinephrine-­‐induced	   thermogenesis	   has	   been	  
estimated	  at	  40%	  (33).	  Moreover,	  a	  study	  by	  Astrup	  et	  al.	  (34)	  showed	  that	  ephedrine-­‐
induced	  thermogenesis	  is	  located	  for	  50%	  in	  skeletal	  muscle.	  In	  our	  study,	  the	  average	  
tracer	  uptake	   in	   skeletal	  muscle	  was	   similar	  during	   ISO	  and	  cold	  exposure,	   indicating	  
similar	   activity	   in	   both	   situations.	   However,	   additional	   studies	   focused	   on	   skeletal	  
muscle	   are	   needed	   to	   measure	   its	   contribution	   during	   cold	   induced	   and	   adrenergic	  
thermogenesis.	  
	   The	   mechanisms	   behind	   skeletal	   muscle	   thermogenesis	   are	   not	   fully	   known.	  
Interestingly,	   Wijers	   et	   al.	   (35)	   demonstrated,	   with	   high-­‐resolution	   respirometry	   in	  
permeabilized	   human	   skeletal	   muscle	   biopsies,	   that	   skeletal	   muscle	   mitochondrial	  
uncoupling	  correlated	  significantly	   to	   the	   increase	   in	  whole	  body	  energy	  expenditure	  
after	   3	   days	   of	   cold	   exposure.	   This	   finding	   indicates	   that	   mitochondrial	   uncoupling	  
could	   be	   such	   a	  mechanism.	   Other	   possible	  mechanisms	   involved	   are	   futile	   calcium	  
cycling,	  protein	  turnover	  and	  substrate	  cycling	  (36).	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   It	  should	  be	  noted	  that	  although	  [18F]FDG-­‐uptake	  shows	  whether	  BAT	  is	  active,	  it	  
provides	  limited	  information	  on	  the	  actual	  thermogenic	  activity	  of	  the	  tissues	  as	  fatty	  
acids	  are	  an	  important	  substrate	  during	  cold	  and	  ISO	  infusion.	  Furthermore,	  the	  uptake	  
of	  [18F]FDG	  in	  BAT	  can	  occur	  without	  simultaneous	  increased	  blood	  perfusion	  as	  shown	  
during	   insulin	   infusion	   (8).	   This	   could	   imply	   that	   BAT	   glucose	   uptake	   takes	   place	  
without	  concurrent	  thermogenesis.	  However,	  due	  to	  practical	  limitations	  we	  were	  not	  
able	  to	  use	  these	  techniques	  in	  the	  present	  study.	  	  	  
	   From	   the	   present	   results	   it	   can	   be	   concluded	   that	   systemic	   non-­‐selective	   ß-­‐AR	  
stimulation	   increased	   thermogenesis	   without	   concomitant	   BAT	   activation,	   indicating	  
that	  other	  tissues	  are	  involved.	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Table	  S3.	  Blood	  parameters	  during	  the	  ISO	  with	  acipimox	  experiment.	  	  
	   ISO+ACI	  experiment	  
Parameter	   Baseline	   Dose	  1	   Dose	  2	   Dose	  3	  
Free	  fatty	  acids	  (µmol/l)	   59.9	  ±	  31.7	   80.0	  ±	  28.0	  	   113.1	  ±	  4.7	  *	   207.4	  ±	  139.7	  *	  
Glycerol	  free	  (µmol/l)	   21.7	  ±	  5.2	   22.8	  ±	  4.0	   25.5	  ±	  4.0	  *	   32.1	  ±	  14.8	  
Triglycerides	  (µmol/l)	   635.8	  ±	  280.8	   587.6	  ±	  231.8	   563.2	  ±	  194.9	   515.9	  ±	  153.0	  
Glucose	  (µmol/l)	   4.8	  ±	  0.5	   4.7	  ±	  0.3	   4.7	  ±	  0.3	   5.0	  ±	  0.2	  
Insuline	  (μU/mL)	   11.6	  ±	  3.5	   13.4	  ±	  4.9	   15.3	  ±	  7.1	   14.4	  ±	  5.0	  *	  
Norepinephrine	  (ng/l)	   228.7	  ±	  28.0	   249.9	  ±	  22.1	   274.9	  ±	  48.5	   289.1	  ±	  77.7	  
Epinephrine	  (ng/l)	   28.0	  ±	  9.0	   24.4	  ±	  6.9	   19.9	  ±	  7.0	  *	   17.9	  ±	  5.2	  *	  
The	  ISO	  doses	  are	  6,	  12	  and	  24	  ng	  (kg	  fat-­‐free	  mass	  (FFM)-­‐1	  min-­‐1)	  for	  dose	  1,	  2	  and	  3	  respectively.	  Results	  are	  
expressed	  as	  means	  ±	  SD.	  The	  difference	  between	  intervention	  and	  baseline	  was	  used	  for	  statistical	  analysis.	  
*P	  <	  0.05,	  ISO	  with	  acipmox	  (n=5).	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Abstract	  
It	   has	  now	  been	  unequivocally	   demonstrated	   that	  humans	  possess	   functional	   brown	  
adipose	   tissue	   (BAT)	   and	   that	   human	   BAT	   can	   be	   recruited	   upon	   chronic	   cold	  
stimulation.	   Recruitment	   of	   BAT	   has	   been	   postulated	   as	   a	   potential	   strategy	   to	  
counteract	  the	  current	  global	  obesity	  epidemic.	  Recently,	  it	  was	  shown	  in	  rodents	  that	  
endurance	  exercise	  training	  could	  stimulate	  the	  recruitment	  of	  brown-­‐like	  adipocytes	  
within	  WAT	  via	  the	  myokine	  irisin,	  which	  is	  the	  cleaved	  circulating	  product	  of	  the	  type	  
1	  membrane	  protein	  FNDC5.	  We	  here	  tested	  cold-­‐stimulated	  BAT	  activity	  via	  [18F]FDG-­‐
PET-­‐CT-­‐imaging	  and	  browning	  of	   subcutaneous	  WAT	  by	  means	  of	  gene	  expression	   in	  
twelve	   endurance	   trained	   athletes	   and	   twelve	   lean	   sedentary	  males.	   Indeed,	  mRNA	  
expression	  of	  FNDC5	  in	  skeletal	  muscle	  was	  significantly	  higher	  in	  endurance	  athletes.	  
However,	   cold-­‐induced	   BAT	   activity	   was	   significantly	   lower	   in	   athletes	   and	   no	  
differences	   in	   gene	   expression	   of	   classical	   brown	   and	   beige	   adipocyte	  markers	  were	  
detected	   between	   the	   groups.	   These	   results	   thus	   indicate	   that	   chronic	   endurance	  
exercise	   does	   not	   lead	   to	   brown	   and	   beige	   adipocyte	   recruitment,	   and	   rather	   is	  
associated	  with	  lower	  metabolic	  activity	  of	  BAT	  in	  humans.	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Introduction	  
The	   presence	   of	   functional	   brown	   adipose	   tissue	   (BAT)	   in	   humans	   has	   now	   been	  
unequivocally	   demonstrated	   by	   multiple	   dedicated	   studies	   (1-­‐6)	   following	   those	   in	  
2009	   (7-­‐9).	   Brown	  adipocytes	  possess	  uncoupling	  protein	  1	   (UCP1),	  which	  uncouples	  
respiration	   from	   ATP	   synthesis	   thereby	   dissipating	   chemical	   energy	   as	   heat.	   The	  
thermogenic	  capacity	  of	  BAT	  makes	   this	  organ	  an	   interesting	   target	   to	   tackle	  obesity	  
and	  associated	  diseases.	  In	  rodents,	  BAT	  has	  an	  important	  role	  in	  fat	  (10)	  and	  glucose	  
metabolism	   (11),	   and	   can	  modulate	   energy	   balance	   (12).	   Also	   in	   adult	   humans,	   BAT	  
activity	  is	  negatively	  correlated	  with	  adiposity	  (7,	  13,	  14).	  Furthermore,	  there	  is	  strong	  
evidence	   for	   a	   role	   of	   human	   BAT	   in	   cold-­‐induced	   heat	   production	   (1,	   15,	   16).	  
Therefore,	   enhancing	   the	   metabolic	   capacity	   of	   BAT	   in	   adult	   humans	   would	   be	   a	  
promising	  way	  to	  increase	  energy	  expenditure.	  	  	  
	   In	   addition	   to	   classical	   or	   constitutional	   BAT,	   a	   distinct	   type	   of	   thermogenic	  
adipocytes	  has	  recently	  been	  identified	  within	  white	  adipose	  tissue	  (WAT),	  designated	  
as	  beige	  (17)	  or	  brite	  (18)	  adipocytes.	  These	  beige	  adipocytes	  typically	  appear	  in	  WAT	  
depots	   after	   stimulation	   (e.g.	   pharmacological	   or	   cold	   stimulation)	   and	   have	  
comparable	  respiratory	  capacity	  as	  classical	  brown	  adipocytes	  (17).	  Beige	  adipocytes	  -­‐	  
next	   to	  classical	  BAT	  adipocytes	   -­‐	  may	  not	  only	  be	  present	  and	   recruited	   in	   the	  neck	  
and	  supraclavicular	  area	  in	  humans	  (19-­‐21),	  but	  may	  also	  be	  recruited	  in	  subcutaneous	  
white	  adipose	  tissue,	  a	  process	  nowadays	  called	  "browning".	  
	   Recently,	  exercise	  has	  been	  hypothesized	  to	   induce	  browning	  of	  WAT	   in	  rodents	  
(22).	   Initially,	   in	  the	  1980’s,	   it	  was	  hypothesized	  that	  exercise	  could	  stimulate	  BAT	  via	  
increased	   sympathetic	   activity	   (23).	   However,	   studies	   in	   rodents	   generally	   did	   not	  
show	   any	   stimulating	   effects	   of	   exercise	   on	   classical	   BAT	   (23-­‐26).	   In	   the	   past	   three	  
years	   however,	   it	   was	   demonstrated	   in	   rodents	   that	   the	   focus	   should	   be	   more	   on	  
browning	   of	   typical	  WAT	   depots	   and	   less	   on	   classical	   BAT	   (22,	   27-­‐30).	   Interestingly,	  
Boström	  et	  al.	   (2012)	  demonstrated	   in	  mice	  that	  exercise	   increases	  the	  expression	  of	  
the	  FNDC5	  gene,	  coding	  for	  a	  type	  1	  membrane	  protein	  that	  is	  cleaved	  after	  translation	  
and	   subsequently	   released	   in	   the	  plasma	  as	   ‘irisin’.	   In	  mice,	   this	  myokine	   stimulated	  
browning	  of	  WAT	  and	   increased	  energy	  expenditure	   leading	   to	   reduced	  body	  weight	  
and	   improved	  glucose	  homeostasis	   (22).	  Recently,	  Zhang	  et	  al.	  demonstrated	   in	  mice	  
that	   irisin	  mediates	  browning	  by	  phosphorylation	  of	  the	  p38	  MAPK	  and	  ERK	  signaling	  
pathway	  (31).	  Boström	  et	  al.	  reported	  that	  endurance	  exercise	  also	   increased	  plasma	  
irisin	   levels	   in	  humans	  and	  that	  human	  irisin	   is	  100%	  identical	  to	  mice	  (22).	  However,	  
recently	   a	   debate	   is	   going	   on	   whether	   irisin	   is	   functional	   in	   humans	   as	   it	   might	   be	  
present	   in	   a	   truncated	   form	   in	   humans	   due	   to	   a	  mutation	   in	   the	   start	   codon	   of	   the	  
FNDC5	  gene	  (32).	  Moreover,	  there	  are	  concerns	  over	  the	  specificity	  of	  measuring	  irisin	  
in	   humans	   (33),	   although	   Lee	   et	   al.	   (34)	   might	   have	   recently	   clarified	   this	   issue.	  
Nevertheless,	  whether	  endurance	  exercise	  per	  se	  recruits	  brown	  and	  beige	  adipocytes	  
in	  humans	   remains	  undetermined.	  We	  therefore	  measured	  cold-­‐induced	  BAT	  activity	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by	   means	   of	   [18F]fluorodeoxyglucose-­‐positron	   emission	   tomography-­‐computed	  
tomography	  ([18F]FDG-­‐PET-­‐CT)-­‐scanning,	  and	  'browning'	  by	  analyzing	  brown	  and	  beige	  
markers	   in	   subcutaneous	  WAT	   in	   endurance	   trained	   athletes	   in	   comparison	   to	   lean	  
sedentary	  controls.	  	  
Results	  
Subject	  characteristics	  
Both	  age	  and	  adiposity	  are	  known	  to	  negatively	  correlate	  with	  BAT	  activity	   in	  human	  
adults.	  We	  therefore	  created	  comparable	  groups	  regarding	  age	  and	  body	  mass	   index	  	  
(Table	   1).	   As	   expected,	   fat	   percentage	   was	   significantly	   lower	   in	   the	   trained	   group	  
(endurance	  athletes)	   compared	   to	   the	  untrained	  group	   (sedentary	  males)	   (P	   <	   0.05),	  
but	  was	   not	   related	   to	  BAT	   activity	   neither	  within	   each	   group,	   nor	  within	   the	   entire	  
study	  population.	  Resting	  heart	   rate	  was	  significantly	   lower	   in	   the	  trained	  group	   (P	  <	  
0.05),	   indicating	   the	   typical	   bradycardia	   found	   after	   regular	   endurance	   exercise	  
training	   (35).	   No	   significant	   differences	   in	   baseline	   concentrations	   of	   thyroid	  
hormones,	   FFA’s,	   and	   glucose	  were	   found.	   Triglyceride	   concentration	   in	   plasma	  was	  
36%	   lower	   in	   the	   trained	   group,	   although	   this	   observation	   failed	   to	   reach	   statistical	  
significance	  (P	  =	  0.099).	  Finally,	  baseline	  insulin	  was	  significantly	  lower	  in	  serum	  of	  the	  
trained	  group	  (P	  <	  0.05).	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Table	  1.	  Subject	  characteristics	  
Characteristic	   Trained	   Untrained	  
Age	  (yrs)	   25±4.4	   23±3.3	  
Body	  mass	  (kg)	   72.4±7.1	   71.9±6.4	  
Height	  (m)	   1.84±0.06	   1.82±0.05	  
BMI	  (kg/m2)	   21.4±1.8	   21.8±1.9	  
Body	  fat	  (%)	  	   13.1±1.8B	   18.1±4.3	  
Fat	  free	  mass	  (kg)	   60.2±5.7	   56.6±4.7	  
VO2	  max	  (mL/min/kg)	   59.2±3.6A	   40.5±2.2	  
Power	  output	  (W/kg)	   5.1±0.3A	   3.6±0.3	  
RMR	  (MJ/day)*	   7.6±1.0	   7.0±1.0	  
Heart	  rate	  (bpm)	   52±9A	   61±7	  
Systolic	  BP	  (mmHg)	   119±9	   119±10	  
Diastolic	  BP	  (mmHg)	   72±7	   73±7	  
TSH	  (mU/L)	   1.98±1.53	   1.33±0.36	  
Total	  T4	  (nmol/L)	   77.1±13.6	   82.7±20.1	  
Free	  T4	  (pmol/L)	   13.7±2.2	   14.0±1.4	  
FFA	  (μmol/L)	   440±253	   567±217	  
Glucose	  (mmol/L)	   4.8±0.3	   5.0±0.3	  
Insuline	  (μU/mL)	   5.7±1.2B	   9.5±5.1	  
Triglycerides	  (μmol/L)	   613±267	   960±643	  
Results	   are	   expressed	   as	   means	   ±	   SD.	   AP	   <	   0.01	   trained	   vs.	   untrained,	   BP	   <	   0.05	   trained	   vs.	   untrained.	  
Differences	  between	  the	  trained	  and	  untrained	  group	  were	  tested	  with	  independent	  sample	  t	  tests.	  *	  RMR	  
was	  corrected	  for	  fat	  free	  mass	  (36).	  RMR	  =	  resting	  metabolic	  rate,	  TSH	  =	  thyroid	  stimulating	  hormone	  
Lower	  cold-­‐induced	  BAT	  activity	  in	  endurance	  athletes	  	  
As	   several	   animal	   studies	   suggest	   that	   endurance	   exercise	   increases	   the	   metabolic	  
capacity	   of	   BAT,	   we	   compared	   energy	   expenditure	   during	   thermoneutral	   conditions	  
with	   two	   hours	   of	   mild	   cold	   exposure,	   and	   calculated	   the	   maximal	   nonshivering	  
thermogenesis	  (NST)	  capacity	  in	  both	  groups.	  Indeed,	  energy	  expenditure	  significantly	  
increased	   during	   cold	   exposure	   in	   the	   trained	   (P	   <	   0.05)	   and	   untrained	   group	   (P	   <	  
0.001,	  Table	  2).	  Mean	  NST	  tended	  to	  be	  lower	  in	  the	  trained	  group,	  although	  this	  was	  
not	  significantly	  different	  (8.0±8.9%	  versus	  11.8±6.5%,	  P	  =	  0.25).	   In	  line	  with	  previous	  
findings	   (16),	   cold	  exposure	   significantly	   increased	   fatty	  acid	  oxidation	  during	   cold	   in	  
both	  groups	  (P	  <	  0.05),	  whereas	  the	  oxidation	  of	  carbohydrates	  significantly	  decreased	  
in	   the	   trained	   group	   (P	   <	   0.05),	   and	   tended	   to	  decrease	   in	   the	  untrained	   group	   (P	  =	  
0.058).	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Table	   2.	   Thermoregulatory,	   cardiovascular	   and	   blood	   parameters	   in	   trained	   and	   untrained	   group	   during	  
thermoneutral	  (baseline)	  and	  mild	  cold	  exposure.	  	  	   	  
	   	   Trained	   	   	   Untrained	  
Variable	   Baseline	   Cold	   	   Baseline	   Cold	  
Energy	  Expenditure	  (kJ/min)	   5.3±0.4	   5.7±0.6B	   4.9±0.4	   5.4±0.6A	  
Nonshivering	  thermogenesis	  (%)	   -­‐	   8.0±8.9	  	   -­‐	   11.82±6.48	  
RQ	  (VCO2/VO2)	   0.85±0.04	   0.81±0.04B	   0.83±0.05	   0.79±0.04B	  
CHO	  oxidation	  (mg/min)	   162±41	   131±41B	   134±52	   111±47	  
Fat	  oxidation	  (mg/min)	   67.5±22.6	   90.9±23.8B	   68.5±18.4	   93.4±23.6A	  
Vasoconstriction	  toe	  (%)	   0	   83±17A	   0	   74±22A	  
Vasoconstriction	  hand	  (%)	   0	   87±13A	   0	   85±9A	  
Vasoconstriction	  underarm	  (%)	   0	   61±14A,C	   0	   34±21B	  
Vasoconstriction	  abdomen	  (%)	   0	   -­‐16±50	   0	   12±39	  
Mean	  skin	  temperature	  (°C)	   33.4±0.5	   29.4±0.6A	   33.2±0.4	   29.5±0.9A	  
Underarm	  temperature	  (°C)	   33.4±1.0	   26.2±2.0A,D	  	   33.9±0.8	   28.0±2.1A	  	  
Hand	  temperature	  (°C)	   31.5±2.1	   22.3±1.3A	   32.0±1.6	   23.3±1.6A	  
Lower	  leg	  temperature	  (°C)	   31.8±0.6	   24.6±0.9B,D	   32.1±0.7	   25.8±1.5A	  
Foot	  temperature	  (°C)	   30.0±1.2	   21.2±1.2A	   30.1±1.3	   22.0±1.8A	  
Core	  temperature	  (°C)	   36.83±0.26	   36.72±0.42	   36.88±0.14	   36.95±0.21	  
Systolic	  BP	  (mmHg)	   119±9	   134±8A	   119±10	   130±11A	  
Diastolic	  BP	  (mmHg)	   72±7	   84±7A	   73±7	   84±8A	  
Heart	  rate	  (beats/min)	   52±9	   49±8B	   61±7	   62±10	  
Free	  fatty	  acids	  (μmol/L)	   440±253	   641±366B	   567±217	   671±196	  
Glycerol	  free	  (μmol/L)	   58.2±22.9	   81.6±39.9B	   80.4±30.9	   86.9±20.9	  
Triglycerides	  (μmol/L)	   613±267	   651±282B	   959±643	   999±525	  
Glucose	  (mmol/L)	   4.8±0.3	   4.7±0.3	   5.0±0.3	   5.1±0.4	  
Insulin	  (mU/mL)	   5.7±1.2	   4.6±0.6B	   9.5±5.1	   12.2±6.3	  
Results	  are	  expressed	  as	  means	  ±	  SD.	  AP	  <	  0.01	  baseline	  vs.	  mild	  cold,	  BP	  <	  0.05	  baseline	  vs.	  mild	  cold,	  CP	  <	  
0.01	  trained	  vs.	  untrained,	  DP	  <	  0.05	  trained	  vs.	  untrained.	  The	  effect	  of	  mild	  cold	  exposure	  was	  tested	  with	  a	  
paired	  samples	  t	  test.	  Differences	  between	  the	  trained	  and	  untrained	  group	  were	  tested	  with	  independent	  
sample	  t	  tests	  
	  
After	   one	   hour	   of	   mild	   cold	   exposure	   the	   glucose	   analog	   [18F]FDG	   was	   injected	   to	  
determine	   cold-­‐induced	   BAT	   activity.	   The	   [18F]FDG-­‐uptake	   in	   BAT	   was	  measured	   via	  
PET	  imaging	  one	  hour	  after	  the	  injection.	  Interestingly,	  total	  cold-­‐induced	  BAT	  activity	  
was	   significantly	   lower	   in	   the	   trained	   group	   compared	   to	   the	   untrained	   group	  
(622±801	   versus	   1837±1308	   SUVtotal,	   P	   <	   0.05)(Figure	   1A,	   1C),	   as	   was	   maximal	   BAT	  
activity	   (6.25±4.09	  versus	  13.09±8.57	  SUVmax,	  P	  <	  0.05)	   (Figure	  1D).	  Furthermore,	   the	  
average	   [18F]FDG-­‐uptake	   in	   supraclavicular	  BAT	  was	   significantly	   lower	   in	   the	   trained	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group	   (3.86±3.00	   versus	   8.68±6.55	   SUVmean,	   P	   <	   0.05;	   Figure	   1B).	   Cold-­‐induced	  
[18F]FDG-­‐uptake	   in	   skeletal	   muscle	   (0.58±0.12	   versus	   0.58±0.09	   SUVmean,	   P	   >	   0.05),	  
subcutaneous	   WAT	   (0.29±0.09	   versus	   0.24±0.07	   SUVmean,	   P	   >	   0.05),	   visceral	   WAT	  
(0.89±0.43	   versus	   0.91±0.61	   SUVmean,	   P	   >	   0.05),	   liver	   (1.65±0.29	   versus	   2.15±1.49	  
SUVmean,	  P	  >	  0.05),	  and	  brain	  (6.50±1.44	  versus	  6.95±0.85	  SUVmean,	  P	  >	  0.05)	  were	  not	  
significantly	   different	   between	   trained	   and	   untrained	   subjects.	   It	   thus	   appears	   that	  




Figure	   1.	   Decreased	   uptake	   of	   [18F)FDG	   in	   brown	   adipose	   tissue	   (BAT)	   during	   cold	   exposure	   in	   trained	  
subjects.	   (A)	   Representative	   [18F)FDG-­‐PET	   images	   demonstrating	   glucose	   uptake	   in	   trained	   and	   untrained	  
test	   subjects.	   The	   supraclavicular	   BAT	   is	   indicated	   with	   black	   arrows.	   (B)	   The	   average	   [18F)FDG-­‐uptake	  
(SUVmean)	  measured	  in	  multiple	  tissues	  in	  trained	  and	  untrained	  subjects.	  (C,	  D)	  BAT	  activity,	  in	  SUV	  total	  and	  
SUV	  max	   respectively,	   in	   trained	   and	   untrained	   subjects.	   Differences	   between	   groups	  were	  measured	   by	  
independent	  sample	  t	  tests.	  Values	  are	  expressed	  as	  mean	  with	  SD.	  *P	  <	  0.05.	  
	  
In	  line	  with	  our	  previous	  findings	  (2,	  16),	  we	  found	  a	  relationship	  between	  BAT	  activity	  
and	  NST	  in	  the	  whole	  study	  group	  (r	  =	  0.67,	  P	  <	  0.001;	  Figure	  2A),	  in	  the	  trained	  group	  
(r	  =	  0.86,	  P	  <	  0.001;	  Figure	  2B),	  and	  a	  trend	  in	  the	  untrained	  group	  (r	  0.57,	  P	  =	  0.053;	  
Figure	  2C),	  supporting	  the	  prominent	  role	  for	  BAT	  in	  NST	  in	  humans.	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Figure	  2.	  Correlation	  between	  BAT	  activity	  and	  NST.	  Correlation	  between	  BAT	  activity	  and	  NST	  in	  trained	  and	  
untrained	   subjects	   together	   (A),	   only	   trained	   subjects	   (B)	   and	   only	   untrained	   subjects	   (C).	   BAT	   activity	   is	  
expressed	  as	  SUVtotal	  and	  NST	  as	  percentage.	  
Chronic	  endurance	  exercise	  does	  not	  induce	  browning	  of	  WAT	  
Browning	  of	  WAT	  has	  been	  suggested	  to	  be	  due	  to	  an	  increase	  in	  the	  plasma	  hormone	  
irisin,	   which	   is	   processed	   from	   the	   skeletal	   muscle	   protein	   FNDC5	   (22).	   There	   is	  
currently	   debate	   on	   whether	   the	   antibody	   used	   to	   measure	   plasma	   FNDC5/Irisin	   is	  
valid	  or	  not	  (32,	  33,	  37)	  and	  whether	  irisin	  in	  humans	  is	  functional,	  since	  a	  mutation	  in	  
the	   start	   codon	  of	   the	   human	   FNDC5	   gene	  might	   lead	   to	   the	   release	   of	   a	   truncated	  
form	  of	  Irisin	  in	  plasma	  (32,	  33).	  We	  therefore	  focused	  on	  mRNA	  expression	  of	  FNDC5	  
in	   skeletal	  muscle	   (m.	   vastus	   lateralis)	   in	   both	   groups	   and	   found	   that	   FNDC5	  mRNA	  
expression	  was	  indeed	  higher	  in	  the	  trained	  group	  (Figure	  3A),	  indicating	  that	  chronic	  
endurance	   exercise	   stimulates	   FNDC5	   expression.	   Subsequently,	   we	   examined	  
whether	  chronic	  endurance	  exercise	   induced	  browning	  of	  WAT	  as	  shown	  by	  previous	  
studies	   in	   rodents	   (22,	   27,	   30).	   To	   this	   end,	  we	   analyzed	   gene	   expression	   of	   several	  
brown	  and	  beige	  adipocyte	  cell	  markers	  in	  abdominal	  subcutaneous	  WAT	  by	  means	  of	  
qPCR.	  An	   important	  marker	   for	  browning	  of	  WAT	   is	  UCP-­‐1.	  However,	  mRNA	  of	  UCP1	  
was	   undetectable	   in	   human	   WAT.	   Another	   candidate	   reflecting	   an	   increased	  
thermogenic	   gene	   program	   is	   PGC-­‐1α,	   but	   we	   did	   not	   detect	   differences	   in	   mRNA	  
expression	   between	   both	   groups	   (P	   >	   0.05;	   Figure	   3B).	   Finally,	   we	   determined	   the	  
mRNA	  expression	  of	  the	  brown	  adipocyte	  marker	  Cidea	  (Figure	  3C),	  and	  the	  two	  beige	  
markers:	   TMEM26	   (Figure	   3D)	   and	   CD137	   (Figure	   3E).	   Again,	   mRNA	   levels	   of	   these	  
genes	  in	  subcutaneous	  WAT	  were	  similar	  between	  the	  trained	  and	  untrained	  subjects	  
(P	   >	   0.05).	   These	   findings	   provide	   evidence	   against	   browning	   of	   subcutaneous	  WAT	  
depots	  in	  humans	  following	  regular	  endurance	  exercise.	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Figure	   3.	   Effect	   of	   chronic	   endurance	   exercise	   on	   FNDC5	   in	   muscle	   and	   browning	   of	   WAT.	   (A)	   mRNA	  
expression	   of	   FNDC5	   was	   determined	   in	   skeletal	   muscle	   (m.	   vastus	   lateralis)	   derived	   from	   trained	   and	  
untrained	  subjects.	   In	   trained	  and	  untrained	  subjects,	  mRNA	  expression	  of	  PGC1α	   (B),	  Cidea	   (C),	  TMEM26	  
(D),	   and	  CD137	   (E)	  was	  determined	   in	  WAT.	  Differences	  between	  groups	  were	  measured	  by	   independent	  
sample	  t	  tests.	  Values	  are	  expressed	  as	  mean	  with	  SD	  *P	  <	  0.05.	  
Vasoconstriction	  and	  body	  temperatures	  during	  cold	  exposure	  
In	  addition	  to	  cold-­‐induced	  heat	  production,	  minimizing	  heat	  loss	  via	  vasoconstriction	  
is	   the	   other	   important	   thermoregulatory	   mechanism	   to	   prevent	   hypothermia.	   We	  
determined	  vasoconstriction	  in	  the	  hand,	  toe,	  underarm,	  and	  abdomen	  by	  measuring	  
changes	   in	   skin	   perfusion	   with	   Laser	   Doppler	   flowmetry.	   Both	   groups	   significantly	  
increased	   vasoconstriction	   in	   the	   toe,	   hand,	   and	   underarm	   (P	   <	   0.001,	   Table	   2),	  
whereas	  no	  significant	  difference	  was	  observed	  in	  the	  abdomen	  during	  cold	  exposure	  
(P	   >	   0.05).	   Vasoconstriction	   in	   the	   hand,	   toe,	   and	   abdomen	   was	   not	   significantly	  
different	  between	  groups	  (P	  >	  0.05).	   Interestingly,	   the	  trained	  group	  showed	  a	   larger	  
vasoconstriction	   in	   the	   underarm	   (61.4±14.1%	   versus	   34.3±21.2%,	  P	   <	   0.01)	   thereby	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minimizing	  heat	  loss	  in	  the	  extremities,	  which	  might	  decrease	  the	  need	  for	  metabolic	  
heat	   production	   in	   trained	   individuals.	   Lower	   skin	   temperatures	   in	   the	   extremities	  
confirmed	  this	   larger	  vasoconstriction.	  The	  absolute	  skin	  temperatures	  of	   the	  trained	  
group	  were	  significantly	  lower	  on	  the	  lower	  leg	  (24.6±0.9	  versus	  25.8±1.5°C,	  P	  <	  0.05)	  
and	  the	  underarm	  (26.2±2.0	  versus	  28.0±2.1°C,	  P	  <	  0.05).	  The	  absolute	  temperature	  on	  
the	  wrist	  and	  dorsal	  part	  of	  the	  foot	  was	  slightly	   lower	   in	  the	  trained	  group	  although	  
this	   difference	   was	   not	   significant	   (P	   =	   0.09	   and	   P	   =	   0.22,	   respectively).	   Mean	   skin	  
temperature	  was	  not	  different	  between	  both	  groups.	  Although	  core	  temperature	  did	  
not	   significantly	   decrease	   in	   the	   trained	   group	   (−0.11°C,	   P	   >	   0.05,	   n=11)	   and	   in	   the	  
untrained	  group	  (0.08°C,	  P	  >	  0.05,	  n=10),	  the	  difference	  between	  both	  groups	  tended	  
to	  be	  statistically	  significant	  (P	  =	  0.08).	  Taken	  together,	  it	  appears	  that	  the	  endurance	  
athletes	   are	   less	   dependent	   on	   a	   metabolic	   response	   and	   rely	   more	   on	  
vasoconstriction	  during	  cold	  stress.	  
The	  effects	  of	  cold	  on	  thermal	  sensation	  and	  comfort,	  blood	  pressure,	  heart	  rate	  and	  
blood	  values	  
During	  the	  two-­‐hour	  cold	  period	  we	  controlled	  ambient	  temperature	  by	  means	  of	  air	  
conditioning	   to	   maximally	   cool	   subjects	   without	   inducing	   shivering.	   The	   average	  
temperature	   in	   the	   climate	   tent	   after	   the	   injection	   of	   [18F]FDG	   (when	   shivering	  was	  
absent)	   was	   not	   significantly	   different	   between	   both	   groups	   (trained:	   15.95±1.41°C	  
versus	   untrained:	   17.07±2.28°C,	  P	   >	   0.05),	   indicating	   comparable	   cold	   stress	   in	   both	  
groups.	   The	   thermal	   sensation	   and	   comfort	   during	   the	   mild	   cold	   experiment	   was	  
comparable	   at	   each	   time	  point	   (P	  >	  0.05).	   Both	  diastolic	   and	   systolic	   blood	  pressure	  
significantly	  increased	  (P	  <	  0.001)	  during	  mild	  cold	  in	  both	  groups	  (Table	  2).	  Heart	  rate	  
decreased	  in	  the	  trained	  group	  (−3±3	  bpm,	  P	  <	  0.01),	  whereas	  it	  did	  not	  change	  in	  the	  
untrained	   group	   (1±6	   bpm,	   P	   >	   0.05),	   with	   a	   tendency	   for	   a	   statistical	   significant	  
difference	   between	   groups	   (P	   =	   0.06).	   Blood	   samples	   were	   taken	   during	   baseline	  
(thermoneutral)	  and	  after	  one	  hour	   in	   the	  cold.	  Cold	  exposure	  significantly	   increased	  
plasma	   FFA,	   free	   glycerol,	   and	   triglycerides	   concentrations	   in	   the	   trained	   group	   (P	  <	  
0.05),	  whereas	  no	  differences	  were	  found	  in	  the	  untrained	  group	  (P	  >	  0.05),	  except	  for	  
a	   tendency	   to	   an	   increase	   in	   plasma	   FFA	   (P	   =	   0.06).	   Furthermore,	   glucose	  
concentrations	  did	  not	  change	  during	  cold	  exposure,	  although	  a	  trend	  for	  a	  decrease	  
was	  observed	  in	  the	  trained	  group	  (P	  =	  0.09).	  Insulin	  significantly	  decreased	  during	  cold	  
exposure	   in	   the	   trained	  group	   (P	  <	  0.05),	  whereas	   it	  did	  not	  change	   in	   the	  untrained	  
group	  (P	  >	  0.05).	  However,	  the	  differences	  between	  thermoneutral	  and	  cold	  conditions	  
of	  these	  blood	  parameters	  were	  not	  significantly	  different	  between	  the	  groups	  (Table	  
2).	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Discussion	  
Health	  problems	  associated	  with	  obesity	  warrant	  strategies	  to	  restore	  energy	  balance.	  
Stimulating	  recruitment	  of	  BAT	  might	  be	  a	  plausible	  strategy	  to	  enhance	  the	  capacity	  
to	  increase	  thermogenesis	  and	  induce	  weight	  loss.	  Endurance	  exercise	  is	  known	  for	  its	  
favorable	  metabolic	   effects,	   and	   it	  was	   recently	   shown	   in	   rodents	   that	   one	   of	   these	  
effects	  involves	  browning	  of	  WAT	  (22,	  27,	  30),	  and	  possibly	  the	  stimulation	  of	  classical	  
BAT	   depots	   (27-­‐29).	   However	   the	   effects	   of	   chronic	   endurance	   exercise	   on	   BAT	   in	  
humans	   remain	  unknown.	  We	  here	   show	   that	   chronic	  endurance	  exercise	   training	   is	  
not	  associated	  with	  an	  increased,	  but	  rather	  decreased	  cold-­‐induced	  BAT	  activity,	  and	  
does	  not	  stimulate	  browning	  of	  subcutaneous	  abdominal	  WAT	  in	  young	  adult	  males.	  	  
	   We	  examined	   cold-­‐induced	  BAT	  activity	   in	   twelve	  endurance-­‐trained	  and	   twelve	  
lean	  sedentary	  males,	  with	  comparable	  age	  and	  BMI.	  Both	  total	  and	  maximal	  [18F]-­‐FDG	  
uptake	   in	   BAT	   was	   significantly	   lower	   in	   athletes.	   With	   respect	   to	   browning	   of	  
subcutaneous	   WAT,	   Boström	   et	   al.	   demonstrated	   that	   this	   was	   mediated	   by	   the	  
exercise-­‐induced	   myokine	   irisin	   (22).	   So	   far,	   human	   studies	   have	   shown	   conflicting	  
results	  on	  the	  stimulating	  effects	  of	  exercise	  on	  FNDC5	  and	   irisin	   (32,	  34,	  38-­‐42).	  We	  
here	  measured	  mRNA	  expression	  of	  the	  precursor	  of	   irisin,	  FNDC5,	  and	  indeed	  found	  
1.6	  fold	  higher	  mRNA	  levels	  in	  the	  trained	  athletes,	  confirming	  the	  stimulating	  effects	  
of	   chronic	   endurance	  exercise	  on	   FNDC5.	  Next,	   browning	  of	   subcutaneous	  WAT	  was	  
determined	   by	   measuring	   typical	   brown	   and	   beige	   adipocyte	   cell	   markers.	   We	  
analyzed	   the	   expression	   of	   UCP-­‐1	   in	   biopsies	   from	   the	   abdominal	   subcutaneous	  
adipose	  tissue	  and	  found	  that	  it	  was	  mostly	  undetectable	  in	  both	  groups.	  Furthermore,	  
the	   mRNA	   expression	   of	   the	   beige	   markers	   CD137	   and	   TMEM26	   were	   comparable	  
between	  groups,	  as	  well	  as	  PGC-­‐1α	  and	  the	  classical	  brown	  adipocyte	  marker	  Cidea.	  A	  
recent	  study	  by	  Norheim	  et	  al.	  (39)	  also	  showed	  very	  low	  UCP1	  expression	  (mean	  Ct	  =	  
36.6±1.8)	   in	   abdominal	   subcutaneous	  WAT	   before	   and	   after	   12	   weeks	   of	   combined	  
endurance-­‐	  and	  strength	  training	  in	  healthy	  and	  prediabetic	  subjects.	  Nevertheless,	  in	  
that	   study	   UCP-­‐1	   expression	   significantly	   increased	   (1.82-­‐fold)	   upon	   training	   when	  
both	   groups	  were	   combined.	   In	   agreement	  with	   our	   study,	   no	   exercise	   effects	  were	  
found	  on	  PRDM16,	   TBX1,	   TMEM26,	   and	  CD137	   expression,	   neither	   in	   healthy	   nor	   in	  
prediabetic	  subjects	  (39).	  As	  further	  evidence	  against	  an	  effect	  of	  exercise	  training	  on	  
browning	  in	  humans,	  we	  found	  no	  difference	  in	  [18F]-­‐FDG-­‐uptake	  in	  subcutaneous	  WAT	  
between	  trained	  and	  untrained	  subjects.	  	  
	   With	   respect	   to	   irisin,	   Raschke	   et	   al.	   (32)	   showed	   that	   incubating	   human	  
subcutaneous	   preadipocytes	   with	   recombinant	   FNDC5	   and	   irisin	   did	   not	   induce	  
browning	   as	   measured	   by	   mRNA	   expression	   of	   PPARγ,	   UCP1,	   TCF21	   or	   ZIC1.	  
Furthermore,	   Norheim	   et	   al.	   (39)	   found	   that	   neither	   FNDC5	   mRNA	   expression	   in	  
subcutaneous	   adipose	   tissue	   nor	   in	   skeletal	   muscle	   nor	   plasma	   irisin	   levels	   were	  
related	   to	   adipose	   tissue	   UCP1	  mRNA	   of	   prediabetic	   and	   healthy	   subjects	   before	   or	  
after	  the	  training	  period.	  However,	  a	  cross	  sectional	  study	  by	  Moreno-­‐Navarrete	  et	  al.	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(43)	  in	  nonobese,	  obese,	  and	  type	  2	  diabetic	  humans	  (BMI	  between	  20	  and	  58	  kg/m2)	  
did	  find	  that	  FNDC5	  expression	  in	  muscle	  was	  associated	  with	  FNDC5	  and	  UCP-­‐1	  gene	  
expression	   in	   subcutaneous	   adipose	   tissue.	   Furthermore,	   they	   found	   that	   circulating	  
irisin	  levels	  were	  negatively	  related	  with	  obesity	  and	  insulin	  resistance.	  More	  recently,	  
Lee	   et	   al.	   (34)	   found	   that	   FNDC5/irisin	   was	   increased	   in	   young	   adults	   during	  
submaximal	   exercise	   and	   during	   acute	   cold	   exposure	   (only	   when	   they	   shivered).	  
Interestingly,	   they	   demonstrated	   that	   FNDC5/irisin	   treatment	   of	   primary	   human	  
adipocytes	  taken	  from	  the	  neck	  stimulated	  only	  beige	  and	  not	  classical	  adipocyte	  gene	  
markers.	   Moreover,	   it	   was	   shown	   that	   primary	   human	   subcutaneous	   adipocytes	  
responded	  minimally	  to	  treatment,	  and	  primary	  visceral	  adipocytes	  did	  not	  respond	  at	  
all.	  These	  findings	  thus	  suggest	  that	  FNDC5/irisin	  might	  stimulate	  browning	  in	  fat	  from	  
the	   neck	   region	   in	   humans.	   Unfortunately,	   in	   this	   study,	   we	   were	   unable	   to	   take	  
biopsies	  from	  these	  regions.	  Collectively,	  given	  the	  contradictory	  findings	  thus	  far,	  the	  
role	   of	   irisin	   in	   humans	   as	   a	   therapeutic	   needs	   further	   investigation.	  We	   here	   show	  
that	  exercise	  per	  se	  does	  not	  lead	  to	  detectable	  browning	  of	  subcutaneous	  abdominal	  
WAT	  in	  humans.	  	  
	   The	  previous	  mentioned	  studies	  have	  solely	  examined	  the	  effects	  of	  exercise	  and	  
irisin	   on	   adipose	   browning	   by	  measuring	   specific	  markers	  within	   adipose	   tissue.	   The	  
present	   study	  also	  measured	   the	  effects	  of	   chronic	  exercise	   training	  on	  cold-­‐induced	  
BAT	   activity	   by	   means	   of	   FDG-­‐PET/CT-­‐imaging,	   which	   reflects	   the	   total	   amount	   of	  
active	   BAT	   in	   each	   individual.	   Recent	   studies	   have	   shown	   that	   human	   BAT	   from	   the	  
neck	  region	  possesses	  both	  classical	  brown	  as	  beige	  adipocytes	  (17,	  20,	  21).	  Therefore,	  
we	  hypothesized	   that	   if	   exercise	   -­‐	   via	   irisin	   -­‐	   can	   induce	  browning,	   it	  would	   result	   in	  
enhanced	  BAT	  activity	   in	  both	   the	  neck	  region	  as	   in	  subcutaneous	  WAT.	  However,	   in	  
support	  with	  the	  mRNA	  expression	  results	  on	  WAT	  browning,	  [18F]FDG-­‐uptake	  was	  not	  
different	  between	  athletes	  and	  sedentary	  subjects	   in	  both	  subcutaneous	  and	  visceral	  
WAT,	   and	  was	   in	   fact	   significantly	   lower	   in	   BAT	   depots	   from	   the	   neck	   region	   in	   the	  
athletes.	  These	  PET-­‐data	  therefore	  strengthen	  the	  conclusion	  that	  chronic	  endurance	  
training	  recruits	  neither	  brown	  nor	  beige	  adipocytes.	  
	   In	  addition	  to	  the	  lower	  observed	  BAT	  activity,	  average	  NST	  was	  also	  lower	  in	  the	  
endurance	   athletes	   (8%	   versus	   12%).	   NST	  was	   strongly	   correlated	  with	   BAT	   activity,	  
supporting	   the	   notion	   that	   BAT	   is	   an	   important	   mediator	   in	   cold-­‐induced	   heat	  
production	  (1,	  3,	  13,	  16,	  44).	  Interestingly,	  the	  athletes	  showed	  larger	  vasoconstriction	  
in	   the	   arm.	   It	   could	   thus	   be	   speculated	   that	   the	   endurance	   athletes	   rely	   more	   on	  
insulation	   rather	   than	   on	   BAT	  mediated	   heat	   production	   during	  mild	   cold	   exposure.	  
This	   larger	   ‘nonfat	   insulation’,	   which	   reflects	   regulated	   insulation	   by	   means	   of	  
vasoconstriction,	  has	  been	  observed	  previously	  in	  long	  distance	  runners	  (45)	  and	  after	  
9	  weeks	  of	  endurance	  exercise	  in	  young	  men	  (46).	  In	  the	  latter	  study,	  the	  subjects	  also	  
showed	   a	  moderately	   lower	  metabolic	   response	   and	   lower	   body	   temperatures	   after	  
the	   training	   period.	   The	   authors	   hypothesized	   that	   this	   physical	   conditioning	   may	  
promote	   vascularization	   of	  muscle	   tissue	   and/or	   alter	   tissue	   sensitivity	   to	   circulating	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catecholamines	  thereby	  increasing	  the	  capacity	  for	  vasoconstriction.	  Despite	  increased	  
insulation,	  there	  was	  a	  trend	  for	   lower	  core	  temperature	  during	  the	  cold	  exposure	   in	  
the	  athletes,	  suggesting	  that	  athletes	  might	  tolerate	  lower	  internal	  body	  temperatures,	  
which	   has	   been	   demonstrated	   previously	   in	   long	   distance	   runners	   (45).	   This	   was	  
however	  not	  reflected	  by	  differences	  in	  thermal	  sensation	  and	  comfort	  between	  both	  
groups.	  	  
	   Interestingly,	   plasma	   FFA,	   free	   glycerol,	   and	   triglycerides	   significantly	   increased	  
during	  cold	  exposure	  in	  the	  trained	  group,	  and	  plasma	  insulin	   levels	  decreased	  in	  the	  
endurance-­‐trained	  athletes	  as	  previously	  observed	  in	  both	  lean	  and	  obese	  individuals	  
(47).	   It	  has	  been	  shown	  in	  sheep	  that	  cold	  exposure	  diminishes	   insulin	  production	  by	  
the	  pancreas	  likely	  through	  increased	  activation	  of	  α-­‐receptors	  in	  pancreatic	  β-­‐cells	  by	  
increased	   sympathetic	   activity	   and	   catecholamine	   release	   (48).	   It	   is	   likely	   that	  
increased	  sympathetic	  stimulation	  by	  cold	  exposure	  stimulated	  WAT	  lipolysis	  thereby	  
increasing	   plasma	   free	   FFA	   and	   glycerol	   to	   supply	   substrates	   for	   cold-­‐induced	  
thermogenesis	   (49).	   In	   addition,	   the	   decrease	   in	   insulin	   levels	   may	   result	   in	   a	  
diminished	  inhibition	  of	  lipolysis,	  partly	  explaining	  the	  increase	  in	  FFA	  and	  free	  glycerol	  
and	  may	   serve	   to	   fuel	   the	   increased	   fatty	  acid	  oxidation	  during	   cold	  exposure	   in	   the	  
athletes.	  The	   increase	  of	  plasma	   triglycerides	  after	   cold	  exposure	  has	  been	  observed	  
previously	   (50),	  and	   is	   in	   contrast	   to	   the	   increased	   triglyceride	  clearance	  observed	   in	  
mice	  by	  Bartelt	  and	  coworkers	  (51).	  	  
	   In	   summary,	   endurance	   trained	   athletes	   had	   lower	   cold-­‐induced	   BAT	   activity	  
compared	  to	  lean	  sedentary	  individuals.	  Moreover,	  despite	  increased	  gene	  expression	  
of	   FNDC5	   in	   skeletal	  muscle	   chronic	   endurance	  exercise	  did	  not	   lead	   to	  browning	  of	  
subcutaneous	  abdominal	  WAT.	   It	   can	   thus	  be	  concluded	   that,	   in	  contrast	   to	   rodents,	  
chronic	  endurance	  exercise	  does	  not	  lead	  to	  an	  increased	  thermogenic	  capacity	  of	  BAT	  
in	  humans.	  	  
Methods	  
Subjects	  	  
Twelve	  healthy	  endurance-­‐trained	  and	  twelve	  lean	  sedentary	  males	  aged	  between	  18-­‐
35	   years	   were	   studied	   between	   January	   and	   September	   2013.	   The	   athletes	   were	  
included	  in	  the	  trained	  group	  when	  they	  performed	  endurance	  exercise	  (long-­‐distance	  
running,	   cycling,	   swimming)	   sessions	   of	   at	   least	   one	   and	   a	   half	   hours	   at	   least	   three	  
times	   per	   week	   during	   the	   last	   two	   years.	   Furthermore,	   they	   were	   screened	   for	  
maximal	   oxygen	   consumption	   (VO2max),	   which	   should	   be	   above	   55	  ml/min/kg.	   The	  
sedentary	  males	  were	   included	   in	   the	  untrained	  group	   if	   they	  did	  not	  perform	  more	  
than	  one	  hour	  of	  sports	  per	  week	  during	  the	  last	  two	  years.	  Furthermore,	  a	  VO2	  max	  
below	   45	   ml/min/kg	   was	   used	   as	   inclusion	   criterion.	   Due	   to	   technical	   problems	   we	  
included	   one	   untrained	   individual	   solely	   based	   on	   his	  maximal	   power	   output,	  which	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was	   less	   than	  4	  Watt/kg	  General	  exclusion	  criteria	  were	  use	  of	  medication,	   smoking,	  
weight	  gain/loss	  of	  more	  than	  3	  kg	  in	  the	  last	  six	  months,	  hypertension,	  (family	  history	  
of)	  diabetes	  and	  diabetes	  related	  diseases,	  and	  contra	  indications	  for	  MRI	  and	  PET-­‐CT.	  
All	   subjects	   signed	   a	  written	   informed	   consent.	   The	   local	  medical	   ethical	   committee	  
approved	  the	  study	  protocol	  and	  all	  subjects	  were	  treated	  according	  to	  the	  declaration	  
of	  Helsinki	  of	  1975,	  as	  revised	  in	  1983.	  	  
Study	  design	  	  
Each	   subject	   underwent	   a	   mild	   cold	   experiment	   followed	   by	   a	   by	  
[18F]fluorodeoxyglucose-­‐positron	   emission	   tomography-­‐computed	   tomography	  
([18F]FDG-­‐PET-­‐CT)-­‐scan	  to	  determine	  BAT	  activity.	  Within	   two	  weeks	   from	  the	  PET-­‐CT	  
scan,	  we	  took	  an	  abdominal	  subcutaneous	  adipose	  biopsy	  (needle)	  6-­‐8	  cm	  lateral	  from	  
the	   umbilicus	   under	   local	   anesthesia	   (2%	   lidocaine)	   to	   determine	   browning	   of	  WAT.	  
Subsequently,	   a	   muscle	   biopsy	   from	  m.	   vastus	   lateralis	   was	   taken	   according	   to	   the	  
technique	   of	   Bergström	   (52)	   to	   determine	   FNDC5	  mRNA	   expression.	   The	   tissue	  was	  
rinsed	   from	   blood,	   and	   directly	   frozen	   in	   melting	   isopentane.	   Subsequently,	   the	  
biopsies	  were	   snap	   frozen	   in	   liquid	  nitrogen	  and	   stored	  at	   -­‐80	   °C	   for	   future	  analysis.	  
These	  measurements	  were	  conducted	  in	  the	  morning	  after	  an	  overnight	  fast.	  The	  mild	  
cold	   experiment	   and	   biopsies	   were	   conducted	   within	   two	   weeks	   from	   each	   other.	  
Furthermore,	   we	   paired	   each	   trained	   individual	   with	   an	   untrained	   subject	   and	  
measured	   both	   within	   two	   weeks	   to	   preclude	   possible	   seasonal	   effects	  
(acclimatization)	  on	  BAT	  activity	  and	  browning	  of	  WAT.	  Due	  to	  practical	  reasons,	  one	  
pair	  was	  measured	  within	  3	  weeks.	  All	  subjects	  were	  asked	  to	  refrain	  from	  exercise	  in	  
the	  three	  days	  previous	  to	  the	  biopsies	  to	  exclude	  any	  acute	  effects	  on	  skeletal	  muscle	  
and	   adipose	   tissue.	   Body	   composition	   was	   determined	   by	   means	   of	   dual	   x-­‐ray	  
absorptiometry	  (type	  discovery	  A;	  Hologic).	  	  
Mild	  cold	  experiment	  and	  PET/CT	  scan	  
BAT	  activity	  was	  measured	  during	  two	  hours	  of	  mild	  cold	  exposure,	  in	  which	  we	  used	  a	  
standardized	  cooling	  protocol	  (for	  details	  see	  (50)).	  All	  subjects	  arrived	  in	  the	  morning	  
after	   an	  overnight	   fast	   and	  were	   asked	   to	   refrain	   from	  exercise	  on	   the	  previous	  day	  
and	   consumed	   a	   standardized	   meal	   the	   evening	   before	   the	   experiment	   	   (55%	  
carbohydrate,	   30%	   fat,	   15%	   protein,	   518	   kcal).	   Measurements	   were	   conducted	   in	   a	  
specially	   equipped	   air-­‐permeable	   tent	   (Colorado	   altitude	   training,	   USA),	   in	   which	  
ambient	   temperature	   could	   be	   tightly	   controlled.	   During	   the	   experiment,	   subjects	  
wore	  standardized	  clothing	  (shorts	  and	  a	  t-­‐shirt;	  0.19	  clo).	  	  
	   We	   measured	   several	   parameters	   during	   the	   mild	   cold	   experiment.	   Core	  
temperature	   was	   sampled	   each	   minute	   via	   a	   telemetric	   pill	   (CoreTemp,	   HT150002,	  
USA),	  which	  was	   orally	   ingested	  one	  hour	   before	   the	   start	   of	   the	   experiment.	  Mean	  
skin	   temperature	   was	   measured	   every	   minute	   via	   wireless	   temperature	   sensors	  
(iButtons,	   Maxim	   integrated,	   USA)	   at	   the	   14	   sites	   prescribed	   by	   ISO-­‐standard	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9886:2004	  (Ergonomics	  –	  Evaluation	  of	  thermal	  strain	  by	  physiological	  measurements,	  
International	  Standards	  Organization,	  Geneva,	  Switzerland).	  Furthermore,	  we	  attached	  
one	  iButton	  on	  the	  palmar	  side	  of	  the	  middle	  finger	  and	  one	  at	  the	  ventral	  site	  of	  the	  
underarm	   to	   determine	   to	   underarm-­‐fingertip	   gradient,	   and	   one	   iButton	   at	   the	  
supraclavicular	   area	   to	   detect	   any	   differences	   in	   skin	   temperature	   at	   the	   most	  
prominent	   BAT	   location	   in	   humans.	   	   The	   level	   of	   skin	   perfusion	   as	   a	   measure	   of	  
vasoconstriction	   was	   determined	   by	   measuring	   skin	   perfusion	   by	   Laser	   Doppler	  
Flowmetry.	   Probes	  were	   attached	  at	   the	  palmar	   side	  of	   the	  hand	  at	   the	  base	  of	   the	  
thumb,	  at	  the	  plantar	  side	  of	  the	  hallux	  (Perimed	  PF4000,	  Sweden),	  at	  the	  ventral	  side	  
of	  the	  forearm	  halfway	  between	  the	  elbow	  and	  the	  wrist,	  and	  at	  the	  abdomen	  halfway	  
between	  the	  umbilicus	  and	  the	  left	  lateral	  side	  of	  the	  body	  (Perimed	  PF5000,	  Sweden).	  
In	  addition,	  heart	  rate	  was	  determined	  each	  minute	  via	  a	  heart	  rate	  monitor	  across	  the	  
chest	  (Polar	  T31,	  USA),	  and	  blood	  pressure	  each	  15	  minutes	  electronically	  by	  a	  blood	  
pressure	   cuff	   on	   the	   left	   upper	   arm	   (Cresta,	   Taiwan).	   Shivering	   was	   determined	   via	  
electromyography	   on	   the	   m.	   vastus	   lateralis	   and	   m.	   pectoralis	   major	   (PASAQ4.01,	  
Maastricht	   Instruments	  BV,	   The	  Netherlands)	   and	  by	   the	  use	  of	  Visual	  Analog	   Scales	  
(VAS).	  These	  scales	  were	  also	  used	  to	  measure	  thermal	  sensation	  and	  comfort	  each	  15	  
minutes	   (53).	  A	   cannula	  was	   inserted	   in	   the	   antecubital	   vein	   to	   sample	  blood	   at	   the	  
end	  of	  the	  baseline	  period	  and	  after	  one	  hour	  in	  the	  cold.	  Finally,	  energy	  expenditure	  
was	  measured	  continuously	  by	  means	  of	  a	  ventilated	  hood	  system	  (Omnical;	  Jaeger).	  	  
PET	  protocol	  and	  analysis	  
We	  used	  a	   static	   PET-­‐CT	   scanning	  protocol	   to	  determine	   [18F]FDG-­‐uptake	   in	  multiple	  
tissues.	   The	   protocol	   started	   with	   a	   low-­‐dose	   CT	   scan	   (120kV,	   30mAs)	   immediately	  
followed	  by	  the	  PET	  scan.	  The	  uptake	  of	  [18F]FDG	  (2	  mCi,	  74	  MBq)	  was	  determined	  by	  
means	   of	   the	   PET	   scan,	   and	   the	   CT	   scan	   was	   used	   for	   attenuation	   and	   scatter	  
correction	  of	  the	  PET	  scan	  and	  to	  determine	  the	  anatomical	   location	  of	  the	  [18F]FDG-­‐
uptake.	   The	   upper	   body	   (pelvis	   to	   crown	   of	   the	   head)	   was	   scanned	   and	   6-­‐7	   bed	  
positions	  with	  6	  minutes	  per	  position.	  The	  voxel	  size	  of	  both	  reconstructed	  image	  sets	  
was	  4	  x	  4	  x	  4	  mm3.	  The	  researcher	   (MJV)	  together	  with	  a	  nuclear-­‐medicine	  physician	  
(BB)	   interpreted	  the	   images	  using	  PMOD	  software	  (version	  3.0;	  PMOD	  Technologies).	  
The	  regions	  of	  interest	  (BAT)	  were	  manually	  outlined	  in	  the	  fusion	  image	  (PET	  and	  CT).	  
Two	  criteria	  were	  used	  to	  classify	  the	  region	  as	  BAT.	  First,	  we	  classified	  the	  region	  of	  
interest	  as	  adipose	  tissue	  by	  means	  of	  Hounsfield	  Units	  (−10	  to	  −180	  HU).	  Second,	  we	  
used	   a	   PET	   threshold	   of	   1.5	   standard	   uptake	   value	   (SUV),	   which	   is	   approximately	   6	  
times	  higher	  than	  uptake	  in	  WAT,	  to	  regard	  the	  tissue	  as	  BAT.	  Taken	  all	  these	  regions	  
together,	  the	  SUVtotal	  was	  calculated,	  which	  is	  the	  average	  SUV	  per	  volume	  of	  interest	  
times	   its	   volume.	   In	   addition,	   we	   measured	   the	   maximal	   [18F]FDG	   uptake	   in	  
supraclavicular	  BAT	  as	  an	  indication	  of	  maximal	  BAT	  activity.	  Finally,	  the	  average	  SUV	  
(SUVmean)	  in	  supraclavicular	  BAT,	  skeletal	  muscle,	  subcutaneous	  and	  visceral	  WAT,	  the	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liver,	   and	   the	  brain	   (cerebellum)	  by	   selecting	   cubes	  as	   volume	  of	   interests	   (for	  more	  
details	  see:	  (16)).	  	  
Blood	  analysis	  
Blood	   samples	   (30	   mL)	   were	   collected	   from	   the	   antecubital	   vein	   at	   the	   end	   of	   the	  
baseline	  period	  and	  after	  one	  hour	  of	  cold	  exposure	  to	  determine	  several	  parameters.	  
The	   concentration	   of	   plasma	   free	   fatty	   acids	   (NEFA-­‐HR	   set,	  Wako	   Chemicals,	   Neuss,	  
Germany),	  free	  glycerol	  (Glycerol	  kit,	  R-­‐Biopharm,	  Darmstadt,	  Germany)	  total	  glycerol	  
(ABX	  Triglyceriden	  CP,	  Radiometer,	  Horiba	  ABX,	  Montpellier,	  France)	  and	  glucose	  (ABX	  
Glucose	  HK	  CP,	  Radiometer,	  Horiba	  ABX,	  Montpellier,	   France)	  were	  measured	  with	  a	  
COBAS	   FARA	   centrifugal	   spectrophotometer	   (Roche	   Diagnostica,	   Basel,	   Switzerland).	  
The	   concentrations	   of	   triglycerides	   in	   plasma	   were	   calculated	   by	   subtracting	   free	  
glycerol	   from	   total	   glycerol	   concentrations.	   Insulin	   was	   measured	   in	   serum	   and	  
analyzed	   on	   a	   Gamma	   Counter	   (2470	   Automatic	   Gamma	   Counter	   Wizard2™	   Wallac,	  
Perkin	   Elmer,	   USA)	   with	   a	   Human	   Insulin	   specific	   RIA	   kit	   (Milipore,	   USA).	   Thyroid	  
stimulating	   hormone	   (TSH)	   was	   determined	   in	   serum	   by	   means	   of	   an	  
electrochemiluminescence	   immunoassay	   kit	   on	   a	   COBAS	   6000	   system	   (Roche	  
Diagnostica).	   Total	   thyroxine	   (T4)	   was	   analyzed	   by	   a	   solid-­‐phase,	   competitive	  
chemiluminescent	   enzyme	   immunoassay	   on	   an	   Immulite	   2000	   system	   (Siemens).	  
Finally,	   free	   thyroxine	   was	   measured	   by	   using	   a	   solid-­‐phase	   time-­‐resolved	  
fluoroimmunoassay	  FT4	  kit	  on	  an	  AutoDELFIA	  system	  (PerkinElmer).	  
RNA	  extraction	  and	  real-­‐time	  PCR	  analysis	  
For	  skeletal	  muscle	  FNDC5,	  RNA	  was	  isolated	  from	  muscle	  tissue,	  using	  Trizol	  according	  
to	  the	  method	  from	  Chomczynski	  et	  al.	  (54).	  RNA	  from	  WAT	  was	  extracted	  using	  Trizol	  
reagent	   followed	   by	   protocol	   described	   in	   the	   RNeasy	   kit	   from	   Qiagen	   (Hildenberg,	  
Germany).	   Quality	   and	   yield	   of	   RNA	   was	   assessed	   using	   a	   NanoDrop	  
spectrophotometer	   from	  Thermo	  Fischer	   scientific.	   cDNA	  was	   created	  using	   the	  high	  
capacity	  RNA-­‐to-­‐cDNA	  kit	  from	  Applied	  Biosystems	  (Foster	  City,	  CA).	  Gene	  expression	  
was	  determined	  using	  a	  7900HT	  Fast	  Real-­‐Time	  PCR	  System	  from	  Applied	  Biosystems.	  
Skeletal	   muscle	   gene	   expression	   data	   was	   normalized	   against	   RPLPO	   using	   the	  
standard	   curve	   method.	   Comparison	   of	   gene	   expression	   data	   for	   WAT	   was	  
accomplished	  using	   the	   2-­‐ΔΔCt	  method.	  Gene	   expression	  data	  was	   normalized	   against	  
the	  geometric	  mean	  of	  TBP	  and	  RPLPO.	  Taqman	  gene	  expression	  assays	  were	  used	  for	  
analysis	   of	   UCP1	   (Hs00222453_m1),	   CIDEA	   (Hs00154455_m1),	   CD137	  
(Hs00155512_m1),	  TMEM26	  (Hs00415619_m1).	  
Statistical	  analysis	  
We	   used	   the	   program	   SPSS	   20.0	   (IBM)	   for	   Macintosh	   for	   statistical	   analysis.	   To	  
compare	  all	   parameters	  between	  baseline	  and	  mild	   cold	  we	   took	   the	  average	  of	   the	  
last	  30	  minutes	  of	  baseline	  and	  30	  minutes	  after	   the	   injection	  of	   the	   [18F]FDG-­‐tracer.	  
CHAPTER	  5 	  
89	  	  
The	   effects	   of	  mild	   cold	   exposure	   on	   all	   variables	  within	   each	   group	  were	   tested	   by	  
means	  of	  paired-­‐sample	  t	  tests.	  Note	  that	  we	  used	  non-­‐parametric	  testing	  (Wilcoxon	  ‘s	  
test)	  to	  measure	  differences	  in	  blood	  parameters	  in	  the	  untrained	  group	  (n=7).	  There	  
were	  5	  missing	  values	  due	  to	  the	   low	  amount	  of	  samples	  that	  could	  be	  drawn	  in	  this	  
group	  during	   the	   cold	   (n=7).	   	   Independent	   sample	   t	   tests	  were	  used	   to	   compare	   the	  
trained	  with	  the	  untrained	  group.	  Furthermore,	  Pearson	  correlation	  was	  performed	  to	  
identify	   relations	   between	   variables	   on	   whole	   group	   level	   (n=24),	   and	   within	   each	  
group	  (n=12).	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Mild	   cold	   acclimation	   is	   known	   to	   increase	   brown	   adipose	   tissue	   (BAT)	   activity	   and	  
cold-­‐induced	   thermogenesis	   (CIT)	   in	  humans.	  We	  here	   tested	   the	  effect	  of	  a	   lifestyle	  
with	  frequent	  exposure	  to	  extreme	  cold	  on	  BAT	  and	  CIT	  in	  a	  Dutch	  man	  known	  as	  ‘the	  
Iceman’,	   who	   has	   multiple	   world	   records	   in	   withstanding	   extreme	   cold	   challenges.	  
Furthermore,	   his	   monozygotic	   twin	   brother	   who	   has	   a	   ‘normal’	   sedentary	   lifestyle	  
without	  extreme	  cold	  exposures	  was	  measured.	  	  
Methods:	  	  
The	  Iceman	  (subject	  A)	  and	  his	  brother	  (subject	  B)	  were	  studied	  during	  mild	  cold	  (13°C)	  
and	   thermoneutral	   conditions	   (31°C).	   Measurements	   included	   BAT	   activity	   and	  
respiratory	   muscle	   activity	   by	   [18F]FDG-­‐PET/CT	   imaging	   and	   energy	   expenditure	  
through	   indirect	   calorimetry.	   In	   addition,	   body	   temperatures,	   cardiovascular	  
parameters,	   skin	   perfusion,	   and	   thermal	   sensation	   and	   comfort	   were	   measured.	  
Finally,	   we	   determined	   polymorphisms	   for	   uncoupling	   protein-­‐1	   and	   β3-­‐adrenergic	  
receptor.	  	  
Results:	  	  
Subjects	  had	  comparable	  BAT	  activity	  (A:	  1144	  SUVtotal	  and	  B:	  1325	  SUVtotal),	  within	  the	  
range	   previously	   observed	   in	   young	   adult	   men.	   They	   were	   genotyped	   with	   the	  
polymorphism	  for	  uncoupling	  protein-­‐1	  (G/G).	  CIT	  was	  relatively	  high	  (A:	  40.1%	  and	  B:	  
41.9%),	  but	  unlike	  during	  our	  previous	   cold	  exposure	   tests	   in	  young	  adult	  men,	  here	  
both	  subjects	  practiced	  a	  g-­‐Tummo	  like	  breathing	  technique,	  which	   involves	  vigorous	  
respiratory	  muscle	  activity.	  This	  was	  confirmed	  by	  high	  [18F]FDG-­‐uptake	  in	  respiratory	  
muscle.	  
Conclusion:	  
No	   significant	   differences	   were	   found	   between	   the	   two	   subjects,	   indicating	   that	   a	  
lifestyle	  with	  frequent	  exposures	  to	  extreme	  cold	  does	  not	  seem	  to	  affect	  BAT	  activity	  
and	   CIT.	   In	   both	   subjects,	   BAT	   was	   not	   higher	   compared	   to	   earlier	   observations,	  
whereas	   CIT	   was	   very	   high,	   suggesting	   that	   g-­‐Tummo	   like	   breathing	   during	   cold	  
exposure	   may	   cause	   additional	   heat	   production	   by	   vigorous	   isometric	   respiratory	  
muscle	  contraction.	  The	  results	  must	  be	  interpreted	  with	  caution	  given	  the	  low	  subject	  
number	   and	   the	   fact	   that	   both	   participants	   practised	   the	   g-­‐Tummo	   like	   breathing	  
technique.	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Introduction	  	  
During	  cold	  exposure	  the	  human	  body	  may	  increase	  heat	  production	  by	  shivering	  and	  
non-­‐shivering	  thermogenesis	   (NST),	  and	  minimize	  heat	   loss	  by	  vasoconstriction	   [1].	  A	  
major	  tissue	  responsible	  for	  NST	  is	  brown	  adipose	  tissue	  (BAT).	  BAT	  produces	  heat	  via	  
uncoupling	   protein-­‐1	   (UCP-­‐1),	   which	   uncouples	   the	   respiratory	   chain	   from	   ATP	  
production	   thereby	   releasing	   energy	   as	   heat.	   A	   lifestyle	   that	   includes	   frequent	   cold	  
exposure	   might	   result	   in	   acclimatization	   and,	   consequently,	   a	   better-­‐equipped	  
thermoregulatory	  machinery	  to	  fight	  the	  cold.	  It	  is	  now	  well	  established	  that	  BAT	  is	  still	  
present	  and	  functional	  in	  human	  adults	  during	  cold	  exposure	  [2-­‐4].	  Furthermore,	  mild	  
cold	  acclimatization	   in	  humans	  has	   shown	   to	   increase	  NST	   [5,6]	  and	  BAT	  activity	   [6].	  
However,	  the	  effects	  of	  a	  lifestyle	  with	  frequent	  exposures	  to	  extreme	  cold	  conditions	  
on	  these	  parameters	  are	  unknown.	  	  
	   It	  has	  been	  shown	  that	  a	  great	  variability	   in	  NST	  and	  BAT	  exists	  within	  the	  same	  
population	   groups,	   which	   may	   be	   attributed	   to	   differences	   in	   lifestyle	   effects	   [7].	  
However,	   a	   genetic	   component	   may	   influence	   the	   capacity	   for	   NST	   as	   well.	   For	  
instance,	   it	  has	  been	  suggested	  that	  polymorphisms	  in	  the	  uncoupling	  protein-­‐1	  gene	  
and	  β-­‐adrenergic	  receptor	  influence	  resting	  energy	  expenditure	  [8]	  and	  accelerate	  age-­‐
related	   decrease	   in	   BAT	   activity	   in	   elderly	   [9].	   It	   is	   thus	   likely	   that	   both	   nature	   (i.e.	  
genetic	  make	  up)	   and	  nurture	   (lifestyle)	   influence	   the	  existence	  and	  heat	   generating	  
potential	   of	   BAT.	   Next	   to	   BAT,	   also	   other	   tissues,	   such	   as	   skeletal	   muscle,	   might	  
contribute	  to	  NST	  [10].	  	  
	   In	   this	   perspective,	   we	   report	   on	   the	   thermoregulatory	   responses	   of	   a	  
monozygotic	   twin.	   One	   of	   the	   twins,	   the	   so-­‐called	   “Iceman”,	   has	   been	   exposed	   to	  
frequent	   periods	   of	   extreme	   cold	   for	   several	   decades.	   He	   is	   world-­‐record	   holder	   in	  
withstanding	  extreme	  cold	  exposure	  under	  several	  disciplines,	  such	  as	  the	  fastest	  half-­‐
marathon	   on	   snow	   and	   ice	   while	   barefoot,	   and	   the	   longest	   duration	   while	   fully	  
immersed	  in	  crushed	  ice	  (1	  hour	  and	  50	  minutes).	  He	  claims	  to	  achieve	  these	  records	  
through	   a	   special	   meditation	   and	   breathing	   technique,	   which	   is	   based	   on	   g-­‐Tummo	  
meditation,	  and	  that	  he	   is	  capable	   to	   regulate	  his	  own	  autonomic	  nervous	  system.	  A	  
recent	  case	  study	  demonstrated	  that	  he	  was	  capable	  to	  control	  the	  autonomic	  stress	  
response	   during	   endotoxemia	   by	   using	   this	   technique	   [11].	   His	   monozygotic	   twin	  
brother	  does	  not	  experience	  extreme	  cold	  exposure	  due	  to	  a	  different	  occupation	  and	  
a	  sedentary	  lifestyle,	  although	  he	  is	  aware	  of	  the	  techniques	  used	  by	  his	  brother.	  We	  
here	  tested	  the	  hypothesis	  that	  the	  iceman	  has	  a	  higher	  cold-­‐induced	  heat	  production	  
and	  cold-­‐induced	  BAT	  activity	  compared	  to	  his	   identical	  twin	  brother.	  This	  case	  study	  
provides	  a	  unique	  comparison	  between	  a	  monozygotic	  twin	  pair,	  one	  being	  extremely	  
cold-­‐acclimated	  the	  other	  being	  not	  cold-­‐acclimated	  at	  all.	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Subjects	  and	  Methods	  
The	  Medical	  Ethical	  Committee	  of	  the	  Maastricht	  University	  Medical	  Centre+	  approved	  
the	  protocols	   and	  both	   the	   Iceman	   (subject	  A)	   and	  his	   twin	  brother	   (subject	  B)	   gave	  
written	   informed	  consent.	  All	  procedures	  were	  conducted	  according	  to	  the	  principles	  
of	   the	  Declaration	  of	  Helsinki.	   The	  monozygotic	   twin	  brothers	   are	  both	  male	   and	  52	  
years	  of	  age.	  They	  were	  screened	  for	  medical	  history,	  and	  were	  absent	  of	  any	  factors	  
related	  to	  the	  metabolic	  syndrome,	  and	  had	  no	  thyroid	  gland	  dysfunction.	  They	  were	  
not	  using	  any	  type	  of	  medication,	  which	  could	  have	  affected	  the	  results.	  Subject	  A	   is	  
well	   known	   for	   his	   capability	   to	   withstand	   extreme	   cold	   challenges.	   He	   is	   a	   self-­‐
employed	  lifestyle	  educator,	  focusing	  on	  the	  capacity	  of	  the	  human	  mind	  to	  control	  its	  
body	  by	  means	  of	  a	  special	  meditation	  and	  breathing	  technique	  (based	  on	  g-­‐Tummo)	  
[12].	   He	   has	   been	   exposing	   himself	   to	   daily	   cold	   water	   swimming/showers	   and	  
regularly	  visits	  Scandinavian	  and	  arctic	  regions	   in	  order	  to	  practice	  and	  train	  extreme	  
cold	   exposure	   in	   shorts	   only.	   Subject	   B	   is	   employed	   as	   an	   international	   truck	   driver,	  
being	   on	   the	   road	   for	   multiple	   days	   in	   a	   row	   and	   experiencing	   longer	   periods	   of	  
inactivity.	   He	   does	   not	   practice	   and	   train	   extreme	   cold	   exposure.	   However,	   he	   is	  
familiar	  with	  the	  special	  meditation	  and	  breathing	  technique	  used	  by	  his	  brother.	  
Study	  design	  and	  measurements	  
Subjects	  were	  measured	  on	  two	  separate	  occasions	  during	  two	  consecutive	  days	  in	  the	  
winter	   season	   with	   comparable	   outdoor	   temperatures.	   The	   study	   protocols	   in	   both	  
subjects	  were	  identical.	  In	  the	  morning	  of	  day	  one,	  BAT	  activity	  was	  measured	  during	  
thermoneutral	  conditions	   (i.e.	   two	  hours	  at	  air	   temperature	  31°C),	  which	  served	  as	  a	  
control-­‐measurement	   (Figure	   1).	   In	   the	   afternoon	  of	  day	  one,	   a	   “shivering	   test”	  was	  
performed	   with	   the	   purpose	   to	   determine	   the	   air	   temperature	   associated	   with	   the	  
onset	  of	  shivering.	  This	  information	  was	  then	  used	  for	  the	  mild	  cold	  experiment	  on	  day	  
two	   to	   determine	   the	   ambient	   temperature	   to	   obtain	   maximal	   cold-­‐induced	  
thermogenesis	   (CIT)	   (i.e.	  at	   the	   lowest	   temperature	  without	  shivering).	  The	  mild	  cold	  
experiment	   on	   day	   two	   started	   with	   a	   45-­‐minute	   baseline	   during	   thermoneutral	  
conditions	  (~31	  ºC),	  followed	  by	  two	  and	  half	  hours	  of	  mild	  cold	  exposure	  (12-­‐13	  ºC).	  
The	  [18F]fluorodeoxyglucose	  (FDG)	  tracer	  was	   injected	   intravenously	  after	  90	  minutes	  
in	  the	  cold	  and	  60	  minutes	   later	  the	  PET-­‐CT	  scan	  was	  performed.	  The	  measurements	  
were	  performed	  in	  a	  specially	  equipped	  air-­‐permeable	  tent	  (Colorado	  altitude	  training,	  
USA),	  in	  which	  ambient	  temperature	  was	  tightly	  controlled.	  Subjects	  were	  measured	  in	  
semi-­‐supine	  position	  on	  an	  air-­‐permeable	  stretcher	  (Model	  Campart	  Rome-­‐XL)	  in	  order	  
to	   lie	   comfortably.	   The	   subjects	   wore	   shorts	   only	   (Clo	   0.06)[13].	   	   During	   the	  
experiments	   we	   measured	   energy	   expenditure	   via	   indirect	   calorimetry	   (Ventilated	  
Hood,	  Omnical	  2,	  Maastricht,	  the	  Netherlands),	  heart	  rate	  via	  a	  monitor	  on	  the	  chest	  
(Polar	  T31,	  USA),	  and	  blood	  pressure	  via	  a	  pressure	  cuff	  on	  the	  left	  upper	  arm	  (Cresta,	  
Taiwan).	   Mean	   arterial	   blood	   pressure	   (MAP)	   was	   calculated	   as	  MAP	   =	   1/3	   Systolic	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pressure	   +	   2/3	   Diastolic	   pressure.	   Skin	   temperatures	   were	   determined	   via	   wireless	  
temperature	   sensors	   placed	   at	   the	   14	   sites	   prescribed	   by	   ISO-­‐standard	   9886:2004	  
(Ergonomics	   –	   Evaluation	   of	   thermal	   strain	   by	   physiological	   measurements,	  
International	   Standards	   Organization,	   Geneva,	   Switzerland)	   (iButtons	   Maxim	  
integrated,	  USA),	  and	  core	  temperature	  via	  a	  telemetric	  pill	  (CorTemp	  HT150002,	  USA),	  
which	   was	   ingested	   one	   hour	   before	   the	   onset	   of	   the	   experiment.	   Vasoconstriction	  
was	  measured	  by	   determining	   the	   change	   in	   skin	   perfusion	   via	   Laser	  Doppler	   at	   the	  
ventral	   side	   of	   the	   hand	   at	   the	   base	   of	   the	   thumb,	   at	   the	   ventral	   side	   of	   the	   hallux	  
(Perimed	   PF4000,	   Sweden),	   at	   the	   ventral	   side	   of	   the	   forearm	   halfway	   between	   the	  
elbow	  and	  the	  wrist,	  and	  at	  the	  abdomen	  halfway	  between	  the	  umbilicus	  and	  the	  left	  
lateral	  side	  of	  the	  body	  (Perimed	  PF5000,	  Sweden).	  Venous	  blood	  samples	  were	  taken	  
during	   baseline	   and	   in	   the	   cold	   for	   analysis	   of	   hormones	   and	  metabolites,	   and	   DNA	  
analysis	   via	   PCR	   to	   identify	   polymorphisms	   for	   uncoupling	   protein-­‐1	   (-­‐3286	   A/G	  
polymorphism)	  [14]	  and	  the	  β3-­‐adrenergic	  receptor	  (Trp64Arg)	  [15].	  	  
	   During	  the	  mild	  cold	  experiment,	  both	  subjects	  completed	  visual	  analogue	  scales	  
(VAS-­‐scales)	   [16],	   on	   sensation,	   thermal	   comfort	   and	   shivering.	   Furthermore,	   BAT	  
activity	   was	   assessed	   by	   [18F]fluorodeoxyglucose-­‐positron	   emission-­‐tomography-­‐
computed	  tomography	  ([18F]FDG-­‐PET-­‐CT)	  (Gemini	  TF	  PET-­‐CT,	  Philips,	  The	  Netherlands).	  
The	   protocol	   and	   analysis	   were	   comparable	   to	   our	   previous	   studies	   using	   static	  
imaging	   [17].	  A	   low-­‐dose	  CT	   scan	   (120	   kV,	   30	  mAs)	  preceded	   the	  PET	   scan,	   and	  was	  
used	  for	  attenuation	  and	  scatter	  correction	  of	  the	  PET	  scan.	  The	  PET	  scan	  was	  used	  to	  
determine	   [18F]FDG-­‐uptake.	   Temperature	   was	   regulated	   with	   a	   heater	   and	   air-­‐
conditioning.	   Body	   composition	   was	   determined	   by	   means	   of	   dual	   x-­‐ray	  
absorptiometry	  (DXA,	  Hologic,	  type	  Discovery	  A,	  USA),	  and	  in	  the	  afternoon,	  a	  biopsy	  
was	  taken	  from	  the	  m.	  vastus	   lateralis	   for	  mitochondrial	  respirometry	  measurements	  
in	   permeabilized	  muscle	   fibers	   by	  means	   of	   the	   Oxygraph-­‐2K	   (Oroboros,	   Austria).	   A	  
part	   of	   the	   biopsy	   was	   placed	   in	   a	   preservation	   medium	   for	   the	   respiration	  
measurements	   (for	   substrate	  details	   see	   [6]),	  and	  a	  portion	  of	   the	  muscle	   tissue	  was	  
immediately	   frozen	   in	  melting	   isopentane	   and	   stored	   at	   -­‐80	   °C	   for	   determination	   of	  
mitochondrial	  DNA	  (mtDNA)	  copy	  number	  (ratio	  ND1	  to	  LPL).	  
Data	  and	  PET-­‐CT	  analysis	  
At	   fixed	   time	   intervals	   of	   25	   minutes	   duration	   during	   baseline	   and	   during	   cold	  
exposure	  (after	   injection	  of	   [18F]FDG)	  energy	  expenditure	  was	  calculated.	  We	  use	  the	  
term	   CIT	   instead	   of	   classical	   NST	   for	   the	   increase	   in	   energy	   expenditure	   (as	   a	  
percentage)	   during	   cold	   exposure,	   as	   respiratory	   muscle	   contraction	   was	   involved.	  
These	   time	   periods	   were	   also	   selected	   for	   analysis	   of	   cardiovascular	   and	   body	  
temperature	   parameters.	   Two	   researchers	   (M.V.	   and	   G.V.)	   and	   a	   nuclear-­‐medicine	  
physician	   (B.B.)	   analyzed	   the	   PET-­‐CT	   scan.	   In	   order	   to	   determine	   BAT	   activity,	   we	  
measured	   the	   average	   [18F]FDG-­‐uptake,	   known	   as	   the	   mean	   standard	   uptake	   value	  
(SUVmean),	  and	  the	  total	  [
18F]FDG-­‐uptake	  (SUVtotal	  =	  SUVmean	  multiplied	  by	  BAT	  volume)	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in	  BAT	  by	  manually	  drawing	  regions	  of	  interest.	  We	  considered	  fat	  tissue	  as	  BAT	  when	  
the	  Hounsfield	  Units	  of	  the	  CT-­‐scan	  were	  between	  -­‐10	  and	  180.	  Moreover,	  a	  minimum	  
of	   1.5	   SUV	   was	   used	   to	   classify	   the	   selected	   fat	   region	   as	   BAT.	   Furthermore,	   we	  
analyzed	   average	   [18F]FDG-­‐uptake	   (SUVmean)	   in	   multiple	   tissues	   in	   fixed	   volumes	   of	  
interest	  according	  to	  the	  procedure	  described	  in	  Vosselman	  et	  al.	  2013	  [18].	  The	  blood	  
parameters	   presented	   in	   the	   subject	   characteristics	   were	   compared	   to	   normal	  
reference	  values	  presented	  in	  the	  assay/kit	  information	  and	  with	  respect	  to	  the	  thyroid	  
parameters,	   references	   values	   were	   obtained	   from	   the	   department	   of	   clinical	  
chemistry	  at	  Maastricht	  University	  Medical	  Centre	  (Maastricht,	  the	  Netherlands).	  Since	  
it	   was	   impossible	   to	   study	   the	   statistical	   difference	   between	   the	   two	   brothers,	   we	  
compared	  the	  current	  results	  with	  data	  from	  previous	  studies	  in	  young	  adult	  men.	  To	  
do	   so,	   we	   made	   boxplots	   of	   the	   data	   from	   young	   adult	   men	   and	   determined	   the	  
interquartile	  range	  and	  the	  95th	  percentile.	  When	  the	  results	  of	  the	  twin	  were	  within	  
the	  interquartile	  range	  observed	  in	  young	  adult	  men,	  we	  regarded	  both	  values	  (subject	  
A	   and	   subject	   B)	   as	   comparable.	   When	   the	   score	   of	   one	   of	   the	   twin	   brothers	   was	  
outside	   the	   interquartile	   range,	   this	   was	   regarded	   as	   different	   from	   each	   other.	  
Furthermore,	   the	   score	  of	   the	   twins	  were	   considered	  as	  different	   from	  young	  adults	  
when	  the	  score	  was	  outside	  of	  the	  95th	  percentile.	  This	  comparison	  has	  its	  limitations	  
due	  to	   the	  differences	   in	  age	  between	  the	  young	  adult	  group	  and	  the	   twin	  brothers.	  
Furthermore,	   it	   should	  be	  noted	   that	   the	   current	   cooling	  protocol	   lasted	  30	  minutes	  
longer	   (2,5	   hours	   versus	   2	   hours),	   and	   clothing	   was	   less	   (clo	   0.1	   versus	   0.49).	  
Therefore,	  temperature,	  skin	  perfusion,	  and	  cardiovascular	  data	  of	  the	  twin	  could	  not	  
be	  compared	  with	   the	  young	  adults.	  However,	   for	   these	  measurements	   intra	   subject	  
comparison	  was	  based	  on	   the	  measurement	   accuracy.	   BAT	  activity	   and	  CIT	   could	  be	  
compared	  due	  to	   the	  use	  of	   the	  same	   individualized	  protocol	   in	  all	   subjects	   in	  which	  
we	  cool	  the	  subjects	  to	  temperatures	  just	  above	  shivering,	  in	  order	  to	  obtain	  maximal	  
NST	  and	  BAT	  activity	   in	  each	  subject	   (for	  more	  details	  on	  this	  protocol	  see	   [17]).	  The	  
respiration	   values	   for	   skeletal	   muscle	   are	   represented	   as	   the	   average	   of	   two	   traces	  
with	  standard	  deviation.	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Figure	  1.	  Study	  protocol.	  The	  thermoneutral	  experiment	  started	  in	  the	  morning	  on	  day	  one.	  After	  one	  hour	  a	  
blood	  sample	  was	  taken	  and	  subsequently	  the	  [18F]FDG	  tracer	  was	  injected	  followed	  by	  the	  PET-­‐CT	  scan	  one	  
hour	   later.	   In	   the	   afternoon	   of	   day	   one,	   the	   shivering	   experiment	   was	   conducted,	   which	   started	   with	   a	  
baseline	   period	   of	   45	   minutes	   during	   31	   °C	   followed	   by	   90	   minutes	   of	   mild	   cold	   exposure	   (31	   °C)	   to	  
determine	   the	   ambient	   temperature	   at	   which	   shivering	   occurred.	   The	   mild	   cold	   experiment	   on	   day	   two	  
consisted	   of	   45	  minutes	   baseline	   (31	   °C)	   followed	   by	   150	  minutes	   of	   cold	   exposure.	   Blood	   samples	  were	  
taken	   at	   the	   end	   of	   the	   baseline	   period	   and	   90	   and	   150	   minutes	   after	   the	   onset	   of	   cold	   exposure.	   The	  
[18F]FDG	  tracer	  was	  injected	  90	  minutes	  after	  the	  onset	  of	  cold	  exposure,	  followed	  by	  the	  PET-­‐CT	  scan	  one	  
hour	  later.	  
Results	  
Characteristics	  of	  monozygotic	  twin	  pair	  
Subject	   A	   had	   a	   lower	   fat	   percentage	   (13.7%	   versus	   18%;	   normal	   range	   11-­‐22%),	  
comparable	  fat	  free	  mass	  (69.4kg	  versus	  68.1	  kg)	  and	  lower	  fasting	  triglyceride	   levels	  
(subject	  A:	  698	  μmol/L	  versus	  subject	  B:	  1060	  μmol/L;	  normal	  range:	  680-­‐1880	  μmol/L)	  
than	  subject	  B	  (Table	  1).	  Fasting	  glucose	   levels	  were	  equal	   (both	  5.7	  mmol/L;	  normal	  
range:	  3.61-­‐6.11	  mmol/L).	  Thyroid	  stimulating	  hormone	   levels	  were	  comparable,	  and	  
within	   the	   normal	   range	   (A:	   1.1	   mU/L	   versus	   B:	   0.9	   mU/L;	   normal	   range	   0.4	   –	   4.3	  
mU/L).	   Total	   T4	  was	   slightly	   lower	   in	   subject	   A,	   and	   free	   T4	   levels	  were	   comparable	  
(total	  T4:	  A:	  84	  nmol/L	  versus	  B:	  96	  nmol/L;	  normal	  range:	  60-­‐150	  nmol/L;	  free	  T4:	  A:	  
14.8	  pmol/L	  versus	  B	  14.7	  pmol/L;	  normal	  range:	  8-­‐18	  pmol/L).	  Furthermore,	  subject	  A	  
had	  a	  more	  active	  lifestyle,	  although	  both	  were	  more	  active	  compared	  to	  the	  average	  
found	   in	   young	   adults,	   indicated	  by	   the	  Baecke	  Questionnaire	   scores	   (total	   score:	  A:	  
11.4	   versus	   B:	   9.7;	   average	   young	   adults:	   ±8.2,	   derived	   from	   [19]).	   Interestingly,	   the	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monozygotic	   twin	   was	   genotyped	   with	   the	   polymorphism	   for	   uncoupling	   protein-­‐1	  
(G/G).	   These	   G-­‐allele	   carriers	   have	   been	   associated	   with	   an	   attenuation	   of	   UCP-­‐1	  
mediated	  thermogenesis	   [20].	  No	  polymorphism	  (no	  Arg64	  allele)	  was	  present	   in	   the	  
β3-­‐adrenergic	  receptor.	  
	  
Table	  1.	  Subject	  characteristics	  monozygotic	  twin	  
Parameter	   Subject	  A	   Subject	  B	  
Height	  (cm)	   183	   184	  
Weight	  (kg)	   82.2	   87.0	  
BMI	  (kg/m2)	   24.7	   25.8	  
Fat	  percentage	  (%)	   13.7	   18	  
Lean	  mass	  (kg)	   69.4	   68.1	  
Fasting	  glucose	  (mmol/L)	   5.7	   5.7	  
Fasting	  triglycerides	  (μmol/L)	   698	   1060	  
Thyroid	  stimulating	  hormone	  (mU/L)	   1.1	   0.9	  
Total	  T4	  (nmol/L)	   14.8	   14.7	  
Free	  T4	  (pmol/L)	   84	   96	  
Resting	  metabolic	  rate	  (MJ/day)	   8.1	   7.8	  
Baecke	  Questionnaire	  Score	  (WI/SI/LI(total))	   3.1/4.3/4	  (11.4)	   2.4/3.5/3.8	  (9.7)	  
LI,	  leisure	  time	  index;	  SI,	  sport	  index;	  WI,	  work	  index.	  	  
Cold	  exposure	  effects	  	  
Interestingly,	   during	   the	   “shivering	   experiment”	   on	   day	   one,	   both	   subjects	   did	   not	  
reach	  the	  point	  of	  shivering.	  Normally,	  in	  such	  conditions	  with	  temperature	  drops	  from	  
31	  to	  13°C,	  young	  adults	  and	  elderly	  start	  shivering	  [21,22].	  The	  next	  day	  we	  maximally	  
decreased	  ambient	  temperature	  and	  temperatures	  dropped	  to	  maximally	  12°C.	  Again,	  
no	   shivering	  was	   observed	   during	   this	   cold	   experiment.	  Mean	   skin	   temperature	  was	  
comparable	   between	   the	   subjects	   during	   baseline	   (A:	   33.22	   °C	   versus	   B:	   33.40	   °C,	  
Table	   2),	   however	   during	   cold	   exposure	   mean	   skin	   temperature	   decreased	   more	  
pronounced	   in	  subject	  B	  compared	  to	  subject	  A	  (A:	  27.57	  °C	  versus	  B:	  25.95	  °C).	  This	  
decrease	  was	  predominantly	  seen	  in	  the	  proximal	  region	  (A:	  29.36	  °C	  versus	  B:	  27.81	  
°C).	   Both	   subjects	   had	   comparable	   vasoconstriction	   in	   the	   hand	   (A:	   91,7%	   versus	   B:	  
91,3%)	  and	  toe	  (A:	  96%	  versus	  B:	  96.4%),	  although	  subject	  A	  had	  a	  slightly	  lower	  distal	  
temperature	  (A:	  21.43	  °C	  versus	  B:	  22.34	  °C).	  Subject	  A	  showed	  more	  vasoconstriction	  
in	   the	   underarm	   (A:	   63.3%	   versus	   B:	   8.8%)	   and	   abdomen	   (A:	   7%	   versus	   B:	   -­‐8.8%	  
(vasodilation)).	  Core	  temperature	  decreased	   in	  both	  subjects	  with	  a	  smaller	  decrease	  
(−0.18	   °C)	   in	   subject	   A	   compared	   to	   subject	   B	   (−0.40	   °C).	   As	   the	   accuracy	   of	   the	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measurement	   is	  ±	  0.1°C	  and	  due	   to	   the	  small	   range	  within	  core	   temperature	   is	  held,	  
we	  interpreted	  the	  difference	  of	  −0.22	  °C	  as	  physiologically	  different.	  There	  was	  a	  clear	  
difference	   in	   cold	   sensation	   and	   comfort	   between	   both	   subjects.	   Both	   subjects	  
experienced	   the	   thermal	   environment	   as	   neutral	   during	  baseline,	   however	   subject	  A	  
reported	   neutral	   to	   slightly	   cool	   during	   the	  mild	   cold	   period,	  whereas	   subject	   B	   felt	  
cold	   (Figure	  2).	  Furthermore,	  subject	  A	  reported	  that	  he	  was	  comfortable	  with	   these	  
temperatures	   during	   the	   entire	   experiment,	   whereas	   subject	   B	   felt	   between	  
uncomfortable	  and	  very	  uncomfortable.	  Cold	  exposure	  slightly	  increased	  heart	  rate	  in	  
subject	   A	   (baseline:	   46	   beats/min	   versus	   cold:	   52	   beats/min),	   whereas	   it	   slightly	  
decreased	   in	   subject	   B	   (baseline:	   51	   beats/min	   versus	   cold:	   47	   beats/min).	   Both	  
subjects	  were	  bradycardic	  during	  rest	  conditions.	  Mean	  arterial	  pressure	  increased	  to	  a	  
similar	  extent	  upon	  cold	  exposure	  in	  both	  subjects	  (A:	  from	  93	  mm/Hg	  to	  109	  mm/Hg;	  
B:	   from	   99	  mm/Hg	   to	   111	  mm/Hg).	   After	   90	  minutes	   in	   the	   cold,	   plasma	   free	   fatty	  
acids	   increased	  during	  cold	  exposure	   in	  both	  subjects	   (A:	  baseline	  625	  µmol/L	  versus	  
cold	   771	   µmol/L;	   B:	   baseline	   264	   µmol/L	   versus	   cold	   705	   µmol/L),	   whereas	   plasma	  
glucose,	   insulin	   and	   epinephrine	   concentrations	   slightly	   decreased	   (Table	   3).	   Plasma	  
norepinephrine	   increased	   in	   both	   subjects,	   however,	   the	   concentration	   during	   cold	  
was	  markedly	  higher	  in	  subject	  B	  (A:	  554	  ng/L	  versus	  B:	  1016	  ng/L),	  suggesting	  greater	  
sympathetic	  activity.	  	  
	  
Table	  2.	  Metabolic,	  cardiovascular	  and	  thermoregulatory	  parameters	  during	  mild	  cold	  experiment.	  
	   Baseline	   Cold	  
	   Subject	  A	   Subject	  B	   	   Subject	  A	   Subject	  B	  
Energy	  expenditure	  (kJ/min)	   5.51	   5.47	   7.71	   7.76	  
Respiratory	  quotient	  (VCO2/VO2)	  	   0.82	   0.87	   0.82	   0.88	  
Heart	  rate	  (beats/min)	   46	   51	   52	   47	  
Systolic	  blood	  pressure	  (mmHg)	   124.3	   127.3	   142.3	   149.3	  
Diastolic	  blood	  pressure	  (mmHg)	   78.0	   84.3	   93.0	   93.0	  
Mean	  arterial	  pressure	  (mmHg)	   93.4	   98.7	   109.4	   111.0	  
Vasoconstriction	  hand	  (%)	   0	   0	   92	   91	  
Vasoconstriction	  toe	  (%)	   0	   0	   96	   96	  
Vasoconstriction	  arm	  (%)	   0	   0	   63	   9	  
Vasoconstriction	  abdomen	  (%)	   0	   0	   39	   -­‐7	  
Core	  temperature	  (°C)	   36.57	   36.76	   36.39	   36.36	  
Mean	  skin	  temperature	  (°C)	   33.22	   33.4	   27.57	   25.95	  
Proximal	  temperature	  (°C)	   33.51	   33.37	   29.36	   27.81	  
Distal	  temperature	  (°C)	   32.99	   32.65	   21.43	   22.34	  
Gradient	  proximal,	  distal	  (°C)	   0.51	   0.72	   7.93	   5.47	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Table	  3.	  Blood	  parameters	  during	  the	  mild	  cold	  experiment	  
	   Baseline	   Cold	  90	  minutes	   Cold	  150	  minutes	  
Parameter	   subject	  A	   subject	  B	   subject	  A	   subject	  B	   subject	  A	   subject	  B	  
Free	  fatty	  acids	  (µmol/L)	   625	   264	   771	   705	   881	   901	  
Glycerol	  free	  (µmol/L)	   97	   57	   112	   142	   139	   184	  
Triglycerides	  (µmol/L)	   698	   1060	   766	   1083	   782	   1106	  
Glucose	  (mmol/L)	   5.8	   5.3	   5.7	   5.0	   5.6	   4.9	  
Insulin	  (µU/mL)	   10.1	   11.0	   8.2	   10.1	   8.1	   6.0	  
Norepinephrine	  (ng/L)	   389	   284	   439	   751	   554	   1016	  
Epinephrine	  (ng/L)	   32	   21	   21	   10	   16	   7	  
TSH	  (mU/L)	   1.1	   0.9	   -­‐	   -­‐	   -­‐	   -­‐	  
Free	  T4	  (pmol/L)	   14.8	   14.7	   -­‐	   -­‐	   -­‐	   -­‐	  
T4	  (nmol/L)	   84	   96	   -­‐	   -­‐	   -­‐	   -­‐	  
	  
	  
Figure	  2.	  Visual	  Analog	  Scale	  (VAS)	  of	  thermal	  sensation	  and	  comfort	  during	  the	  mild	  cold	  experiment.	  This	  
figure	  illustrates	  the	  thermal	  sensation	  (A)	  and	  comfort	  (B)	  of	  both	  subjects	  during	  the	  mild	  cold	  experiment.	  	  
Cold-­‐induced	  thermogenesis	  and	  [18F]FDG-­‐uptake	  in	  BAT	  and	  skeletal	  muscle	  
Both	   subjects	   increased	   energy	   expenditure	   to	   a	   similar	   extent	   in	   the	   cold	   (A:	   from	  
5.51	   kJ/min	   to	   7.71	   kJ/min	   versus	   B:	   from	   5.47	   kJ/min	   to	   7.76	   kJ/min,	   Table	   2),	  
resulting	   in	  a	  CIT	  of	  40.1%	  and	  41.9%	   for	   subject	  A	  and	  B,	   respectively.	  These	  values	  
were	   clearly	   higher	   compared	   to	   the	   increase	   in	   energy	   expenditure	   we	   observed	  
during	  mild	  cold	  experiments	  in	  young	  adult	  men	  (interquartile	  range:	  7.2	  –	  18%;	  95th	  
percentile:	  25.7%,	  Figure	  3A).	  However,	  it	  should	  be	  noted	  that	  the	  CIT	  in	  the	  current	  
experiment	  is	  not	  equal	  to	  classical	  NST,	  as	  the	  twin	  used	  respiratory	  muscle	  isometric	  
contraction	   to	  generate	  heat	  as	  well.	  As	  expected,	  both	  subjects	  A	  and	  B	  showed	  no	  
active	   BAT	   during	   the	   thermoneutral	   experiment	   (Figure	   4A,	   4D).	   Interestingly,	   cold	  
exposure	  led	  to	  a	  comparable	  increase	  in	  BAT	  activity,	  although	  it	  was	  slightly	  higher	  in	  
subject	  B	  (A:	  1144	  SUVtotal;	  B:	  1325	  SUVtotal).	  These	  values	  are	  regarded	  as	  comparable	  
since	  they	  both	  fall	  within	  the	  interquartile	  range	  (368	  –	  1930	  SUVtotal;	  95
th	  percentile:	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4036	  SUVtotal)	  of	  BAT	  activity	  found	  in	  young	  adult	  men	  (Figure	  3B)	  [17,18].	  Thus,	  BAT	  
activity	   is	   regarded	   as	   comparable	   to	   the	   values	   found	   in	   young	   adult	   men.	   Brown	  
adipose	   tissue	   was	   present	   in	   the	   neck-­‐,	   supraclavicular-­‐,	   paravertebral-­‐,	   and	   the	  
perirenal	  area,	  which	  is	  comparable	  to	  the	  BAT	  distribution	  observed	  in	  young	  adults.	  
We	  also	  determined	  [18F]FDG-­‐uptake	  in	  WAT	  and	  skeletal	  muscle	  (SM)	  (Figure	  4C,	  4F).	  
We	   did	   not	   observe	   any	   differences	   between	   the	   two	   subjects	   in	   glucose	   uptake	   in	  
these	  tissues	  during	  both	  the	  thermoneutral	  (SM	  A:	  0.7	  SUVmean	  versus	  B:	  0.64	  SUVmean;	  
WAT	   A:	   0.33	   SUVmean	   versus	   B:	   0.22	   SUVmean)	   and	  mild	   cold	   experiment	   (SM	  A:	   0.75	  
SUVmean	  versus	  B:	  0.63	  SUVmean;	  WAT	  A:	  0.35	  SUVmean	  versus	  B:	  0.24	  SUVmean).	  
	  	  
	  
Figure	  3.	  Comparison	  of	  CIT,	  BAT	  activity	  and	  skeletal	  muscle	  intrinsic	  mitochondrial	  uncoupling	  between	  the	  
monozygotic	   twin	  and	  young	  adult	  men.	  Boxplots	   indicating	   the	  median	  and	   interquartile	   range	  of	  CIT	   (A)	  
and	  BAT	  activity	  (B)	  found	  in	  young	  adult	  men	  during	  previous	  studies	  (6,	  17,	  18,	  29)(CIT	  n=43;	  BAT	  activity	  
n=45).	  C)	  Boxplot	  showing	  the	  skeletal	  muscle	  mitochondrial	  proton	  leak	  in	  young	  adult	  men	  (n=30)	  from	  a	  
previous	  study	  (n=8)	  and	  unpublished	  results	  (n=22).	  In	  each	  boxplot	  subject	  A	  is	  indicated	  as	  a	  black	  square	  
and	  subject	  B	  as	  an	  open	  square.	  The	  whisker	  bars	  represent	  the	  5th	  (lower)	  and	  95th	  (upper)	  percentile.	  	  
	  
The	  cellular	  respiration	  data	  of	  the	  m.	  vastus	   lateralis	  fibers	  revealed	  that	  the	  state	  4	  
respiration,	   reflecting	   mitochondrial	   proton	   leak	   per	   mitochondrion,	   was	   lower	   in	  
subject	   A	   compared	   to	   subject	   B	   (A:	   113.35±18.11	   pmol/(s*mg)/(MtDNA	   copy	  
numbers)	   x	   10.000	   versus	   B:	   147.45±5.28	   pmol/(s*mg)/(MtDNA	   copy	   numbers)	   x	  
10.000).	   The	   mitochondrial	   proton	   leak	   in	   the	   Iceman	   was	   within	   the	   interquartile	  
range	   we	   observed	   in	   young	   adult	   men	   (n=30)	   from	   a	   previous	   study	   and	   non-­‐
published	   data	   (interquartile	   range:	   95.57	   –	   142.13	   pmol/(s*mg)/(MtDNA	   copy	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numbers)	   x	  10.000;	  Figure	   3C)	   [6].	   Subject	  B	   thus	  had	  a	  higher	  mitochondrial	  proton	  
leak	   compared	   to	   his	   brother,	   as	   it	  was	   outside	   the	   interquartile	   range.	   However,	   it	  
was	   not	   different	   from	   young	   adult	   males	   (95th	   percentile:	   213.13	  
pmol/(s*mg)/(MtDNA	  copy	  numbers)	  x	  10.000).	  	  
	   Interestingly,	   both	   subjects	   immediately	   switched	   to	   the	   g-­‐Tummo	  
meditation/breathing	  technique	  at	  the	  onset	  of	  cold	  exposure,	  and	  although	  subject	  B	  
does	   not	   practice	   g-­‐Tummo	   meditation	   regularly,	   highly	   similar	   breathing	   patterns	  
were	   observed	   (visual	   recognition).	   Therefore,	   we	   decided	   to	   analyze	   the	   [18F]FDG-­‐
uptake	  in	  two	  important	  respiratory	  muscles	  (RM),	  the	  mm.	  intercostales	  interior	  and	  
exterior	   and	   the	   m.	   scalenus.	   Glucose	   uptake	   increased	   fourfold	   in	   these	   muscles	  
during	   the	   cold	   experiment	   compared	   to	   thermoneutral	   conditions	   (Figure	   4C,	   4F),	  
likely	   explaining	   a	   part	   of	   the	   high	   CIT	   levels.	   It	   is	   known	   that	   the	   energy	   cost	   of	  
breathing	   is	   around	   1-­‐2%	   of	   total	   oxygen	   consumption,	   and	   that	   when	   ventilation	  
increases,	  the	  oxygen	  consumption	  per	  liter	  of	  ventilation	  increases	  [23].	  It	  might	  thus	  
be	  that	  over	  10%	  of	  the	  CIT	  is	  explained	  by	  increased	  cost	  of	  breathing.	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Figure	   4.	   Brown	   adipose	   tissue	   and	   respiratory	   muscle	   activity	   during	   the	   thermoneutral	   (TN)	   and	   cold	  
exposure	   experiment.	   A,	   C)	   PET	   images	   during	   thermoneutral	   (left)	   and	   cold	   (right)	   conditions	   showing	  
[18F]FDG-­‐uptake	  in	  brown	  adipose	  tissue	  (BAT;	  red	  arrows)	  and	  respiratory	  muscles	  (RM;	  white	  arrows).	  B,	  D)	  
Transaxial	   slices	   of	   subject	  A	   and	  B	   (5mm	   thick)	   of	   thoracic	   area	   (upper)	   and	   supraclavicular	   area	   (lower)	  
demonstrating	  BAT	  activity	   (red	  arrows)	  and	  RM	  activity	   (white	  arrows).	  E,	  F)	   [18F]FDG-­‐uptake	   (SUVmean)	   in	  
BAT,	  white	  adipose	  tissue	  (WAT),	  skeletal	  muscle	  (SM),	  and	  respiratory	  muscles	  (RM)	  during	  thermoneutral	  
(TN)	  and	  cold	  conditions.	  
Discussion	  
The	  present	  study	  investigated	  the	  metabolic	  and	  insulative	  responses	  during	  mild	  cold	  
in	  the	  so	  called	  ‘Iceman’,	  who	  has	  a	  lifestyle	  with	  frequent	  exposure	  to	  extreme	  cold,	  
and	  in	  his	  monozygotic	  twin	  brother	  who	  is	  not	  frequently	  exposed	  to	  these	  extreme	  
conditions.	   It	   was	   hypothesized	   that	   the	   Iceman	   would	   have	   a	   greater	   CIT	   and	   BAT	  
activity.	  However,	  we	  found	  comparable	  CIT,	  BAT	  activity,	  and	  vasoconstriction	  in	  the	  
extremities	   (hand	   and	   toe)	   during	   mild	   cold	   exposure	   and	   a	   slightly	   lower	   skeletal	  
muscle	  mitochondrial	  proton	  leak	  in	  the	  Iceman	  compared	  to	  his	  twin	  brother.	  	  
	   Based	  on	   the	   frequent	  exposure	  of	   the	   Iceman	  to	  extreme	  cold,	  we	  expected	   to	  
find	   greater	   BAT	   activity	   in	   the	   Iceman	   compared	   to	   his	   twin	  brother.	   It	   can	  be	   that	  
these	   (short-­‐term)	   extreme	   cold	   challenges	   do	   not	   recruit	   BAT.	   BAT	   is	   likely	   to	   be	  
important	  during	  extended	  periods	  of	  mild	  cold	  exposure	  [24],	  and	  can	  maintain	  long	  
periods	   of	   heat	   production.	   BAT	   thermogenesis	   has	   adaptive	   value	  because	   it	   is	   less	  
exhaustive	  compared	  to	  shivering,	  due	  to	  its	  capacity	  for	  mitochondrial	  uncoupling	  via	  
the	   specialized	   uncoupling	   protein	   1	   (UCP-­‐1).	   We	   have	   recently	   shown	   that	   an	  
extended	  period	  of	  mild	  cold	  exposure	  recruits	  BAT.	   In	  that	  study	  we	  exposed	  young	  
adults	  to	  mild	  cold	  (15-­‐16	  °C)	  conditions	  for	  ten	  consecutive	  days	  [6],	  and	  found	  that	  
both	   BAT	   activity	   and	   NST	   increased.	   It	   is	   thus	   likely	   that	   long	   periods	   of	   mild	   cold	  
exposure	   are	   more	   effective	   in	   increasing	   BAT	   activity	   and	   CIT	   than	   single	   bouts	   of	  
extreme	  cold	  exposure.	  On	  the	  other	  hand,	  an	  explanation	  for	  the	  lack	  of	  difference	  in	  
BAT	  activity	  in	  both	  subjects	  might	  be	  that	  the	  twin	  had	  a	  G/G	  polymorphism	  for	  UCP-­‐
1,	  which	  could	  negatively	  affect	  the	  plasticity	  of	  BAT	  [25].	  This	  polymorphism	  therefore	  
might	  preclude	  the	  recruiting	  effects	  of	  extreme	  cold	  exposure	  on	  BAT	  activity.	  Yet,	  the	  
amount	  of	  BAT	  activity	  was	  comparable	  to	  young	  adult	  men	  and	  is	  likely	  high	  for	  their	  
age,	   as	   BAT	   is	   known	   to	   decrease	  with	   ageing.	   A	   study	   on	   the	   effect	   of	   age	   on	   BAT	  
found	  active	  BAT	  in	  only	  10%	  of	  the	  subjects	  between	  50	  and	  60	  years	  old	  [9].	  	  	  
	   With	   respect	   to	   the	   insulative	   response,	   comparable	   vasoconstriction	   was	  
observed	   in	   the	  hand	   and	   toe.	  However,	   a	   relatively	   large	   vasoconstriction	   response	  
was	  found	  on	  the	  arm	  in	  the	  Iceman.	  This	  indicates	  a	  better	  insulation	  in	  the	  proximal	  
region.	   Furthermore,	   the	   drop	   in	   core	   temperature	   was	   lower	   in	   the	   Iceman	   (−0.18	  
versus	  −0.4	  °C),	  indicating	  that	  the	  Iceman	  is	  better	  capable	  to	  maintain	  his	  body	  core	  
temperature	   during	   mild	   cold	   conditions.	   The	   effects	   of	   the	   frequent	   exposure	   to	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extreme	  cold	  of	  the	  Iceman	  were	  well	  reflected	  by	  the	  thermal	  sensation	  and	  comfort.	  
The	   Iceman	   felt	   slightly	   cool	   and	   comfortable	   during	   the	   entire	   mild	   cold	   protocol,	  
whereas	  his	  brother	  experienced	  it	  as	  cold	  and	  uncomfortable.	  Thus,	  even	  though	  they	  
had	  comparable	  metabolic	  reactions,	  there	  was	  a	  difference	  in	  subjective	  response	  to	  
cold.	  Finally,	  plasma	  norepinephrine	  concentrations	  indicate	  that	  the	  mild	  cold	  induced	  
a	   greater	   sympathetic	   stimulation	   in	   subject	   B.	   The	   sympathetic	   stimulation	   of	   BAT	  
therefore	  might	  have	  been	  greater	  in	  subject	  B.	  	  
	   An	   interesting	   observation	   was	   the	   high	   heat	   production	   during	   cold	   (>40%)	   in	  
both	   subjects.	   In	   our	   studies	   with	   young	   adults	   we	   normally	   observe	   NST	   levels	  
(without	  g-­‐Tummo)	  between	  −10	  and	  30%	   [6,17,18].	  Given	   the	   fact	   that	  BAT	  activity	  
and	  the	  intrinsic	  capacity	  for	  mitochondrial	  uncoupling	  in	  SM	  was	  comparable	  to	  young	  
adults,	  other	  tissues	  and/or	  mechanisms	  must	  explain	  the	  high	  increase	  in	  CIT.	  Possible	  
mechanisms	  that	  have	  been	  suggested	  are	  futile	  calcium	  cycling,	  protein	  turnover	  and	  
substrate	  cycling	  [26].	  However,	  in	  this	  special	  case	  a	  likely	  explanation	  for	  the	  high	  CIT	  
levels	   is	  the	  g-­‐Tummo	  like	  breathing	  technique	  (and	  possibly	  meditation	  in	  subject	  A)	  
used	   by	   both	   subjects	   [12].	   G-­‐Tummo	   meditation	   consists	   of	   a	   somatic	   (isometric	  
muscle	  contraction)	  and	  a	  meditative	  component	  (visualization	  of	  flames).	  The	  somatic	  
component,	   which	   consists	   of	   deep	   abdominal	   “vase”	   breathing	   has	   been	   shown	  
increased	   body	   core	   temperature,	   likely	   via	   increased	   heat	   production	   in	   both	  
experienced	   g-­‐Tummo	   meditators	   from	   Eastern	   Tibet	   and	   non-­‐meditators	   (Western	  
people)	   [12].	   The	   meditative	   component	   exerted	   by	   the	   g-­‐Tummo	   meditators	   was	  
capable	  of	  sustaining	  temperature	  increases	  for	  longer	  periods.	  The	  monozygotic	  twin	  
exerted	   this	  breathing	   technique	  as	   soon	  as	   the	   cooling	  protocols	   started.	  Metabolic	  
activity	  of	  the	  respiratory	  muscles	  was	  clearly	  shown	  by	   increased	  [18F]FDG-­‐uptake	   in	  
the	  respiratory	  muscles	  during	  mild	  cold,	  which	  was	  absent	  during	  the	  thermoneutral	  
experiments.	   It	   is	   therefore	   likely	   that	   a	   great	   part	   of	   the	   increased	   CIT	   can	   be	  
explained	   by	   this	   breathing	   technique	   and	   could	   thus	   be	   a	   potential	   mechanism	   to	  
fight	  cold	  challenges.	  We	  were	  not	  able	  to	  measure	  the	  effect	  of	  meditation	  on	  CIT	  and	  
BAT	   activity.	   Whether	   the	   visualization	   component,	   as	   found	   by	   Kozhevnikov	   et	   al.	  
[12],	  is	  capable	  of	  increasing	  thermogenesis	  via	  BAT	  activity	  remains	  unclear.	  	  	  
	   During	  the	  cold	  experiments	  both	  subjects	  did	  not	  shiver,	  whereas	  normally	  young	  
adults	  do.	  However,	  they	  were	  very	  close	  to	  shivering,	  because	  immediately	  after	  the	  
experiment	  shivering	  occurred.	  This	  was	   likely	  due	  to	  the	  redistribution	  of	  cold	  blood	  
leading	   to	   an	   after	   drop	   in	   core	   temperature	   (subject	   A:	   36.39	   to	   36.10	   ºC	   versus	   B	  
36.36	   to	   35.95	   ºC).	   Our	   results	   indicate	   that	   the	   delay	   of	   shivering	  might	   be	   due	   to	  
their	   increased	   respiratory	   muscle	   contraction	   (because	   of	   gTummo	   meditation	  
practices).	  This	  parallels	  the	  fact	  that	  exercising	   in	  the	  cold	  does	  not	   induce	  shivering	  
owing	  to	  increased	  heat	  production	  [27].	  The	  exact	  role	  of	  the	  meditative	  component	  
on	   temperature	   perception	   remains	   unknown.	   Another	   interesting	   observation	   was	  
the	  bradycardia	   in	  both	  subjects	   indicating	  a	  possible	  alteration	   in	  cardiac	  autonomic	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control.	   Whether	   this	   is	   due	   to	   their	   meditation/breathing	   technique	   or	   a	   certain	  
genetic	  factor	  (e.g.	  [28])	  cannot	  be	  answered.	  
	   It	  should	  be	  noted	  that	  it	  is	  not	  possible	  to	  perform	  proper	  statistical	  analysis	  in	  a	  
case	   study.	   The	   present	   results	   do	   provide	   new	   indications	   and	   ideas,	   which	   should	  
lead	   to	   follow-­‐up	   research.	   However,	   this	   case	   study	   is	   unique	   due	   to	   the	   identical	  
genetic	   background	   of	   the	   subjects,	   which	   makes	   it	   possible	   to	   attribute	   the	  
differences	   in	   results	   to	   lifestyle	   characteristics.	   In	   summary,	  we	  here	   show	   that	   the	  
‘Iceman’,	  who	  has	  a	  lifestyle	  with	  frequent	  exposure	  to	  extreme	  cold,	  does	  not	  have	  a	  
greater	  heat	  production	  and	  BAT	  activity	  during	  mild	  cold	  conditions	  compared	  to	  his	  
non-­‐acclimatized	  monozygotic	   twin	   brother.	   Hence,	   the	   lifestyle	   of	   the	   Iceman	   does	  
not	  affect	  the	  metabolic	  response	  to	  mild	  cold.	  The	  Iceman	  did	  have	  a	  relatively	  high	  
insulative	  response	  and	  his	  thermal	  sensation	  and	  comfort	  were	  less	  affected	  by	  cold	  
exposure.	   Based	   on	   these	   findings,	   it	   could	   be	   hypothesized	   that	   frequent	   but	   short	  
term	  extreme	   cold	  exposure	   is	   less	   effective	   in	  BAT	   recruitment	   compared	   to	   longer	  
periods	  of	  mild	  cold	  exposure.	  Interestingly,	  both	  brothers	  showed	  a	  high	  cold-­‐induced	  
heat	   production	   compared	   to	   previous	   mild	   cold	   studies	   in	   young	   adults.	   This	   was	  
likely	  caused	  by	  contributions	  of	  both	  BAT	  activity	  and	  high	  levels	  of	  respiratory	  muscle	  
contraction	   associated	  with	   g-­‐Tummo	  meditation.	   G-­‐tummo	   like	   breathing	  may	   thus	  
be	  responsible	  for	  heat	  production	  in	  the	  cold	  in	  addition	  to	  classical	  NST.	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Introduction	  
The	   recent	   rediscovery	  of	   functional	  BAT	   in	  adult	  humans	  has	   revived	   the	   interest	   in	  
this	   metabolic	   tissue.	   Regarding	   the	   current	   worldwide	   obesity	   problem,	   increasing	  
thermogenesis	  via	  BAT	  might	  be	  of	  preventive	  and	  therapeutic	  value.	  This	  thesis	   first	  
reviewed	  the	  literature	  on	  potential	  ways	  to	  activate	  BAT	  in	  humans	  (chapter	  2).	  Next,	  
it	  was	   investigated	   in	  young	  adult	  humans	  whether	  BAT	   is	  active	  upon	  a	  high	  calorie	  
meal	  and	  is	  involved	  in	  diet-­‐induced	  thermogenesis	  (DIT)	  (chapter	  3).	  In	  chapter	  4,	  BAT	  
activity	   was	   measured	   during	   systemic	   β-­‐AR	   stimulation	   of	   thermogenesis.	  
Subsequently,	  the	  effects	  of	  chronic	  endurance	  exercise	  on	  BAT	  activity	  and	  browning	  
of	   WAT	   were	   analysed	   (chapter	   5).	   Finally	   the	   effects	   of	   frequent	   extreme	   cold	  
exposure	   on	   BAT	   and	   non-­‐shivering	   thermogenesis	   (NST)	   were	   examined	   in	   the	   52	  
years	  old	  Dutch	  “Iceman”	  and	  his	  monozygotic	  twin	  brother.	   In	  this	  final	  chapter,	  the	  
role	  of	  BAT	  in	  facultative	  thermogenesis	  will	  be	  discussed.	  Future	  perspectives	  will	  be	  
presented	  on	  the	  role	  of	  BAT	  in	  DIT,	  and	  on	  the	  effects	  of	  systemic	  β-­‐AR	  stimulation	  of	  
BAT.	  Finally,	  alternative	  routes	  for	  BAT	  stimulation	  in	  humans	  will	  be	  addressed.	  
The	  role	  of	  human	  BAT	  in	  facultative	  thermogenesis	  
In	  rodents,	  it	  is	  clear	  that	  BAT	  is	  the	  most	  important	  heat-­‐producing	  organ	  during	  NST.	  
Furthermore,	  an	  important	  role	  for	  BAT	  in	  DIT	  has	  been	  suggested	  as	  well	  (1,	  2).	  This	  
facultative	  thermogenesis	  is	  mediated	  by	  the	  SNS	  and	  can	  be	  mimicked	  by	  stimulating	  
the	   β-­‐ARs	   present	   on	   BAT.	   Facultative	   thermogenesis	   has	   been	   shown	   to	   exist	   in	  
humans,	   although	   the	   effector	   organs	   are	   not	  well	   known.	   In	   this	   thesis	  we	   studied	  
BAT	  during	   cold	   exposure,	   after	   food	   intake,	   and	  during	  β-­‐AR	   stimulation	   (Figure	   1).	  
We	  related	  BAT	  activity	  with	  the	  increases	  in	  thermogenesis.	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Figure	  1.	  Schematic	  overview	  of	  the	  different	  forms	  of	  acute	  BAT	  stimulation	  in	  this	  thesis.	  In	  this	  thesis	  we	  
examined	  the	  acute	  effects	  of	  both	  cold	  exposure	  and	  food	  intake	  on	  BAT	  activity.	  Cold	  exposure	  activates	  
BAT	  via	   the	  central	   SNS,	  and	   it	   is	  also	   thought	   that	   the	  central	   SNS	  mediates	  diet-­‐induced	  BAT	  activity.	   In	  
addition,	   we	   examined	   the	   effects	   of	   systemic	   activation	   of	   BAT	   via	   intraveneous	   injection	   of	   the	   β-­‐AR-­‐
agonist	   Isoprenaline,	   which	   was	   injected	   intravenously	   ISO	   =	   Isoprenaline,	   SNS	   =	   sympathetic	   nervous	  
system,	  UCP1	  =	  uncoupling	  protein	  1,	  βAR	  =	  beta-­‐adrenergic	  receptors.	  
Nonshivering	  thermogenesis	  
Cold	  exposure	  is	  known	  to	  be	  the	  most	  potent	  activator	  of	  BAT	  and	  we	  have	  therefore	  
used	   cold-­‐induced	   BAT	   activity	   as	   a	   positive	   control	   for	   the	   interventions.	   During	   all	  
cold	   exposure	   experiments	   energy	   expenditure	   increased	  without	   shivering,	   with	   an	  
average	  NST	  of	  12.2±7.9%	  when	  combining	  the	  cold	  experiments	  described	  in	  chapter	  
3-­‐5.	  The	  extremely	  high	  cold-­‐induced	  thermogenesis	  (40%)	  observed	  in	  the	  case	  study	  
(chapter	   6)	   also	   included	   isometric	   contraction	   of	   respiratory	  muscle,	   and	   therefore	  
cannot	  be	  interpreted	  as	  solely	  NST	  and	  was	  thus	  excluded	  from	  this	  calculation.	  There	  
was	   a	   high	   interindividual	   variability	   in	   NST	   and	   BAT	   activity	   (chapter	   3-­‐5),	   which	   is	  
commonly	  found	  in	  these	  types	  of	  experiments	  (3).	  Interestingly,	  BAT	  is	  likely	  involved	  
in	   NST	   as	   we	   repeatedly	   observed	   significant	   relationships	   between	   NST	   and	   BAT	  
activity	   in	  chapter	   3	   and	   5.	   Combining	  all	   cold	  experiments	  also	   reveals	   a	   significant	  
relationship	  between	  both	  parameters	  (r2	  0.19;	  P	  <	  0.01).	  The	  relation	  of	  BAT	  with	  NST	  
has	  also	  been	  demonstrated	  by	  other	  studies	  (4-­‐8).	  A	  next	  step	  is	  quantification	  of	  the	  
actual	  contribution	  of	  BAT	  to	  NST.	  Muzik	  et	  al.	  (9)	  calculated	  the	  contribution	  of	  BAT	  to	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NST	   by	   studying	   oxidative	   metabolism	   in	   BAT	   using	   15O2	   and	   combining	   this	   with	  
[18]FDG-­‐PET	   scans.	   They	   found	   that	   BAT	   likely	   contributed	   to	   less	   than	   20	   kcal/day	  
during	   moderate	   cold	   stress.	   These	   findings	   indicate	   a	   minor	   role	   for	   BAT	   in	   NST.	  
However,	  their	  20	  minutes	  of	  air-­‐cooling	  (15.5	  °C,	  light	  clothing)	  might	  not	  have	  been	  
long	   enough	   to	   activate	   BAT.	   Our	   observations	   demonstrate	   that	   the	   time	   span	  
necessary	  to	  attain	  maximal	  NST	  levels	  ranges	  from	  twenty	  to	  in	  rare	  cases	  60	  minutes.	  
Therefore,	  we	  propose	  to	  use	  a	  standardized	  but	  individually	  attuned	  cooling	  protocol	  
(see	  methods	  chapter	  4).	  In	  this	  protocol,	  all	  subjects	  are	  cooled	  until	  shivering	  occurs	  
in	  order	  to	  maximally	  activate	  BAT	  before	  measuring	  BAT	  activity,	  which	  is	  described	  in	  
detail	   by	   van	   der	   Lans	   et	   al.	   (10).	   Thus,	   future	   research	   should	   aim	   at	   using	   these	  
standardized	   cooling	   protocols	   in	   combination	   with	   various	   PET-­‐tracers	   to	   more	  
precisely	  quantitate	  the	  contribution	  of	  BAT	  to	  NST.	  
	   In	  addition	  to	  BAT,	  there	  are	  likely	  other	  tissues	  and	  mechanisms	  involved	  in	  NST	  
as	   about	   only	   19%	   of	   the	   variation	   can	   be	   explained	   by	   BAT	   in	   our	   experiments.	  
Skeletal	   muscle	   might	   be	   an	   important	   tissue	   in	   NST.	   Astrup	   et	   al.	   already	  
demonstrated	  that	  muscle	  contributed	  up	  to	  50%	  during	  sympathetic	  stimulation	  (11).	  
Interestingly,	  it	  was	  demonstrated	  in	  humans	  that	  mitochondrial	  uncoupling	  in	  skeletal	  
muscle	  was	  related	  to	  NST	  (12),	  although	  this	  was	  not	  confirmed	  by	  van	  der	  Lans	  et	  al.	  
(8).	  Next	  to	  mitochondrial	  uncoupling,	  futile	  calcium	  cycling	  via	  sarcolipin	  is	  proposed	  
as	   another	   mechanism	   in	   muscle	   that	   could	   increase	   thermogenesis.	   Sarcolipin	  
knockout	  mice	  developed	  hypothermia	  and	  were	  predisposed	  to	  diet-­‐induced	  obesity	  
(13).	  Future	  studies	  are	  needed	  to	  examine	  the	  role	  for	  skeletal	  muscle	  in	  NST.	  	  	  
Diet-­‐induced	  thermogenesis	  
In	  chapter	  3	  we	  investigated	  whether	  human	  BAT	  is	  activated	  upon	  high	  caloric	  intake	  
and	   is	   related	   to	   DIT.	   This	   form	   of	   facultative	   thermogenesis	   can	   be	   divided	   in	   an	  
obligatory	   and	   a	   facultative	   part.	   The	   obligatory	   part	   is	   due	   to	   the	   intake	   and	  
processing	   of	   the	   food	   (14),	   whereas	   the	   remaining	   part	   of	   DIT	   is	   facultative	   and	   is	  
likely	  mediated	  by	  mitochondrial	  uncoupling,	   futile	  cycles	  and/or	   ion	  shuttling	  across	  
membranes	  (15).	  Interestingly,	  it	  has	  been	  repeatedly	  demonstrated	  by	  Glick	  et	  al.	  that	  
single	   meals	   activate	   BAT	   in	   rodents	   (16-­‐19).	   Furthermore,	   DIT	   was	   greater	   in	   cold	  
acclimated	   animals,	   who	   have	   increased	   BAT	   activity,	   which	   suggests	   that	   BAT	   is	  
involved	  in	  DIT	  (20).	  Facultative	  DIT	  is	  likely	  regulated	  by	  the	  SNS	  as	  demonstrated	  by	  
increased	  norepinephrine	  turnover	  in	  BAT	  after	  a	  single	  meal	  (21)	  and	  blockade	  of	  DIT	  
by	   propranolol	   (22).	   In	   humans,	   multiple	   studies	   have	   measured	   (postprandial)	  
facultative	  DIT	  during	  β-­‐AR	  blockade	  and	  most	  studies	  found	  decreased	   levels	  of	  DIT,	  
although	  this	  was	  not	  consistently	  found	  (23).	  The	  tissues	  responsible	  were	  thought	  to	  
be	   the	   liver,	  white	  adipose	   tissue,	   and	   skeletal	  muscle,	  whereas	  no	   role	   for	  BAT	  was	  
suggested	   (23).	   With	   respect	   to	   the	   macronutrient	   composition	   of	   the	   diet,	   several	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studies	  have	  shown	  that	  mainly	  carbohydrate-­‐rich	  meals	  were	  capable	  of	  stimulating	  
SNS	  mediated	   DIT	   (14).	   In	   our	   experiment	   (chapter	   3)	   the	   effects	   of	   a	   high-­‐calorie,	  
carbohydrate-­‐rich	  meal	   (1622±222	  kcal;	  78%	  carbohydrate,	  10%	   fat,	  12%	  protein)	  on	  
energy	  expenditure	  and	  BAT	  was	  investigated	  in	  eleven	  young	  male	  adults.	  We	  found	  
that	  the	  meal	  significantly	  increased	  energy	  expenditure	  with	  an	  average	  DIT	  of	  ~20%.	  
Again,	  a	  high	   interindividual	  variation	  was	   found	   (6.9-­‐31.3%).	  Unfortunately	  we	  were	  
unable	   to	   distinguish	   between	   the	   obligatory	   and	   facultative	   component	   of	   DIT.	  
Interestingly,	   we	   found	   higher	   postprandial	   [18]FDG-­‐uptake	   in	   supraclavicular	   BAT	  
compared	   to	   thermoneutral	   conditions	   measured	   in	   a	   previous	   study	   (24).	  
Furthermore,	   the	  [18]FDG-­‐uptake	   in	  supraclavicular	  BAT	  was	  greater	  compared	  to	  the	  
postprandial	   uptake	   in	   WAT	   and	   the	   liver,	   and	   comparable	   to	   skeletal	   muscle.	  
Compared	   to	   cold-­‐induced	   BAT	   activity,	   diet-­‐induced	   BAT	   activity	   was	   four	   times	  
lower.	  However,	  true	  BAT	  activity	  might	  have	  been	  underestimated	  because	  of	  tracer	  
dilution	  as	  a	  large	  part	  of	  the	  tracer	  was	  taken	  up	  by	  skeletal	  muscle.	  This	  high	  uptake	  
in	  skeletal	  muscle	  diminished	  the	  availability	  of	  the	  tracer	  for	  BAT	  and	  other	  tissues	  as	  
clearly	   illustrated	   in	   the	   brain	   (see	   chapter	   3:	   Figure	   3A,	   3E).	   Thus,	   the	   increased	  
[18]FDG-­‐uptake	  implied	  that	  BAT	  is	  actively	  involved	  in	  wasting	  excessive	  caloric	  intake	  
and	  is	  involved	  in	  facultative	  DIT.	  However,	  BAT	  [18]FDG-­‐uptake	  was	  not	  related	  to	  DIT.	  
	   Until	  now,	  there	  has	  been	  one	  other	  human	  study	  trying	  to	  measure	  BAT	  activity	  
after	  a	  meal	  (25).	  In	  this	  study	  BAT	  activity	  was	  measured	  during	  cold	  exposure	  after	  a	  
high-­‐fat	  meal	  (545	  kcal;	  27%	  carbohydrate,	  56%	  fat,	  17%	  protein)	  and	  during	  fasting	  in	  
young	   adult	   males.	   Unexpectedly,	   it	   was	   demonstrated	   that	   cold-­‐induced	   [18]FDG-­‐
uptake	  in	  BAT	  was	  lower	  after	  the	  meal	  compared	  to	  fasting.	  However,	  these	  findings	  
are	  likely	  explained	  by	  the	  design	  of	  this	  study.	  First,	  the	  combination	  of	  cold	  exposure	  
with	   dietary	   intake	   most	   likely	   obscured	   diet-­‐induced	   BAT	   activity.	   In	   order	   to	  
investigate	  the	  role	  of	  BAT	  within	  DIT,	  diet	  and	  cold	  exposure	  should	  not	  be	  combined.	  
Second,	   the	   problem	   of	   tracer	   dilution	   by	   skeletal	   muscle	   was	   also	   present	   in	   this	  
study,	  limiting	  the	  availability	  of	  the	  tracer	  for	  BAT.	  They	  did	  not	  take	  this	  into	  account	  
in	  their	  analysis	  as	  was	  done	  in	  chapter	  3,	  and	  might	  have	  underestimated	  BAT	  activity	  
during	   the	  postprandial	  period.	  Third,	   the	   caloric	   load	  was	  around	  one	   third	  of	  what	  
was	   used	   in	   our	   experiment,	   which	   may	   not	   have	   been	   sufficient	   to	   trigger	   BAT	  
activation.	  	  
	   The	  results	  from	  chapter	  3	  clearly	  show	  that	  BAT	  is	  activated	  after	  a	  carbohydrate-­‐
rich,	  energy	  dense	  meal.	  However,	  BAT	  activity	  and	  DIT	  were	  not	  related.	  This	  is	  likely	  
due	  to	  the	  relative	  low	  facultative	  part	  compared	  to	  the	  obligatory	  part	  of	  DIT,	  which	  
makes	   it	   difficult	   to	   entangle	   such	   a	   relationship.	  More	   specific	  methods	   to	   quantify	  
the	   contribution	   of	   BAT	   to	   DIT	   are	   therefore	   warranted.	   On	   the	   other	   hand	   other	  
tissues	  may	  also	  be	  involved	  in	  facultative	  DIT	  such	  as	  the	  liver	  and	  skeletal	  muscle.	  A	  
large	   role	   for	   splanchnic	   tissues	   (50%)	   and	   skeletal	   muscle	   (30-­‐35%)	   has	   been	  
attributed	   to	   DIT	   in	   previous	   studies	   (26,	   27).	   Furthermore,	   skeletal	   muscle	  
mitochondrial	  uncoupling	  has	  been	  suggested	  to	  be	  involved	  in	  DIT	  during	  three	  days	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of	  overfeeding	   as	  well	   (28).	  However,	   no	   relationships	  between	  DIT	   and	   FDG-­‐uptake	  
and	  these	  tissues	  were	  found	  in	  our	  study.	  
Perspectives	  on	  BAT	  in	  relation	  to	  DIT	  
The	  findings	  presented	  in	  chapter	  3	  provide	  the	  first	  evidence	  that	  BAT	  is	  active	  after	  a	  
high-­‐calorie	   meal	   rich	   in	   carbohydrates.	   Whether	   this	   is	   also	   true	   for	   meals	   with	   a	  
different	  macronutrient	   composition	   remains	   to	   be	   studied.	   In	   rats,	   a	   high-­‐fat	   meal	  
was	   less	  effective	   in	  activating	  BAT	  than	  a	  high-­‐carbohydrate	  meal	  (29).	   Interestingly,	  
long	   term	   overfeeding	   of	   unbalanced	  meals	   in	   protein	   content	   (both	   low-­‐	   and	   high	  
protein	   content)	   results	   in	   lower	   metabolic	   efficiency,	   which	   can	   be	   explained	   by	  
increased	  DIT	  (30).	  However,	  the	  effects	  of	  a	  single	  low/high-­‐protein	  meal	  are	  not	  well	  
known.	  This	  topic	  thus	  requires	  further	  research.	  
	   In	  order	  to	  determine	  the	  contribution	  of	  BAT	  to	  facultative	  DIT,	  it	  is	  necessary	  to	  
investigate	  whether	  in	  BAT,	  apart	  from	  glucose	  uptake	  as	  measured	  by	  [18]FDG-­‐PET/CT,	  
the	   actual	   oxygen	  metabolism	   is	   increased	   in	   the	   postprandial	   situation.	   This	   lack	   of	  
information	  on	  BAT	  metabolism	  is	  a	   limitation	  of	  [18]FDG-­‐PET	  that	  applies	  to	  all	  types	  
of	   interventions	   in	   this	   thesis.	   Uptake	   of	   [18]FDG	   does	   not	   reflect	   mitochondrial	  
uncoupling	  but	  more	  the	  indirect	  capacity	  of	  the	  tissue	  to	  take	  up	  glucose,	  as	  directed	  
by	  the	  expression	  of	  GLUT,	  and	  a	  number	  of	  internal	  (e.g.	  UCP1	  activity)	  and	  external	  
factors	   (e.g.	   insulin)	   (31).	  One	  could	  argue	   that	   the	  postprandial	   tracer	  uptake	   solely	  
reflected	   postprandial	   glucose	   uptake	   for	   storage	   as	   glycogen	   or	   for	   other	   cellular	  
purposes	   apart	   from	  mitochondrial	   uncoupling.	   To	   examine	   this	   one	   could	  measure	  
oxygen	  consumption	  and	  blood	  perfusion	  by	  using	  oxygen	  labelled	  tracers,	  as	  has	  been	  
done	   previously	   during	   cold	   exposure	   (4,	   9).	   Alternatively	   the	   use	   of	   the	   tracer	   11C-­‐
acetate	  could	  shed	  light	  on	  whether	  oxidative	  metabolism	  in	  BAT	  is	  involved	  (5).	  	  
	   In	  addition	   to	  single	  meals,	   the	  role	  of	  BAT	  during	   longer	  periods	  of	  overfeeding	  
needs	  to	  be	  studied.	  In	  rodents,	  Rothwell	  &	  Stock	  demonstrated	  that	  BAT	  is	  involved	  in	  
DIT	   during	   overfeeding	   (32),	   and	   Stock	   suggested	   the	   same	   mechanism	   to	   occur	   in	  
humans	   (30).	   Moreover,	   Feldmann	   et	   al.	   showed	   in	   2009	   that	   knocking	   out	   BAT	  
abolishes	  DIT	   and	   induces	   obesity	   in	  mice	   (33).	   A	   recent	   study	   by	   Schlögl	   et	   al.	   (34)	  
investigated	  whether	  24	  hours	  of	  200%	  overfeeding	  (60%	  fat,	  20%	  carbohydrate,	  20%	  
protein)	   would	   lead	   to	   an	   extended	   activation	   of	   BAT	   in	   humans.	   DIT	   was	   doubled	  
(280±164	   kcal)	   during	   overfeeding	   compared	   to	   DIT	   when	   subjects	   were	   in	   energy	  
balance.	  However,	  no	  glucose	  (FDG)	  uptake	  in	  BAT	  was	  found	  4	  and	  12	  hours	  after	  the	  
24-­‐hour	   overfeeding	   period.	   In	   our	   study,	   BAT	   glucose	   uptake	   was	   increased	   75	  
minutes	   after	   the	   meal.	   The	   different	   experimental	   set-­‐up	   likely	   explains	   these	  
different	  results.	  We	  measured	  acute	  postprandial	  effects,	  while	   in	  Schlögl	  et	  al.	  BAT	  
activation	  was	  studied	  over	  a	  more	  extended	  period	  of	  time.	  Thus	  far,	  it	  is	  unknown	  if	  
BAT	   is	   activated	   each	   time	   after	   a	   meal	   or	   that	   it	   adjusts	   its	   activity	   via	   an	   energy	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sensing	   mechanism	   such	   as	   leptin,	   which	   is	   thought	   to	   occur	   during	   overfeeding	   in	  
rodents	  (35).	  When	  the	  former	  would	  be	  the	  case,	  4	  hours	  after	  the	  meal	  may	  be	  too	  
late,	  and	   if	   the	   latter	  would	  be	  true,	  24	  hours	  of	  overfeeding	  would	  be	  too	  short.	  To	  
study	   whether	   BAT	   is	   activated	   during	   overfeeding	   therefore	   requires	   longitudinal	  
study	  designs	  with	  longer	  periods	  of	  overfeeding.	  One	  possible	  study	  set-­‐up	  would	  be	  
to	   expose	   humans	   to	   an	   overfeeding	   diet	   for	   minimally	   one	   week.	   One	   could	   use	  
indirect	   calorimetry	   in	   respiration	   chamber	   setting	   to	  measure	  DIT	   continuously	   and	  
use	  PET-­‐CT-­‐scanning	  during	  to	  measure	  cold-­‐induced	  BAT	  activity	  before,	  halfway,	  and	  
after	  the	  overfeeding	  period.	  This	  would	  provide	  valuable	  information	  on	  whether	  BAT	  
adapts	   to	   overfeeding	   and	   if	   this	   is	   associated	   with	   increased	   DIT.	   On	   the	   contrary,	  
caloric	   restriction	   is	   known	   to	   reduce	   energy	   expenditure	   and	   DIT,	   and	   it	   would	   be	  
interesting	  to	  study	  whether	  this	  is	  reflected	  by	  adaptations	  BAT	  activity	  as	  well.	  Finally	  
it	   would	   be	   worth	   studying	   whether	   interventions	   that	   lead	   to	   increased	   BAT	  
recruitment,	   such	  as	   cold	  acclimation,	   are	  also	  associated	  with	   increased	  DIT	  upon	  a	  
single	  meal	  challenge.	  
Beta-­‐adrenergic	  stimulation	  of	  thermogenesis	  
The	  SNS	  is	  known	  to	  regulate	  NST	  and	  likely	  DIT	  in	  rodents.	  The	  same	  role	  for	  the	  SNS	  
likely	  applies	  to	  humans	  as	  well	  (28).	  The	  SNS	  stimulates	  facultative	  thermogenesis	  by	  
acting	   on	   (mainly)	   the	   β-­‐adrenergic	   receptors	   present	   in	   the	   cell	   membranes	   of	  
effector	   tissues.	   Sympathomimetics	   or	   β-­‐AR-­‐agonists	   can	  mimic	   this	   sympathetically	  
induced	  thermogenesis	  by	  targeting	  these	  adrenergic	  receptors.	  In	  rodents,	  adrenergic	  
thermogenesis	   primarily	   originates	   from	   BAT	   (36).	   In	   chapter	   4	   we	   investigated	  
whether	   BAT	   is	   also	   involved	   in	   β-­‐AR	   stimulation	   of	   thermogenesis	   in	   humans.	   We	  
therefore	   measured	   both	   energy	   expenditure	   and	   BAT	   activity	   during	   systemic	  
stimulation	   of	   the	   β-­‐ARs	   by	   infusion	   of	   the	   non-­‐selective	   agonist	   isoprenaline	   (ISO).	  
Thermogenesis	   increased	   in	  correspondence	  with	  the	  dosage	  used	  (chapter	  4:	  Figure	  
1A)	  up	   to	  a	  maximum	  of	  19.7±7.2%	  during	   the	   final	  dose	  of	  24	  ng/kg	   fat-­‐free	  mass-­‐1	  
min-­‐1.	  These	   levels	  are	   in	   line	  with	  previous	  human	  studies	  using	  similar	  doses	  of	   ISO	  
(37-­‐39).	  Unexpectedly,	  even	  though	  ISO	  stimulated	  thermogenesis	  to	  a	  similar	  level	  as	  
during	  cold	  exposure	  (16.9±7.8%),	  this	  was	  not	  associated	  with	  increased	  BAT	  activity.	  
Cypess	  et	  al.	  (40),	  who	  studied	  the	  effects	  of	  ephedrine	  (sympathomimetic)	  on	  energy	  
expenditure	   and	   BAT	   activity	   in	   lean	   human	   adults,	   observed	   comparable	   findings.	  
During	   intramuscular	   injection	   of	   1	   mg/kg	   ephedrine,	   energy	   expenditure	   increased	  
with	   9%	   without	   concomitant	   BAT	   activity.	   Carey	   et	   al.	   (41)	   did	   find	   increased	   BAT	  
activity	   in	   lean	   (not	   in	   obese)	   human	   adults	   when	   administering	   2.5	   mg/kg	   orally.	  
However,	   BAT	   activity	   was	   considerably	   lower	   than	   during	   cold	   exposure.	   Energy	  
expenditure	  increased	  with	  18%	  in	  lean	  and	  13%	  in	  obese	  young	  adults.	  Given	  that	  the	  
obese	   did	   not	   show	   BAT	   activity,	   it	   could	   be	   hypothesized	   that	   a	   part	   of	   this	   5%	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difference	  was	  explained	  by	  BAT	  activity.	   The	  authors	   concluded	   that	   the	  amount	  of	  
BAT	   activity	   found	   likely	   contributed	   less	   than	   1%	   to	   the	   ephedrine-­‐induced	  
thermogenesis,	  which	  was	   based	   on	   the	   previous	   calculations	   of	   the	   contribution	   of	  
cold-­‐induced	   BAT	   to	   NST	   by	   Muzik	   et	   al.	   	   (9).	   However,	   as	   explained	   previously,	  
methodological	   issues	   might	   have	   underestimated	   these	   calculations	   of	   BAT’s	  
contribution	  to	  NST.	  Moreover,	  no	  relationship	  was	  found	  between	  ephedrine-­‐induced	  
BAT	  activity	  and	  energy	  expenditure.	  	  
	   Based	  on	  these	  findings,	  it	  can	  thus	  be	  concluded	  that	  other	  tissues	  than	  BAT	  play	  
a	   role	   during	   systemic	   βAR-­‐stimulation	   of	   thermogenesis.	   Given	   the	   widespread	  
distribution	   of	   adrenergic	   receptors	   in	   the	   body	   (e.g.	   white	   adipose	   tissue,	   liver,	  
skeletal	  muscle,	  heart,	   lungs),	  multiple	  tissues	  likely	  contribute	  to	  this	  broad	  systemic	  
adrenergic	  stimulation	  of	  thermogenesis.	   It	  was	  suggested	  that	  a	  small	  part	  (<	  5%)	  of	  
adrenergic	   thermogenesis	   could	   be	   explained	   by	   the	   energy	   cost	   of	   cardiac	   and	  
respiratory	  work	  (42).	  As	  during	  NST	  and	  facultative	  DIT,	  skeletal	  muscle	  likely	  plays	  an	  
important	   role	   here	   as	   well.	   It	   was	   already	   suggested	   by	   Astrup	   et	   al.	   in	   1985	   that	  
skeletal	  muscle	  most	  likely	  explains	  50%	  of	  the	  ephedrine-­‐induced	  thermogenesis	  (11).	  
Furthermore,	   infusion	   of	   epinephrine	   demonstrated	   that	   40%	   of	   the	   induced	  
thermogenesis	  originates	  from	  skeletal	  muscle	  and	  5%	  from	  adipose	  tissue	  (43).	  	  	  
	   These	   findings	   thus	   indicate	   that	   systemic	   adrenergic	   stimulation	   is	   not	   a	  
promising	   route	   to	   stimulate	   BAT	   thermogenesis.	   The	   lack	   of	   BAT	   activity	   observed	  
during	   ISO	   infusion	  might	   be	   explained	   by	   too	   low	   concentrations	   of	   the	   agonist	   at	  
receptor	   level.	   During	   central	   stimulation	   (e.g.	   cold	   exposure),	   sympathetic	   nerves	  
release	   high	   concentrations	   of	   NE	   at	   receptor	   level,	   which	   cannot	   be	   reached	   by	  
agonists	  via	  the	  plasma	  (44).	  The	  reason	  why	  ephedrine	  did	  activate	  BAT	  slightly	  during	  
high	   doses	   is	   likely	   due	   to	   its	   indirect	   effect	   on	   stimulating	   NE	   release	   at	   the	  
sympathetic	   nerve	   endings	   (40).	   Dulloo	   et	   al.	   (45)	   demonstrated	   in	   mice	   that	   the	  
effects	  of	  ephedrine	  on	  BAT	  are	  fully	  dependent	  on	  functional	  sympathetic	  innervation	  
and	  thus	  on	  postsynaptic	  NE	  release.	  This	  release	  of	  NE	  during	  ephedrine	  stimulation	  
was	   indeed	   reflected	  by	   increased	  plasma	  spill	   over	  of	  NE	   (~370	  ng/L)	   (41).	   That	   ISO	  
does	   not	   stimulate	   the	   SNS	   centrally	   was	   confirmed	   by	   the	   fact	   that	   plasma	   NE	  
concentrations	  were	  not	   changed	   (chapter	   4).	   Thus,	   stimulating	   the	   release	  of	  NE	  at	  
the	  postsynaptic	   sympathetic	  nerves	   in	  BAT	   is	  more	  effective	   than	  broad	  systemic	  β-­‐
AR-­‐stimulation.	  	  
	   A	  second	  explanation	  for	  the	  lack	  of	  BAT	  activation	  might	  be	  the	  low	  specificity	  of	  
ISO	   for	   the	   β3-­‐AR.	   Indeed,	   the	   sensitivity	   of	   the	   β1-­‐	   and	   β2-­‐AR	   to	   ISO	   is	   very	   high,	  
whereas	   it	   is	   a	   100	   times	   lower	   for	   the	   β3AR	   (46).	   In	   rodents,	   the	   β3-­‐AR	   is	   the	  most	  
important	   receptor	   type	   regarding	   acute	   thermogenic	   stimulation	   of	   BAT	   and	  
browning	   of	   WAT	   in	   rodents	   (36).	   In	   humans,	   the	   presence	   of	   β3-­‐AR	   mRNA	   in	  
supraclavicular	  BAT	  has	  been	  demonstrated	  in	  adults	  (47)	  and	  from	  peritumoral	  BAT	  in	  
a	   patient	   with	   pheochromocytoma	   (48).	   Interestingly,	   in	   the	   latter	   study	   it	   was	  
demonstrated	   that	   80%	  of	   the	   β-­‐AR	   subtypes	  were	   β3-­‐ARs.	   Furthermore,	   Krief	   et	   al.	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(49)	   found	   that	   mRNA	   of	   the	   β3-­‐AR	   receptor	   correlated	   with	   UCP1	   mRNA.	   These	  
findings	  thus	  suggest	  that	  specifically	  targeting	  the	  β3-­‐AR	  might	  be	  an	  effective	  way	  to	  
stimulate	  BAT	  thermogenesis.	   In	  rodents,	  β3-­‐AR	  agonists	  have	  shown	  to	   induce	  acute	  
thermogenic	   responses	   (50,	   51).	   Furthermore,	   long-­‐term	   administration	   of	   β3-­‐AR	  
agonists	  stimulated	  weight	  loss	  and	  had	  antidiabetic	  effects	  (50,	  52).	  There	  has	  been	  a	  
long	  search	  for	  specific	  β3-­‐AR	  agonists	  to	  stimulate	  thermogenesis	  and	   induce	  weight	  
loss	   in	  humans	   (53).	  Thus	   far,	  only	   the	  agonist	  L-­‐796568	  had	  acute	  effects	  on	  energy	  
expenditure	  (54),	  although	  this	  effect	  was	  lost	  during	  28-­‐day	  treatment	  (55).	  Another	  
indication	  for	  the	  role	  of	  the	  β3-­‐AR	  in	  stimulating	  thermogenesis	  comes	  from	  a	  recent	  
study	  by	  Wijers	  et	  al.	   (56).	   In	   this	   study,	  administration	  of	  160	  mg	  propranolol	   (βAR-­‐
blocker)	   was	   not	   capable	   to	   block	   cold-­‐induced	   thermogenesis	   in	   humans	   (56).	   It	   is	  
known	   that	   the	   β3AR	   has	   100-­‐1000	   times	   lower	   sensitivity	   for	   propranolol	   (36),	  
requiring	  dosages	  not	  suitable	  for	  human	  use.	  These	  findings	  thus	  suggest	  that	  CIT,	  and	  
possibly	  BAT	  activation,	  is	  mediated	  via	  the	  β3AR.	  The	  development	  of	  a	  more	  specific	  
β3AR-­‐agonist	   for	   humans	   could	   therefore	   clarify	   if	   this	   receptor	   is	   indeed	   the	   most	  
important	   of	   the	  βAR	   family	   to	   stimulate	   human	  BAT.	  Nevertheless,	   the	   finding	   that	  
propranolol	  reduces	  [18]FDG-­‐uptake	  in	  BAT	  still	  suggests	  that	  other	  β-­‐ARs	  are	  involved	  
(57,	  58).	  	  
Perspectives	  on	  adrenergic	  stimulation	  of	  BAT	  thermogenesis	  
Thus,	   systemic	   adrenergic	   stimulation,	   as	   shown	   by	   ephedrine	   and	   ISO,	   in	   humans	  
increases	   thermogenesis	   up	   to	   20%,	   with	   only	   a	   minor	   role	   for	   BAT.	   Future	   studies	  
should	  examine	   the	   role	  of	   skeletal	  muscle	   in	   this	   type	  of	   facultative	   thermogenesis,	  
and	  which	  mechanisms	  are	  behind	  the	  muscle-­‐induced	  adrenergic	  thermogenesis.	  One	  
possible	  way	  to	  measure	  whether	  skeletal	  muscle	  mitochondrial	  uncoupling	  is	  involved	  
would	  be	   to	  use	  magnetic	   resonance	   spectroscopy	   (MRS).	  With	   this	   technique	   it	  has	  
been	   demonstrated	   to	  measure	  mitochondrial	   uncoupling	   in	   skeletal	   muscle	   in	   vivo	  
(59).	   Measuring	   mitochondrial	   uncoupling	   via	   MRS	   in	   skeletal	   muscle	   during	  
administration	  of	  adrenergic	  agonists	  would	  therefore	  be	  interesting.	  
	   With	   respect	   to	   targeting	   BAT	   via	   the	   adrenergic	   receptors,	   more	   research	   is	  
required	  to	  examine	  the	  exact	  role	  for	  each	  receptor.	  Although,	  the	  β3-­‐AR	  is	  suggested	  
to	   be	   the	  most	   important	   receptor	   in	   stimulating	   BAT	   thermogenesis,	   a	   role	   for	   the	  
other	   receptors	   cannot	   be	   excluded	   thus	   far.	   To	   examine	   this,	   future	   in	   vivo	   studies	  
could	  use	  more	   specific	   β-­‐AR	   agonists	   or	   combine	   less	   specific	   agonists	  with	   specific	  
antagonists.	  While	   setting	   up	   these	   types	   of	   experiments,	   it	   should	   be	   realized	   that	  
adrenergic	   stimulation	   goes	   along	   with	   cardiovascular	   side	   effects.	   This	   is	  
predominantly	   caused	   by	   stimulation	   of	   the	   β1-­‐ARs	   on	   the	   heart.	   In	   our	   experiment	  
(chapter	   3),	   heart	   rate	   increased	   from	   60±5	   to	   84±10	   beats/min	   and	   systolic	   blood	  
pressure	   from	   121±9	   to	   148±14	   mmHg.	   The	   studies	   using	   ephedrine	   also	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demonstrated	   these	   side	   effects.	   Thus,	   to	   investigate	   the	   role	   of	   the	   β1-­‐AR	   in	   BAT	  
activation,	  a	  specific	  β1-­‐AR	  antagonist,	  such	  as	  atenolol,	  could	  be	  combined	  with	  cold	  
exposure.	  To	  date,	  there	  is	  no	  clear	  evidence	  for	  a	  role	  for	  the	  β2-­‐ARs	  in	  mediating	  BAT	  
activity.	  Nevertheless,	  this	  receptor	  type	  has	  been	  found	  in	  the	  immortalized	  PAZ6	  cell	  
line	  derived	  from	  the	  stromal	  vascular	  fraction	  of	  a	  human	  infant	  (48).	  It	  might	  thus	  be	  
interesting	   to	   test	   whether	   a	   β2-­‐AR-­‐agonist	   (e.g.	   salbutamol)	   could	   stimulate	   BAT.	  
Salbutamol	   has	   been	   tested	   in	   humans	   before	   and	   was	   known	   to	   induce	   energy	  
expenditure,	   lipid	   oxidation,	   and	   lipolysis	   (60).	   Interestingly,	   in	   this	   study	   it	  was	   also	  
shown	   that	   obese	   people	   demonstrated	   a	   blunted	   effect	   on	   these	   parameters	   with	  
salbutamol	   administration.	   It	   might	   thus	   be	   that	   this	   reduced	   thermogenesis	   partly	  
originates	   from	   lower	   BAT	   activity	   observed	   in	   obese	   subjects.	   However,	   again,	  
Salbutamol	   is	   not	   specific	   enough	   as	   it	   targets	   β1ARs	   as	  well,	   leading	   to	   tachycardia.	  
With	  respect	  to	  BAT	  recruitment,	  it	  should	  be	  kept	  in	  mind	  that	  the	  β1-­‐AR	  likely	  plays	  
an	  important	  role	  given	  its	  presence	  in	  brown	  preadipocytes	  (36).	  Regarding	  browning	  
of	  WAT,	  the	  β3-­‐AR	  is	  important	  given	  that	  β3-­‐AR	  agonists	  stimulate	  this	  process.	  	  	  
Alternative	  strategies	  for	  stimulating	  BAT	  in	  man	  
The	  previous	  sections	  have	  demonstrated	  that	  both	  cold	  exposure	  and	  diet	  stimulate	  
BAT	  thermogenesis	  most	  likely	  via	  the	  SNS.	  Targeting	  the	  SNS	  to	  stimulate	  BAT	  can	  be	  
achieved	  systemically,	  such	  as	  by	  adrenergic	  agonists.	  Another	  route	  to	  stimulate	  BAT	  
is	  to	  manipulate	  the	  SNS	  centrally.	  Indeed,	  cold	  acclimation,	  which	  acts	  via	  central	  SNS	  
pathways,	  has	  now	  been	  demonstrated	   to	   increase	   the	  metabolic	   capacity	  of	  BAT	   in	  
humans	  (8,	  61,	  62).	  The	  case	  study	  from	  chapter	  6	  indicates	  that	  frequent	  exposure	  to	  
extreme	  cold	  is	   less	  effective,	  although	  other	   intermittent	  cold	  exposure	  regimes	  and	  
more	   systematic	   studies	   are	   needed	   before	   definite	   conclusions	   can	   be	   drawn.	  
Another	  route	  to	  stimulate	  the	  sympathetic	  outflow	  to	  BAT	  is	  by	  using	  certain	  type	  of	  
food	  ingredients	  that	  target	  the	  transient	  receptor	  potential	  (TRP)	  channels,	  which	  are	  
the	  temperature	  receptors	   involved	   in	  signalling	  cold	  and	  heat	  sensation	  to	  the	  brain	  
(63).	  Both	  capsaicin	  (capsaicin-­‐like	  compounds	  found	  in	  non-­‐pungent	  red	  pepper)	  and	  
grains	   of	   paradise	   (Guinea	   pepper	   or	   Alligator	   pepper)	   induced	   acute	   and	   chronic	  
thermogenic	   responses	   in	  BAT	  positive	   subjects	  whereas	  no	  effect	  was	   found	   in	  BAT	  
negative	  subjects	  (63-­‐65).	  Other	  bioactive	  food	  ingredients	  (e.g.	  caffeine,	  polyphenols),	  
and	  drugs	  (e.g.	  sibutramine)	  might	  be	  capable	  to	  stimulate	  BAT	  as	  well,	  and	  remain	  to	  
be	  investigated.	  Interestingly,	  a	  recent	  study	  by	  Lopez	  et	  al.	  (66)	  demonstrated	  that	  the	  
thyroid	   stimulates	   BAT	   likely	   via	   the	   hypothalamus	   as	   well	   (66),	   as	   opposed	   to	   the	  
previous	   thought	   that	   the	   thyroid	  hormone	  only	   stimulates	  BAT	  peripherally	  and	  not	  
via	   central	   mechanisms.	   Interestingly,	   centrally	   acting	   drugs	   (such	   as	   antipsychotics,	  
SSRIs,	  sympathomimetics)	  are	  known	  to	  affect	  energy	  balance.	  Gaining	  information	  on	  
the	   mechanisms	   involved	   might	   provide	   crucial	   information	   on	   how	   to	   target	   BAT	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centrally	   (67).	   The	   same	   holds	   for	   the	   central	   pathways	   involved	   in	   regulation	   of	  
adaptive	  DIT.	  Manipulating	  these	  pathways	  could	  be	  very	  potent	  and	  target	  BAT	   in	  a	  
specific	  way.	  This	  might	  overcome	  the	  cardiovascular	  side	  effects	   that	  are	  associated	  
with	   peripheral	   SNS	   activation.	   However,	   whether	   these	   central	   types	   of	   therapies	  
might	  be	  applicable	  and	  are	  not	  associated	  with	  side	  effects	  remain	  to	  be	  found	  out.	  	  
	   Besides	   central	   sympathetic	   stimulation,	   animal	   studies	   have	   demonstrated	  
alternative	  routes	  that	  stimulate	  BAT	  and	  browning	  of	  WAT,	  such	  as	  the	  endogenous	  
hormones	  natriuretic	  peptides	  and	   irisin	   (see	  chapter	   2),	   fibroblast	  growth	   factor	  21,	  
bile	  acids,	  and	  bone	  morphogenic	  proteins	  (as	  reviewed	  in	  (68)).	  In	  chapter	  5,	  we	  have	  
examined	  the	  effects	  of	  frequent	  endurance	  exercise	  on	  BAT	  and	  browning	  of	  WAT	  as	  
an	  alternative	  route.	  In	  rodents,	  it	  has	  been	  shown	  that	  endurance	  exercise	  stimulated	  
BAT	  activity	  and,	  more	  convincingly,	  browning	  of	  WAT	  via	  the	  myokine	  irisin.	  To	  study	  
this,	  we	   compared	   BAT	   activity	   and	   browning	   of	  WAT	   in	   endurance	   trained	   athletes	  
with	  sedentary	  lean	  males	  (chapter	  5).	  In	  contrast	  to	  findings	  in	  rodents,	  we	  found	  that	  
endurance	   trained	  athletes	  had	   lower	  BAT	  activity	   compared	   to	   the	   sedentary	  males	  
and	  no	  browning	  of	  WAT	  was	  found.	  This	  thus	  suggests	  that	  endurance	  exercise	  is	  not	  
an	   effective	   alternative	   route	   to	   stimulate	   BAT	   in	   humans.	   However,	   whether	   irisin	  
might	  be	  relevant	  as	  a	  therapeutic	  needs	  further	  investigation.	  	  
	   In	   general,	   to	   what	   extent	   BAT	   can	   be	   recruited	   on	   the	   long	   term	   and	   actually	  
contributes	   to	  whole	  body	  energy	  expenditure	   are	   issues	   that	  need	   to	  be	  addressed	  
before	   the	   potential	   of	   BAT	   in	   preventing	   and	   treating	   obesity	   can	   be	   assessed.	  
Furthermore,	  it	   is	  important	  to	  find	  out	  to	  what	  degree	  sustained	  BAT	  thermogenesis	  
is	  compensated	  by	  increased	  energy	  intake.	  
Concluding	  remarks	  
BAT	  in	  adult	  humans	  is	  back	  on	  the	  scientific	  agenda	  as	  a	  potential	  contributor	  to	  NST	  
and	   may	   therefore	   play	   a	   role	   in	   the	   prevention	   of	   obesity.	   In	   this	   thesis	   we	  
investigated	   several	  ways	   to	   stimulate	  BAT	   in	  humans.	   It	   can	  be	   concluded	   that	   cold	  
exposure	   is	   the	   most	   effective	   BAT	   stimulator	   in	   humans,	   and	   there	   is	   substantial	  
evidence	  from	  literature	  that	  BAT	  can	  be	  recruited	  upon	  cold	  acclimation.	  Systemic	  β-­‐
adrenergic	  stimulation	  appeared	  to	  be	  less	  effective,	  although	  more	  specific	  activation	  
of	  the	  β3AR	  might	  be	  a	  viable	  way	  to	  stimulate	  BAT.	  In	  addition,	  we	  provided	  evidence	  
for	  diet-­‐induced	  BAT	  activity.	  Future	  studies	  need	  to	  investigate	  to	  what	  extent	  BAT	  is	  
involved	  in	  facultative	  DIT,	  and	  if	  BAT	  is	  thus	  involved	  in	  energy	  balance	  regulation	  by	  
wasting	   excessive	   caloric	   intake.	   The	   results	   from	   this	   thesis	   provide	   important	  
information	  on	  ways	  to	  stimulate	  BAT	  in	  humans	  that	  opens	  new	  avenues	  to	  develop	  
optimal	  (long-­‐term)	  strategies	  to	  stimulate	  the	  thermogenic	  capacity	  of	  BAT	  and	  its	  link	  
to	  health.	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The	  number	  of	  people	  with	  overweight	  and	  obesity	  has	  dramatically	   increased	   in	  the	  
last	   decennia.	   Obesity	   is	   a	   high	   risk	   factor	   for	   developing	   diseases	   such	   as	   type	   2	  
diabetes,	  cardiovascular	  diseases,	  and	  certain	  forms	  of	  cancer.	  Obesity	  develops	  from	  
an	   imbalance	   between	   energy	   intake	   and	   energy	   expenditure.	   Stimulating	   energy	  
expenditure	   is	   thus	   a	   strategy	   to	   induce	   weight	   loss	   and	   to	   prevent	   and/or	   treat	  
obesity.	  Brown	  adipose	  tissue	   (BAT)	   is	  known	  for	   its	  high	  capacity	   to	   increase	  energy	  
expenditure	   upon	   cold,	   known	   as	   nonshivering	   thermogenesis	   (NST),	   making	   it	   an	  
attractive	  target	  for	  weight	  reduction,	  or	  at	  least	  weight	  maintenance.	  	  
	   Until	  recently	  it	  was	  thought	  that	  only	  human	  neonates	  and	  babies	  had	  significant	  
amounts	   of	   BAT.	  However,	   several	   studies	   in	   2009	  demonstrated	   that	   human	   adults	  
still	  have	  functional	  BAT.	  	  By	  means	  of	  [18F]fluorodeoxyglucose	  (FDG)-­‐positron	  emission	  
tomography	   (PET)/computed	   tomography	   (CT)-­‐scanning	   it	   has	   been	   shown	   that	   BAT	  
can	   be	   activated	   upon	   cold	   exposure	   and	   is	   positively	   associated	  with	   non-­‐shivering	  
thermogenesis	  (NST).	  Furthermore,	  it	  appears	  that	  overweight	  and	  obese	  people	  have	  
lower	   BAT	   activity.	   BAT	   is	   also	   associated	  with	   increased	   thermogenesis	   after	   single	  
meals	   and	   periods	   of	   overfeeding,	   known	   as	   diet-­‐induced	   thermogenesis	   (DIT).	   Both	  
NST	  and	  DIT	  are	  under	  control	  of	   the	  sympathetic	  nervous	  system	  (SNS).	  Stimulating	  
the	  SNS	  and	  adrenergic	  receptors	  indeed	  increases	  BAT	  thermogenesis	  in	  rodents	  and	  
is	   regarded	   as	   a	   possible	   route	   to	   induce	  weight	   loss.	   In	   this	   thesis	   we	   studied	   BAT	  
during	   cold	   exposure,	   after	   feeding,	   and	   during	   β-­‐AR	   stimulation.	   We	   related	   BAT	  
activity	   with	   the	   increases	   in	   thermogenesis.	   Finally	   we	   examined	   the	   role	   of	  
endurance	  training	  and	  extreme	  cold	  exposure	  on	  BAT	  in	  humans.	  	  
	   Much	   research	  on	  BAT	  has	  been	  conducted	   in	   rodents	  and	   little	   is	   known	  about	  
human	  BAT.	  Therefore	  we	  compared	  the	  anatomy	  and	  morphology	  of	  rodent	  BAT	  with	  
human	  BAT	  in	  chapter	  2.	  Human	  BAT	  is	  found	  on	  different	  anatomical	  locations	  and	  is	  
not	  present	   in	  distinct	  dense	  BAT	  depots	  as	   found	   in	   rodents,	  but	  more	   in	   islands	  of	  
brown	   adipocytes	   residing	   within	   WAT.	   In	   addition	   to	   brown	   adipocytes,	   beige	  
adipocytes	   are	   found	   in	   rodents	   as	   well.	   These	   beige	   fat	   cells	   are	   important	   in	   the	  
recruitment	   of	   BAT.	   Recent	   studies	   have	   demonstrated	   the	   presence	   of	   beige	  
adipocytes	   in	   adult	   humans	   as	  well.	  Next,	   chapter	   2	   summarizes	   the	   current	   human	  
BAT	   activators	   and	   addresses	   the	   most	   promising	   routes	   to	   stimulate	   BAT	   in	   man,	  
based	  on	  the	  latest	  rodent	  studies.	  At	  this	  moment,	  cold	  exposure	  is	  the	  most	  effective	  
BAT	  stimulator,	  and	  high	  doses	  of	   the	  ephedrine	   (sympathomimetic	  drug)	  have	  been	  
shown	  to	  moderately	  activate	  BAT	  in	  humans.	   Indirect	  evidence	  exists	  that	  activators	  
of	   the	   transient	   receptor	   potential	   channels,	   such	   as	   capsaicin,	  might	   stimulate	   BAT	  
thermogenesis.	   In	   the	   last	   part	   of	   chapter	   2	   it	   is	   explained	   that	   endurance	   exercise	  
might	  be	   a	  way	   to	   stimulate	  BAT	  and	  browning	  of	  WAT	   in	  humans	   via	   the	  hormone	  
irisin,	  as	  shown	  in	  rodents.	  Furthermore,	  natriuretic	  peptides	  induce	  browning	  in	  WAT	  
from	   rodents	   and	   human	  multipotent	   adipose-­‐derived	   stem	   cells.	   In	   humans,	   these	  
SUMMARY	  
129	  	  
peptides	   have	   been	   associated	   with	   stimulation	   of	   fatty	   acid	   oxidation	   and	   energy	  
expenditure.	   Future	   human	   studies	   should	   therefore	   investigate	   their	   potential	   in	  
stimulating	  BAT.	  
	   Animal	   studies	   have	   demonstrated	   that	   BAT	   is	   involved	   in	   regulating	   energy	  
balance	   by	   burning	   excessive	   caloric	   intake,	   known	   as	   facultative	   DIT.	   Therefore	  we	  
studied	  the	  role	  of	  BAT	  after	  a	  high	  calorie	  meal	   in	  eleven	  young	  adult	  male	  subjects	  
(chapter	  3).	  Both	  energy	  expenditure	  and	  BAT	  activity	  were	  measured	  after	  the	  intake	  
of	  high	  calorie,	  carbohydrate-­‐rich	  meal	  and	  cold	  exposure	  was	  used	  a	  positive	  control.	  
It	   was	   shown	   that	   the	   postprandial	   uptake	   of	   [18F]FDG	   in	   supraclavicular	   BAT	   was	  
higher	   than	   in	   WAT	   and	   the	   liver.	   Furthermore	   the	   uptake	   in	   BAT	   was	   also	   higher	  
during	   thermoneutral	   fasting	   conditions.	   This	   provided	   a	   first	   indication	   that	   BAT	   is	  
involved	   in	   burning	   excessive	   caloric	   intake	   in	   humans.	   However,	   we	   did	   not	   find	   a	  
correlation	  between	  BAT	  and	  DIT,	  and	  BAT	  activity	  after	  the	  meal	  was	  still	  significantly	  
lower	   than	  during	   cold	  exposure.	  The	   latter	  might	  be	  explained	  by	   the	  high	   [18F]FDG	  
uptake	   in	   skeletal	  muscle	   leading	   to	   tracer	   dilution.	   The	   results	   legitimate	   additional	  
research	  to	  the	  contribution	  of	  BAT	  to	  DIT	  upon	  overfeeding	  in	  humans.	  	  
	   Cold	   exposure	   and	   food	   intake	   activate	   the	   SNS,	   which	   in	   turn	   stimulates	   BAT	  
thermogenesis	   in	   rodents.	   Upon	   sympathetic	   stimulation	   norepinephrine	   is	   released	  
and	  acts	  on	  the	  adrenergic	  receptors	  on	  brown	  adipocytes.	  Whether	  human	  BAT	  can	  
be	   stimulated	   via	   the	   adrenergic	   receptors	   has	   been	   studied	   in	   chapter	   4.	   We	  
measured	   both	   energy	   expenditure	   and	   BAT	   activity	   during	   systemic	   infusion	   of	   the	  
non-­‐selective	   β-­‐AR	   agonist	   isoprenaline	   and	   compared	   this	   to	   cold	   exposure	   in	   ten	  
male	  subjects.	  Surprisingly,	  it	  was	  shown	  that	  isoprenaline	  did	  not	  activate	  BAT	  in	  nine	  
out	   of	   ten	   subjects,	   whereas	   energy	   expenditure	   increased	   with	   20%.	   These	   results	  
indicate	  that	  other	  tissues	  are	  likely	  involved	  in	  the	  β-­‐AR-­‐induced	  thermogenesis,	  such	  
as	   skeletal	  muscle.	   It	  might	  be	   that	   ISO	  was	  not	  given	   in	   sufficient	   concentrations	   to	  
activate	   the	   β-­‐ARs.	   However,	   we	   were	   unable	   to	   give	   higher	   dosages	   due	   to	   the	  
associated	   cardiovascular	   stress.	   Future	   studies	   should	   therefore	   investigate	   the	  
possibilities	   to	   target	   BAT	   via	   central	   SNS	   stimulation	   and	   via	   more	   specific	   β-­‐AR	  
agonists.	  	  
	   In	  addition	  to	  cold	  and	  β-­‐adrenergic	  stimulation,	  other	  routes	  to	  stimulate	  BAT	  are	  
proposed	   in	   literature	   such	   as	   endurance	   exercise	   (chapter	   2).	   It	   has	   been	  
demonstrated	   in	   rodents	   that	   endurance	   exercise	   stimulates	   classical	   BAT,	   although	  
this	  has	  not	  been	  consistently	  found.	  The	  stimulating	  effects	  of	  endurance	  exercise	  are	  
more	   pronounced	   on	   typical	   WAT	   depots.	   It	   has	   been	   demonstrated	   in	   mice	   that	  
endurance	  exercise	  stimulates	  the	  release	  of	  the	  myokine	  irisin	  in	  plasma	  that	  leads	  to	  
browning	  of	  WAT.	  In	  chapter	  5,	  we	  investigated	  whether	  regular	  endurance	  exercise	  is	  
associated	  with	  higher	  BAT	  activity	  and	  more	  browning	  of	  subcutaneous	  WAT.	  Twelve	  
endurance-­‐trained	   and	   sedentary	   lean	   males	   were	   included	   in	   the	   study	   and	   BAT	  
activity	   was	  measured	   during	   cold	   exposure.	   In	   addition,	   a	   muscle	   and	  WAT	   biopsy	  
were	   taken	   to	  analyse	  gene	  expression	   for	   FNDC5	   in	  muscle,	   and	   several	  brown	  and	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beige	   adipocyte	   markers	   in	   adipose	   tissue.	   In	   muscle,	   we	   found	   that	   FNDC5	   mRNA	  
(precursor	   of	   irisin)	   was	   significantly	   higher	   in	   the	   endurance	   athletes.	   This	   thus	  
demonstrates	  the	  stimulating	  effects	  of	  exercise	  on	  FNDC5	  and	  likely	  irisin	  production	  
by	   skeletal	  muscle	   in	  humans.	   Surprisingly,	   it	  was	   found	   that	   the	  endurance	  athletes	  
had	   lower	   cold-­‐induced	   BAT	   activity	   compared	   to	   the	   sedentary	   subjects,	   and	   no	  
differences	  were	  found	  in	  mRNA	  expression	  for	  all	  brown	  and	  beige	  adipocyte	  markers	  
in	   WAT.	   These	   findings	   thus	   indicate	   that	   regular	   endurance	   exercise	   does	   not	  
stimulate	  BAT	  and	  browning	  in	  humans.	  	  
	   Finally,	   we	   investigated	   the	   effects	   of	   frequent	   extreme	   cold	   exposure	   on	   BAT	  
activity	  by	  measuring	  the	  so-­‐called	  ‘Iceman’	  and	  his	  non-­‐acclimated	  monozygotic	  twin	  
brother	   (52	   years	   old)	   in	   chapter	   6.	   The	   Iceman	   holds	   multiple	   world	   records	   in	  
withstanding	   extreme	   cold	   exposure,	   such	   as	   the	   longest	   duration	   while	   fully	  
immersed	   in	   crushed	   ice	   (1	   hour	   and	   50	   minutes).	   In	   this	   case	   study,	   it	   was	  
demonstrated	   that	   both	   subjects	   had	   comparable	   BAT	   activity	   during	   mild	   cold,	  
comparable	   to	   young	   adults,	   but	   rather	   high	   for	   their	   age,	   given	   that	   BAT	   activity	  
decreases	   with	   age.	   Moreover,	   we	   did	   not	   find	   differences	   in	   cold-­‐induced	  
thermogenesis	  between	  the	  twin,	  but	  both	  had	  a	  very	  high	  thermogenesis	  compared	  
to	  young	  adults.	  This	  high	  cold-­‐induced	  thermogenesis	  was	   likely	  caused	  -­‐	   in	  addition	  
to	   BAT	   -­‐	   by	   the	   g-­‐Tummo	   like	   breathing	   technique	   used	   by	   both	   subjects	   involving	  
isometric	  respiratory	  muscle	  contraction.	  Indeed,	  high	  FDG-­‐uptake	  was	  found	  in	  these	  
muscles.	   Thus	   in	   addition	   to	   heat	   production	   by	   BAT	   (NST),	   isometric	   contraction	   of	  
skeletal	   muscle	   contributed	   to	   the	   very	   high	   cold-­‐induced	   energy	   expenditure.	  
Interestingly,	  there	  was	  a	  clear	  difference	  in	  the	  subjective	  response	  to	  cold	  exposure,	  
as	   the	   Iceman	   reported	   the	   cold	   exposure	   as	   neutral	   and	   comfortable,	   whereas	   his	  
twin	  brother	   found	   it	   relatively	  cold	  and	  uncomfortable.	  Given	  their	  comparable	  BAT	  
activity,	  it	  might	  be	  that	  short	  exposures	  to	  extreme	  cold,	  as	  practiced	  by	  the	  Iceman,	  
are	   less	  effective	   in	  BAT	  stimulation	  than	  mild	   longer	  periods	  of	  mild	  cold	  exposures.	  
However,	   longitudinal	   studies	   with	   larger	   groups	   are	   needed	   to	   confirm	   this	  
observation.	  
	   This	   thesis	   shows	   that	   cold	   exposure	   is	   the	   most	   effective	   BAT	   activator.	  
Moreover,	   we	   found	   a	   positive	   relationship	   between	   BAT	   activity	   and	   NST.	   An	  
important	  next	  step	  will	  be	  to	  quantify	  the	  capacity	  of	  BAT	  to	  increase	  thermogenesis.	  
The	  finding	  that	  BAT	  is	  activated	  after	  a	  high-­‐calorie	  meal	  is	  promising.	  Whether	  BAT	  is	  
actively	   involved	   in	  wasting	   excessive	   caloric	   intake	  needs	   to	   be	   studied.	   Finally,	   the	  
results	  from	  studies	  on	  BAT	  activators	  in	  animals	  are	  promising.	  These	  findings	  provide	  
starting	  points	  in	  the	  search	  for	  BAT	  stimulating	  strategies	  in	  humans	  that	  might	  help	  




Het	   aantal	   mensen	   met	   overgewicht	   en	   obesitas	   is	   sterk	   toegenomen	   in	   de	   laatste	  
decennia.	   Obesitas	   vormt	   een	   risicofactor	   voor	   ziektes	   zoals	   type	   2	   diabetes,	  
cardiovasculaire	  ziektes,	  en	  sommige	  vormen	  van	  kanker.	  Obesitas	  ontstaat	  door	  een	  
verstoring	  in	  de	  energiebalans	  waarbij	  de	  inname	  van	  energie	  hoger	  is	  dan	  het	  gebruik.	  
Het	  stimuleren	  van	  het	  energiegebruik	  is	  daarom	  een	  strategie	  om	  gewicht	  te	  verliezen	  
en	  zou	  kunnen	  bijdragen	  aan	  het	  voorkomen	  en	  behandelen	  van	  obesitas.	  Een	  manier	  
om	  het	  energiegebruik	  te	  stimuleren	  is	  via	  bruin	  vet.	  Bruin	  vet	  is	  in	  staat	  om	  warmte	  te	  
produceren	   tijdens	   koude	   omstandigheden,	   de	   zogenaamde	   ‘nonshivering	  
thermogenesis’	  (NST)	  oftewel	  niet-­‐rillende	  thermogenese.	  Deze	  capaciteit	  om	  warmte	  
te	  produceren	  –	  door	  het	  verbranden	  van	  calorieën	  -­‐	  maakt	  bruin	  vet	  een	  interessante	  
kandidaat	  om	  gewicht	  te	  verliezen	  en/of	  gewichtsverlies	  te	  behouden.	  	  
	   Tot	   voor	   kort	   werd	   aangenomen	   dat	   bij	   de	   mens	   alleen	   baby’s	   significante	  
hoeveelheden	  bruin	  hebben.	  Echter,	  in	  2009	  is	  aangetoond	  dat	  ook	  volwassenen	  over	  
functioneel	   bruin	   vet	   beschikken.	   Met	   behulp	   van	   [18F]fluorodeoxyglucose	   positron	  
emissie	   tomografie/computed	   tomografie	   (FDG-­‐PET/CT)-­‐scanning	   is	   aangetoond	   dat	  
bruin	  vet	  geactiveerd	  kan	  worden	  wanneer	  mensen	  worden	  blootgesteld	  aan	  koude.	  
Ook	   blijkt	   dat	   de	   mate	   van	   bruin	   vet	   activiteit	   is	   gerelateerd	   aan	   de	   stijging	   van	  
warmteproductie	  in	  het	  lichaam	  tijdens	  koude.	  Daarnaast	  laten	  de	  resultaten	  zien	  dat	  
proefpersonen	  met	  overgewicht	  minder	  bruin	  vet	  hebben	  dan	  slanke	  proefpersonen.	  
Tijdens	  het	  onderzoekstraject,	  beschreven	  in	  deze	  thesis,	  hebben	  we	  gekeken	  naar	  de	  
rol	  en	  activatie	  van	  bruin	  vet	  bij	  de	  mens.	  We	  hebben	  bruin	  vet	  activiteit	  gemeten	  na	  
inname	  van	  voeding,	  en	  gedurende	  stimulatie	  van	  de	  β-­‐adrenerge	  (β-­‐AR)	  receptoren.	  
Beide	   condities	   hebben	   we	   vergeleken	   met	   bruin	   vet	   activiteit	   bij	   blootstelling	   aan	  
milde	  koude	  (ongeveer	  15°C).	  Ook	  hebben	  we	  gekeken	  of	  mensen	  met	  meer	  bruin	  vet	  
ook	   een	   hogere	   warmteproductie	   hebben.	   Daarnaast	   hebben	   we	   onderzocht	   of	  
personen	  die	  aan	  duursport	  doen	  meer	  bruin	   vet	  hebben	  dan	  ongetrainde	  personen	  
en	  hebben	  we	  gekeken	  wat	  het	  effect	  is	  van	  extreme	  koude	  blootstelling	  op	  bruin	  vet	  
en	  warmteproductie	  in	  ‘de	  Iceman’.	  	  
	   Tot	  nu	  toe	  is	  verreweg	  het	  meeste	  onderzoek	  naar	  bruin	  vet	  uitgevoerd	  bij	  dieren.	  
Daarom	   hebben	   we	   in	   hoofdstuk	   2	   de	   anatomie	   en	   morfologie	   van	   bruin	   vet	   in	  
knaagdieren	   vergeleken	   met	   dat	   in	   de	   mens.	   Bruin	   vet	   in	   de	   mens	   bevindt	   zich	   op	  
andere	  anatomische	  locaties	  en	  heeft	  een	  andere	  structuur	  en	  dichtheid.	  Bij	  de	  mens	  
komt	  bruin	   vet	   voor	   als	   eilandjes	   van	  bruin	   vetcellen	   tussen	  het	  witte	   vetweefsel.	   In	  
knaagdieren	   kunnen	   naast	   bruine	   vetcellen,	   beige	   vetcellen	   worden	   onderscheiden.	  
Deze	  laatste	  vetcellen	  zijn	  van	  belang	  bij	  vermeerdering	  van	  bruin	  vet.	  Recente	  studies	  
hebben	   aangetoond	   dat	   ook	   de	   mens	   over	   zowel	   bruin	   als	   beige	   vet	   beschikt.	  
Vervolgens	  wordt	   in	  hoofdstuk	   2	   een	  overzicht	   gegeven	  van	  de	  potentiele	   varianten	  
om	  bruin	  vet	  te	  activeren	  in	  de	  mens,	  gebaseerd	  op	  recente	  studies	  in	  knaagdieren.	  Op	  
dit	  moment	  is	  koude	  de	  meest	  succesvolle	  bruin	  vet	  activator.	  Daarnaast	  kan	  een	  hoge	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dosering	  efedrine	  (sympathicomimeticum)	  bruin	  vet	  activeren	  in	  de	  mens.	  Bovendien	  
bestaat	   er	   indirect	   bewijs	   dat	   activators	   van	   transient	   receptor	   potential	   channels,	  
zoals	  capsaïcine,	  thermogenese	  stimuleren	  door	  middel	  van	  bruin	  vet	  activatie.	  In	  het	  
laatste	  deel	   van	  hoofdstuk	   2	  wordt	  uitgelegd	  dat	  duurtraining	  een	  mogelijke	  manier	  
kan	   zijn	   om	   bruin	   vet	   en	   ‘browning’	   (aanmaak	   van	   beige	   vet	   cellen	   in	   wit	   vet)	   te	  
stimuleren	   in	   de	   mens	   via	   het	   hormoon	   irisine.	   Tenslotte	   wordt	   het	   stimulerende	  
effect	  van	  natriuretische	  hormonen	  (ANP	  en	  BNP)	  op	  browning	  bij	  knaagdieren	  en	  op	  
humane	  stamcellen	  verkregen	  uit	  vet	  (human	  multipotent	  adipose-­‐derived	  stem	  cells)	  
samengevat.	  Uit	  onderzoek	  in	  de	  mens	  blijkt	  dat	  deze	  hormonen	  gerelateerd	  zijn	  aan	  
stimulatie	   van	   vetzuur	   oxidatie	   	   en	   energiegebruik.	   Toekomstige	   studies	   zouden	  
daarom	  moeten	  onderzoeken	  wat	  de	  potentie	  van	  deze	  hormonen	  is	  in	  het	  stimuleren	  
van	  bruin	  vet	  in	  de	  mens.	  	  
	   Dierstudies	  hebben	  aangetoond	  dat	  bruin	  vet	  betrokken	   is	  bij	  het	   reguleren	  van	  
de	  energiebalans	  door	  middel	  van	  het	  verbranden	  van	  overtollige	  calorie	   inname.	  Dit	  
proces	   staat	   bekend	   als	   dieet-­‐geïnduceerde	   thermogenese.	   Om	   dit	   in	   de	   mens	   te	  
onderzoeken	  hebben	  we	  bruin	  vet	  activiteit	   gemeten	  na	   inname	  van	  een	  calorierijke	  
maaltijd	   in	   elf	   jongvolwassen	   mannen	   (hoofdstuk	   3).	   Zowel	   het	   energiegebruik	   als	  
bruin	  vet	  activiteit	  hebben	  we	  gemeten	  na	   inname	  van	  een	  calorierijke	  maaltijd	  met	  
een	   hoog	   percentage	   aan	   koolhydraten,	   en	   tijdens	   blootstelling	   aan	  milde	   koude	   in	  
gevaste	  toestand	  (positieve	  controle).	  De	  resultaten	   lieten	  zien	  dat	  na	  de	  maaltijd	  de	  
opname	  van	  [18F]FDG	  in	  supraclaviculair	  bruin	  vet	  significant	  hoger	  was	  dan	  in	  wit	  vet	  
en	  in	  de	  lever.	  Daarnaast	  bleek	  de	  opname	  in	  bruin	  vet	  ook	  significant	  hoger	  te	  zijn	  in	  
vergelijking	   met	   de	   gevaste,	   thermoneutrale	   conditie.	   Deze	   studie	   geeft	   een	   eerste	  
aanwijzing	   dat	   bruin	   vet	   betrokken	   is	   bij	   het	   verbranden	   van	   overtollige	   energie	  
inname.	  Echter,	  we	  hebben	  geen	  relatie	  tussen	  de	  hoeveelheid	  bruin	  vet	  activiteit	  en	  
de	   mate	   van	   dieet-­‐geïnduceerde	   thermogenese	   gevonden.	   Daarnaast	   bleek	   de	  
activiteit	  na	   voeding	  ook	   lager	   te	   zijn	  dan	   tijdens	   koude	  blootstelling.	  Dit	   laatste	   zou	  
kunnen	  worden	   verklaard	   door	   de	   hoge	   opname	   van	   [18F]FDG	   in	   de	   skeletspier	   wat	  
leidde	  tot	  verdunning	  van	  de	  tracer	  waardoor	  minder	  beschikbaar	  was	  voor	  het	  bruin	  
vet	   (hoofdstuk	   3).	   Deze	   resultaten	   geven	   aanknopingspunten	   tot	   vervolgonderzoek	  
naar	  de	  bijdrage	  van	  bruin	  vet	  aan	  dieet-­‐geïnduceerde	  thermogenese	  na	  overvoeding	  
in	  de	  mens.	  	  
	   Bruin	   vet	  wordt	   geactiveerd	   via	   het	   sympathisch	   zenuwstelsel.	  Na	   sympathische	  
stimulatie	  wordt	  noradrenaline	  vrijgemaakt	  door	  de	  zenuwuiteinden	  dat	  vervolgens	  de	  
adrenerge	  receptoren	  op	  de	  bruin	  vet	  cellen	  prikkelt.	  In	  hoofdstuk	  4	   is	  gekeken	  of	  de	  
stimulatie	  van	  de	  	  bèta-­‐adrenerge	  receptoren	  (β-­‐AR)	  leidt	  tot	  activering	  van	  bruin	  vet	  
in	  de	  mens.	  We	  hebben	  het	  energiegebruik	  en	  bruin	  vet	  activiteit	  gemeten	  tijdens	  de	  
infusie	  van	  de	  non-­‐selectieve	  β-­‐AR-­‐agonist	  isoprenaline,	  en	  tijdens	  koude	  blootstelling	  
(positieve	   controle)	   in	   tien	   jongvolwassen	   mannen.	   Opvallend	   was	   dat	   isoprenaline	  
bruin	  vet	  niet	  activeerde	  in	  9	  van	  de	  10	  proefpersonen	  terwijl	  het	  energiegebruik	  wel	  
met	  20%	  toenam.	  Deze	  resultaten	  tonen	  aan	  dat	  andere	  weefsels	  verantwoordelijk	  zijn	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voor	   deze	   toename,	   zoals	   bijvoorbeeld	   de	   skeletspier.	   Het	   is	   mogelijk	   dat	   de	  
toegediende	  concentratie	  isoprenaline	  niet	  hoog	  genoeg	  was	  om	  de	  β-­‐AR	  op	  bruin	  vet	  
te	  activeren.	  Hogere	  concentraties	  zijn	  echter	  niet	  mogelijk	  vanwege	  het	  stimulerende	  
effect	   op	   de	   hartslag.	   Toekomstige	   studies	   zouden	   daarom	   moeten	   kijken	   naar	   de	  
mogelijkheden	   om	   BAT	   te	   activeren	   via	   het	   centrale	   zenuwstelsel	   of	   via	   meer	  
specifieke	  β-­‐AR	  agonisten.	  
	   Naast	   koude	   en	   β-­‐AR	   stimulatie	   zijn	   er	   ook	   alternatieve	   routes	   om	   bruin	   vet	   te	  
stimuleren,	   zoals	   beschreven	   in	   hoofdstuk	   2.	   In	   knaagdieren	   is	   aangetoond	   dat	  
duurtraining	  (klassiek)	  bruin	  vet	  stimuleert,	  dit	  is	  echter	  niet	  in	  alle	  studies	  gevonden.	  
De	  stimulerende	  effecten	  van	  duurtraining	  op	  bruin	  vet	  waren	  voornamelijk	  zichtbaar	  
in	  de	  vorm	  van	  browning	  van	  de	  typische	  wit	  vet	  depots.	  Een	  studie	   in	  muizen	  heeft	  
laten	   zien	   dat	   duurtraining	   de	   aanmaak	   van	   beige	   vet	   stimuleerde	   via	   het	   hormoon	  
irisine.	   In	   hoofdstuk	   5	   hebben	   we	   onderzocht	   of	   regelmatige	   duurtraining	   is	  
geassocieerd	  met	  een	  hogere	  bruin	  vet	  activiteit	  en	  meer	   ‘browning’	  van	  onderhuids	  
wit	   vetweefsel	   in	   de	   mens.	   In	   deze	   studie	   hebben	   we	   bruin	   vet	   gemeten	   in	   twaalf	  
getrainde	   en	   twaalf	   ongetrainde	   jongvolwassenen	   tijdens	   blootstelling	   aan	   kou.	  	  
Daarnaast	  hebben	  we	  zowel	  een	  stukje	  spier	  als	  wit	  vet	  afgenomen.	  In	  de	  spier	  hebben	  
we	   de	   genexpressie	   bepaald	   voor	   FNDC5,	   wat	   de	   voorloper	   (precursor)	   van	   het	  
hormoon	  irisine	  is.	  In	  het	  wit	  vetweefsel	  hebben	  we	  gekeken	  naar	  de	  genexpressie	  van	  
verschillende	  markers	  die	  de	  mate	  van	  browning	  aantonen.	  De	   resultaten	   lieten	   zien	  
dat	  de	  atleten	  inderdaad	  een	  verhoogde	  FNDC5	  mRNA	  expressie	  hadden	  in	  de	  spier	  en	  
dus	   mogelijk	   een	   verhoogde	   aanmaak	   van	   irisine.	   Verassend	   genoeg	   was	   de	  
hoeveelheid	   koude-­‐geïnduceerd	  bruin	   vet	   in	  de	   atleten	   significant	   lager	   ten	  opzichte	  
van	  de	  ongetrainde	  mannen.	  Bovendien	  was	  er	  geen	  verschil	  in	  de	  genexpressie	  van	  de	  
onderzochte	   markers	   voor	   browning	   in	   het	   witte	   vetweefsel.	   Deze	   resultaten	   laten	  
indirect	  zien	  dat	  regelmatige	  duurtraining	  bruin	  vet	  en	  browning	  niet	  stimuleren.	  	  	  
	   Ten	   slotte	   hebben	   we	   in	   hoofdstuk	   6	   gekeken	   naar	   de	   effecten	   van	   frequente	  
blootstelling	   aan	   extreme	   koude	   bij	   de	   zogenaamde	   ‘Iceman’	   en	   zijn	   eeneiige	  
tweelingbroer	  (52	  jaar).	  	  De	  Iceman	  heeft	  verschillende	  wereldrecords	  in	  het	  doorstaan	  
van	  extreem	  koude	  omstandigheden,	  zoals	  een	  verblijf	  van	  1	  uur	  en	  50	  minuten	  in	  een	  
bak	   met	   schaafijs	   (‘crushed’-­‐ice).	   Zijn	   tweelingbroer	   ondergaat	   deze	   extreme	   koude	  
blootstelling	   niet.	   Uit	   de	   case	   studie	   bleek	   dat	   de	   tweelingbroers	   eenzelfde	  
hoeveelheid	   actief	   bruin	   vet	   hadden	   tijdens	  milde	   koude	   en	   dat	   er	   geen	   verschil	   in	  
warmteproductie	  was	  tussen	  hen.	  Ze	  hadden	  een	  vergelijkbare	  hoeveelheid	  bruin	  vet	  
als	   jongvolwassenen,	   wat	   hoog	   is	   voor	   hun	   leeftijd,	   aangezien	   bruin	   vet	   activiteit	  
afneemt	  met	   de	   leeftijd.	   Opvallend	  was	   hun	   zeer	   hoge	   stijging	   in	   warmteproductie,	  
welke	   hoger	   was	   dan	   in	   jongvolwassenen.	   Deze	   zeer	   hoge	   warmteproductie	   werd	  
hoogstwaarschijnlijk	   bereikt	   door	  –	  naast	   bruin	   vet	   activiteit	   –	   een	   g-­‐Tummo-­‐achtige	  
ademhaling	   door	   beiden.	   Deze	   manier	   van	   ademhaling	   bestaat	   uit	   krachtige	  
isometrische	   contractie	   van	   de	   ademhalingsspieren.	   De	   bijdrage	   van	   de	  
ademhalingsspieren	   aan	   de	   warmteproductie	   werd	   bevestigd	   door	   de	   verhoogde	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[18F]FDG	  opname	  in	  deze	  spieren.	  Er	  bleek	  wel	  een	  duidelijk	  verschil	   in	  perceptie	  van	  
koude	   tussen	   de	   tweeling.	   De	   Iceman	   ervoer	   de	   koude	   als	   neutraal	   en	   comfortabel	  
terwijl	   zijn	   tweelingbroer	   het	   koud	   en	   oncomfortabel	   vond.	   Gezien	   de	   gelijke	  
hoeveelheid	   bruin	   vet	   in	   de	   tweelingbroers,	   is	   het	   mogelijk	   dat	   frequente,	   kortere	  
periodes	  van	  blootstelling	  aan	  extreme	  koude	  minder	  effectief	  zijn	  in	  de	  stimulatie	  van	  
bruin	  vet	  dan	  blootstelling	  aan	  langere	  periodes	  van	  milde	  koude.	  Echter,	  longitudinale	  
studies	  met	  grotere	  groepen	  zijn	  nodig	  om	  dit	  te	  kunnen	  bevestigen.	  	  
	   De	  resultaten	  uit	  deze	  thesis	  bevestigen	  dat	  koude	  de	  meest	  effectieve	  strategie	  is	  
om	  bruin	  vet	  te	  activeren.	  Daarnaast	  bestaat	  er	  een	  positieve	  relatie	  tussen	  bruin	  vet	  
en	  warmteproductie	  in	  de	  mens.	  Een	  zeer	  interessante	  bevinding	  van	  deze	  thesis	  is	  dat	  
bruin	  vet	  actief	   is	  na	  inname	  van	  een	  calorierijke	  maaltijd.	  Of	  bruin	  vet	  daadwerkelijk	  
een	   belangrijke	   rol	   speelt	   in	   de	   verbranding	   van	   overtollige	   calorie-­‐inname	   is	   een	  
belangrijke	  vraag	  voor	  toekomstig	  onderzoek.	  Tenslotte	  bieden	  de	  verschillende	  bruin	  
vet	   activators	   in	   knaagdieren	   veel	   perspectief	   in	   de	   zoektocht	   naar	   strategieën	   om	  
bruin	   vet	   in	   de	  mens	   te	   stimuleren	   en	  mogelijk	   overgewicht	   en	   obesitas	   te	   kunnen	  
voorkomen	  en	  te	  behandelen.	  	  	  








Social	  relevance	  –	  obesity	  epidemic	  
Currently,	  the	  world	  is	  facing	  an	  alarming	  increase	  of	  obesity	  prevalence,	  which	  extents	  
to	  developing	  countries	  and	  obesity	   is	   thus	  not	   longer	   regarded	  as	  a	   typical	  Western	  
disease.	  Obesity	  prevalence	  has	  nearly	  doubled	  since	  1980,	  and	  in	  2008	  more	  than	  1.4	  
billion	  adults	  were	  overweight	  of	  whom	  200	  million	  men	  and	  300	  million	  women	  were	  
obese.	  Strikingly,	  more	  than	  40	  million	  children	  under	  the	  age	  of	  five	  are	  obese.	  In	  the	  
Netherlands,	  48.5%	  of	  the	  people	  (19	  years	  and	  older)	  are	  overweight	  and	  12.7%	  are	  
obese.	  The	  future	  perspectives	  on	  the	  development	  of	  obesity	  are	  disturbing	  since	  it	  is	  
predicted	  that	  obesity	  prevalence	  will	   increase	  with	  33%	  (in	  the	  United	  States)	   in	  the	  
next	  two	  decades.	  This	  is	  an	  alarming	  trend	  as	  obesity	  is	  related	  to	  metabolic	  diseases	  
such	   as	   type	   2	   diabetes,	   cardiovascular	   diseases,	   and	   certain	   forms	   of	   cancer.	  
Furthermore,	   this	   will	   further	   hinder	   efforts	   for	   healthcare	   cost	   containment.	  
Therefore,	   strategies	   are	   warranted	   to	   counteract	   this	   global	   obesity	   epidemic.	   The	  
overall	   aim	   of	   brown	   adipose	   tissue	   (BAT)	   research	   is	   to	   explore	   its	   role	   in	   the	  
development,	  prevention,	   and	   treatment	  of	  obesity.	   This	   thesis	   investigated	  possible	  
strategies	  to	  activate	  BAT	  in	  humans	  and	  examine	  its	  role	  in	  energy	  expenditure.	  
Scientific	  background	  –	  development	  of	  obesity	  
Obesity	  develops	  as	  a	  consequence	  of	  a	  positive	  energy	  balance	  in	  which	  energy	  intake	  
exceeds	  energy	  expenditure.	  To	  restore	  and/or	  maintain	  a	  healthy	  energy	  balance,	  one	  
could	  reduce	  energy	  intake	  or	  increase	  energy	  expenditure.	  Reduction	  of	  energy	  intake	  
by	  diet	  is	  one	  of	  the	  most	  studied	  interventions,	  however	  this	  type	  of	  intervention	  has	  
a	  high	  relapse	  rate	  and	  people	  thus	  often	  cannot	  maintain	  their	  initial	  weight	  loss.	  On	  
the	   other	   hand,	   stimulating	   energy	   expenditure	   could	   be	   a	   plausible	   alternative	   to	  
restore	  a	  healthy	  energy	  balance.	  Physical	  activity	  or	  exercise	  is	  one	  of	  the	  most	  used	  
strategies	  to	  induce	  weight	  loss	  by	  increasing	  energy	  expenditure.	  Again,	  even	  though	  
exercise	  promotes	  healthier	  outcomes	   in	  relation	  to	  the	  metabolic	  syndrome,	  people	  
often	  have	  difficulties	  maintaining	  regular	  exercise	  regimes	  and	  its	  role	  on	  weight	  loss	  
is	   therefore	   limited.	   Moreover,	   in	   certain	   circumstances	   people	   are	   not	   able	   to	  
perform	   physical	   exercise.	   Finding	   alternative	   strategies	   to	   increase	   energy	  
expenditure	   are	   therefore	   important.	   Notably,	   even	   slight	   increases	   in	   energy	  
expenditure	  can	  have	  effects	  on	  energy	  balance	  in	  the	  long	  run.	  One	  way	  to	  increase	  
energy	   expenditure	   is	   cold	   exposure.	   Slight	   reductions	   in	   ambient	   temperature	   can	  
already	  increase	  energy	  expenditure	  with	  5-­‐30%	  in	  humans	  without	  inducing	  shivering.	  
An	  important	  tissue	  in	  mediating	  this	  is	  BAT.	  	  	  
	   In	   small	   mammals,	   BAT	   is	   the	   most	   important	   organ	   to	   maintain	   body	  
temperature,	  and	  moreover,	  it	  has	  been	  suggested	  that	  it	  is	  directly	  involved	  in	  energy	  
balance	  regulation.	  Interestingly,	  mice	  without	  BAT	  tend	  to	  become	  obese.	  The	  recent	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observations	   that	  BAT	   is	   still	   present	   in	   considerable	  amounts	   in	  humans,	  has	  driven	  
human	  BAT	  research	  in	  the	  last	  5	  years.	  Findings	  thus	  far	  demonstrate	  that	  there	  is	  a	  
negative	   relationship	   between	   BAT	   and	   adiposity,	   indicating	   overweight	   and	   obese	  
people	   to	   have	   less	   active	   BAT.	   Thus	   BAT	   might	   play	   a	   role	   in	   weight	   regulation	   in	  
humans	  as	  well.	  In	  this	  thesis	  we	  explored	  whether	  human	  BAT	  is	  involved	  in	  burning	  
excessive	  caloric	  intake.	  The	  other	  goal	  was	  to	  find	  ways	  to	  activate	  BAT	  in	  humans	  and	  
explore	   its	   relationship	  with	   energy	   expenditure.	   There	   is	   now	   strong	   evidence	   that	  
BAT	   contributes	   to	   cold-­‐induced	   energy	   expenditure,	   as	   confirmed	   in	   the	   present	  
thesis.	  Therefore,	  BAT	  might	  have	  potential	   in	  targeting	  the	  current	  obesity	  problem,	  
and	  therefore	  more	  research	  in	  humans	  is	  required.	  	  
Target	  groups	  	  
Finding	   strategies	   to	   prevent	   and	   treat	   obesity	   are	   crucial	   given	   the	   development	   of	  
associated	   metabolic	   diseases	   affecting	   millions	   of	   people	   worldwide	   leading	   to	  
exploding	   healthcare	   costs.	   Therefore,	   the	   search	   for	   novel	   strategies	   to	   counteract	  
obesity	  is	  important	  for	  the	  general	  public,	  especially	  for	  people	  that	  have	  an	  increased	  
risk	   in	   developing	   overweight	   and	   obesity.	   Stimulating	   energy	   expenditure	   by	  
activating	  and	  recruitment	  of	  BAT	  could	  be	  one	  such	  strategy.	  	  
	   In	   order	   to	   tackle	   overweight	   and	   obesity,	   health	   institutions,	   health	   care	  
professionals,	   and	   general	   society	   need	   to	   be	   informed	   about	   possible	   strategies.	  
Translation	  of	   scientific	   knowledge	   to	   society	   is	   therefore	  essential.	   In	   this	   thesis	  we	  
clearly	  demonstrate	  that	  cold	  exposure	  increases	  energy	  expenditure	  and	  BAT	  activity.	  
This	   activation	   of	   BAT	   thermogenesis	   occurs	   at	   relatively	   low	   temperatures	   when	  
shivering	  is	  absent.	  Recent	  research	  demonstrates	  that	  mild	  reductions	  in	  temperature	  
can	   already	   activate	   BAT.	   This	  means	   that	   lowering	   ambient	   temperature	   in	   houses	  
and	   offices	  might	   be	   one	  way	   to	   burn	   calories.	   Clearly,	  more	   research	   is	   needed	   to	  
generate	   conclusive	   results	   about	   the	   potential	   of	   this	   intervention	   in	   stimulating	  
weight	   loss.	   Nevertheless,	   in	   order	   to	   stimulate	   the	   translation	   of	   science	   to	   society	  
and	   obtain	   awareness	   and	   support	   from	   the	   general	   public,	   communicating	   these	  
observations	  outside	  science	  is	  important.	  	  
	   Next	   to	   this	   behavioural	   intervention	   to	   target	   overweight	   and	   obesity,	  
pharmaceutical	   interventions	   stimulating	   energy	   expenditure	   and	   BAT	   activity	   are	  
important.	  Targeting	  BAT	  via	  pharmaceutical	  agents	  requires	  a	  good	  understanding	  of	  
BAT	  physiology	  and	  the	  molecular	  pathways	  that	  lead	  to	  BAT	  stimulation.	  Human	  BAT	  
research	   is	   therefore	   essential,	   as	  well	   as	   a	   good	   collaboration	   between	   universities	  
and	  the	  pharmaceutical	   industry.	  This	  thesis	  contributes	  to	  a	  better	  understanding	  of	  
human	  BAT	  physiology	  and	  strategies	  to	  pharmaceutically	  target	  human	  BAT.	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Activities	  and	  products	  
All	  research	  described	  in	  this	  thesis	  has	  been	  conducted	  at	  the	  department	  of	  Human	  
Biology	   in	   collaboration	   with	   Nuclear	   Medicine	   of	   Maastricht	   University	   Medical	  
Center+.	  This	  collaboration	  between	  the	  University	  and	  a	  hospital	  is	  a	  good	  example	  of	  
how	   basic	   science	   can	   be	   performed	   in	   a	   hospital	   setting,	   combining	   knowledge	   of	  
scientists	  and	  medical	  specialists.	  This	  collaboration	  is	  essential	  given	  that	  the	  current	  
technique	   to	   measure	   human	   BAT	   requires	   the	   knowledge	   of	   nuclear	   medical	  
specialists.	   BAT	   is	   currently	   measured	   by	   means	   of	   [18F]fluorodeoxyglucose-­‐positron	  
emission	   tomography-­‐computed	   tomography	   ([18F]FDG-­‐PET-­‐CT)-­‐scanning.	   In	   order	   to	  
increase	   the	   knowledge	   on	   human	   BAT,	   good	   collaboration	   between	   hospital	   and	  
university	  setting	  is	  essential.	  	  	  
	   In	   order	   to	   use	   BAT	   as	   a	   possible	   treatment	   for	   overweight	   and	   obesity,	   more	  
extensive	   knowledge	   is	   required.	   The	   present	   findings	   do	   indicate	   that	   the	   most	  
effective	   way	   to	   activate	   BAT	   in	   humans	   is	   by	   exposure	   to	   mild	   cold.	   As	   explained	  
previously,	   reduction	   of	   ambient	   temperature	   in	   houses	   and	   offices	   is	   therefore	   a	  
strategy	   to	   increase	  energy	  expenditure	  via	  BAT.	  With	   respect	   to	   the	  pharmaceutical	  
approach,	   this	   thesis	   clearly	   demonstrated	   that	   systemic,	   non-­‐selective	   adrenergic	  
stimulation	  of	  BAT	  is	  ineffective	  in	  humans.	  Furthermore,	  the	  associated	  cardiovascular	  
stress	  (i.e.	  increased	  heart	  rate	  and	  systolic	  blood	  pressure)	  is	  problematic	  using	  these	  
types	  of	   stimulants.	  Therefore,	   future	   studies	   should	   investigate	  more	   selective	  ß-­‐AR	  
agonists	  that	  could	  target	  BAT,	  such	  as	  the	  ß3-­‐AR,	  without	  causing	  these	  side	  effects.	  
Moreover,	  non-­‐adrenergic	  agents	  and	  agents	  that	  are	  able	  to	  stimulate	  BAT	  centrally	  
(i.e.	  via	  the	  brain)	   instead	  of	  systemically	  (i.e.	  via	  the	  blood)	  might	  be	  more	  effective.	  
Recent	   studies	   in	   rodents	   indicate	   the	   potential	   ways	   to	   stimulate	   this	   tissue	   and	  
should	  be	  investigated	  in	  humans.	  
	   The	  results	  described	   in	  this	  thesis	  are	  written	   in	  original	  articles	  that	  have	  been	  
published	   or	   submitted	   to	   scientific	   journals	   in	   the	   field	   of	   obesity	   and	   diabetes.	  
Moreover,	  these	  articles	  can	  be	  found	  online	  and	  are	  accessible	  to	  scientists	  who	  are	  
interested	   in	   this	   topic.	   In	   addition	   to	   this,	   results	   have	   been	   presented	   on	  
international	  conferences	  and	  some	  have	  been	  published	  in	  a	  national	  newspaper.	  The	  
present	   results	   help	   to	   understand	   BAT	   physiology	   in	   humans	   and	   can	   be	   used	   for	  
future	  studies	  on	  exploring	  strategies	  to	  stimulate	  BAT	  in	  humans.	  	  
	  
Innovation	  
The	  work	  described	   in	  this	   thesis	   is	  mostly	  new	  in	  the	  field	  of	  BAT	  research.	  Prof.	  dr.	  
W.D.	   van	  Marken	   Lichtenbelt	   was	   among	   the	   first	   researchers	   to	   rediscover	   BAT	   in	  
human	  adults	  in	  2009,	  and	  more	  BAT	  researchers	  joined	  his	  group	  from	  then	  onwards.	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This	  thesis	  confirms	  the	  experiments	  in	  2009	  showing	  that	  cold	  exposure	  is	  an	  effective	  
strategy	  to	  activate	  human	  BAT.	  The	  innovative	  part	  of	  this	  thesis	  was	  to	  explore	  other	  
strategies	   to	   activate	   human	   BAT.	   The	   experiment	   on	   ß-­‐AR	   stimulation	   of	   BAT	   in	  
humans	   was	   the	   first	   to	   investigate	   a	   possible	   role	   for	   BAT	   in	   the	   well-­‐known	  
adrenergic	  stimulation	  of	   thermogenesis.	  Furthermore,	   it	  was	  the	   first	   to	  explore	  the	  
role	   of	   the	   sympathetic	   nervous	   system	   and	   the	   adrenergic	   receptors	   in	   stimulating	  
human	  BAT	  in	  vivo.	  	  
	   Moreover,	   in	   this	   thesis	  we	   explored	  whether	   human	   BAT	   is	   involved	   in	  weight	  
regulation	   by	   burning	   excessive	   caloric	   intake.	   That	   BAT	   could	   play	   a	   role	   in	   weight	  
regulation	  has	  been	  demonstrated	  in	  animals.	   In	  this	  thesis	   it	  appeared	  that	  BAT	  was	  
indeed	   activated	   upon	   a	   single	   high	   calorie	   meal,	   although	   no	   direct	   relationship	  
between	  postprandial	  BAT	  activity	  and	  diet-­‐induced	  thermogenesis	  was	  found.	  These	  
findings	  suggest	  that	  BAT	  might	  be	  activated	  after	  excessive	  food	  intake,	  but	  whether	  
it	   actively	   burns	   calories	   and	   to	  what	   extent	   remains	   to	  be	   found	  out.	   Clearly,	  more	  
evidence	  is	  needed	  to	  confirm	  whether	  BAT	  can	  burn	  excessive	  caloric	  intake.	  	  
	   Animal	   studies	   have	   provided	   several	   strategies	   to	   recruit	   BAT	   in	  white	   adipose	  
tissue,	  as	  explained	  in	  chapter	  2.	  We	  here	  tested	  one	  of	  these	  promising	  strategies	  in	  
humans,	  namely	  endurance	  exercise.	  The	  finding	  in	  mice	  that	  endurance	  exercise	  can	  
recruit	   BAT	   via	   the	   hormone	   irisin	   was	   not	   confirmed	   in	   human	   adults.	   Regular	  
endurance	   training	   was	   not	   associated	   with	   increased	   browning	   of	   white	   adipose	  
tissue	  and	  seems	  to	  result	  in	  even	  less	  BAT	  activity.	  
Planning	  and	  realization	  
In	   this	   thesis	   we	   measured	   BAT	   activity	   in	   humans	   during	   several	   interventions	   by	  
means	  of	  [18F]FDG-­‐PET-­‐CT-­‐scanning.	  We	  have	  clearly	  demonstrated	  that	  cold	  exposure	  
is	   the	   most	   effective	   way	   to	   activate	   BAT	   in	   humans.	   Recently	   our	   lab	   has	  
demonstrated	  that	  BAT	  can	  also	  be	  recruited	  upon	  longer	  periods	  of	  cold	  exposure	  in	  
healthy	   human	   adults	   with	   a	   concomitant	   increase	   in	   the	   capacity	   for	   nonshivering	  
thermogenesis.	   This	   effect	   of	   cold	   acclimatization	   on	   BAT	   and	   nonshivering	  
thermogenesis	   is	   now	   being	   explored	   in	   obese	   and	   type	   2	   diabetic	   people	   by	   the	  
research	  team	  of	  Prof.	  dr.	  W.D.	  van	  Marken	  Lichtenbelt.	  As	  explained	  before,	   finding	  
alternative	   ways	   to	   activate	   and	   recruit	   human	   BAT	   are	   important.	   Currently	   the	  
effects	  of	  bile	  acids	  on	  human	  BAT	  are	  being	  conducted	  at	  the	  department	  of	  Human	  
Biology	  and	  Nuclear	  Medicine.	  Another	   important	   step	  will	  be	   to	   further	  explore	   the	  
role	  of	  BAT	  during	  situations	  of	  overfeeding.	  	  
	   From	  a	  methodological	  point	  of	   view,	   it	  will	  be	   important	   to	   find	  alternatives	   to	  
[18F]FDG-­‐PET-­‐CT-­‐scanning	  for	  BAT	  measurement	  in	  the	  future.	  First,	  because	  it	  is	  a	  very	  
expensive	   technique,	   and	   second,	   it	   is	   associated	   with	   a	   radioactive	   burden	   for	   the	  
study	  participants,	  which	  also	  limits	  the	  amount	  of	  scans	  that	  can	  be	  used	  per	  subject.	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For	   longitudinal	   studies	   on	   human	   BAT,	   it	   will	   be	   important	   to	   find	   less	   invasive	  
methods.	   Another	   important	   aspect	   is	   that	   [18F]FDG-­‐PET-­‐CT solely	  measures	   glucose	  
uptake	  and	  not	  oxidative	  metabolism	  in	  BAT.	  An	  important	  future	  step	  is	  to	  gain	  more	  
knowledge	   about	   the	   heat	   producing	   capacity	   of	   BAT	   during	   several	   conditions	   of	  
stimulation.	  Therefore	  measuring	  oxidative	  metabolism	  in	  BAT	  will	  be	  important.	  Such	  
a	   measurement	   provides	   more	   information	   to	   what	   extent	   full	   BAT	   activation	   can	  
contribute	  to	  total	  daily	  metabolism	  and	  ultimately	  weight	  loss.	  	  
	   Finally,	   future	   research	   should	   also	   examine	   the	   effects	   of	   long	   term	   BAT	  
stimulation	  on	  energy	  balance	  and	  measure	  whether	  or	  not	  the	  human	  body	  adapts	  to	  
this	   continuous	   stimulation	   of	   energy	   expenditure,	   for	   instance	   by	   increase	   energy	  
intake.	  








Het	   is	   september	   2014	   en	   ik	   realiseer	   me	   dat	   ik	   nu	   echt	   ga	   	   promoveren.	   Dr.	  
Vosselman,	   wie	   had	   dat	   gedacht.	   In	   ieder	   geval	   tijdens	   mijn	   middelbare	   school	  
niemand,	  inclusief	  mijzelf,	  maar	  goed,	  een	  mens	  kan	  veranderen.	  Toen	  ik	  in	  2009	  aan	  
mijn	  PhD	  begon	   zat	   ik	   geregeld	  met	  de	  handen	   in	  het	  haar	   tijdens	  het	   lezen	  van	  die	  
moleculaire	  bruin	  vet	  artikelen.	  “Hoe	  gaat	  mij	  dit	  in	  hemelsnaam	  lukken?”	  Gedurende	  
de	  vier	   jaar	   kwam	   ik	  er	  wel	   achter	  dat	  er	  een	   flinke	   leercurve	   in	  een	  PhD	   traject	   zit.	  
Gelukkig	  maar…	   In	   deze	   vier	   jaar	   heb	   ik	   ontzettend	   veel	   geleerd	   van	  mijn	   collega’s.	  
Uiteindelijk	   schrijf	   je	   zelf	   het	   proefschrift,	   maar	   al	   het	   werk	   dat	   is	   verzet	   tijdens	   de	  
afgelopen	   vier	   jaar	   is	   onmogelijk	   in	   je	   eentje	   te	   volbrengen.	   Het	   is	   dan	   ook	   de	  
samenwerking	   binnen	   onze	   onderzoeksgroep	   die	   ik	   zo	   heb	   gewaardeerd.	   Bedankt	  
daarvoor!	  
	  
Wouter,	   ik	   had	   me	   geen	   betere	   supervisor	   kunnen	   wensen.	   Jouw	   passie,	  
betrokkenheid	  en	  humor	  hebben	  de	  vier	  jaar	  echt	  glans	  gegeven.	  De	  deur	  stond	  altijd	  
open	  en	  je	  gaf	  bovendien	  veel	  ruimte	  voor	  zelfstandigheid.	  Zo	  af	  en	  toe	  gaf	  je	  weer	  een	  
zetje	  in	  de	  goede	  richting	  als	  ik	  wat	  aan	  het	  zwemmen	  was.	  Naast	  het	  creëren	  van	  een	  
goede	  werksfeer	  zorgde	  je	  ook	  voor	  genoeg	  sociaal	  vertier.	  De	  vele	  zeiltochtjes	  over	  de	  
maas	   verkleed	   in	   piraten	   outfit	   en	   de	   aansluitende	   etentjes	   bij	   jou,	   Anne,	   en	  Merel	  
thuis	  waren	  altijd	  fantastisch.	  Voor	  deze	  hartelijke	  ontvangst	  en	  heerlijke	  etentjes	  wil	  
ik	   Anne	   natuurlijk	   ook	   hartelijk	   bedanken!	   Het	   weekendje	   London	   met	   onze	  
Thermugroep	  in	  een	  hok	  van	  12m2	  liet	  wel	  blijken	  dat	  we	  allemaal	  goed	  door	  één	  deur	  
konden.	  Ik	  vind	  het	  geweldig	  dat	  je	  nu	  professor	  bent	  geworden,	  want	  dat	  heb	  je	  zeker	  
verdiend.	  Ga	  vooral	  zo	  door	  als	  begeleider	  en	  ik	  hoop	  dat	  er	  nog	  vele	  mooie	  bruin	  vet	  
onderzoeken	  zullen	  plaatsvinden!	  
	  
Patrick,	  ook	  met	  jou	  was	  het	  prettig	  samenwerken.	  Jouw	  gedrevenheid	  en	  daadkracht	  
werkte	  zeer	  aanstekelijk.	  Bedankt	  voor	  de	  hulp	  bij	  het	  schrijven	  van	  de	  manuscripten.	  
Ik	   verbaasde	  mij	   iedere	   keer	   weer	   hoe	   ontzettend	   snel	   je	   een	   heel	   manuscript	   had	  
verbeterd.	  Heb	  daar	   veel	   van	  geleerd,	  met	  name	  ook	  dat	   je	   af	   en	   toe	  gewoon	  moet	  
doorpakken	  en	  niet	  te	  lang	  moet	  blijven	  treuzelen	  over	  een	  paar	  zinnen.	  Sorry	  nog	  dat	  
de	  jonge	  garde	  de	  HB	  tourpool	  wat	  heeft	  laten	  verwateren.	  Ik	  geloof	  dat	  de	  uitreiking	  
nog	  steeds	  moet	  plaatsvinden	  van	  het	  jaar	  2013.	  Dacht	  dat	  jij	  ook	  net	  toevallig	  winnaar	  
was	  dat	  jaar	  ;-­‐)	  
	  
Marleen,	   bedankt	   voor	   de	   hulp	   tijdens	   het	   uitvoeren	   van	   mijn	   meest	   spannende	  
experiment.	  Het	  monitoren	  van	  het	  hart	  met	  een	  ECG,	  na	  het	  toedienen	  van	  een	  stofje	  
dat	  het	  hart	  op	  hol	  doet	  slaan	  was	  wel	  even	  wat	  anders	  dan	  iemand	  twee	  uur	  in	  de	  kou	  
zetten.	  Fijn	  dat	  jij	  in	  de	  gaten	  hield	  of	  ik	  niet	  een	  nanomolletje	  teveel	  gaf!	  	  
	  
Kamer	  2.318!	  Wat	  een	  tijd.	  Eén	  om	  nooit	  te	  vergeten,	  want	  Boris,	  Erik,	  wat	  waren	  we	  
een	   top	   team.	   Boris,	   tja,	   waar	  moet	   ik	   beginnen.	   Denk	   dat	   we	   teveel	   hebben	  mee-­‐
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gemaakt	  om	  hier	   te	  beschrijven,	  maar	  kort	  samengevat:	  brand,	  balletje-­‐balletje,	  bier,	  
honden,	   London-­‐baby,	   Iceman,	   fietsraces,	   bubbelbad,	   ongeluk-­‐met-­‐bril,	   kerstboom,	  
champagne,	   risk,	   borsjt,	   16,	   Valkenburg,	   Oktoberfest-­‐proost-­‐tand-­‐uit-­‐de-­‐mond,	   SBF,	  
het	   ‘nieuwe	  werken’,	  Mappista,	   Intimate…	  waarschijnlijk	   vergeet	   ik	   nu	   nog	   de	   helft.	  
Papa	  Boris,	  we	  blijven	  elkaar	  sowieso	  nog	  zien,	  maar	  veel	  geluk	  met	  Eva	  en	  Lisa,	  en	  op	  
naar	  prof.	  Kingma!	  Erik,	  Knaller,	  hetzelfde	  geldt	  voor	  jou,	  teveel	  gebeurtenissen	  om	  op	  
te	   schrijven:	   balletje-­‐balletje,	   SBF,	   geluidsoverlast,	   handstand-­‐push-­‐up,	   stikstof-­‐
bom(metje),	   google-­‐translate,	   Istanbul,	   A-­‐A-­‐A-­‐Afrika,	   Qlimax,	   zzzzzzzzz,	   where	   is	   it?,	  
eueueue,	   dialect,	   mossels,	   vrijgezellenfeest,	   boomstammen	   slepen,	   bruiloft,	   Tabata-­‐
langs-­‐de-­‐drukke-­‐autobaan-­‐in-­‐Istanbul…	  Ook	   jij	   bent	   inmiddels	   Papa!	   Ik	   zie	   een	   trend	  
met	  één	  outlier	  in	  2.318.	  Ook	  wij	  zien	  elkaar	  nog	  geregeld,	  maar	  wil	   je	  ook	  bedanken	  
voor	  de	  gave	  tijd	  en	  wens	  je	  veel	  geluk	  met	  Anna	  en	  Emilie	  en	  succes	  met	  het	  afronden	  
van	  het	  proefschrift!	  	  	  
	  
Guy,	  jij	  bent	  eigenlijk	  degene	  die	  me	  heeft	  overtuigd	  om	  bruin	  vet	  onderzoek	  te	  doen.	  
Nadat	  jij	  me	  had	  laten	  zien	  hoe	  zo’n	  bruin	  vet	  experiment	  er	  aan	  toe	  ging	  kon	  ik	  geen	  
nee	  meer	  zeggen	  ;-­‐).	  Ook	  met	  jou	  heb	  ik	  geweldige	  dingen	  meegemaakt.	  Om	  maar	  in	  
dezelfde	   stijl	   door	   te	   gaan:	   	   the	   Butcher,	   bluf,	   Oroboros-­‐tripje,	   Londen,	   roltrap,	  
Stockholm,	   dr.	   Muzaffer	   Kushan	   a.k.a.	   dr.	   Death,	   I’m	   with	   blue,	   living	   the	   life,	  
schoenen,	   alles-­‐is-­‐mogelijk,	   150m,	   party-­‐on,	   Groningen-­‐net-­‐doen-­‐alsof-­‐we-­‐niet-­‐te-­‐
brak-­‐waren-­‐voor-­‐de-­‐Iceman-­‐presentatie,	   lantaarnpaaltje	   Ceramique,	   	   dat-­‐kan-­‐
makkelijk!	   Naast	   deze	   dolle	   pret,	   wil	   ik	   je	   ook	   bedanken	   voor	   de	   hulp	   tijdens	   de	  
experimenten	  en	  biopten	  die	   je	  hebt	  uitgevoerd.	  Dat	   je	  een	  top-­‐chirurg	  gaat	  worden	  
staat	  vast.	  Blijf	  vooral	  wie	  je	  bent	  en	  we	  zullen	  elkaar	  nog	  vaak	  genoeg	  ontmoeten	  en	  
deze	  herinneringen	  ophalen.	  Veel	  geluk	  met	  Maartje	  in	  Rotterdam!	  
	  
Anouk,	  wij	  hebben	  denk	  ik	  de	  helft	  van	  mijn	  experimenten	  samen	  uitgevoerd	  en	  ik	  kan	  
me	   niet	   anders	   herinneren	   dan	   dat	  we	   een	   top	   combi	  waren!	   Het	   voelde	   soms	   ook	  
alsof	  we	  samen	  deze	  PhD	  aan	  het	  doen	  waren.	  Als	  ik	  	  wat	  vergeten	  was,	  zorgde	  jouw	  
planning	   kwaliteiten	   ervoor	   dat	   het	   alsnog	   goed	   kwam.	  Wij	   hebben	   ook	   ontzettend	  
veel	   beleefd	   samen	   en	   zijn	   alle	   congressen	   samen	   afgegaan.	   Kers	   op	   de	   taart	   was	  
natuurlijk	   onze	   Kopenhagen	   trip!	  Wat	   een	   luxe	   als	   PhD	   studentjes	   ;-­‐).	  Om	  New	  York	  
niet	  te	  vergeten..	  dat	  was	  eigenlijk	  nog	  gekker!	   Ik	  waardeer	   je	  collegialiteit	  enorm	  en	  
hoop	  dat	  je	  een	  leuke	  vervolgstap	  kan	  maken	  in	  je	  carrière.	  Daarnaast	  ook	  veel	  geluk	  
samen	  met	  Pieter-­‐Jan,	  want	  o	  wat	  een	  vrolijkheid	  sinds	  je	  hem	  leerde	  kennen	  J.	  	  
	  
Mark,	  het	  was	  ook	  zeer	  fijn	  om	  samen	  met	  jou	  te	  werken.	  Je	  bent	  de	  relaxedheid	  zelve,	  
en	  was	  nooit	   te	  beroerd	  om	  een	  collega	  te	  helpen.	  Super!	  Als	   je	  die	  relaxedheid	  nou	  
ook	  eens	  toepaste	  op	  de	  potjes	  Ruzzle,	  dan	  kan	  ik	  ook	  eens	  winnen!	  Veel	  succes	  nog	  
met	   het	   afronden	   van	   de	   laatste	   experimenten!	   Christel,	   ook	   jij	   bedankt	   voor	   de	  
collegialiteit	  en	  heel	  veel	  succes	  bij	  het	  CTCM!	  Evie,	  jij	  zorgde	  voor	  een	  beetje	  power	  in	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onze	   groep	   en	   bent	   een	   echte	   aanpakker.	   Je	   hebt	   een	  mooi	   doel	   voor	   ogen	   en	  met	  
jouw	  gedrevenheid	  gaat	  dat	  zeker	   lukken!	  Het	   laatste	   jaar	  op	  2.318	  was	  heel	  gezellig	  
met	  jou	  erbij.	  Je	  hebt	  je	  kranig	  geweerd	  tussen	  die	  bommen	  testosteron.	  Lisje,	  ook	  jij	  
bracht	   wat	   extra	   pit	   in	   de	   groep!	   Je	   bent	   een	   aardige	   flap-­‐uit	   en	   ik	   heb	   me	   goed	  
vermaakt	  het	   laatste	  half	   jaar	  met	   jou	  op	  de	  kamer.	  Van	  de	  onzinnige	  roddels	   tot	  de	  
moeilijkere	  en	  serieuze	  gesprekken	  des	  levens,	  ze	  waren	  altijd	  prettig.	  Hannah,	  jij	  hebt	  
de	  kneepjes	  van	  het	  bruin	  vet	  vak	  geleerd	  bij	  me	  en	  blijkbaar	  vond	  je	  het	  zo	  boeiend	  
dat	   je	   besloot	   om	   een	   PhD	   te	   doen	   ;-­‐).	   Je	  was	   een	   fijne	   collega!	   Sorry	   nog	   voor	   die	  
keren	  dat	  ik	  chagrijnig	  was	  ’s	  morgens	  om	  7	  uur	  en	  dat	  ik	  je	  verjaardag	  was	  vergeten.	  
Veel	  succes	  nog	  en	  maak	  er	  wat	  moois	  van!	  Reni,	  ook	  jij	  bedankt	  voor	  de	  hulp	  tijdens	  
mijn	  laatste	  experimenten!	  Je	  was	  ook	  zeer	  behulpzaam	  en	  hebt	  me	  het	  nodige	  werk	  
uit	   handen	   genomen.	  Ook	   al	  mijn	  mannelijke	   proefpersonen	  waren	   onder	   de	   indruk	  
van	  jullie	  ;-­‐).	  Marije,	  ik	  heb	  je	  maar	  eventjes	  meegemaakt	  als	  collega,	  maar	  ik	  wil	  je	  ook	  
veel	  succes	  wensen	  met	  je	  PhD.	  Je	  zult	  het	  vast	  goed	  kunnen	  vinden	  in	  de	  groep.	  Joris,	  
dank	  je	  wel	  voor	  de	  prettige	  samenwerking	  tijdens	  ons	  onderzoek	  bij	  de	  duuratleten!	  
Hebben	  we	  toch	  mooi	  volbracht	  met	  die	  topsporters.	  	  
	  
Bram,	  met	   jou	  heb	   ik	  ook	  veel	  beleefd.	  Al	  die	  avonden	  brainstormen	  met	  Boris	  over	  
hoe	  we	  de	  wereld	   van	   appjes	   konden	   veroveren	  waren	   geweldig.	  Daarnaast	   hebben	  
we	  de	  nodige	  HB	  stapavonden	  samen	  afgesloten.	  Een	  hoop	  gekkigheid	  meegemaakt,	  
wat	  soms	   iets	  doorsloeg	  door	  dat	   laatste	  biertje	   ;-­‐).	  We	  zullen	  zeker	  en	  vast	  nog	  wel	  
wat	   stapavondjes	   meemaken	   in	   de	   toekomst.	   Jij	   succes	   met	   de	   laatste	   loodjes!	  
Masper,	   Guy,	   jullie	   ook	   bedankt	   Duitse	   en	   Belgische	   gezelligheid!	   Misschien	   is	   het	  
Oktoberfest	   2015	   een	   goed	   moment	   om	   een	   reünie	   te	   houden.	   Jos,	   de	   sociale	  
gangmaker	  van	  HB,	  dank	  voor	  het	  organiseren	  van	  de	  leuke	  activiteiten!	  Ook	  al	  heb	  ik	  
(te)	  vaak	  gepast	  door	  mijn	  voetbal-­‐ambitie,	  het	  was	  zeker	  gezellig!	  Goed	  dat	  jij	  begrijpt	  
dat	   je	   pas	   een	   goed	   team	  hebt	   als	   je	   ook	  naast	  werktijd	  met	   elkaar	   kan	  opschieten.	  
Silvie,	   Esther,	   Lena,	   bedankt	   voor	   het	   verhogen	   van	   het	   “partygehalte”	   op	   de	   HB	  
feesten!	  Verder	  wil	  ik	  alle	  andere	  collega’s	  van	  HB	  bedanken	  voor	  de	  leuke	  tijd!	  
	  
Wat	   betreft	   het	   uitvoeren	   van	   mijn	   experimenten	   was	   de	   hulp	   van	   Nucleaire	  
Geneeskunde	  ontzettend	  belangrijk.	  Professor	  Mottaghy	  bedankt	  hiervoor.	  Boudewijn,	  
bedankt	  voor	  de	  tips	  en	  hulp	  bij	  het	  uitvoeren	  van	  mijn	  studies.	  Het	  was	  prettig	  om	  jou	  
als	  arts	  te	  hebben,	  want	  er	  kan	  altijd	  iets	  gebeuren	  bij	  humaan	  onderzoek!	  We	  hebben	  
aardig	   wat	   uurtjes	   samen	   doorgebracht	   achter	   de	   PMOD	   computer	   en	   naast	   de	  
serieuze	  bruin	  vet	  discussies	  was	  een	  lolletje	  ook	  zeer	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